Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,42679,-0.149452983924245,0.00310578955864911,-0.155540331459197,-0.143365636389293,0
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GCG,Pro-glucagon,42346,0.480979250206083,0.012145212195386,0.457174634303126,0.50478386610904,0
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MFGE8,Lactadherin,42611,0.18363637632219,0.00414090506982374,0.175520202385336,0.191752550259045,0
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,42611,-0.140947204273416,0.00314470440203452,-0.147110824901403,-0.134783583645428,0
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRAP1,Proline-rich acidic protein 1,40527,0.160883412809427,0.00394931896209095,0.153142747643729,0.168624077975126,0
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRSS8,Prostasin,42568,0.165298712108105,0.00403140418065542,0.15739715991402,0.17320026430219,0
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PON3,Serum paraoxonase/lactonase 3,42676,-0.106581522719652,0.00274959225913191,-0.111970723547551,-0.101192321891754,1.11303347155001e-308
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPY,Pro-neuropeptide Y,42721,0.236726405550923,0.00622056546726629,0.224534097235081,0.248918713866764,3.87640868031197e-301
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LDLR,Low-density lipoprotein receptor,42644,0.181242468310587,0.00496313064100933,0.171514732254209,0.190970204366965,1.80085069699718e-278
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADIPOQ,Adiponectin,40539,-0.24212200156078,0.00668037323134418,-0.255215533094215,-0.229028470027346,2.88156305919267e-272
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGSF9,Protein turtle homolog A,40511,0.286522274356181,0.00801493572822362,0.270813000328863,0.3022315483835,2.79893420474859e-265
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOF,Apolipoprotein F,40532,-0.0792655835077221,0.00232297386874828,-0.0838186122904688,-0.0747125547249755,5.16100148793494e-243
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AGRP,Agouti-related protein,42754,0.170066028327576,0.0050482690652119,0.160171420959761,0.179960635695392,5.32520796011162e-239
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,42770,-0.390822513170815,0.0117609409685913,-0.413873957469254,-0.367771068872376,7.27130001883029e-233
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LPL,Lipoprotein lipase,42636,-0.147842776043665,0.00456899466484887,-0.156798005586769,-0.138887546500561,2.94121476812297e-221
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,42495,0.0943208172676944,0.00298862731058236,0.088463107738953,0.100178526796436,7.05566925198595e-211
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOM,Apolipoprotein M,42663,-0.0846769207379395,0.00278151031786758,-0.09012868096096,-0.0792251605149191,6.4539234865431e-197
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMPRSS15,Enteropeptidase,42587,0.271456752927649,0.00898407498500441,0.253847965957041,0.289065539898258,4.49120449537622e-194
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C9,Complement component C9,40532,-0.154158716470583,0.00523195394001987,-0.164413346193022,-0.143904086748144,6.23963631180192e-184
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RTN4R,Reticulon-4 receptor,42721,0.0996851529051926,0.00339406175465975,0.0930327918660595,0.106337513944326,7.25799643055735e-184
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PYY,Peptide YY,40116,0.295528958656697,0.0100825252659803,0.275767209135375,0.315290708178018,7.34605956959861e-182
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LGALS4,Galectin-4,42618,0.162769925688815,0.00559336384212792,0.151806932558244,0.173732918819386,1.34520014200542e-180
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INHBC,Inhibin beta C chain,42611,0.117186481028419,0.00404457130634052,0.109259121267992,0.125113840788847,4.34034145571573e-179
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,40283,-0.0858218455443912,0.00308154588164788,-0.0918616754724211,-0.0797820156163614,4.71249167056777e-165
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OXT,Oxytocin-neurophysin 1,42711,0.374613698201226,0.0136902418644388,0.347780824146926,0.401446572255527,1.68832223602562e-160
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UPB1,Beta-ureidopropionase,40511,0.243314863572041,0.00887164248034475,0.225926444310565,0.260703282833517,2.18556213275194e-160
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACY1,Aminoacylase-1,42636,0.162426028114351,0.00599005461631032,0.150685521066383,0.174166535162319,1.07292961766208e-157
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPM,Carboxypeptidase M,42655,0.0902669423583286,0.00333798741380882,0.0837244870272634,0.0968093976893939,7.03170898262512e-157
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPR37,Prosaposin receptor GPR37,42357,0.182557813387968,0.00678481691727809,0.169259572230103,0.195856054545834,2.78373990423188e-155
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MVK,Mevalonate kinase,42370,0.211482500779641,0.00790766479088836,0.1959834777895,0.226981523769782,1.74519528218098e-153
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLTP,Phospholipid transfer protein,42752,-0.0942123548388803,0.00355119150216174,-0.101172690183117,-0.0872520194946433,3.08156087575711e-151
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAMDC4,Apical endosomal glycoprotein,40451,0.144065491384542,0.00544290320376506,0.133397401105162,0.154733581663921,8.10144458546329e-150
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,42357,0.210510336254442,0.00808479385060079,0.194664140307265,0.22635653220162,8.78494967593776e-146
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOD,Apolipoprotein D,40033,-0.112407498313414,0.004318024759156,-0.12087082684136,-0.103944169785469,5.76895733799599e-145
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CES1,Liver carboxylesterase 1,42661,0.206574945127417,0.00804164615358314,0.190813318666394,0.22233657158844,4.08013521413989e-142
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPHA1,Ephrin type-A receptor 1,42658,0.084167610678051,0.00328265467780882,0.0777336075095458,0.0906016138465563,1.32622928678193e-141
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC39A5,Zinc transporter ZIP5,42594,0.1360526829752,0.00533616951531391,0.125593790725185,0.146511575225215,4.6020160526508e-140
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NTRK3,NT-3 growth factor receptor,42711,-0.0549259862442338,0.00216709747897059,-0.0591734973030162,-0.0506784751854515,1.68839059743048e-138
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42679,0.0884264038084028,0.00349139710373389,0.0815832654850844,0.0952695421317212,2.68688668292291e-138
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FURIN,Furin,42679,0.0806300191945927,0.00324208430529632,0.074275533956212,0.0869845044329735,1.57452480688122e-133
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD300LG,CMRF35-like molecule 9,42611,-0.0951324724502906,0.00382586414779277,-0.102631166179964,-0.0876337787206168,1.79991733351414e-133
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SHBG,Sex hormone-binding globulin,40532,-0.125150029098503,0.00503051587920041,-0.135009840221736,-0.11529021797527,4.56532643998801e-133
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF21,Fibroblast growth factor 21,42689,0.286717512861267,0.011639116615514,0.26390484429486,0.309530181427675,4.20865038255719e-131
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42495,0.0829925542737925,0.00339036581046424,0.0763474372852826,0.0896376712623024,1.77488178832353e-129
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,42370,0.134566567247783,0.00554084432037902,0.123706512379841,0.145426622115726,1.7007172176279e-127
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,42705,0.11341497239247,0.00468288787628447,0.104236512154953,0.122593432629988,6.97326347355053e-127
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCN1,CCN family member 1,42569,0.172594598817588,0.00733361592668656,0.158220711601282,0.186968486033893,4.87276523634367e-120
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL16,C-C motif chemokine 16,42794,0.122436494542294,0.00520685505483847,0.11223105863481,0.132641930449777,7.04102105114119e-120
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLUL1,Clusterin-like protein 1,42621,-0.105071851147395,0.00448095468958924,-0.113854522338989,-0.0962891799557996,3.34688913663783e-119
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MCAM,Cell surface glycoprotein MUC18,42689,-0.0784447670292429,0.00335614176354663,-0.0850228048857943,-0.0718667291726915,1.76798728029176e-118
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFASC,Neurofascin,42754,0.0673478218337768,0.00289618274986112,0.061671303644049,0.0730243400235046,2.52329531811353e-117
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NHLRC3,NHL repeat-containing protein 3,40013,0.0741463521328357,0.00322037466893574,0.0678344177817217,0.0804582864839498,1.47389249008338e-114
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACE2,Angiotensin-converting enzyme 2,42357,0.122392471142953,0.00537536231709374,0.11185676100145,0.132928181284457,1.36749075072945e-112
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MUC13,Mucin-13,42311,0.117572941719586,0.00522586981571204,0.10733023688079,0.127815646558382,5.14199941819883e-110
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,42585,0.121892953586643,0.00544122896177228,0.11122814482157,0.132557762351717,3.78808947216827e-109
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA14,Carbonic anhydrase 14,42721,-0.0805089167718681,0.00359911189585759,-0.087563176087749,-0.0734546574559872,7.3325046220534e-109
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DSG2,Desmoglein-2,42611,-0.0605778078183892,0.00271911648392706,-0.0659072761268862,-0.0552483395098922,5.36757999840603e-108
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPY,Pancreatic prohormone,42600,0.23044365453735,0.0103482182904965,0.210161146687977,0.250726162386723,6.61879271289444e-108
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSD,Cathepsin D,41747,0.0935476954655224,0.00421147622777543,0.0852932020590825,0.101802188871962,2.98383177976652e-107
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GSTA1,Glutathione S-transferase A1,42611,0.182714584463704,0.00823223864278855,0.166579396723838,0.198849772203569,3.22785316243288e-107
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBP5,Retinol-binding protein 5,42587,0.123715248143811,0.00557460843279711,0.112789015615529,0.134641480672093,3.42270746257388e-107
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL17RB,Interleukin-17 receptor B,42416,-0.117607839225604,0.00532219346857838,-0.128039338424017,-0.10717634002719,2.76411056530947e-106
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MET,Hepatocyte growth factor receptor,42654,-0.0437643878398144,0.00199032589418042,-0.047665426592408,-0.0398633490872208,2.61982421874691e-105
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,42721,0.0718585377370529,0.00327359796294952,0.0654422857296719,0.078274789744434,5.70953919388516e-105
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,42663,-0.0652582247982809,0.00301838040074657,-0.0711742503837441,-0.0593421992128176,6.20306393911588e-102
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GHR,Growth hormone receptor,40283,0.0612118164300263,0.00283923757078878,0.0556469107912803,0.0667767220687723,5.05809000665953e-101
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCLY,Selenocysteine lyase,42674,0.100205574834092,0.0046674701804386,0.0910573332804325,0.109353816387752,1.45605047780928e-100
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLA,Alpha-galactosidase A,40267,0.079243383377893,0.0037325144709472,0.0719276550148365,0.0865591117409495,4.42621751539599e-98
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINF1,Pigment epithelium-derived factor,40351,0.0564821132763244,0.00266631458514436,0.0512561366894415,0.0617080898632073,1.11824004603144e-97
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,40462,0.179392977737888,0.00854349169860038,0.162647734008632,0.196138221467145,4.70454884526218e-96
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,42636,-0.0569427316744172,0.00271634877085365,-0.0622667752652903,-0.051618688083544,4.88222735524204e-96
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD4,T-cell surface glycoprotein CD4,42570,0.0649212238832834,0.00309815363626695,0.0588488427562001,0.0709936050103666,5.86234769419919e-96
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,42794,-0.0715834395625097,0.0034177526586739,-0.0782822347735106,-0.0648846443515089,6.81587323565898e-96
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,42346,0.13494740912693,0.00644554242022507,0.122314145983289,0.147580672270571,9.0124320926106e-96
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,42587,0.169956501322932,0.00814688144769827,0.153988613685443,0.185924388960421,3.87415862701509e-95
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",42587,0.168297318734596,0.00807551475996534,0.152469309805064,0.184125327664128,5.937880949591e-95
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42594,-0.0820237313903164,0.00394372616231679,-0.0897534346684573,-0.0742940281121754,1.38280124790675e-94
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,42636,0.0637801801909823,0.00307210060910696,0.0577588629971327,0.069801497384832,2.91275989213725e-94
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTH,Parathyroid hormone,40182,0.170455646283519,0.00819895270451306,0.154385698982673,0.186525593584364,3.42564352433713e-94
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F9,Coagulation factor IX,42663,0.037442352378638,0.00180840565336719,0.0338978772980383,0.0409868274592377,9.02299402075757e-94
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,42733,0.0651802174272166,0.00314827867905699,0.0590095912162649,0.0713508436381683,9.0829965864684e-94
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HGF,Hepatocyte growth factor,42754,0.0721036529002111,0.00348400704808921,0.0652749990859562,0.0789323067144659,1.05795966184259e-93
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AFM,Afamin,40539,0.0413426615800098,0.00199697003874624,0.0374286003040671,0.0452567228559524,1.73090332246042e-93
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOC1,Apolipoprotein C-I,40516,-0.0763240861234603,0.00369962817578777,-0.0835753573480043,-0.0690728148989162,7.41518097876718e-93
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSB,Cathepsin B,42659,-0.111197785116244,0.00540111366926448,-0.121783967908002,-0.100611602324486,9.3818772003826e-93
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCG2,Secretogranin-2,42636,0.0699678624005899,0.00342917890646961,0.0632466717439095,0.0766890530572704,3.70567628176986e-91
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,42771,-0.126629867378164,0.00621462907929682,-0.138810540373586,-0.114449194382742,6.20879006394167e-91
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMBP,Protein AMBP,42706,0.0426225196103399,0.00209843526817629,0.0385095864847143,0.0467354527359654,2.25870656562069e-90
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42587,0.0681668437077624,0.00336263458171916,0.0615760799275928,0.0747576074879319,5.08128180483174e-90
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GSTA3,Glutathione S-transferase A3,42346,0.154133076801869,0.00764262383177675,0.139153534091586,0.169112619512151,4.17426274455469e-89
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CKB,Creatine kinase B-type,40527,-0.121329955118483,0.006042872497479,-0.133173985213542,-0.109485925023425,3.86660533323101e-88
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MME,Neprilysin,42587,0.163167588342905,0.00814152621713168,0.147210196957327,0.179124979728483,4.66395926080383e-88
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",42311,0.109943600855546,0.00549977186427948,0.0991640480015585,0.120723153709534,1.33389395868414e-87
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,42477,0.30006096451489,0.0150330407151384,0.270596204713218,0.329525724316561,2.32534944877031e-87
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42679,0.0735785549939083,0.00370040304544614,0.0663257650248339,0.0808313449629828,9.76057285167152e-87
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,42346,0.116706025390675,0.00591915078814812,0.105104489845904,0.128307560935445,2.63248724058503e-85
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,42587,0.136288259460985,0.00698807358086678,0.122591635242486,0.149984883679484,1.48739961515819e-83
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,42692,0.047487545672267,0.00243619097550237,0.0427126113602823,0.0522624799842517,1.77751286803296e-83
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PGF,Placenta growth factor,42754,0.0517959414698968,0.00266905251148142,0.0465645985473932,0.0570272843924004,9.05135876919705e-83
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,42587,0.154134007753355,0.00795996502745538,0.138532476299542,0.169735539207168,2.08484377366318e-82
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,40527,0.0663383797735477,0.00342788071377065,0.0596197335745573,0.0730570259725382,4.0682681371443e-82
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNTN3,Contactin-3,42611,0.0598771711529082,0.00313006926009726,0.0537422354031176,0.0660121069026988,1.68080773160145e-80
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REN,Renin,42636,0.164555021981061,0.00861112028737386,0.147677226217809,0.181432817744314,2.43349276560984e-80
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42754,0.0794892661451584,0.00417195288090723,0.0713122384985802,0.0876662937917366,6.80905708008045e-80
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,42794,0.0752934983227812,0.00396818867664317,0.0675158485165606,0.0830711481290018,2.93154033652969e-79
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,42443,0.0909610540377715,0.00484516615560914,0.0814645283727775,0.100457579702765,1.25967541154026e-77
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TTR,Transthyretin,40424,0.047531832854458,0.00253702605622381,0.0425592617842593,0.0525044039246566,3.80937137027494e-77
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GIP,Gastric inhibitory polypeptide,40223,0.109735192766004,0.00589519014444876,0.0981806200828846,0.121289765449124,3.58893225670539e-76
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAM20A,Pseudokinase FAM20A,40511,0.0527818009817052,0.00283833971761309,0.0472186551351835,0.0583449468282268,4.67935571587669e-76
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,40511,0.137807040482992,0.00745171619841917,0.123201676734091,0.152412404231894,2.98615519133195e-75
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,40277,0.0861739595123667,0.00467681814573474,0.0770073959467266,0.0953405230780068,1.05931243657769e-74
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,40483,0.139025088874936,0.00755540047194979,0.124216503949914,0.153833673799957,1.58431127708914e-74
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSO,Cathepsin O,42754,0.0565972492973631,0.00308646426596411,0.0505477793360734,0.0626467192586527,3.2848528179101e-74
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42754,0.0738316777774081,0.00402668203992559,0.065939380979154,0.0817239745756623,3.38252525434383e-74
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,42679,0.0409151205969065,0.00224854049781756,0.0365079812211841,0.0453222599726289,4.12849033243947e-73
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL18R1,Interleukin-18 receptor 1,42754,0.0601019206290873,0.00331339745539909,0.0536076616165051,0.0665961796416695,1.13047278950158e-72
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,42357,0.101150243696281,0.00558467122475125,0.0902042880957688,0.112096199296794,1.93309477615007e-72
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,42408,0.086844238381534,0.00482293599626187,0.0773912838288607,0.0962971929342072,1.24095831598116e-71
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPIND1,Heparin cofactor 2,40516,0.0508961923396149,0.00282610502121623,0.045357026498031,0.0564353581811987,1.6317805674732e-71
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MEP1A,Meprin A subunit alpha,40449,0.131142928248315,0.00728561599327063,0.116863120901505,0.145422735595126,1.93868341279895e-71
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,40283,0.0892429483797641,0.0050032220373408,0.0794366331865761,0.0990492635729521,3.46710169600432e-70
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42587,0.0707143503830946,0.00400391653416332,0.0628666739761345,0.0785620267900547,5.03939960934281e-69
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMOT,Angiomotin,40283,0.0690474114354472,0.003906176936989,0.0613913046389487,0.0767035182319456,5.60040741323788e-69
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F11R,Junctional adhesion molecule A,42611,0.0983856353054549,0.00557365555584279,0.0874612704160031,0.109310000194907,5.91014086670086e-69
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPA2,Carboxypeptidase A2,42670,0.116834340508786,0.00664637464593729,0.103807446202749,0.129861234814823,2.0784526140545e-68
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,42346,0.143516239952086,0.00816393915618722,0.127514919205959,0.159517560698213,2.14544175071807e-68
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KHK,Ketohexokinase,40223,0.110963411483665,0.00630590990947745,0.0986038280610894,0.123322994906241,2.23427969340687e-68
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,42587,0.152661306047202,0.00869091368103782,0.135627115232368,0.169695496862037,2.62991621738635e-68
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRIP2,Cysteine-rich protein 2,42495,0.0645510707953945,0.00367626018117134,0.0573456008402987,0.0717565407504903,2.98849843542271e-68
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHI3L1,Chitinase-3-like protein 1,42416,0.145857209931186,0.00831178907430684,0.129566103345544,0.162148316516827,3.62805919170082e-68
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GDF15,Growth/differentiation factor 15,42794,0.0818108611104776,0.00466536020974729,0.0726667550993729,0.0909549671215823,4.27958701389352e-68
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UMOD,Uromodulin,42764,-0.0974449457140173,0.00556145122514098,-0.108345390115294,-0.086544501312741,5.49434409373878e-68
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,42587,0.183046706680462,0.010500380304337,0.162465961283961,0.203627452076962,2.58857282063819e-67
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,40504,-0.0868596222477828,0.00498192082315242,-0.0966241870611615,-0.0770950574344041,3.37537156419675e-67
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MENT,Protein MENT,40283,-0.0404484566930069,0.00233965194747164,-0.0450341745100513,-0.0358627388759625,4.22778400049421e-66
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",40223,0.0992896434374804,0.00575065714073599,0.0880183554416378,0.110560931433323,6.24110533760088e-66
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LEP,Leptin,42636,0.114478934529682,0.00668171359271773,0.101382775887955,0.127575093171409,4.11864034539474e-65
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AGR3,Anterior gradient protein 3,42326,0.102961941193045,0.00602122864195212,0.0911603330548185,0.114763549331271,7.48384290517729e-65
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGAV,Integrin alpha-V,42721,-0.0282228470616665,0.00165161817644172,-0.0314600186874923,-0.0249856754358407,8.71278916265718e-65
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,40532,0.0382841467495361,0.00223842372812381,0.0338968362424134,0.0426714572566588,9.09700091819783e-65
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HAO1,Hydroxyacid oxidase 1,42721,0.214519693369826,0.0125695580894002,0.189883359514602,0.239156027225051,1.24735437900727e-64
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,40451,0.0892811535959526,0.00522644451156693,0.0790373223532814,0.0995249848386238,1.30059740598742e-64
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL15,C-C motif chemokine 15,42794,0.0768263921153251,0.00451059113464018,0.0679856334914303,0.0856671507392198,2.19237533366102e-64
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OMD,Osteomodulin,42676,-0.0722747878971733,0.00426545268410327,-0.0806350751580157,-0.0639145006363309,9.68506751291814e-64
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SELE,E-selectin,42794,0.0865649102247077,0.00510969648871584,0.0765499051068246,0.0965799153425907,1.00368380923047e-63
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KYNU,Kynureninase,42754,0.0756833540490291,0.00446904881971575,0.0669240183623863,0.084442689735672,1.11951570501827e-63
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGA11,Integrin alpha-11,42594,-0.0574678469138801,0.00341630257650352,-0.064163799963827,-0.0507718938639332,7.46726022852263e-63
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAM3B,Protein FAM3B,42587,0.0598524659210464,0.00355929633844956,0.0528762450976852,0.0668286867444075,8.22973738370858e-63
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLAT,Tissue-type plasminogen activator,42760,0.085467918087731,0.0050832089116381,0.0755048286209204,0.0954310075545417,8.35497441450249e-63
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FABP1,"Fatty acid-binding protein, liver",42618,0.158238500937785,0.00952210583912455,0.139575173493101,0.176901828382469,2.11672253977062e-61
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,40283,0.0634411947842088,0.00381802259605236,0.0559578704959461,0.0709245190724714,2.91839685581169e-61
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,42250,0.0924449285088298,0.0055692489972825,0.0815292004741561,0.103360656543504,2.99416958791865e-61
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,POSTN,Periostin,40527,-0.0643293962217885,0.00388894921617966,-0.0719517366855006,-0.0567070557580764,9.46615154708099e-61
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPPC,C-type natriuretic peptide,42594,0.0833093407522114,0.00504263736523935,0.0734257715163423,0.0931929099880805,1.03140740163015e-60
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NCAM2,Neural cell adhesion molecule 2,42611,-0.0453025931540963,0.00274217614732822,-0.0506772584028596,-0.0399279279053329,1.03489027807008e-60
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HJV,Hemojuvelin,40482,0.0732439085023017,0.00444484713697595,0.0645320081138289,0.0819558088907746,2.64885908588963e-60
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42495,0.0969161654183994,0.00590001522418222,0.0853521355790022,0.108480195257797,4.82229591302616e-60
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,42711,0.0586220405243912,0.0035807828543238,0.0516037061299166,0.0656403749188658,1.14911578207946e-59
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SORD,Sorbitol dehydrogenase,42658,0.109845166424482,0.00671986041360898,0.0966742400138082,0.123016092835155,1.72586927553254e-59
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TFPI,Tissue factor pathway inhibitor,42618,-0.0508832667224063,0.00312031146547725,-0.0569990771947417,-0.0447674562500709,3.25454878372833e-59
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MTSS1,Protein MTSS 1,40449,0.183291169408789,0.0112384660961971,0.161263775860243,0.205318562957335,4.03107176498514e-59
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD2AP,CD2-associated protein,42636,0.103909272779789,0.00640684128805247,0.0913518638552064,0.116466681704372,1.34246845068467e-58
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF23,Fibroblast growth factor 23,42711,0.0889489390467889,0.00549005708096317,0.0781884271681011,0.0997094509254767,1.73925801579306e-58
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NCS1,Neuronal calcium sensor 1,42721,0.0471582482136086,0.00291209245202639,0.0414505470076369,0.0528659494195804,1.97051506472676e-58
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,42594,0.0447793754085057,0.00276517893177786,0.0393596247022211,0.0501991261147903,1.99125532382197e-58
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,42476,0.119576109926368,0.00739560409134373,0.105080725907334,0.134071493945402,3.02198174296262e-58
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",42357,0.150255147777473,0.00932682467082094,0.131974571422664,0.168535724132282,7.74688956933485e-58
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42495,0.0630521524994671,0.00391596122115269,0.0553768685060078,0.0707274364929264,8.77474912438524e-58
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,40223,-0.0982569742589727,0.00611814422534809,-0.110248536940655,-0.0862654115772904,2.17505019878062e-57
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPB1,Carboxypeptidase B,42794,0.0979415349431424,0.00611975822169455,0.0859468088286211,0.109936261057664,3.96995884993033e-57
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BPIFB1,BPI fold-containing family B member 1,42573,-0.100858059096907,0.00630391812887438,-0.1132137386295,-0.0885023795643128,4.37253465512089e-57
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCHE,Cholinesterase,40346,0.0449929095258955,0.00281651447407351,0.0394725411567114,0.0505132778950796,8.17260442235533e-57
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",42794,0.0821632116947025,0.00516944605634068,0.0720310974242748,0.0922953259651302,2.24193390522952e-56
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FUOM,Fucose mutarotase,40283,0.100930132001009,0.00639402844139965,0.088397836255866,0.113462427746153,1.58317043518082e-55
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,40451,0.0905025919075096,0.00573677499615827,0.0792585129150394,0.10174667089998,1.78875701363428e-55
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AGRN,Agrin,42676,0.0578453881800726,0.00367152722565261,0.0506491948177934,0.0650415815423517,1.97583760324437e-55
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AGR2,Anterior gradient protein 2 homolog,42215,0.161667134397375,0.010260359060717,0.141556830638369,0.18177743815638,2.01340419412474e-55
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL27,C-C motif chemokine 27,42636,0.0935440859147163,0.00594388364124294,0.0818940739778801,0.105194097851552,2.59145088113961e-55
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,40116,0.0889291626277422,0.00564900532645904,0.0778571121878825,0.100001213067602,3.1262135606746e-55
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINA4,Kallistatin,40342,0.0382244696515834,0.0024329059651808,0.033455973959829,0.0429929653433378,4.90770882161031e-55
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IDUA,Alpha-L-iduronidase,42721,0.0732500695539772,0.00466758328634872,0.0641016063127337,0.0823985327952207,5.12901243824804e-55
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42754,-0.0401056956945487,0.00257362936460274,-0.0451500092491701,-0.0350613821399274,2.7922186745505e-54
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AREG,Amphiregulin,42587,0.0670339996017427,0.0043045251286955,0.0585971303494995,0.0754708688539859,3.3204142748973e-54
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,42652,-0.0560317698350678,0.00360760293934704,-0.063102671596188,-0.0489608680739476,6.22741963292887e-54
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLXNB2,Plexin-B2,42743,0.0378605985550909,0.00243932086385542,0.0330795296619343,0.0426416674482475,7.27532049169025e-54
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD209,CD209 antigen,42668,-0.0609147512130539,0.00392916228647861,-0.068615909294552,-0.0532135931315559,9.59731244003159e-54
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,42668,-0.0475699976401356,0.00308440769502399,-0.0536154367223826,-0.0415245585578886,3.27775192989314e-53
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NOMO1,Nodal modulator 1,42611,0.0358716108871621,0.00233113034045644,0.0313025954198675,0.0404406263544567,5.57545840146477e-53
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,42590,0.0776610747856185,0.00506972979495986,0.0677244043874972,0.0875977451837399,1.60050307246852e-52
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F7,Coagulation factor VII,42671,0.0478666327446649,0.00312937082337574,0.0417330659308485,0.0540001995584814,2.24009471389681e-52
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL23,C-C motif chemokine 23,42676,0.0645603811185776,0.00423674328215234,0.0562563642855591,0.0728643979515962,5.34445605268107e-52
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",42346,0.125159182596303,0.00822101233406967,0.109045998421526,0.141272366771079,6.75184558987779e-52
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DPY30,Protein dpy-30 homolog,42651,0.092285837746064,0.00606387410248128,0.0804006445052007,0.104171030986927,7.15167005076755e-52
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL32,Interleukin-32,42594,-0.0677532404425316,0.0044609891692547,-0.0764967792142708,-0.0590097016707923,1.14394013909917e-51
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CFI,Complement factor I,40539,0.03003691469765,0.00197626032377561,0.0261634444630498,0.0339103849322502,1.15957156600443e-51
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,42594,-0.0535515961740052,0.00354498996602748,-0.0604997765074191,-0.0466034158405913,3.88025875281056e-51
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL6,C-X-C motif chemokine 6,42754,0.116320147233645,0.00770747699819607,0.101213492317181,0.13142680215011,4.75702534707602e-51
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,42370,0.0701965548122931,0.00465386727574367,0.0610749749518355,0.0793181346727507,5.53881799896712e-51
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,40116,0.103080040906016,0.00684552189186085,0.0896628179979691,0.116497263814064,9.86257391674234e-51
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,42594,0.0782596941333992,0.00522940627572545,0.0680100578329773,0.0885093304338211,3.14809853600632e-50
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERMAP,Erythroid membrane-associated protein,40199,0.0673085469400639,0.00452475993475413,0.0584400174679458,0.0761770764121819,1.43686975300286e-49
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRSS2,Trypsin-2,42689,0.0838521725129332,0.00564348759224203,0.0727909368321388,0.0949134081937275,1.51553919657193e-49
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,42611,-0.0617682586078621,0.00416823752907304,-0.0699380041648452,-0.0535985130508789,2.71579121667548e-49
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OCLN,Occludin,40482,0.0673880941894952,0.00455115504154486,0.0584678303080673,0.0763083580709231,3.82292983944456e-49
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GRP,Gastrin-releasing peptide,40223,0.0838522895251547,0.00566554287290838,0.0727478254942543,0.0949567535560551,4.30213244756484e-49
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,42346,0.0560599191939435,0.00379380477118082,0.0486240618424291,0.063495776545458,5.11628408307491e-49
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTGR1,Prostaglandin reductase 1,40511,0.12496293639741,0.00847545708284769,0.108351040515029,0.141574832279792,9.50291627680697e-49
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CST3,Cystatin-C,42659,0.0449500247706776,0.00305421784874157,0.0389637577871441,0.050936291754211,1.19023871973822e-48
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACAN,Aggrecan core protein,42488,-0.0411624999731448,0.00281368972972327,-0.0466773318434024,-0.0356476681028872,4.31306325928942e-48
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",42562,0.104103749707377,0.00711863132139158,0.0901512323174492,0.118056267097304,4.63095267515087e-48
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EFNA4,Ephrin-A4,42475,0.0501317241170113,0.00342872670622779,0.0434114197728048,0.0568520284612177,4.86544960251768e-48
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HEG1,Protein HEG homolog 1,40283,0.0399521041244773,0.00273032672108385,0.0346006637511529,0.0453035444978016,4.86562522176316e-48
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOA1,Apolipoprotein A-I,40539,-0.0407763014541583,0.00279551228486482,-0.0462555055324934,-0.0352970973758233,9.27522949209093e-48
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REG4,Regenerating islet-derived protein 4,42638,0.0774181852257603,0.00533006106206233,0.0669712655441181,0.0878651049074025,1.92864832393225e-47
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAM3C,Protein FAM3C,42613,0.045601998543985,0.00314726888738435,0.0394333515247116,0.0517706455632583,3.21180243495594e-47
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GH1,Somatotropin,42613,-0.250830772180095,0.0173372636623079,-0.284811808958219,-0.216849735401971,4.38023167413587e-47
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,42587,0.0528479838513907,0.00365626834919557,0.0456816978869674,0.060014269815814,5.33306690847931e-47
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HEPH,Hephaestin,40511,0.0386777432301381,0.00268062491195477,0.0334237184027068,0.0439317680575695,8.88193634766142e-47
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42638,0.0463333239044718,0.00321963390936028,0.0400228414421256,0.0526438063668179,1.31037025392293e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,42618,0.0397966035641228,0.00276966259714658,0.0343680648737155,0.0452251422545301,1.79701842930363e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB6A,Ras-related protein Rab-6A,42594,-0.066484134139491,0.00463242830688525,-0.0755636936209861,-0.0574045746579959,2.28667437912751e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MLN,Promotilin,42594,0.127569251456246,0.00894314120163885,0.110040694701034,0.145097808211458,7.88551225046065e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EGFR,Epidermal growth factor receptor,42794,-0.0235150488001407,0.00164910945460829,-0.026747303331173,-0.0202827942691085,8.3959490477245e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GUSB,Beta-glucuronidase,42711,0.086863754405284,0.00611521484570962,0.0748779333076932,0.0988495755028749,1.82334540143408e-45
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL12B,Interleukin-12 subunit beta,42754,0.0812876668485251,0.00573152902086457,0.0700538699676305,0.0925214637294196,2.47763397992934e-45
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LSP1,Lymphocyte-specific protein 1,42594,0.0567778879605657,0.00400467470194374,0.0489287255447559,0.0646270503763754,2.66791178455307e-45
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPA1,Carboxypeptidase A1,42794,0.0893753826331798,0.00631240032728927,0.0770030779916928,0.101747687274667,3.45475461916505e-45
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENO3,Beta-enolase,40223,0.0843778075342612,0.00595860426581835,0.0726989431732573,0.0960566718952652,3.98467745559088e-45
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LGALS9,Galectin-9,42620,0.0461269559507636,0.00326155114937325,0.0397343156979921,0.0525195962035352,4.36757660384806e-45
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD248,Endosialin,40527,-0.0584055707298211,0.00412694261211833,-0.066494378249573,-0.0503167632100692,4.37469511919104e-45
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL12A_IL12B,Interleukin-12,42587,0.11719999274659,0.00828753617510122,0.100956421843392,0.133443563649788,4.43266321187902e-45
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GZMA,Granzyme A,42754,0.0506794269023557,0.00358753616459239,0.0436478560197546,0.0577109977849567,5.43317913555864e-45
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,40511,0.0955245868987632,0.00676961748678566,0.0822561366246633,0.108793037172863,7.81425816343473e-45
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSME1,Proteasome activator complex subunit 1,42480,0.0526397547762989,0.00374101151155315,0.0453073722136547,0.0599721373389431,1.19741883609039e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,42721,0.0516195176108456,0.00367412475044632,0.0444182330999708,0.0588208021217204,1.59502139356147e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,40483,-0.0522780830787452,0.00373826622543474,-0.0596050848805973,-0.0449510812768931,4.51144036284014e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,42611,0.0645326099160272,0.00461983147328676,0.0554777402283851,0.0735874796036692,4.92781905375051e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42587,0.0620663216750565,0.00444340796977152,0.0533572420543043,0.0707754012958086,4.96327602049915e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNASET2,Ribonuclease T2,42749,0.0387438763490008,0.0027955013909273,0.0332646936227832,0.0442230590752183,2.20646333197967e-43
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42721,0.0481004767581962,0.00347711684898002,0.0412853277341954,0.0549156257821971,3.15383309364646e-43
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,42594,0.0895185019496303,0.00647914955511888,0.0768193688215972,0.102217635077663,4.00861713493456e-43
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPO,Erythropoietin,42594,0.10312034284276,0.00746598440602577,0.0884870134069496,0.117753672278571,4.25604007426661e-43
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADM,Pro-adrenomedullin,42721,0.0373805367495773,0.00271272142475039,0.0320636027570665,0.0426974707420881,6.57833486867232e-43
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEMA3F,Semaphorin-3F,42636,0.03754551141855,0.00274392794666619,0.0321674126430842,0.0429236101940157,2.46020043152445e-42
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD5,T-cell surface glycoprotein CD5,42706,0.0498716330348409,0.00364521216214045,0.0427270171970457,0.0570162488726362,2.50980122919152e-42
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,42594,0.0538294137379944,0.00393454027362736,0.0461177148016847,0.061541112674304,2.52886160220827e-42
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42689,-0.0517820801049097,0.00379311295869633,-0.0592165815039545,-0.0443475787058649,3.76172312261765e-42
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH1,Cadherin-1,42188,0.0549433580815847,0.00403642297062706,0.0470319690591557,0.0628547471040138,6.5932164282508e-42
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINA5,Plasma serine protease inhibitor,40387,0.043371210465056,0.00318922512246724,0.0371203292250202,0.0496220917050918,8.67832368408485e-42
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FETUB,Fetuin-B,42663,0.0441360376663679,0.00325020264194052,0.0377656404881645,0.0505064348445713,9.97486570048124e-42
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,42569,0.0348652089746575,0.00257776081470179,0.029812797777842,0.039917620171473,2.0727198817278e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GSN,Gelsolin,40488,-0.0266394704951429,0.00197326792452669,-0.0305070756272152,-0.0227718653630706,3.25471808951395e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NECTIN2,Nectin-2,42613,0.0429610270122481,0.0031937368573849,0.0367013027717737,0.0492207512527225,5.5480891559465e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,XCL1,Lymphotactin,42721,0.076230415068034,0.00567496086014274,0.0651074917821542,0.0873533383539138,7.10276770459896e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUMB,Protein numb homolog,40199,0.111510161280969,0.00831213504624664,0.095218376590326,0.127801945971613,1.02628757182435e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TXLNA,Alpha-taxilin,42495,0.118042066878912,0.00883116376127539,0.100732985906812,0.135351147851012,1.7306616014229e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,40283,0.100793014518366,0.00753826142105056,0.0860180221331068,0.115568006903625,1.84046366037042e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42618,0.0541019604804694,0.00406306811099089,0.0461383469829272,0.0620655739780115,3.3809640069279e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42711,0.0695858292428026,0.00523205138009011,0.0593310085378259,0.0798406499477792,4.13968182297095e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,40199,0.0600177235229114,0.00450927050505519,0.0511795533330033,0.0688558937128196,4.14037208187717e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PXN,Paxillin,42311,0.0688090302303569,0.00517699764518521,0.0586621148457939,0.0789559456149199,4.71985522765427e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,42676,0.0405258736557101,0.00304941864353055,0.0345490131143903,0.04650273419703,4.74373027533079e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WIF1,Wnt inhibitory factor 1,42721,-0.0463805664679141,0.00349082396298087,-0.0532225814353566,-0.0395385515004716,4.94407215607355e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,42746,0.0510179466448546,0.00384096885743467,0.0434896476842826,0.0585462456054265,5.19617607237872e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42613,0.152259135220808,0.0114866732966399,0.129745255559394,0.174773014882222,7.48546687297341e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BECN1,Beclin-1,40223,0.0802237769900974,0.00605561082594716,0.068354779771241,0.0920927742089539,9.33953472350385e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LBR,Delta(14)-sterol reductase LBR,42711,0.0888536635427593,0.00671347913754873,0.0756952444331638,0.102012082652355,9.71873047422938e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,40367,0.0458145002086591,0.00346651795088777,0.039020125024919,0.0526088753923991,1.39956784003189e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCXR,L-xylulose reductase,42679,0.0700513186761728,0.00530780635251251,0.0596480182252483,0.0804546191270974,1.58810129159686e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCARB2,Lysosome membrane protein 2,42302,0.0466438560957755,0.00353539373806597,0.0397144843691662,0.0535732278223848,1.70942185383198e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CFH,Complement factor H,39956,0.0307021113151817,0.0023278343147535,0.0261395560582648,0.0352646665720985,2.04791134875335e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PIGR,Polymeric immunoglobulin receptor,42464,0.0477627247081192,0.00362542060297919,0.04065690032628,0.0548685490899584,2.17675692715733e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42689,0.0562440714916351,0.00427074849077632,0.0478734044497136,0.0646147385335567,2.2957946957788e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAXX,Protein PAXX,40283,0.0605754738433801,0.00460572343040751,0.0515482559197814,0.0696026917669788,3.24693247356965e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LEPR,Leptin receptor,42636,-0.041477479916464,0.00315592111680514,-0.0476630853054021,-0.0352918745275259,3.2676993492214e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TREH,Trehalase,40527,0.0987206696068816,0.00751483390854197,0.0839915951461393,0.113449744067624,3.91341364660058e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,42587,0.0885356050023823,0.00674520038204279,0.0753150122535785,0.101756197751186,4.08861087182958e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPE,Carboxypeptidase E,42588,-0.051277076166367,0.00390695095630631,-0.0589347000407273,-0.0436194522920066,4.1497841715578e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42495,0.0961939405872103,0.00734294695341125,0.0818017645585243,0.110586116615896,5.72309990575171e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,42346,0.0896629440524291,0.00685496442981873,0.0762272137699844,0.103098674334874,7.48588086753337e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42689,-0.0588050797094513,0.00449685235549964,-0.0676189103262306,-0.049991249092672,7.68050797653616e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HYAL1,Hyaluronidase-1,42544,0.0307006110855498,0.00234766424475854,0.0260991891658231,0.0353020330052766,7.71104867494815e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAT2,Linker for activation of T-cells family member 2,42587,0.162666913629062,0.0124491155718044,0.138266647108326,0.187067180149799,8.82672127741223e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANG,Angiogenin,42618,0.0443117408641729,0.00339672018764846,0.0376541692963819,0.0509693124319639,1.15891258851852e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42587,0.0573639362250939,0.00440580993568517,0.0487285487511509,0.0659993236990368,1.6117103737506e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,42587,0.0776689404003926,0.00598679181429251,0.0659348284443793,0.0894030523564059,2.94461241132254e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,42611,0.0702032320313898,0.00541474566596979,0.059590330526089,0.0808161335366906,3.2691410178388e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",40482,0.0816134636538468,0.00629694457353435,0.0692714522897195,0.0939554750179742,3.81758428900075e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,42794,-0.032531747500317,0.00251573911609526,-0.0374625961678637,-0.0276008988327703,5.02143615531039e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TFF3,Trefoil factor 3,42613,0.0564951495677207,0.00436891695259928,0.0479320723406261,0.0650582267948153,5.06476409239801e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42611,0.0422614978704835,0.00327225335067328,0.0358478813031639,0.0486751144378031,6.22439218141179e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNASE4,Ribonuclease 4,40169,0.0383839425469127,0.00297706632196052,0.0325488925558701,0.0442189925379553,9.23557399553085e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EGLN1,Egl nine homolog 1,42594,0.0718479568323396,0.00559026175526772,0.0608910437920149,0.0828048698726643,1.39101559615992e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,YES1,Tyrosine-protein kinase Yes,42587,0.146461278956322,0.0114393095441815,0.124040232249726,0.168882325662918,2.59890621264417e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VEGFA,Vascular endothelial growth factor A,42716,0.0754240906345473,0.00591330117715771,0.0638340203273182,0.0870141609417764,4.77995570444599e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,42346,0.0658440771857057,0.00516281793161744,0.0557249540397355,0.0759632003316759,4.93731543086385e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,42587,-0.0322701593169137,0.00253381059347641,-0.0372364280801274,-0.0273038905536999,6.12245646622806e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SBSN,Suprabasin,40511,-0.0450296211139171,0.00354915691966556,-0.0519859686764616,-0.0380732735513726,1.23292005264353e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNAPIN,SNARE-associated protein Snapin,40482,0.0737964147048594,0.0058234896817091,0.0623823749287095,0.0852104544810092,1.49516018256429e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,40451,0.0887532148932223,0.00700570489248977,0.0750220333039423,0.102484396482502,1.56469299012662e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SULT2A1,Bile salt sulfotransferase,42594,0.0714563004685144,0.00566136795450518,0.0603600192776843,0.0825525816593446,2.57848889068823e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,42594,0.0884974088980631,0.00701778880109314,0.0747425428479205,0.102252274948206,2.97108630114963e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42638,-0.0436544815967085,0.00346721755258929,-0.0504502279997835,-0.0368587351936335,3.80201693541803e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,42370,0.0880430846236477,0.00699837533067334,0.074326268975528,0.101759900271767,4.35719397293819e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42587,0.123103268756394,0.00979003499803562,0.103914800160244,0.142291737352544,4.67016419925521e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TOP2B,DNA topoisomerase 2-beta,40199,0.10123498307499,0.00805465599744356,0.0854478573200003,0.117022108829979,5.55554331270301e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL13,C-X-C motif chemokine 13,42711,0.0795366548122797,0.00633404814959775,0.0671219204390681,0.0919513891854913,5.77577922435871e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSME2,Proteasome activator complex subunit 2,42441,0.0458243739400227,0.00365389808575603,0.0386627336919409,0.0529860141881045,7.09826513482712e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,40449,0.0372006810078217,0.00297090097592138,0.0313777150950158,0.0430236469206276,9.82763832545634e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,42555,0.041459748585014,0.00331460458957019,0.0349631235894564,0.0479563735805715,1.06684704923013e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42683,0.0389737993424258,0.00312203395836292,0.0328546127840345,0.0450929859008171,1.44470506233318e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL3,C-C motif chemokine 3,42594,0.0723487992392052,0.00580449388096167,0.0609719912325203,0.0837256072458901,1.83863564593674e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,42679,-0.0551923996013576,0.00443419940541209,-0.0638834304359653,-0.0465013687667499,2.27158102468363e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,42580,0.0258208944649144,0.00207567522308723,0.0217525710276635,0.0298892179021654,2.49229733921581e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDHR2,Cadherin-related family member 2,42587,0.0885959580745117,0.00714086025362209,0.0745998719774124,0.102592044171611,3.73989590369737e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42570,0.131412445700732,0.0106141472135373,0.110608717162199,0.152216174239265,5.15811605702419e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,40483,0.0595243529270576,0.00481001203325827,0.0500967293418714,0.0689519765122438,6.00463903823324e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,42611,-0.0656861687888877,0.00533290945166734,-0.0761386713141557,-0.0552336662636197,1.12746980957672e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,42346,0.136552346466844,0.0110944627521921,0.114807199472547,0.15829749346114,1.26953284472753e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL17,C-X-C motif chemokine 17,42754,0.0504329985232224,0.00410368933955356,0.0423897674176975,0.0584762296287474,1.57113472635772e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BACH1,Transcription regulator protein BACH1,42594,0.0904079647064717,0.00735825317119936,0.0759857884909209,0.104830140922022,1.63936049043794e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42594,0.119261539337266,0.009719791662097,0.100210747679556,0.138312330994976,2.00901728529568e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GAST,Gastrin,40483,0.181091656027667,0.0147524860026779,0.152176783462418,0.210006528592916,2.03623612418873e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DTYMK,Thymidylate kinase,40511,0.0841454607618445,0.00687434044499869,0.0706717534896471,0.097619168034042,3.10753076548562e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,42475,0.109712875119326,0.00896995686514957,0.0921317596636329,0.127293990575019,3.23741353703908e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,42794,0.0470136844542187,0.00384883375036978,0.0394699703034939,0.0545573986049435,3.89957799795826e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EZR,Ezrin,42711,0.0294744509577686,0.00241329136304675,0.024744399886197,0.0342045020293403,3.98929760453313e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SARG,Specifically androgen-regulated gene protein,40456,0.134225183064285,0.0109842327440526,0.112696086885942,0.155754279242628,4.00620036509861e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHMP6,Charged multivesicular body protein 6,40511,0.0691863833024966,0.00566569967730837,0.0580816119349722,0.080291154670021,4.42337008108503e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AGXT,Serine--pyruvate aminotransferase,42636,0.0930541150669935,0.00763297042615078,0.0780934930317379,0.108014737102249,5.24310457327303e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,42636,0.0536076934876858,0.00439767473265928,0.0449882510116736,0.062227135963698,5.3113995064312e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CFHR4,Complement factor H-related protein 4,40509,-0.0923496675916073,0.00757753016824842,-0.107201626721374,-0.0774977084618404,5.92747597718459e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTBS,Di-N-acetylchitobiase,40383,0.0331651193967715,0.00272451143705547,0.0278250769801428,0.0385051618134002,7.09755608817457e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ESM1,Endothelial cell-specific molecule 1,42618,-0.0423808815447181,0.00348418460612934,-0.0492098833727316,-0.0355518797167046,7.30318790640751e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CES3,Carboxylesterase 3,42587,0.0866350772441158,0.00712794103885782,0.0726643128079544,0.100605841680277,8.20063626415219e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,42594,0.129467664134807,0.010655154485024,0.10858356134416,0.150351766925454,8.56235499135171e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,40116,0.0778852134175985,0.00642985931435764,0.0652826891614575,0.0904877376737395,1.47785057428259e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FABP5,Fatty acid-binding protein 5,42678,0.0826734535980139,0.00683309406265148,0.069280589235217,0.0960663179608107,1.59499684988181e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNAP23,Synaptosomal-associated protein 23,42636,0.105728544536442,0.00875503375062134,0.0885686783852238,0.122888410687659,2.09790207914356e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNAP29,Synaptosomal-associated protein 29,42679,0.111187072751252,0.00921126258791992,0.0931329980789291,0.129241147423575,2.23961347654697e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEP85,Centrosomal protein of 85 kDa,42346,0.0779884542491176,0.00646250407452361,0.0653219462630513,0.0906549622351839,2.34326570920813e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,40199,0.103145623236862,0.00854717892485455,0.0863931525441466,0.119898093929576,2.53576340359981e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEZ6L2,Seizure 6-like protein 2,42587,-0.0290587582775284,0.00240941164030739,-0.0337812050925309,-0.0243363114625259,2.54015478553327e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FYB1,FYN-binding protein 1,42590,0.111511461469211,0.00927272747471678,0.0933369156187664,0.129686007319656,3.85459886433964e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSZ,Cathepsin Z,42648,0.0392578833209329,0.00326521508214402,0.0328580617599307,0.0456577048819352,3.9738232101702e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42636,0.0425198454526524,0.00354171851343649,0.0355780771663169,0.049461613738988,4.90924274296558e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARF6,ADP-ribosylation factor 6,40449,0.130034672267075,0.0108362972902721,0.108795529578142,0.151273814956009,5.65085722962177e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,42238,0.0240165767674286,0.00200432394937497,0.0200881018266537,0.0279450517082035,6.54144712587931e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYH9,Myosin-9,40527,0.138233360280193,0.0115808481775888,0.115534897852119,0.160931822708267,1.19986877998889e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",40511,0.0890775961550747,0.00748129080144971,0.0744142661842333,0.103740926125916,1.70657815939503e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,40449,0.0365702831300809,0.00307446774276003,0.0305443263542712,0.0425962399058905,1.96902237324096e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNTN5,Contactin-5,42640,-0.0459096764802628,0.00386164709491312,-0.0534785047862925,-0.038340848174233,1.97139495402391e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,42794,-0.0395913416743711,0.00333926782041123,-0.0461363066023771,-0.0330463767463651,2.8780366612728e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUCB2,Nucleobindin-2,42683,0.0442490064163591,0.00373332960325501,0.0369316803939793,0.0515663324387389,3.02169984066531e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL16,Pro-interleukin-16,42754,0.0493934874819968,0.00417479569059086,0.0412108879284387,0.0575760870355549,3.86744176945275e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,42689,0.0492261750621737,0.00416589548881815,0.0410610199040901,0.0573913302202573,4.6170758490509e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,42611,0.0368901083060857,0.00312339734111556,0.0307682495174992,0.0430119670946722,4.94082020129054e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,40199,0.081985596500987,0.00695023955135173,0.0683631269803376,0.0956080660216364,6.3646559830669e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,42311,0.0342831415223945,0.00292012541221216,0.0285596957144587,0.0400065873303303,1.14074691386639e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,42311,0.0608466947217378,0.00518746539718237,0.0506792625432603,0.0710141269002152,1.29337377366409e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCAN,Brevican core protein,42495,-0.0410610703314161,0.00350806604370121,-0.0479368797770705,-0.0341852608857618,1.71937893396778e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THOP1,Thimet oligopeptidase,42571,0.0364486309257109,0.00312294882173777,0.0303276512351049,0.0425696106163169,2.53647779731401e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAT,Linker for activation of T-cells family member 1,42754,0.0886987283992087,0.00760327891823657,0.073796301719465,0.103601155078952,2.68742042059699e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCTN1,Dynactin subunit 1,42721,0.0761413575671802,0.00652788208989901,0.0633467086709782,0.0889360064633823,2.74755345400403e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCN1,Ficolin-1,40515,0.0660141650972164,0.00566835526995447,0.0549041887681056,0.0771241414263271,3.61611893812033e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNASE6,Ribonuclease K6,40468,0.0403617166259121,0.00346787691987887,0.0335646778629495,0.0471587553888746,3.94419612106337e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IKBKG,NF-kappa-B essential modulator,42594,0.106484293344469,0.00916874881958027,0.0885135456580917,0.124455041030846,4.93567812285319e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGBL1,Integrin beta-like protein 1,40527,0.0458193560857216,0.00394929517366846,0.0380787375453314,0.0535599746261118,6.02659382731346e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ELN,Elastin,40511,0.0431423357211945,0.00371949636848403,0.0358521228389658,0.0504325486034232,6.23786324399485e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42651,0.0681694397170999,0.00589221086430468,0.0566207064230627,0.0797181730111371,8.23613952801184e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42689,0.0500844351712852,0.00433303984264342,0.0415916770797041,0.0585771932628663,9.30790827080963e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,40483,0.100204971566398,0.00867057943864096,0.0832106358666616,0.117199307266134,1.01414022243467e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FSTL3,Follistatin-related protein 3,42574,0.0396869064238935,0.00343665460634351,0.0329510633954602,0.0464227494523268,1.05481400618288e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL11,Eotaxin,42754,0.0428112645733568,0.00371309052795739,0.0355336071385603,0.0500889220081533,1.29644773364321e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,40451,0.0775509235538568,0.00672553940751595,0.0643688663151255,0.0907329807925881,1.37018388964113e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,42594,0.0724722587486871,0.00629780504149747,0.0601285608673521,0.0848159566300222,1.68119037685212e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,42587,0.0981454864985013,0.00854268465874132,0.0814018245673683,0.114889148429634,2.08396117610756e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,40223,0.0977797485121672,0.00851580507209482,0.0810887705708613,0.114470726453473,2.41198351458306e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMN,Protein amnionless,42370,0.0545491428339676,0.00476424518940763,0.0452112222627286,0.0638870634052065,3.27871534895581e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPL,N-acetylneuraminate lyase,40511,0.052881800447209,0.00461750725001242,0.0438314862371847,0.0619321146572334,3.35194644274267e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBKS,Ribokinase,42317,0.0574157772766453,0.00501606507488035,0.0475842897298798,0.0672472648234108,3.40969577853769e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNCG,Gamma-synuclein,42495,0.0795538968025196,0.00696332211671648,0.0659057854537553,0.0932020081512839,4.34716561144386e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,42591,0.0507154008584803,0.00444220260340902,0.0420086837557986,0.059422117961162,4.75011903857298e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STC1,Stanniocalcin-1,42711,0.0521938646231334,0.00457369130954534,0.0432294296564245,0.0611582995898423,5.01232024376965e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40980,-0.0366206016512423,0.00321347575645264,-0.0429190141338895,-0.0303221891685951,6.28228463018093e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,40449,0.0916200723705096,0.00803958766166438,0.0758624805536474,0.107377664187372,6.3770686706778e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,42620,0.0567466809602132,0.00499110613392185,0.0469641129377264,0.0665292489827,8.1150586528121e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,40532,-0.0316866165775746,0.00278583557785561,-0.0371468543101716,-0.0262263788449776,8.15536180052031e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL1R2,Interleukin-1 receptor type 2,42600,0.022912259758067,0.0020188125575227,0.0189553871453225,0.0268691323708115,1.02065689552129e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,42594,0.066095074874231,0.00583001973054711,0.0546682362023586,0.0775219135461033,1.1739883403459e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSTB,Cystatin-B,42437,0.0488350714396505,0.00431420457328483,0.0403792304760123,0.0572909124032888,1.43484880844252e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FMNL1,Formin-like protein 1,42311,0.0710392024236071,0.00627621587834898,0.0587378193020431,0.0833405855451711,1.45228528962623e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42636,0.0317146853713642,0.00280278775807127,0.0262212213655445,0.0372081493771839,1.49754209686663e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,42679,-0.0275582584283866,0.00243550822693105,-0.0323318545531715,-0.0227846623036018,1.49962132508223e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42611,0.0344461373091749,0.00304915121757902,0.02846980092272,0.0404224736956297,1.84521441899998e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TGFA,Protransforming growth factor alpha,42594,0.0540427463631427,0.00479820494166204,0.0446382646774851,0.0634472280488003,2.70216666670992e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42587,0.0316749596353966,0.00281298860109854,0.0261615019772435,0.0371884172935498,2.79108788821824e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGB1,Integrin beta-1,42638,-0.0244371902342253,0.00217106111662175,-0.0286924700228039,-0.0201819104456466,2.92850927014322e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,42636,0.0427374223648436,0.00380009968435557,0.0352892269835067,0.0501856177461805,3.25767209959333e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,42794,0.0750964249569216,0.00667908551813111,0.0620054173413846,0.0881874325724585,3.35294087162912e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LGALS3BP,Galectin-3-binding protein,40539,0.0349296182727912,0.00311118195584552,0.028831701639334,0.0410275349062484,4.27155349060717e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AXIN1,Axin-1,42594,0.107011774993749,0.00954390085601446,0.0883057293159602,0.125717820671537,4.763793416035e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,40116,0.0410885298822121,0.00367148264772352,0.033892423892674,0.0482846358717502,6.4625867313359e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MTDH,Protein LYRIC,40199,0.106351384735687,0.00951170189503259,0.0877084490214235,0.124994320449951,7.21748324927155e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,40449,0.0672998276437941,0.00602349495482281,0.0554937775323414,0.0791058777552468,7.84776685636953e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,42721,0.091451398388793,0.00819187984467966,0.0753953138932208,0.107507482884365,8.20556648909072e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PVR,Poliovirus receptor,42711,0.041560835491194,0.00372314880672313,0.0342634638300167,0.0488582071523714,8.28506562830881e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,42587,-0.0300742749927965,0.00269828315948561,-0.0353629099853883,-0.0247856400002047,1.00515402045511e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C19orf12,Protein C19orf12,42311,0.071820514305191,0.00645544928369419,0.0591678337091504,0.0844731949012316,1.26515888544629e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DKK4,Dickkopf-related protein 4,42477,0.0522043994538364,0.0046969948960079,0.0429982894576609,0.0614105094500119,1.42651027446579e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH2,Cadherin-2,42636,0.0399874081781962,0.00360057283660849,0.0329302854184436,0.0470445309379489,1.56365033000934e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,40483,0.0776779788888911,0.00699547076640883,0.0639668561867298,0.0913891015910524,1.68395215326484e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,40465,0.0904399316613971,0.00814816494660178,0.0744695283660576,0.106410334956737,1.77317720694484e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,40116,0.0828362286899214,0.00746615513266779,0.0682025646298925,0.0974698927499503,1.88438421608352e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNXB,Tenascin-X,42611,-0.0290280924480439,0.0026196116159299,-0.0341625312152665,-0.0238936536808213,2.0587865596654e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,S100P,Protein S100-P,42357,0.0613082233093188,0.00554106777780155,0.0504477304648277,0.0721687161538098,2.49080851224506e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INSL5,Insulin-like peptide INSL5,40449,0.110689343937298,0.0100146628552703,0.0910606047409678,0.130318083133628,2.97124486142921e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,40171,0.0440824141446817,0.00399118507234229,0.0362596914028908,0.0519051368864726,3.26460050367685e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,S100A4,Protein S100-A4,42679,0.0635668732008964,0.00575935091551025,0.0522785454064963,0.0748552009952965,3.33938125769398e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",42370,0.0665478974118024,0.00603451044466599,0.0547202569402571,0.0783755378833478,3.72269203595427e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,40449,0.0579223504910982,0.00525154301729393,0.0476293261772021,0.0682153748049943,3.83353192253596e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EEF1D,Elongation factor 1-delta,40511,0.101976819766973,0.00925718164841018,0.0838327437360892,0.120120895797857,4.4446707341131e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ELOA,Elongin-A,42587,0.0597236392193045,0.00542391895327369,0.0490927580708881,0.0703545203677209,4.4549954383531e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CFC1,Cryptic protein,42346,0.0527402992128454,0.00480715539775859,0.0433182746332385,0.0621623237924522,6.94309727172948e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,40169,0.0547789015895816,0.0049920189103867,0.0449945445252237,0.0645632586539396,7.168480493573e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,42346,0.0549524320645878,0.00501335507736832,0.0451262561129459,0.0647786080162297,7.74688107325904e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NCAN,Neurocan core protein,42711,-0.0422330558622928,0.00385562570320376,-0.0497900822405722,-0.0346760294840134,8.35577564005766e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,42501,0.0325038400348855,0.00297030493905391,0.0266820423543399,0.0383256377154312,9.43198386494311e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DPP4,Dipeptidyl peptidase 4,42441,-0.0312798578783468,0.00286327011449395,-0.036891867302755,-0.0256678484539387,1.15472047758872e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,42594,0.0641591109126813,0.00587839096084747,0.0526374646294203,0.0756807571959424,1.28560748664249e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CALCA,Calcitonin,42476,0.0696568853840551,0.00639411234305137,0.0571244251916744,0.0821893455764357,1.61102399201641e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH17,Cadherin-17,42636,0.0768660558234209,0.0070634385321174,0.0630217163004708,0.090710395346371,1.82332934385296e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MTSS2,Protein MTSS 2,40451,0.108711193041381,0.00999059313860726,0.0891296304897106,0.128292755593051,1.93697994470561e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MBL2,Mannose-binding protein C,40379,-0.12047521679777,0.0110757662279805,-0.142183718604611,-0.098766714990928,2.02666156328563e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,42674,-0.0267452522847874,0.00246059708584025,-0.0315680225730343,-0.0219224819965405,2.09462091807473e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ASPN,Asporin,40511,-0.0310779126165868,0.00285877353509327,-0.0366811087453696,-0.025474716487804,2.16226852280869e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,42640,0.0441605702222624,0.00406759183774824,0.0361880902202759,0.052133050224249,2.40667085969035e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,40483,0.0904247123198932,0.00832635403653064,0.0741050584082932,0.106744366231493,2.43814561240043e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA6,Carbonic anhydrase 6,42581,-0.0688074993780566,0.00634312082448551,-0.0812400161940482,-0.056374982562065,2.65964160113117e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",40223,0.0754042668231278,0.00695120950843885,0.0617798961865877,0.089028637459668,2.80933643462149e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD63,CD63 antigen,42475,0.0558683124563591,0.00515784554290712,0.0457589351922611,0.065977689720457,3.1649502840762e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42587,-0.0455895508977555,0.00420958059849061,-0.0538403288707971,-0.0373387729247139,3.21896046868434e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,40483,0.069441679109956,0.00643661991036277,0.056825904085645,0.082057454134267,5.28022330223858e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,42760,0.0210823482734468,0.00195603279042343,0.0172485240042169,0.0249161725426767,5.6164069856597e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,40283,0.091112557076834,0.00845503332899615,0.0745406917520016,0.107684422401666,6.06676775413352e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCR,Breakpoint cluster region protein,42594,0.0989733215533599,0.00918931347932476,0.0809622671338834,0.116984375972836,6.11681528995576e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TJAP1,Tight junction-associated protein 1,42679,0.0895975817389876,0.00832278994684327,0.0732849134431748,0.1059102500348,6.45530222174246e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTRB1,Chymotrypsinogen B,42611,0.0632832469593414,0.00588068634193785,0.0517571017291432,0.0748093921895395,6.75720491262422e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,42346,0.0683090736060726,0.00635512796050996,0.0558530228034731,0.0807651244086721,7.77232926040337e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSS,Cathepsin S,39872,0.0265885678949025,0.00247788340124162,0.0217319164284689,0.0314452193613361,1.00310518712934e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRIM5,Tripartite motif-containing protein 5,42594,0.0922849586328861,0.00860547234607349,0.0754182328345821,0.10915168443119,1.00813143683423e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NRP1,Neuropilin-1,42705,-0.0301180989062497,0.00281497169585043,-0.0356354434301166,-0.0246007543823829,1.31125512641565e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDC27,Cell division cycle protein 27 homolog,42346,0.0651256704186732,0.00609136043740841,0.0531866039613527,0.0770647368759937,1.4344264634249e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,40451,0.0855501005198215,0.00801191962228343,0.069846738060146,0.101253462979497,1.73009705788256e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,42346,0.0777180393209209,0.00728411600624049,0.0634411719486895,0.0919949066931523,1.81355854337771e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ASAH2,Neutral ceramidase,42495,0.0575702703982009,0.00541595885178103,0.04695499104871,0.0681855497476917,2.76259859363483e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",42587,0.0638661512162669,0.0060116246242481,0.0520833669527406,0.0756489354797932,2.93874468124595e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,40223,0.0778267525107977,0.0073342947052827,0.0634515348884436,0.0922019701331518,3.5288404781323e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,42676,0.043431582764692,0.00409658380922222,0.0354022784986165,0.0514608870307676,3.70107307113256e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL21,C-C motif chemokine 21,42676,0.0454347591970864,0.00428899282311463,0.0370283332637817,0.0538411851303911,4.05278582015651e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IMMT,MICOS complex subunit MIC60,40451,0.0486463440527515,0.00459065873306989,0.0396486529359345,0.0576440351695685,4.09219276217933e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,42357,-0.0230514476278594,0.00217912955339594,-0.0273225415525154,-0.0187803537032034,4.78046848816083e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,YTHDF3,YTH domain-containing family protein 3,42370,0.0904107003986854,0.00857492674518059,0.0736038439781315,0.107217556819239,6.89350384220062e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HEXIM1,Protein HEXIM1,42594,0.0857493126669256,0.00813616023626125,0.0698024386038536,0.101696186729998,7.18696909086634e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSMG3,Proteasome assembly chaperone 3,42594,0.0545112997163072,0.00517410062522138,0.0443700624908733,0.0646525369417411,7.486253585493e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFNGR2,Interferon gamma receptor 2,42495,0.0555111346533058,0.00527509089510448,0.045171956498901,0.0658503128077105,8.52398069481011e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42711,-0.0502799623094078,0.00478089867933559,-0.0596505237209056,-0.04090940089791,9.08557652642267e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,42594,0.109804363735149,0.0104514645877516,0.0893194931431557,0.130289234327142,1.01903887790459e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD207,C-type lectin domain family 4 member K,42365,0.042333661478839,0.00403429610047705,0.0344264411219039,0.050240881835774,1.16885592372954e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,42357,0.100319604922789,0.00957333857085731,0.081555861323909,0.11908334852167,1.35944093191744e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42638,0.0382977634354624,0.00365644981321396,0.0311311218015631,0.0454644050693618,1.42619865655197e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FEN1,Flap endonuclease 1,42346,0.0675465403564571,0.00645417807389503,0.0548963513316228,0.0801967293812914,1.56646840973366e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42654,0.089997750935835,0.00861068929794937,0.0731207999118542,0.106874701959816,1.79832952088332e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNTN1,Contactin-1,42794,-0.0295452025355408,0.00282716843603508,-0.0350864526701695,-0.024003952400912,1.82079631973811e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNASE1,Ribonuclease pancreatic,40532,0.0281793702618355,0.00269653349166254,0.0228941646181769,0.0334645759054941,1.9074459973511e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FUS,RNA-binding protein FUS,42336,0.0420966249152851,0.00403051200686227,0.0341968213818351,0.0499964284487351,1.95306542569899e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,40199,0.133385083267475,0.012770395696739,0.108355107701866,0.158415058833083,2.03327384439298e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COLEC12,Collectin-12,42618,0.0296610658216953,0.00284388191592187,0.0240870572664884,0.0352350743769021,2.26646487918168e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",40209,0.0841899329638408,0.00808785502898647,0.0683377371070273,0.100042128820654,2.94066559819214e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEP20,Centrosomal protein 20,42346,0.0785649897569425,0.00756701502362773,0.0637336403106322,0.0933963392032529,3.72328976492411e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLO1,Lactoylglutathione lyase,42357,0.0609508000064882,0.00589257606789494,0.0494013509134141,0.0725002490995623,5.57309029245701e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,POF1B,Protein POF1B,40199,0.0491199471900467,0.00475210063838397,0.0398058299388141,0.0584340644412793,6.26615792511941e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEP43,Centrosomal protein 43,42255,0.0723622767486726,0.00701109388577225,0.058620532732559,0.0861040207647863,7.04894877983589e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,40199,0.0472700604719979,0.00457831317183921,0.0382965666551931,0.0562435542888028,7.07033491015983e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPP1R9B,Neurabin-2,42754,0.0975234140418714,0.00946020212806279,0.0789814178708684,0.116065410212874,7.93982581412296e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",40408,0.113851623886406,0.0110411572734532,0.0922109556304377,0.135492292142374,8.06342764987737e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NAA80,N-alpha-acetyltransferase 80,40182,0.125998911353881,0.0122195140922701,0.102048663733032,0.14994915897473,8.12898005054668e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD72,B-cell differentiation antigen CD72,40283,0.0465084492099246,0.00451315565571228,0.0376626641247285,0.0553542342951207,8.64509492887545e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,42711,0.0990540169200453,0.00963102460939369,0.0801772086856337,0.117930825154457,1.01675898251425e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDT,D-dopachrome decarboxylase,40527,0.0433332716029384,0.00421617894777601,0.0350695608652974,0.0515969823405793,1.13782438479057e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REG1B,Lithostathine-1-beta,42794,0.06102925644216,0.00595014863135999,0.0493669651246944,0.0726915477596256,1.35619015095818e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SRPK2,SRSF protein kinase 2,42594,0.0861610695180944,0.00841210185219645,0.0696733498877894,0.102648789148399,1.57458997233534e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APLP1,Amyloid-like protein 1,42636,-0.0536323338694463,0.00524090812296768,-0.063904513790463,-0.0433601539484297,1.72763201156238e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK14,Kallikrein-14,42721,-0.0489558805525224,0.00478668315037137,-0.0583377795272503,-0.0395739815777945,1.83271224577263e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGR,Tyrosine-protein kinase Fgr,42311,0.0594405216425559,0.00581554004016194,0.0480420631638384,0.0708389801212733,1.97208249096669e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFX1,Transcriptional repressor NF-X1,40116,0.0705611277057073,0.00690292742510481,0.0570313899525018,0.0840908654589127,2.0373781017814e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DLK1,Protein delta homolog 1,42794,0.056928141658728,0.00557994040419172,0.0459914584665123,0.0678648248509438,2.36998450298828e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,42676,0.0407115900373466,0.00399851254681188,0.0328745054455953,0.0485486746290979,2.92991121913863e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,42611,0.0520478819068219,0.005111907937395,0.0420285423495276,0.0620672214641161,2.93246110431452e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,40283,0.0310456216435339,0.00305028150364843,0.025067069896383,0.0370241733906848,3.17813598739646e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEL1L,Protein sel-1 homolog 1,40223,0.0337796304589687,0.00332087160369481,0.0272707221157269,0.0402885388022105,3.38393907712644e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,40449,0.142534219257158,0.0140150128217326,0.115064794126562,0.170003644387754,3.42986638368114e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC16A1,Monocarboxylate transporter 1,42311,0.0593248667269581,0.00584771385068945,0.0478633475796068,0.0707863858743094,4.28160142448649e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,S100A14,Protein S100-A14,40482,0.0566098080003903,0.00558263113558882,0.0456678509746363,0.0675517650261444,4.63761200258383e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F10,Coagulation factor X,40532,0.0292943720126682,0.00288923599190194,0.0236314694685404,0.034957274556796,4.68972725936801e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,40302,0.114874437739816,0.0113399377981367,0.0926481596554683,0.137100715824164,5.16616023096629e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,QDPR,Dihydropteridine reductase,42581,0.0435804531208866,0.00430399631880108,0.0351446203360365,0.0520162859057367,5.19188349090271e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GFRA1,GDNF family receptor alpha-1,42689,0.0304724491173793,0.00301071004557141,0.0245714574280593,0.0363734408066992,5.41085376085466e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42611,0.0624401218293861,0.00617278338810926,0.050341466388692,0.0745387772700803,5.75431114475156e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42611,0.0393435679278271,0.00389003744255701,0.0317190945404153,0.0469680413152388,5.84016321312478e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLSCR3,Phospholipid scramblase 3,40457,0.0594169623139415,0.00587590011746593,0.0479001980837083,0.0709337265441747,6.18499594393032e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RPL14,60S ribosomal protein L14,40223,0.0411486318632955,0.00407117963905887,0.0331691197707401,0.0491281439558509,6.51678684770361e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,40527,-0.0340494919857003,0.00336927294534559,-0.0406532669585776,-0.0274457170128229,6.56841542516827e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42495,0.0545027306336794,0.00539661072737592,0.0439253736080226,0.0650800876593361,6.7749622453465e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IDS,Iduronate 2-sulfatase,42754,-0.0089465230548627,0.000886583691070764,-0.0106842270893614,-0.007208819020364,7.35026799730857e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,42311,0.0798349116134344,0.00791393689923162,0.0643235952909405,0.0953462279359284,7.63533620726531e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SUSD2,Sushi domain-containing protein 2,42611,-0.0295607590371792,0.00293078217272864,-0.0353050920957274,-0.0238164259786311,7.72413356838403e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLA2G15,Phospholipase A2 group XV,42679,0.0271631635247047,0.00269777108675429,0.0218755321946663,0.0324507948547431,9.21388056098271e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,42346,0.067221867812248,0.00667687742578138,0.0541351880577165,0.0803085475667795,9.34168684231851e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,40482,0.099256077683307,0.0098613249155858,0.0799278808487588,0.118584274517855,9.91390731992073e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,40451,0.0728672593261284,0.00724468384104278,0.0586676789976845,0.0870668396545722,1.06612077371853e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,40511,0.0792852273881353,0.00788944936509736,0.0638219066325445,0.0947485481437262,1.15996597602165e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42754,0.0994634428185724,0.00990638405297544,0.0800469300747405,0.118879955562404,1.22543918226179e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TGFBR2,TGF-beta receptor type-2,42679,0.0365721508430569,0.0036438839985279,0.0294301382059423,0.0437141634801716,1.27393522491149e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD302,CD302 antigen,42587,0.0326584889107406,0.00325635175867892,0.0262760394637299,0.0390409383577513,1.37440775362647e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNST,Consortin,42636,0.110046225509631,0.0109825462313703,0.0885204348961447,0.131572016123116,1.50439947553542e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,42595,0.0329544301523584,0.00329139230852979,0.02650330122764,0.0394055590770767,1.62778446149006e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH15,Cadherin-15,42692,0.0632571027382343,0.00632432117893654,0.0508614332275187,0.0756527722489499,1.79908202431179e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDHR5,Cadherin-related family member 5,42636,0.0392983032594547,0.00392973193975436,0.0315960286575362,0.0470005778613732,1.8359558678382e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,40199,0.0541002082173988,0.00540866609399246,0.0434992226731736,0.064701193761624,1.87115401071338e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,42311,0.0614676991708587,0.00615977011307493,0.0493945497492318,0.0735408485924856,2.28420956961748e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GOLM2,Protein GOLM2,42711,0.0233173150110276,0.00233778476215527,0.0187352568772032,0.0278993731448519,2.38275837282494e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIAE,Sialate O-acetylesterase,42646,0.0462879311987426,0.00464333825775722,0.0371869882135385,0.0553888741839468,2.51795142756191e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,40223,0.0751885552669905,0.00754828453288257,0.0603939175825407,0.0899831929514404,2.83079026685081e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANGPT2,Angiopoietin-2,42721,0.0380890879599137,0.00383606062465253,0.0305704091355947,0.0456077667842326,3.72836631039675e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",40483,0.042244005566629,0.0042533082089209,0.0339075214771441,0.050580489656114,3.7581505543905e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42587,0.0535924701182265,0.00540138515258839,0.0430057552191533,0.0641791850172997,4.01390215429205e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42611,0.045415341931031,0.00458214057546761,0.0364343464031145,0.0543963374589475,4.45880708571269e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,40451,0.114082533504128,0.0115192550614199,0.0915047935837453,0.136660273424511,4.98544520127197e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL18,Interleukin-18,42566,0.0466226683696777,0.00470999099115656,0.0373910860270109,0.0558542507123446,5.06160370954887e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,42674,0.072583476295159,0.00735228044325241,0.0581730066263842,0.0869939459639337,6.56840914504204e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NIT2,Omega-amidase NIT2,40462,0.0731102753638559,0.00740925520346356,0.0585881351650673,0.0876324155626444,7.13329660711616e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ULBP2,UL16-binding protein 2,42495,0.039967291061477,0.00405403218777632,0.0320213879734354,0.0479131941495186,7.53145663339095e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42746,0.040389126104074,0.0040983162808915,0.0323564261935267,0.0484218260146213,7.77827028646803e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLA2,Src-like-adapter 2,40482,0.103649227864191,0.0105214884968876,0.0830271104102914,0.124271345318091,8.3700633828134e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TDRKH,Tudor and KH domain-containing protein,42311,0.084362133419319,0.00857815093955019,0.0675489575778007,0.101175309260837,9.58025364576282e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CBS,Cystathionine beta-synthase,40223,0.0513907582965508,0.00522416343944959,0.0411513979552296,0.061630118637872,9.66265256960015e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HLA_E,,42594,0.0306537865654346,0.00312308295138296,0.024532543980724,0.0367750291501452,1.15432790228467e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DAG1,Dystroglycan,42676,0.045573991711871,0.0046481447361521,0.0364636280290129,0.0546843553947291,1.27813450445684e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,42613,0.0805363571979803,0.00822648223902197,0.0644124520094972,0.0966602623864633,1.48059515240376e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,42611,0.0231020574225323,0.002362077134356,0.0184723862391946,0.0277317286058701,1.6251908240759e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMP1,Interstitial collagenase,42136,0.0906704470081893,0.00927878215788349,0.0724840339787377,0.108856860037641,1.77928655501843e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERBIN,Erbin,42587,0.100744574350238,0.0103134925843856,0.0805301288848422,0.120959019815634,1.8316969103227e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VSNL1,Visinin-like protein 1,40483,0.0380630576162919,0.00389766118554158,0.0304236416926304,0.0457024735399534,1.94029996902112e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,42711,0.0515217694977872,0.00527997820249371,0.0411730122208995,0.0618705267746749,2.0225260874415e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPP1,Tripeptidyl-peptidase 1,42545,0.0445086430129752,0.00457635634191483,0.0355389845828221,0.0534783014431282,2.77554414608502e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDCD5,Programmed cell death protein 5,42711,0.0566416478248774,0.00582565343368012,0.0452233670948644,0.0680599285548904,2.85160940245949e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP6AP2,Renin receptor,42346,0.0397965974623262,0.00409388367528688,0.0317725854587639,0.0478206094658885,2.91584964258131e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL3A1,Collagen alpha-1(III) chain,40527,0.0230517462923803,0.00237571322375125,0.0183953483738279,0.0277081442109328,3.56776125778355e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCN4,CCN family member 4,42721,0.0393919773735579,0.00406167495724348,0.0314310944573606,0.0473528602897551,3.61440993039431e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42587,0.0751603006938371,0.007759402895132,0.0599518710193784,0.0903687303682958,4.07271902882859e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLAU,Urokinase-type plasminogen activator,42611,-0.0289794937989884,0.00299388558805378,-0.0348475095515738,-0.023111478046403,4.34924241668816e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TCOF1,Treacle protein,40511,0.0316935276693733,0.00327504288020889,0.0252744436241638,0.0381126117145827,4.58475440423112e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,40058,0.0523322882564017,0.00540994904392515,0.0417287881303084,0.062935788382495,4.80244846680215e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FOXO1,Forkhead box protein O1,42594,0.0824842010487587,0.0085653261398882,0.0656961618145778,0.0992722402829396,7.03052316085654e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,L1CAM,Neural cell adhesion molecule L1,42679,-0.0286348789764882,0.00297529636279501,-0.0344664598475664,-0.02280329810541,7.42832925971974e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLXNA4,Plexin-A4,42594,0.0794594609523198,0.00827617707780222,0.0632381538798275,0.0956807680248122,9.30350965976779e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNC,Tenascin,42689,-0.0470947299951384,0.00491130210872971,-0.0567208821282487,-0.0374685778620282,1.04249928781857e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,42357,0.0564748891628761,0.00589644653315188,0.0449178539578984,0.0680319243678538,1.16649350760741e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,42594,0.0408203318510222,0.00426226658967925,0.0324662893352508,0.0491743743667935,1.17035870849443e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,42654,-0.0436044995157585,0.00455570721665478,-0.0525336856604019,-0.0346753133711152,1.2358762777956e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BMP10,Bone morphogenetic protein 10,40283,-0.027996189988691,0.00293364097694315,-0.0337461263034996,-0.0222462536738824,1.67550681376445e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPARCL1,SPARC-like protein 1,42644,-0.0268555507866354,0.00281520894714684,-0.0323733603230432,-0.0213377412502276,1.67929500351824e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TALDO1,Transaldolase,40499,0.042613038037714,0.00446668694752001,0.0338583316205748,0.0513677444548533,1.71751369394431e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD27,CD27 antigen,42679,0.0429037883072751,0.00450029059519218,0.0340832187406984,0.0517243578738517,1.7760431929953e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCGN,Secretagogin,42370,0.0438023253097198,0.00459517203300504,0.0347957881250299,0.0528088624944097,1.8050058058203e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PALM2,Paralemmin-2,40483,0.0363482288809588,0.00383392216589909,0.0288337414357965,0.043862716326121,3.03004291666035e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DGKA,Diacylglycerol kinase alpha,40199,0.0526051223512801,0.0055526676881294,0.0417218936825465,0.0634883510200138,3.24878583878038e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSE,Cathepsin E,40283,0.0494334194862745,0.00522228989688887,0.0391977312883723,0.0596691076841767,3.50015422074138e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STAB2,Stabilin-2,40527,0.0269129541547526,0.00284644845697529,0.021333915179081,0.0324919931304242,3.86728253500815e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NRP2,Neuropilin-2,42611,-0.0275610115465575,0.00291659270740068,-0.0332775332530628,-0.0218444898400522,3.95168000210981e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,42611,-0.0430495424997508,0.00455618500333526,-0.0519796651062879,-0.0341194198932137,3.99448165581941e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,40290,0.042430926926599,0.00449150837365646,0.0336275705142324,0.0512342833389657,4.18794968287457e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ISM1,Isthmin-1,42594,0.0367598670948737,0.00389329355060313,0.0291290117356916,0.0443907224540559,4.25945589070214e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATG16L1,Autophagy-related protein 16-1,40449,0.080731400896998,0.00855837205566627,0.0639569916678921,0.0975058101261039,4.76433507883107e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",40449,0.0999689011092758,0.0106079175202458,0.079177382769594,0.120760419448958,5.18974223472742e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42636,0.06027004362736,0.00640330884313037,0.0477195582948244,0.0728205289598955,5.63011138065792e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,A1BG,Alpha-1B-glycoprotein,40539,0.0162510811323177,0.00172885518870078,0.0128625249624642,0.0196396373021713,6.50551220477443e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDGFC,Platelet-derived growth factor C,42346,0.0271809181885317,0.00289354944523914,0.021509561275863,0.0328522751012004,6.73969971522807e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,40451,0.0456517807447564,0.0048692314957937,0.0361080870130008,0.0551954744765121,8.1932976865131e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KAZN,Kazrin,40449,0.098682352307419,0.0105649448378654,0.0779750604252029,0.119389644189635,1.13831000223702e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,40283,0.0741244760411511,0.00794024130957417,0.0585616030743857,0.0896873490079165,1.19880473904222e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNMBP,Dynamin-binding protein,42495,0.0565784118518559,0.00606335566004486,0.044694234758168,0.0684625889455439,1.21022782373038e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LYN,Tyrosine-protein kinase Lyn,42587,0.0792658058795372,0.00849546183939971,0.0626147006743137,0.0959169110847606,1.21851823606785e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,40030,0.0317458515012653,0.00340513062925247,0.0250717954679304,0.0384199075346001,1.35109274240649e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42495,0.0410970358286081,0.00441145463082881,0.0324505847521836,0.0497434869050325,1.39569721078172e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NME3,Nucleoside diphosphate kinase 3,42638,-0.0226432641401743,0.00243753703336359,-0.027420836725567,-0.0178656915547817,1.7866192596353e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,42711,0.0612027929318438,0.00659031138438381,0.0482857826184515,0.074119803245236,1.82945954079394e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL10,C-X-C motif chemokine 10,42676,0.0637614129179848,0.00686601832759485,0.0503040169958989,0.0772188088400707,1.83463192247184e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TAX1BP1,Tax1-binding protein 1,40483,0.0595051488757183,0.00640686402077856,0.0469476953949923,0.0720626023564442,1.86418485982931e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLB1,Beta-galactosidase,42495,0.0388366422469162,0.00418782694194626,0.0306285014407015,0.0470447830531309,2.07157539675896e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NCAM1,Neural cell adhesion molecule 1,42689,-0.0284805912624543,0.00307502937157052,-0.0345076488307325,-0.0224535336941761,2.30767170434459e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OSM,Oncostatin-M,42534,0.0657204277233685,0.00709651276138984,0.0518112627110445,0.0796295927356926,2.33181403685931e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADD1,Alpha-adducin,40283,0.0669817418172266,0.00723405808400549,0.0528029879725759,0.0811604956618774,2.43769381626458e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,40116,0.0582128313895325,0.00629013887780664,0.0458841591890314,0.0705415035900335,2.55072952836333e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,40511,0.0592801086742874,0.00641300688151039,0.0467106151865271,0.0718496021620478,2.80534645265395e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,40482,0.049805231722349,0.00538866320389331,0.0392434518427182,0.0603670116019799,2.83625509279651e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EHBP1,EH domain-binding protein 1,40511,0.0695797166361041,0.00752860720957315,0.0548236465053407,0.0843357867668674,2.84960514787131e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",42311,0.0482469968293368,0.00522543369841002,0.0380051467804532,0.0584888468782205,3.02739495055345e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,40287,0.0606383070038923,0.00658824684059063,0.0477253431963347,0.07355127081145,4.06563541113151e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLRD1,Natural killer cells antigen CD94,42754,0.0438730750656947,0.00477439112384682,0.034515268462955,0.0532308816684345,4.5231604115794e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,42636,0.0323734044053655,0.00352390330315422,0.0254665539311833,0.0392802548795478,4.63200305879526e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,40283,0.0617976742392652,0.00672634659200065,0.0486140349189439,0.0749813135595865,4.73953352356469e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,42594,0.0353315999863639,0.00384709584063447,0.0277912921387204,0.0428719078340075,4.75690795718732e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,42587,0.127272942328383,0.0138586031793359,0.100110080096885,0.154435804559881,4.76995978625271e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BMPER,BMP-binding endothelial regulator protein,40283,0.0216631314795671,0.00236469033236114,0.0170283384281393,0.0262979245309949,6.03976445284378e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINH1,Serpin H1,40302,0.119915942603017,0.0130899157296164,0.0942597077729687,0.145572177433065,6.04617332638622e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42679,0.0261803351742524,0.00286326262886559,0.0205683404216758,0.0317923299268289,6.89825890672978e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHAD,Chondroadherin,40283,-0.0484340975680083,0.00530200039051804,-0.0588260183334237,-0.038042176802593,7.67078206507575e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",40223,0.0344265090830265,0.00376909072715981,0.0270390912577933,0.0418139269082598,7.75941276296981e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,42311,0.0616278145361116,0.00675784956015262,0.0483824293982125,0.0748731996740107,8.63754845435621e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,40483,0.0991171980720634,0.0108679495556688,0.0778160169429526,0.120418379201174,8.77055717377822e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,40283,0.0535006953896811,0.00587318576760728,0.0419892512851708,0.0650121394941913,9.71113648884712e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SHISA5,Protein shisa-5,40527,0.0257833986093962,0.00283214558307899,0.0202323932665614,0.0313344039522311,1.01752987580681e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL25,C-C motif chemokine 25,42754,0.0442624513892899,0.00486371106831381,0.0347295776953949,0.053795325083185,1.02246809434878e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL9,C-X-C motif chemokine 9,42676,0.0626592421247331,0.00689226405722632,0.0491504045725695,0.0761680796768967,1.11417350803424e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,40483,0.0817335574102585,0.0089892495317716,0.0641146283279861,0.0993524864925308,1.1306761792941e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,40511,0.0272340763555071,0.00299927659576683,0.0213554942278041,0.0331126584832101,1.26282549741958e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HNMT,Histamine N-methyltransferase,42439,0.0440184453464425,0.00485896085700816,0.0344948820667065,0.0535420086261785,1.49564954961865e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BRAP,BRCA1-associated protein,40342,0.100047836836386,0.0110514505302347,0.078386993797126,0.121708679875646,1.62302311065945e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",40136,0.0748201988716175,0.00826827764137411,0.0586143746945242,0.0910260230487108,1.68563660388734e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CES2,Cocaine esterase,42587,0.0503480215595068,0.00556670425344968,0.0394372812227454,0.0612587618962682,1.70795432687368e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSF,Cathepsin F,42679,0.0363812585859553,0.00402329239152855,0.0284956054985593,0.0442669116733512,1.73520481426585e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DKK1,Dickkopf-related protein 1,42711,0.0536624453257135,0.00594313500478458,0.0420139007163358,0.0653109899350913,1.95833835223962e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GOLGA3,Golgin subfamily A member 3,40482,0.0717487269326553,0.00795125057630468,0.0561642758030981,0.0873331780622124,2.11444357284933e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PENK,Proenkephalin-A,40283,0.0301336460835824,0.00334022123831344,0.0235868124564881,0.0366804797106767,2.16134612655338e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SORT1,Sortilin,42613,0.0337821904632269,0.00374691679265784,0.0264382335496175,0.0411261473768362,2.21198912351209e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,42654,0.0473421594356393,0.00525882768513203,0.0370348571727806,0.0576494616984981,2.50073913712177e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42569,0.0698140344609581,0.00775499998945012,0.0546142344816359,0.0850138344402804,2.50185957974855e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TFF1,Trefoil factor 1,42556,0.0758417060464105,0.00842992017996447,0.0593190624936801,0.0923643495991408,2.63528474817883e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THBS2,Thrombospondin-2,42611,0.0354179578712527,0.00394507373546712,0.0276856133497372,0.0431503023927683,3.12649292037184e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL22,C-C motif chemokine 22,42509,0.0483730016340418,0.00538837773313097,0.0378117812771051,0.0589342219909785,3.14313595674433e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINA9,Serpin A9,42538,0.0653762667774779,0.00728867368435731,0.0510904663561375,0.0796620671988182,3.36895204241316e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BOC,Brother of CDO,42357,-0.0213464040512229,0.00238977097659539,-0.0260303551653498,-0.0166624529370959,4.71603054472607e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,40283,0.0196765195853709,0.00220272995046936,0.0153591688824509,0.0239938702882908,4.80910877979158e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,40483,0.036173639723589,0.00405150906369328,0.0282326819587501,0.0441145974884278,4.98779707455759e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42495,0.0854585653824917,0.00957823233982214,0.0666852299964404,0.104231900768543,5.163871340735e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,METAP2,Methionine aminopeptidase 2,42689,0.0513865804304011,0.00576308400760614,0.0400909357754931,0.0626822250853091,5.42340919840922e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42587,-0.0178355761558998,0.00200033432242947,-0.0217562314278615,-0.013914920883938,5.43855118595153e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42587,0.0307453983229503,0.00345464136334238,0.0239743012507992,0.0375164953951014,6.30897520442427e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,40527,-0.0246004177567664,0.00276353707406722,-0.0300169504219382,-0.0191838850915947,6.32977143854214e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COCH,Cochlin,40511,0.0424016688977334,0.00476545435774306,0.033061378356557,0.0517419594389098,6.56574333964818e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,40283,0.0346967231198475,0.00390321708560592,0.02704641763206,0.0423470286076351,7.10174280617498e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PQBP1,Polyglutamine-binding protein 1,42346,0.0513013413189938,0.00577768300897352,0.0399770826214057,0.0626256000165819,7.59623359646291e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SYTL4,Synaptotagmin-like protein 4,40511,0.0664481071770634,0.00748509141868866,0.0517773279964336,0.0811188863576932,7.87315426991444e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OGFR,Opioid growth factor receptor,42587,0.0292639261739482,0.00329841631974925,0.0227990301872397,0.0357288221606567,8.07685079451974e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINB8,Serpin B8,42754,0.0519252546486166,0.00585286126574865,0.0404536465677493,0.063396862729484,8.08978784950039e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42594,0.0344064915960527,0.00388096596739823,0.0267997982999522,0.0420131848921532,8.57172944050663e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,40532,0.058953427754449,0.00666100794624493,0.0458978521798089,0.072009003329089,1.0000678675312e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AP3B1,AP-3 complex subunit beta-1,40449,0.0686350085908437,0.00775533443869562,0.0534345530910003,0.0838354640906872,1.00543913814652e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COMP,Cartilage oligomeric matrix protein,42511,-0.0302987503421093,0.00342816862680058,-0.0370179608506385,-0.0235795398335802,1.09372993015863e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,40483,0.0805628661378216,0.00911336657529442,0.0627006676502445,0.0984250646253986,1.09811920419136e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,42706,0.0594468180552875,0.00672862309136495,0.0462587167962122,0.0726349193143628,1.12400075998424e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,42370,0.060870905275656,0.00689089417817696,0.0473647526864292,0.0743770578648829,1.14129226439825e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SELP,P-selectin,42689,0.0500797830317222,0.00567361363033909,0.0389595003162576,0.0612000657471868,1.20839970257571e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RLN2,Prorelaxin H2,40257,0.0449217664924341,0.00508811396991608,0.0349490631113985,0.0548944698734696,1.21759582502723e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB27B,Ras-related protein Rab-27B,40511,0.0737099749175786,0.00835753221298162,0.0573292117801346,0.0900907380550225,1.31680017656171e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,42357,0.0440363830115,0.00499623949210517,0.0342437536069739,0.0538290124160261,1.35873928426789e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42495,0.0513925295395025,0.00583108843828899,0.0399635962004561,0.0628214628785489,1.36150812889127e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,40449,0.042023248609414,0.00476959182067294,0.032674848640895,0.0513716485779329,1.42630224770483e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,B2M,Beta-2-microglobulin,40539,0.0280990244393471,0.00319894804913474,0.0218290862630431,0.0343689626156512,1.80644734322928e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SH2B3,SH2B adapter protein 3,42346,0.0865073720500148,0.00985626708029531,0.0671890885726359,0.105825655527394,1.88588851383474e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAM3D,Protein FAM3D,40449,0.0766195757616446,0.0087358783281544,0.059497254238462,0.0937418972848273,2.03105956469514e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42495,0.0402930740035412,0.00459925035746246,0.0312785433029148,0.0493076047041677,2.17112613258008e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,JAM3,Junctional adhesion molecule C,40283,0.0452435528012977,0.00516516633642364,0.0351198267819074,0.0553672788206881,2.2486409915089e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NIT1,Deaminated glutathione amidase,40223,0.0422381507711054,0.00482206844432091,0.0327868966202364,0.0516894049219744,2.25063734245675e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LGALS8,Galectin-8,42711,0.0530460836694134,0.00605898265204459,0.041170477671406,0.0649216896674208,2.28181778888552e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CX3CL1,Fractalkine,42495,-0.0304902565492973,0.00349466222992112,-0.0373397945199427,-0.0236407185786519,2.98034231234197e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TFF2,Trefoil factor 2,42654,0.0516392241676917,0.00592705994003102,0.0400221866852309,0.0632562616501525,3.31754479960578e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLIN1,Perilipin-1,42311,0.0308945419464322,0.00354885145287836,0.0239387930987906,0.0378502907940738,3.53603334561385e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DOK2,Docking protein 2,42636,0.106012725677047,0.0121837890757201,0.0821324990886357,0.129892952265459,3.664385629962e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ICAM4,Intercellular adhesion molecule 4,42594,-0.046468252734363,0.00535146068746489,-0.0569571156817942,-0.0359793897869319,4.28550479203822e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RFC4,Replication factor C subunit 4,40451,0.0186372930168692,0.0021489889215267,0.0144252747306769,0.0228493113030616,4.80280507515446e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,40199,0.0431107463840405,0.00497791922964522,0.0333540246939358,0.0528674680741451,5.35715883849495e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL20,C-C motif chemokine 20,42754,0.0805247860329986,0.00930474551542826,0.0622874848227592,0.098762087243238,5.51939819051573e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,42370,0.0341891270518055,0.00395060239121145,0.026445946365031,0.0419323077385799,5.53674973219792e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,42495,0.0503057760909168,0.00581464160119708,0.0389090785525705,0.061702473629263,5.65719539554724e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TF,Serotransferrin,40539,0.0187748182811738,0.00217098039082405,0.0145196967151587,0.023029939847189,5.94034728244913e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,42754,0.0481313828784025,0.00556892207804173,0.0372162956054407,0.0590464701513643,6.09094765726609e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VCAN,Versican core protein,42711,-0.0268237571158936,0.00310685370077114,-0.0329131903694051,-0.0207343238623822,6.59616748906663e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RASSF2,Ras association domain-containing protein 2,42346,0.0495709674614081,0.00576173662118762,0.0382779636838803,0.0608639712389358,8.60318142232999e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,42654,-0.0758594460634706,0.00884427164999939,-0.0931942184974694,-0.0585246736294718,1.07705132420115e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VEGFD,Vascular endothelial growth factor D,42734,-0.0314049424934806,0.00366409093100577,-0.0385865607182519,-0.0242233242687093,1.13598551170903e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OGA,Protein O-GlcNAcase,40449,0.0609024712969449,0.00710640087038399,0.0469739255909923,0.0748310170028975,1.1688723578349e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,42476,0.0960793358057122,0.0112235632869116,0.0740811517633654,0.118077519848059,1.24624633022528e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,40482,0.0420956071988806,0.00492433220379661,0.0324439160794393,0.0517472983183219,1.40745149967439e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NSFL1C,NSFL1 cofactor p47,42711,0.0561047347609402,0.00656727294879154,0.0432328797813087,0.0689765897405716,1.44557910447102e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,42618,-0.0329758754806126,0.00386264472099334,-0.0405466591337596,-0.0254050918274657,1.52267797793923e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CETN2,Centrin-2,42311,0.0580979062723135,0.00682937311702873,0.0447123349629372,0.0714834775816898,1.97589000505964e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHCHD6,MICOS complex subunit MIC25,40451,0.0250359124429013,0.0029425108722116,0.0192685911333665,0.030803233752436,1.98735553940732e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADA,Adenosine deaminase,42754,0.0299013253416978,0.00351710246496319,0.0230078045103699,0.0367948461730256,2.06210834263455e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,40449,0.0654473194434033,0.00770593615383898,0.0503436845818789,0.0805509543049276,2.26445575017947e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C4BPB,C4b-binding protein beta chain,42679,-0.0346961182569922,0.00409367729856155,-0.0427197257621728,-0.0266725107518115,2.58079663115764e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",42676,0.0243753293195555,0.00287666483579513,0.018737066241397,0.0300135923977139,2.62689274764064e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CMIP,C-Maf-inducing protein,40451,0.0712714475731722,0.0084091976047682,0.0547894202678266,0.0877534748785179,2.63385820134379e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,42586,0.0163153041665633,0.00192695140799344,0.0125384794068962,0.0200921289262305,2.78028314237674e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',40483,0.0371681499774595,0.00439170721378589,0.0285604038384392,0.0457758961164799,2.92071902955383e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL4,C-C motif chemokine 4,42642,0.058803991768004,0.00695224135820025,0.0451775987059315,0.0724303848300764,2.99128978533797e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANXA2,Annexin A2,40054,0.0624638653172917,0.00738350927079056,0.0479921871465422,0.0769355434880412,3.01886102880482e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,42357,0.0795315278280736,0.00940453718932092,0.0610986349370046,0.0979644207191426,3.03770414026208e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NCK2,Cytoplasmic protein NCK2,42676,0.0895793621654495,0.010599806479202,0.0688037414662135,0.110354982864685,3.18096373343339e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEMIP2,Cell surface hyaluronidase,40199,0.0296255945269107,0.00350618902274097,0.0227534640423384,0.036497725011483,3.29319633853358e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAMR1,Inactive serine protease PAMR1,42611,0.0229022389444102,0.0027131319072594,0.0175845004061818,0.0282199774826387,3.4589291167021e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42721,0.0298634722995599,0.00353977918515239,0.0229255050966613,0.0368014395024586,3.59785334968563e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SFRP4,Secreted frizzled-related protein 4,40283,0.0346269101542944,0.00410648022654558,0.026578208910265,0.0426756113983237,3.81008696680136e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD160,CD160 antigen,42754,0.0420125264606166,0.00498394870411301,0.0322439870005551,0.0517810659206781,3.81663179368817e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,40502,-0.0130561420088923,0.00154900458804257,-0.0160921910014558,-0.0100200930163289,3.91721160048396e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,42611,0.0314614489822379,0.00373508079863318,0.0241406906169168,0.0387822073475589,4.03179331881492e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NADK,NAD kinase,42636,0.0467701456742262,0.00555819740670559,0.0358760787570833,0.0576642125913692,4.33663843381532e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ESYT2,Extended synaptotagmin-2,40483,0.0702284494241201,0.00834452803889221,0.0538731744678914,0.0865837243803489,4.36085462522229e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42679,0.0814114701384631,0.0096779393594336,0.0624427089939733,0.100380231282953,4.43045006538647e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MFAP5,Microfibrillar-associated protein 5,42794,0.0351326757990477,0.00417705325409133,0.0269456514210287,0.0433197001770667,4.47184796382756e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,42754,0.0568130765788016,0.00676087899634252,0.0435617537459702,0.0700643994116329,4.77352699607835e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,40449,0.0703767317669791,0.00838391706439615,0.0539442543207627,0.0868092092131956,5.24913897649766e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42673,-0.0276980472987823,0.00330206474722507,-0.0341700942033434,-0.0212260003942211,5.42807133757688e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NCF2,Neutrophil cytosol factor 2,42578,0.0703268579532186,0.00839751194541104,0.053867734540213,0.0867859813662242,6.08179912896074e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COMMD1,COMM domain-containing protein 1,40223,0.0513177158441161,0.00613379853368942,0.0392954707180848,0.0633399609701474,6.65697955065491e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STK11,Serine/threonine-protein kinase STK11,42357,0.0614664547633709,0.00735795162566834,0.0470448695770609,0.0758880399496808,7.27074627183367e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,42676,0.0236468374208385,0.00283311362338527,0.0180939347190033,0.0291997401226736,7.70520469936247e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IMPACT,Protein IMPACT,40483,0.0474689410357585,0.00568584000820829,0.0363246946196703,0.0586131874518468,7.7108650582803e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,40223,0.064649395308309,0.00774532913707986,0.0494685501996324,0.0798302404169855,7.84455553341887e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CALB2,Calretinin,42311,0.0272337154268965,0.00326408124380633,0.0208361161890361,0.0336313146647569,7.93147203597336e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,42676,0.104516279676225,0.0125273585800462,0.0799626568593348,0.129069902493116,7.93879132418196e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNF,Tumor necrosis factor,42339,0.0326424354844038,0.00391936580676878,0.024960478503137,0.0403243924656706,8.99249063003174e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,42676,0.0237492247310546,0.00285361055603879,0.0181561480412186,0.0293423014208906,9.43374235594145e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AAMDC,Mth938 domain-containing protein,40223,0.0448817080092566,0.00539999204949194,0.0342977235922524,0.0554656924262608,1.0562863864885e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,40483,0.0262007405843467,0.00315313583524435,0.0200205943472677,0.0323808868214256,1.07154990161595e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL1A1,Collagen alpha-1(I) chain,42794,-0.0211801914970548,0.00255087429599117,-0.0261799051171975,-0.0161804778769121,1.10925830891348e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VASN,Vasorin,42449,-0.0232110850799675,0.00280317467849981,-0.0287053074498271,-0.0177168627101079,1.345770023791e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",40482,0.0667685323745886,0.00807563871263969,0.0509402804978148,0.0825967842513624,1.51602550541141e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATXN3,Ataxin-3,40483,0.0522249679615859,0.00631671840724132,0.0398441998833929,0.0646057360397789,1.51800529104349e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,40449,0.09123155709822,0.011035335142033,0.0696023002198354,0.112860813976605,1.52503412493775e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD6,T-cell differentiation antigen CD6,42746,0.0442056296177809,0.00534937436770656,0.0337208558570761,0.0546904033784858,1.54251564488586e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39983,0.0414753287398446,0.00502150628125057,0.0316331764285935,0.0513174810510958,1.63324462409656e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42495,0.0600464147560871,0.00727573016752259,0.0457859836277428,0.0743068458844314,1.68954917609685e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42611,0.0325831792506948,0.00395158171266226,0.0248380790938767,0.0403282794075128,1.79507445724778e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OTUD7B,OTU domain-containing protein 7B,40482,0.0518070795543316,0.00628738317842158,0.0394838085246253,0.0641303505840379,1.91455741526245e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLF4,Krueppel-like factor 4,40136,0.0336599609024928,0.00408544844960852,0.0256524819412601,0.0416674398637255,1.93464241478574e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,40199,0.0367427015969549,0.00446199307800959,0.0279971951640561,0.0454882080298537,2.00529954129762e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMSB10,Thymosin beta-10,42611,0.061809207611348,0.00750858332928966,0.0470923842859403,0.0765260309367558,2.01328547013025e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42657,0.0857170538959442,0.0104134208381764,0.0653067490531185,0.10612735873877,2.01946332315308e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AZI2,5-azacytidine-induced protein 2,40482,0.0459894169705931,0.00559152586842552,0.035030026268479,0.0569488076727071,2.16851464548513e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGA5,Integrin alpha-5,42611,0.0208749409192231,0.00253997558715775,0.0158965887683939,0.0258532930700522,2.24732306685046e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,40199,0.0741845252890432,0.00904211602073281,0.0564619778884069,0.0919070726896795,2.57685043210979e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WDR46,WD repeat-containing protein 46,40451,0.0298671445313023,0.00365782575288563,0.0226978060556464,0.0370364830069581,3.54887565152619e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,42754,0.039718226653544,0.00486924405340896,0.0301745083088624,0.0492619449982255,3.73588974947797e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL7,C-C motif chemokine 7,42594,0.0488261880271491,0.00599022721554277,0.0370853426846853,0.060567033369613,3.9284911006598e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TADA3,Transcriptional adapter 3,40451,0.0327701379997317,0.00402027573999412,0.0248903975493433,0.0406498784501202,3.98403316055275e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARSA,Arylsulfatase A,42611,0.0367836063022316,0.0045185988205542,0.0279271526139453,0.0456400599905178,4.28182455667109e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,42357,0.0350015365680694,0.00429996238634438,0.0265736102908344,0.0434294628453044,4.30733024590974e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,42192,0.0707698336135989,0.00869880121434534,0.0537201832334821,0.0878194839937158,4.46993708476554e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,42594,0.0912456039043015,0.0112271708392875,0.069240349059298,0.113250858749305,4.77562994202227e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD83,CD83 antigen,42594,0.0291098069256048,0.00358289134737537,0.0220873398847491,0.0361322739664605,4.87633795319982e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPOCK1,Testican-1,42495,-0.0212101307414687,0.00261486229101754,-0.0263352608318631,-0.0160850006510743,5.44109725123366e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL18BP,Interleukin-18-binding protein,42689,0.0266466171825456,0.00328975932766984,0.0201986889003128,0.0330945454647785,5.97139176604875e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,40532,0.0224398940898065,0.00276986870256666,0.0170109514327759,0.0278688367468372,5.98792774090104e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZNRD2,Protein ZNRD2,40449,0.057317500937254,0.00708511307226261,0.0434306793156193,0.0712043225588887,6.58661275652381e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAM13A,Protein FAM13A,40449,0.0552324196767855,0.0068324425827439,0.0418408322146075,0.0686240071389636,6.91726709843036e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDHD2,Phospholipase DDHD2,40482,0.0537916246202076,0.00665814997410349,0.0407416506709648,0.0668415985694505,7.19030163173746e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OPLAH,5-oxoprolinase,40223,0.0555263391238674,0.00687882985270075,0.0420438326125739,0.0690088456351608,7.62976424241479e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MDK,Midkine,42638,0.0417606150568476,0.00518056345243587,0.0316067106900733,0.0519145194236219,8.20175093905832e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,40449,0.0327035454292648,0.00405706259291027,0.0247517027471606,0.0406553881113689,8.33944246881844e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ASS1,Argininosuccinate synthase,40116,0.0637568881242581,0.00792013106910132,0.0482334312288195,0.0792803450196967,9.13965662566124e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,42346,0.0473400900413202,0.00589314795672808,0.0357895200461332,0.0588906600365073,1.03114817689544e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,40302,0.0428761223816466,0.00536224801492262,0.0323661162723982,0.0533861284908949,1.41352273731741e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,40223,0.0264089883322186,0.00330382976195003,0.0199334819987966,0.0328844946656407,1.44302069566136e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42676,0.0224923404571092,0.00281490125482091,0.0169751339976602,0.0280095469165582,1.45304757997479e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRTAC1,Cartilage acidic protein 1,42794,-0.0242813349923177,0.00303960669378693,-0.0302389641121401,-0.0183237058724953,1.4773728525923e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,42370,0.0485719504619141,0.00608626977913644,0.0366428616948066,0.0605010392290215,1.57640386762155e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EREG,Proepiregulin,42476,0.0649161674983267,0.00813800684048499,0.0489656740909761,0.0808666609056773,1.62266181368773e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GMPR2,GMP reductase 2,40283,0.0546699750631064,0.0068518804706805,0.0412402893405726,0.0680996607856402,1.6226750653421e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,42679,0.0267091875327929,0.00334963486759417,0.0201439031923084,0.0332744718732775,1.66244614398854e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42587,0.0285913059011922,0.00358747633967818,0.021559852275423,0.0356227595269615,1.71787825654658e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATXN2L,Ataxin-2-like protein,40482,0.0390769455085574,0.00490429667521974,0.0294645240251267,0.0486893669919881,1.76896449380416e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,40449,0.0517726510056795,0.00649891852702563,0.0390347706927092,0.0645105313186497,1.79165633205411e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FST,Follistatin,42654,-0.0398001382696566,0.00499823450352908,-0.0495966778965736,-0.0300035986427397,1.81552485142328e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCDH17,Protocadherin-17,42636,0.0301231944308618,0.0037911906502338,0.0226924607564035,0.03755392810532,2.08599137770786e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",40223,0.0520960309478017,0.0065565186924222,0.0392452543106542,0.0649468075849492,2.11909064494123e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,42594,0.0632568669845615,0.0079653543802117,0.0476447723993465,0.0788689615697764,2.15588430505515e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMPRSS5,Transmembrane protease serine 5,42438,-0.0307160376511901,0.00386808354171417,-0.0382974813929498,-0.0231345939094303,2.1683645090664e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,40223,-0.0285715189648006,0.00360056907782704,-0.0356286343573416,-0.0215144035722596,2.30345836563634e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",40482,0.0623711107165647,0.00786274092343133,0.0469601385066393,0.0777820829264901,2.35053890252572e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNM3,Dynamin-3,40482,0.0442140631867355,0.0055808734703137,0.0332755511849206,0.0551525751885504,2.5477177977406e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DBI,Acyl-CoA-binding protein,42562,0.0612987082931118,0.00773941288562554,0.0461294590372857,0.0764679575489378,2.55505329574265e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,42357,0.0307035934930112,0.00387689987370699,0.0231048697405455,0.0383023172454769,2.57254304880012e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GASK1A,Golgi-associated kinase 1A,40116,0.0349129189019131,0.0044079180043455,0.026273399613396,0.0435524381904303,2.5950266086985e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42562,0.0542098876085131,0.00684884689462091,0.0407861476950561,0.0676336275219701,2.66247126366283e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",40223,0.0780641779539351,0.00986164260427956,0.0587353584495472,0.097392997458323,2.68898245212186e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GMPR,GMP reductase 1,42754,0.0395703298377434,0.00500300531855502,0.0297644394133756,0.0493762202621113,2.78753634221402e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STAMBP,STAM-binding protein,42476,0.0505090419158081,0.00638683570160663,0.0379908439406592,0.0630272398909571,2.81442989674703e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,42295,0.0461768564587059,0.00584385331811017,0.03472290395521,0.0576308089622018,2.96807506347079e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WASHC3,WASH complex subunit 3,40483,0.0599812661097892,0.00759300912049533,0.0450989682336183,0.07486356398596,3.05890314197457e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,40199,-0.026447128359278,0.00334907374704482,-0.0330113129034858,-0.0198829438150701,3.13236392551339e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPHA2,Ephrin type-A receptor 2,42125,0.0271169082146045,0.00343748801802648,0.0203794316992726,0.0338543847299364,3.30106148143934e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REG1A,Lithostathine-1-alpha,42575,0.0418847238712499,0.00531731877801076,0.0314627790663488,0.0523066686761509,3.60981585720209e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,40173,0.021988494640279,0.00279665494466774,0.0165070509487302,0.0274699383318277,4.12028411063553e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,42586,0.0514830886517742,0.00655029256086431,0.0386445152324801,0.0643216620710682,4.14465014488576e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMP7,Matrilysin,42333,0.040435469216431,0.00514562794396618,0.0303500384462573,0.0505208999866047,4.19837322468915e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATOX1,Copper transport protein ATOX1,42679,0.0553335514998805,0.00705479436068292,0.041506154552942,0.069160948446819,4.71356046151972e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,40449,0.081775421369556,0.010424033858903,0.0613443150061062,0.102206527733006,4.72491412208392e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,40223,0.0466420617518287,0.00594784666721486,0.0349842822840876,0.0582998412195698,4.84912256850802e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LARP1,La-related protein 1,40451,0.0488218270677618,0.00622836897939356,0.0366142238681505,0.0610294302673732,4.96548464534794e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CFHR5,Complement factor H-related protein 5,40382,-0.0338249227030697,0.0043185110922169,-0.0422892044438149,-0.0253606409623246,5.21302219479357e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLIN3,Perilipin-3,42636,0.0334673872415928,0.00427944721438443,0.0250796707013993,0.0418551037817863,5.652300096596e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,40283,0.0564560509931317,0.00722225539124162,0.0423004304262982,0.0706116715599653,5.90113331811786e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,42721,0.0423815877198212,0.00543001274189547,0.0317387627457061,0.0530244126939363,6.38234581039893e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCN2,CCN family member 2,42624,0.0436731030724547,0.00559720236641019,0.0327025864342907,0.0546436197106187,6.50748465080774e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,40283,0.0427643212223681,0.00548151934046989,0.0320205433150471,0.0535080991296891,6.66408992043206e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSAP,Prosaposin,40440,0.0229740444525143,0.0029482767858866,0.0171954219521765,0.028752666952852,7.15547785085268e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL5,C-C motif chemokine 5,42689,0.0786154561917829,0.0101012860600226,0.0588169355141386,0.0984139768694271,7.6128796812124e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,42676,0.0822204337656555,0.010565407556961,0.0615122349540118,0.102928632577299,7.65405047243577e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRAF2,TNF receptor-associated factor 2,42594,0.054628889950065,0.00702306450510951,0.0408636835200503,0.0683940963800796,7.87384149862919e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,42346,0.0375722618004896,0.00483954507626728,0.0280867534510058,0.0470577701499735,8.86408155316731e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,40199,0.0763321253128752,0.00984128501510486,0.0570432066832696,0.0956210439424807,9.51524882440451e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,40223,0.0806379969159415,0.0103998811591296,0.0602542298440475,0.101021763987835,9.70742575248935e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DPEP1,Dipeptidase 1,42476,-0.0392502187435205,0.00506945027158228,-0.0491863412758218,-0.0293140962112193,1.04514618992837e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,40182,0.0546572165179,0.00705818483703319,0.040823174237315,0.0684912587984851,1.04961899377821e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NGRN,Neugrin,40483,0.0182434730114038,0.00235700943192344,0.0136237345248339,0.0228632114979738,1.0781491340913e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SELL,L-selectin,40539,-0.0188335040716547,0.00243396557665536,-0.0236040766018992,-0.0140629315414102,1.09734705555999e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",40481,0.0313161807307408,0.00405013295550003,0.0233779201379607,0.0392544413235208,1.14738126024411e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATRN,"Attractin, Isoform 2",40539,0.0131861959592291,0.00170565088886866,0.00984312021704652,0.0165292717014117,1.15815084313632e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSPAN8,Tetraspanin-8,40449,0.0806802631884032,0.010442184996693,0.0602135805948849,0.101146945781921,1.20046471963073e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NBN,Nibrin,42370,0.0419523121326326,0.00543295452672677,0.0313037212602482,0.0526009030050171,1.22930900521699e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCBP2,Poly(rC)-binding protein 2,40482,0.0563977077674036,0.00731392941205465,0.0420624061197765,0.0707330094150308,1.35318925973428e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATG4A,Cysteine protease ATG4A,42346,0.0460262385932201,0.00597059761021338,0.0343238672772019,0.0577286099092384,1.3608421259534e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,42611,0.0760542956848514,0.00987745989067871,0.0566944742991212,0.0954141170705817,1.45813867387068e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,42658,0.0546706309234034,0.0071018618366352,0.0407509817235984,0.0685902801232083,1.47737628655183e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,42346,0.0257930145212477,0.00335292384961557,0.0192212837760012,0.0323647452664942,1.54299190730298e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,42307,0.0609877356831761,0.00793523079668125,0.0454346833216808,0.0765407880446713,1.6297078764277e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SOST,Sclerostin,42613,0.0304121890564232,0.00395717038383263,0.0226561351041113,0.0381682430087352,1.63165813554696e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,40527,-0.0166277429246734,0.00216316551664257,-0.0208675473372928,-0.0123879385120539,1.63361510022515e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,42794,-0.0226340979163616,0.00294643452663075,-0.0284091095885578,-0.0168590862441653,1.67488711426858e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,42611,0.0441652870644704,0.00575078549165721,0.0328937475008222,0.0554368266281185,1.70251926037312e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,42600,0.0376448263552026,0.0049051895775873,0.0280306547831315,0.0472589979272737,1.7752972931842e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,42346,0.0310182980192071,0.00404521075786103,0.0230896849337995,0.0389469111046147,1.87077752362462e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,40539,-0.0207812438613329,0.00272345431843788,-0.0261192143254711,-0.0154432733971946,2.52613112617919e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,42240,0.0313418418564819,0.00410924674135645,0.0232877182434232,0.0393959654695405,2.56596526390634e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASP10,Caspase-10,42311,0.055403948091022,0.00726765410205338,0.0411593460509973,0.0696485501310466,2.64116832227332e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOBR,Apolipoprotein B receptor,40223,-0.0331408432854079,0.00434695633472518,-0.0416608777014693,-0.0246208088693466,2.66295993527171e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42611,0.0333113203652371,0.00437851328224755,0.0247294343320319,0.0418932063984423,2.97095223873114e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GDF2,Growth/differentiation factor 2,42636,-0.0277451562419904,0.00364760798030705,-0.0348944678833922,-0.0205958446005885,3.00532433868543e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD69,Early activation antigen CD69,42585,0.0675096607902395,0.00887775871828756,0.0501092537023959,0.0849100678780831,3.05361989796029e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD36,Platelet glycoprotein 4,40199,0.0346350031341958,0.00455817990053812,0.0257009705291411,0.0435690357392505,3.24084268110159e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LMNB2,Lamin-B2,40483,0.0221807580815142,0.0029200080423934,0.0164575423184232,0.0279039738446053,3.29216829871753e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,40116,0.0518237292597924,0.00683911280273671,0.0384190681664284,0.0652283903531563,3.80629257158723e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,42587,0.0258836442135426,0.00342140504801626,0.0191776903194308,0.0325895981076545,4.12457662904245e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42594,0.0270792415349874,0.0035821033488124,0.0200583189713151,0.0341001640986597,4.30570060410091e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,42547,0.0216363365522719,0.00286269413071396,0.0160254560560725,0.0272472170484713,4.35836639540346e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,40116,0.0511438496090126,0.00677737586607564,0.0378601929115043,0.0644275063065208,4.83566678949677e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRG3,Proteoglycan 3,40527,-0.0383077651728322,0.00507668726716859,-0.0482580722164826,-0.0283574581291818,4.83860728741993e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,40483,0.0492674855539305,0.00653342963637999,0.0364619634666257,0.0620730076412353,5.02785788786692e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPI,Glucose-6-phosphate isomerase,40532,0.0360778143941446,0.00478493429784613,0.0266993431703662,0.0454562856179231,5.06297469897229e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",40267,0.0651506590330073,0.00864065091860656,0.0482149832325385,0.0820863348334762,5.06641246741592e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42587,0.0339402374293688,0.00450402729794187,0.0251123439254027,0.0427681309333348,5.17521086196838e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,40511,0.0205017300235484,0.00272511850297082,0.0151604977577255,0.0258429622893712,5.74807345433529e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,42760,0.0255214752840975,0.00339309492827404,0.0188710092246804,0.0321719413435146,5.7510284812162e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41948,0.0334566901436835,0.00445111656704244,0.0247325016722803,0.0421808786150867,6.00283008264981e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,42346,0.0495501861556532,0.00659465093254169,0.0366246703278715,0.0624757019834349,6.11915813300599e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYDGF,Myeloid-derived growth factor,40511,0.0748208789803525,0.00997156455493839,0.0552766124526733,0.0943651455080317,6.68304094269909e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNCA,Alpha-synuclein,40283,0.0879567232518303,0.0117286730376017,0.0649685240981309,0.11094492240553,6.90632680947687e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,40483,0.0248295449356649,0.00331294977204267,0.0183361633824613,0.0313229264888686,7.1421622420832e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,42346,0.0586314925036354,0.00783592735786321,0.0432730748822235,0.0739899101250473,7.76117720438913e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAYN,Layilin,42476,0.0287205665553773,0.00384206245293737,0.0211901241476201,0.0362510089631346,8.18482499064342e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,P4HB,Protein disulfide-isomerase,42563,0.0289932071255041,0.00388044202429277,0.0213875407578902,0.0365988734931179,8.41240526330676e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMP12,Macrophage metalloelastase,42592,0.0425481429169946,0.00569756376171156,0.0313809179440399,0.0537153678899492,8.65976030761716e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,42351,0.0417029881973427,0.00558893272531958,0.0307486800557163,0.0526572963389691,9.07643067235069e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VWC2,Brorin,42456,0.0311478641890577,0.00417809600199009,0.0229587960251571,0.0393369323529582,9.54108663322467e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH5,Cadherin-5,42794,-0.0228471510743138,0.00306516684436962,-0.0288548780892782,-0.0168394240593493,9.61612541760332e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL14,C-C motif chemokine 14,42618,0.0305895434521292,0.00410423114692454,0.0225452504041571,0.0386338365001012,9.66944588964332e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDA,Cytidine deaminase,40494,0.0355763962862337,0.00477600329875894,0.0262154298206662,0.0449373627518013,1.00910849781212e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42594,0.075510332975847,0.0101531734512596,0.0556101130113781,0.0954105529403158,1.09156974671059e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINE2,Glia-derived nexin,40511,0.0485591128950368,0.00652840379996199,0.0357634414471113,0.0613547843429623,1.09505569841457e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",42476,0.0718220044097887,0.00965993076098962,0.052888540118249,0.0907554687013283,1.10933284663144e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UROD,Uroporphyrinogen decarboxylase,40283,0.0521692230851355,0.00701599015331983,0.0384178823846286,0.0659205637856424,1.1163588990182e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,USO1,General vesicular transport factor p115,42587,0.06752398282274,0.00911555754528128,0.0496574900339887,0.0853904756114913,1.36343335665243e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OPHN1,Oligophrenin-1,40483,0.080220223578635,0.0108422770396137,0.0589693605809921,0.101471086576278,1.47132016817874e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,42711,0.0501046593989728,0.00677638960870752,0.0368229357659061,0.0633863830320396,1.50848022077328e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,42346,0.0452563803136029,0.00612513310918413,0.033251119419602,0.0572616412076038,1.57286998307633e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,42370,-0.0297910219418463,0.00403250939634198,-0.0376947403586766,-0.0218873035250161,1.58361285709925e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BTD,Biotinidase,40539,0.0154735334391819,0.00209641314554229,0.011364563673919,0.0195825032044448,1.68142644983858e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,42636,0.0588825914035487,0.00798015147026006,0.043241494521839,0.0745236882852584,1.69303716285592e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,40482,0.0502961325704643,0.00681813907509052,0.0369325799832869,0.0636596851576418,1.73490409626599e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCARF1,Scavenger receptor class F member 1,42794,0.0313299628008661,0.00424805276478285,0.0230037793818918,0.0396561462198405,1.73673126811601e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MITD1,MIT domain-containing protein 1,42495,0.0713959051931062,0.00968546382431111,0.0524123960974564,0.090379414288756,1.78748891531403e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,40223,0.0405803044692768,0.00551201783505405,0.0297767495125709,0.0513838594259828,1.93861157149045e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STAT2,Signal transducer and activator of transcription 2,40199,0.0568723150271906,0.00772916765033976,0.0417231464325246,0.0720214836218565,1.99770963931904e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,42794,0.0242808137218637,0.00330078277232844,0.0178112794881,0.0307503479556275,2.00232143646481e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAMB1,Laminin subunit beta-1,40223,0.0227876219029255,0.0030971042658281,0.0167172975419024,0.0288579462639486,2.00372671223726e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DTNB,Dystrobrevin beta,40430,0.0320380612091626,0.00435515157564144,0.0235019641209053,0.0405741582974198,2.0215740510872e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,42346,0.0467108977864424,0.00635152581707866,0.0342619071849682,0.0591598883879166,2.0331799527266e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSL,Cathepsin L1,42636,0.0185467632894813,0.00252399728911662,0.0135997286028127,0.0234937979761499,2.12525490926963e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42778,0.0213896937968003,0.00291109129875198,0.0156839548512464,0.0270954327423542,2.13219504084486e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STX4,Syntaxin-4,42587,0.0442877444471702,0.00603102844084666,0.0324669287031107,0.0561085601912296,2.20395920541266e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD58,Lymphocyte function-associated antigen 3,42600,-0.0132470704557432,0.00180763492957305,-0.0167900349177064,-0.00970410599378,2.46241537855549e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F12,Coagulation factor XII,40539,0.0309444584248674,0.00422682665630919,0.0226598781785014,0.0392290386712334,2.62839812368681e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FOXO3,Forkhead box protein O3,42346,0.0704126632470905,0.00963111847622703,0.0515356710336855,0.0892896554604955,2.80578217066377e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPR,Nucleoprotein TPR,40116,0.0361788161118957,0.00494911747395979,0.0264785458629345,0.0458790863608569,2.85488220739124e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SH3GLB2,Endophilin-B2,40483,0.0494243094980197,0.00677091621851393,0.0361533137097324,0.062695305286307,3.08238078118353e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRKL,Crk-like protein,42636,0.0774028092338131,0.0106130528602671,0.0566012256276895,0.0982043928399366,3.19681352261369e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,40223,0.0323733221837048,0.00444234605269911,0.0236663239204146,0.0410803204469951,3.37493573998304e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,42370,0.0285353702486684,0.00391835504737729,0.0208553943558089,0.0362153461415279,3.46325737341451e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,42594,0.0764333983453119,0.0104981048960276,0.0558571127490979,0.0970096839415259,3.50641866628337e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42495,0.079240129120968,0.0108950843652793,0.0578857637650206,0.100594494476915,3.71208690224921e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCTN2,Dynactin subunit 2,42587,0.0690561917266015,0.00951327421840462,0.0504101742585284,0.0877022091946746,4.11663396113695e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42794,0.0174083753147631,0.00239938631972992,0.0127055781280925,0.0221111725014338,4.22328665045857e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,40182,0.0593852316419193,0.00819025037224076,0.0433323409123274,0.0754381223715112,4.42418678932151e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,40451,0.0281313463986655,0.00388392432996658,0.020518854711931,0.0357438380854,4.67443111624254e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42594,0.0521971038503842,0.00720841082842825,0.0380686186266648,0.0663255890741036,4.6919537767073e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HPSE,Heparanase,40408,0.0688614485814034,0.00951971657881661,0.0502028040869229,0.087520093075884,5.01164117983241e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LPP,Lipoma-preferred partner,40116,0.0484255612348661,0.00669620340214729,0.0353010025666575,0.0615501199030748,5.08554106288022e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,42566,0.0283901562873912,0.00393036349942653,0.0206866438285152,0.0360936687462672,5.34902383333506e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BID,BH3-interacting domain death agonist,42594,0.0490855340494821,0.00679729251751205,0.0357628407151584,0.0624082273838057,5.42556859580287e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OLFM4,Olfactomedin-4,39870,0.090973889897,0.0126158101034342,0.0662469020942689,0.115700877699731,5.92594027695782e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,40451,0.0252157153396519,0.00350038640945344,0.0183549579771232,0.0320764727021807,6.23447278851355e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,40511,0.0440939929619514,0.00612726458505881,0.0320845543752361,0.0561034315486666,6.57533343843091e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,40511,0.0355271950680123,0.00494126059033881,0.0258423243109483,0.0452120658250764,6.8922353784674e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,40383,0.043520711734454,0.00605860351355194,0.0316458488478922,0.0553955746210158,7.23761267353817e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSC22D1,TSC22 domain family protein 1,40482,0.0475847994267781,0.006627752959222,0.034594403626703,0.0605751952268533,7.42928461289622e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,40482,0.0444691685474254,0.00619928532057369,0.032318569319101,0.0566197677757499,7.78091887514076e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,JAM2,Junctional adhesion molecule B,42711,0.020740495759755,0.00289207376505473,0.0150720311802477,0.0264089603392622,7.80390508044543e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCL2L15,Bcl-2-like protein 15,40199,0.0411733170611898,0.00574207663214701,0.0299188468621816,0.0524277872601979,7.95426654099946e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNTN4,Contactin-4,42611,-0.0175332749142692,0.00244702638643826,-0.0223294466316882,-0.0127371031968502,8.17660020393926e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL8,Interleukin-8,42494,0.0506871772213191,0.00708131891199327,0.0368077921538123,0.064566562288826,8.6236616496411e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARSB,Arylsulfatase B,42587,0.0398575310627161,0.00557814224183146,0.0289243722687265,0.0507906898567058,9.44394711968395e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEC31A,Protein transport protein Sec31A,40223,0.0556324827496617,0.00779223277954419,0.0403597065017551,0.0709052589975684,9.95778871105718e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,40482,0.0477925054515285,0.0066980306277674,0.0346643654211044,0.0609206454819526,1.02488313816494e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,40421,0.021950402970473,0.00307911409857603,0.015915339337264,0.0279854666036821,1.07459307766971e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AP2B1,AP-2 complex subunit beta,40182,0.0350252414406777,0.00491326163036699,0.0253952486451584,0.044655234236197,1.0766807999714e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GAS6,Growth arrest-specific protein 6,42718,-0.0183610612183955,0.00257737992597834,-0.0234127258733131,-0.013309396563478,1.10202600185571e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSNAX,Translin-associated protein X,40116,0.0286169541751645,0.00402361444154399,0.0207306698697383,0.0365032384805907,1.21307701803883e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RETN,Resistin,42598,0.0312744072322318,0.00440577322730005,0.0226390917067237,0.0399097227577399,1.32459149579429e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,40449,0.0223710848316574,0.0031528913127588,0.0161914178586502,0.0285507518046646,1.36708192403273e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,40183,0.0602589081340268,0.00852175602343757,0.0435562663280891,0.0769615499399644,1.62945980105987e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPPK1,Epiplakin,40223,0.052257013855539,0.00739190526298804,0.0377688795400824,0.0667451481709955,1.64901458340787e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C8B,Complement component C8 beta chain,40539,-0.021905870761845,0.00309885097071119,-0.027979618664439,-0.0158321228592511,1.65179139469599e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,YJU2,Splicing factor YJU2,40451,0.0233324368353714,0.00330149622506459,0.0168615042342448,0.029803369436498,1.67398728042988e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,42587,0.0246955592474654,0.00349503004700831,0.0178453003553291,0.0315458181396017,1.67459148605596e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLRX,Glutaredoxin-1,42546,0.0402245801915696,0.00569643287600547,0.0290595717545989,0.0513895886285404,1.73033728183141e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,42370,0.0380811909439376,0.00539356922576324,0.0275097952614416,0.0486525866264335,1.74244002161949e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RALY,RNA-binding protein Raly,40451,0.0340760638569364,0.00483388579795254,0.0246016476929494,0.0435504800209234,1.90185831969141e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,40451,0.0484519221556046,0.00687328994692825,0.0349802738596253,0.061923570451584,1.90333680103863e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNX15,Sorting nexin-15,40283,0.0389504970000477,0.00552692888257209,0.0281177163902064,0.049783277609889,1.93107190939694e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PROC,Vitamin K-dependent protein C,42663,0.0179361483700114,0.0025514353828716,0.012935335019583,0.0229369617204397,2.16748952014189e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",40449,0.103735732750371,0.0147932096643517,0.0747410418082414,0.1327304236925,2.47707244095333e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DAB2,Disabled homolog 2,42721,0.0774130807369615,0.0110485466690594,0.055757929265605,0.0990682322083179,2.55677431783469e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42495,0.0552760968653998,0.00790046504974225,0.039791185367905,0.0707610083628946,2.74873531670973e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,42676,0.0606722171661786,0.00867439797035585,0.0436703971442811,0.0776740371880761,2.78954132366528e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FOXJ3,Forkhead box protein J3,40199,0.0311178155763814,0.00444959979183875,0.0223965999843774,0.0398390311683853,2.83870303399575e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,40199,0.04044413307521,0.00578923425444771,0.0290972339364924,0.0517910322139275,2.98968308603239e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,42587,0.0274106003576995,0.00392765715560896,0.019712392332706,0.0351088083826931,3.11567065131744e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,40482,0.0592941820687174,0.00849899452864868,0.042636152792566,0.0759522113448689,3.19306194052685e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD80,T-lymphocyte activation antigen CD80,40511,0.0247906690738958,0.00355555136987192,0.0178217883889468,0.0317595497588447,3.28964809730343e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,42602,0.0247254416677357,0.00354785369458508,0.0177716484263489,0.0316792349091225,3.33816904846211e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42582,0.0482850727158452,0.00694674044349396,0.0346694614465971,0.0619006839850934,3.80168512916007e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ING1,Inhibitor of growth protein 1,42292,0.033317231462926,0.00479324515666897,0.0239224709558548,0.0427119919699972,3.8022859688522e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STX8,Syntaxin-8,42594,0.0336425873624674,0.00484254470113701,0.0241511997482389,0.0431339749766959,3.89548835346969e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,40482,0.0530453853144812,0.00764498304122594,0.0380612185536784,0.068029552075284,4.17719739192839e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",40283,0.0731879565177217,0.0105485527913579,0.0525127930466602,0.0938631199887832,4.19265643676462e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACYP1,Acylphosphatase-1,40250,0.0463208724668148,0.00667801953481265,0.033231954178582,0.0594097907550476,4.24924438662581e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LGALS3,Galectin-3,42669,0.0210994616408558,0.003043844883828,0.015133525668553,0.0270653976131587,4.34287600159718e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RRAS,Ras-related protein R-Ras,40182,0.0912950300816503,0.0131690998858012,0.0654835943054799,0.117106465857821,4.36596265345689e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,42476,0.0164484758869096,0.00237477753072819,0.0117939119266824,0.0211030398471369,4.51801605470129e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,42620,0.0398064258828176,0.00574949087204972,0.0285374237736002,0.0510754279920351,4.60744648874226e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",40482,0.0302969270705353,0.00437750237714574,0.0217170224113296,0.0388768317297409,4.72590997376384e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,42737,0.0299909678222701,0.00433685792770096,0.0214907262839762,0.038491209360564,4.8757587832783e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TBCC,Tubulin-specific chaperone C,42495,0.0560824154977644,0.008114071192107,0.0401788359612347,0.0719859950342941,5.00536290884916e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CIT,Citron Rho-interacting kinase,40182,0.0319255426293058,0.00462117820940773,0.0228680333388666,0.0409830519197449,5.16786840973734e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HRG,Histidine-rich glycoprotein,40479,0.0217468969025003,0.00314883968746127,0.0155751711150762,0.0279186226899244,5.24115169851032e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VNN1,Pantetheinase,40532,0.0512940708988579,0.00743177908697233,0.0367277838883922,0.0658603579093237,5.40144982555963e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STX7,Syntaxin-7,40199,0.03518830277046,0.00509822407578616,0.0251957835819191,0.0451808219590008,5.40689955123361e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,40451,0.0614018486843219,0.00890878156667931,0.0439406368136304,0.0788630605550133,5.78378657090363e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,YWHAQ,14-3-3 protein theta,40283,0.051545617207676,0.00748189551389257,0.0368811020004465,0.0662101324149054,5.90721795243932e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HS1BP3,HCLS1-binding protein 3,40223,0.0619491069805135,0.00899607676570498,0.0443167965197317,0.0795814174412952,6.04032275560343e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,40449,0.0312645571281086,0.00454225070521374,0.0223617457458897,0.0401673685103275,6.16972215761482e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FKBPL,FK506-binding protein-like,40449,0.0409548228899458,0.00595026581174592,0.0292923018989238,0.0526173438809678,6.17827226492798e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB33A,Ras-related protein Rab-33A,40116,0.0459837042436893,0.00668210100964469,0.0328867862647858,0.0590806222225929,6.24155685514317e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL11,C-X-C motif chemokine 11,42711,0.0557415328617329,0.00810530851197823,0.0398551281782555,0.0716279375452102,6.3738989097565e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,42711,0.0320877379351221,0.00467960561212686,0.0229157109353534,0.0412597649348907,7.34104871066219e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRSS22,Brain-specific serine protease 4,40199,0.0255533969281718,0.00373203961400656,0.0182385992847189,0.0328681945716246,7.94135607192918e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GFAP,Glial fibrillary acidic protein,42326,-0.0340713101109132,0.004981130435925,-0.0438343257653262,-0.0243082944565002,8.26567625176662e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLIT2,Slit homolog 2 protein,42311,0.0366048649847121,0.00535586611896055,0.0261073673915494,0.0471023625778747,8.59064198624902e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,42346,0.0302264425768277,0.00442637837652053,0.0215507409588475,0.0389021441948079,8.94469552352377e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,40116,0.0198294577963269,0.00290382576573095,0.0141379592954942,0.0255209562971595,9.02157381043584e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ST13,Hsc70-interacting protein,40283,0.0392265896469396,0.00574598117852461,0.0279644665370314,0.0504887127568478,9.13727530831935e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUB1,NEDD8 ultimate buster 1,42594,0.0573374124574232,0.00840284735786267,0.0408678316360124,0.0738069932788341,9.2621687108661e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL5A1,Collagen alpha-1(V) chain,40283,0.0287670836046826,0.00422209277746806,0.0204917817608452,0.03704238544852,1.00212298846633e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42594,0.0657690738180474,0.00966026067610206,0.0468349628928874,0.0847031847432075,1.03029407280606e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F2R,Proteinase-activated receptor 1,42654,0.0386427448216574,0.00568392730736198,0.0275022472992279,0.0497832423440868,1.10094082299031e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFNLR1,Interferon lambda receptor 1,42594,0.0250875758684176,0.00369081414845699,0.0178535801374419,0.0323215715993933,1.11107320327871e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC3B,Tetranectin,40269,-0.0145373108276348,0.00214375218809543,-0.0187390651163018,-0.0103355565389677,1.25209350141254e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RILP,Rab-interacting lysosomal protein,42674,0.0408968519663998,0.00603399342327416,0.0290702248567825,0.0527234790760172,1.27143365363117e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,42711,0.0216945842106371,0.00320898241510223,0.0154049786770368,0.0279841897442375,1.43080578606952e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,40449,0.0434470877870396,0.00643706667311802,0.0308304371077283,0.0560637384663509,1.5562867207527e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,42495,0.0161765845831983,0.00239740157387843,0.0114776774983966,0.020875491668,1.56588492948538e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD164,Sialomucin core protein 24,42611,0.0187511945834713,0.00277974899563969,0.0133028865520175,0.0241995026149251,1.58595451489253e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSPB6,Heat shock protein beta-6,42721,0.0270421745942912,0.00401059474106466,0.0191814089018045,0.0349029402867779,1.61796186170712e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,42346,0.0358841990701045,0.00532400316897909,0.0254491528589055,0.0463192452813035,1.64901116106857e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,40302,0.0313024702106739,0.00464430691908739,0.0221996286492626,0.0404053117720851,1.6627011781621e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APP,Amyloid-beta precursor protein,42592,0.0454159128347487,0.00674222449496785,0.0322011528246117,0.0586306728448856,1.69401447846219e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,42590,0.056947263726727,0.00845804555078797,0.0403694944471825,0.0735250330062714,1.73078552526116e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD200,OX-2 membrane glycoprotein,42594,-0.0187331732338939,0.00278842862898773,-0.0241984933467099,-0.0132678531210779,1.91434786840161e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,42311,0.0261201648155345,0.00389303773322474,0.018489810858414,0.033750518772655,2.03371227291113e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THY1,Thy-1 membrane glycoprotein,42711,0.0205506478001207,0.00306512908078407,0.0145429948017839,0.0265583007984575,2.0989125928561e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42654,0.0515587876764987,0.00769330231203781,0.0364799151449046,0.0666376602080928,2.14097849024398e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GIMAP7,GTPase IMAP family member 7,40283,-0.0217708743788625,0.00325408062443838,-0.0281488724027617,-0.0153928763549632,2.33392500984074e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,40482,-0.01828874855001,0.00273555948375968,-0.023650445138179,-0.0129270519618411,2.40892390854856e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,40302,0.0385067742841211,0.00575967741692633,0.0272178065469454,0.0497957420212967,2.41042790308751e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,42587,0.0372922726117304,0.00558015979761164,0.0263551594084116,0.0482293858150492,2.43342184835109e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH3,Cadherin-3,42711,0.025485497379917,0.00381527942893926,0.018007549699196,0.0329634450606379,2.4854274707456e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,40511,-0.0219197144450156,0.00328097903594069,-0.0283504333554593,-0.0154889955345718,2.48711497598099e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DHPS,Deoxyhypusine synthase,40451,0.0275432659499156,0.00412285154497501,0.0194624769217646,0.0356240549780666,2.49128699228358e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANGPT1,Angiopoietin-1,42554,0.0567794911125432,0.00851622012979132,0.0400876996581522,0.0734712825669342,2.70941824470902e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OGN,Mimecan,42611,0.0300121044830397,0.00451070208287499,0.0211711284006047,0.0388530805654747,2.97242687186152e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GIMAP8,GTPase IMAP family member 8,40080,0.0357738651399602,0.00537893924652989,0.0252311442167616,0.0463165860631588,3.05624553871193e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASC3,Protein CASC3,40182,0.0283561803637583,0.0042648216006687,0.0199971300264476,0.0367152307010689,3.09389916099387e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLXNB3,Plexin-B3,42597,0.0315945138464423,0.00475533534623428,0.0222740565678231,0.0409149711250615,3.17043450908722e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD300E,CMRF35-like molecule 2,42677,0.0292150750777618,0.00439767337385663,0.0205956352650028,0.0378345148905208,3.18501257718454e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,42443,0.0773592187253972,0.0116550890860422,0.0545152441167545,0.10020319333404,3.31743286229426e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,40511,0.0718841564575701,0.0108407232183808,0.0506363389495436,0.0931319739655966,3.48746737309306e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,42346,0.0308980048070891,0.00466328058435849,0.0217579748617465,0.0400380347524317,3.58801595442631e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MATN3,Matrilin-3,42475,-0.0220486054854379,0.00332837962816089,-0.0285722295566332,-0.0155249814142425,3.62029911698408e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD93,Complement component C1q receptor,42141,-0.021755802773935,0.00328473485543673,-0.028193883090591,-0.015317722457279,3.65132283664554e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SUSD5,Sushi domain-containing protein 5,40235,-0.0235247632260622,0.00355751555700998,-0.0304974937178018,-0.0165520327343226,3.94812200217414e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",42611,0.0511074773732608,0.00774398386715999,0.0359292689936272,0.0662856857528943,4.27650542331843e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGAM,Integrin alpha-M,42611,-0.0211590211191655,0.00321899025721475,-0.0274682420233064,-0.0148498002150246,5.10706523445908e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL2,C-C motif chemokine 2,42475,0.03547093001393,0.00539746565000104,0.0248918973399279,0.046049962687932,5.15745465874239e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PARK7,Parkinson disease protein 7,42611,0.0345163300145215,0.00525417605203937,0.0242181449525243,0.0448145150765187,5.24120617538332e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,40223,0.0327832416058813,0.00499020273751241,0.0230024442403569,0.0425640389714056,5.27503900772718e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TLR3,Toll-like receptor 3,42754,0.0406543873376136,0.00620183666798548,0.028498787468362,0.0528099872068651,5.75709052014384e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EFNA1,Ephrin-A1,42590,0.0202097831511002,0.00308382416671845,0.0141654877843321,0.0262540785178684,5.82677386220397e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DBNL,Drebrin-like protein,42676,0.0608823516937102,0.00929785767066433,0.0426585506592081,0.0791061527282123,6.04262860115047e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TP53,Cellular tumor antigen p53,42346,0.0286113760104985,0.00437004100775728,0.0200460956352942,0.0371766563857028,6.08174826146272e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,40483,0.0215037055076013,0.00328469525212658,0.0150657028134332,0.0279417082017694,6.13993231523829e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GRAP2,GRB2-related adapter protein 2,42636,0.0842569444535897,0.0128847901106535,0.0590027558367089,0.109511133070471,6.40603233937739e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCARA5,Scavenger receptor class A member 5,42711,0.0205086731056043,0.00313713395807162,0.0143598905477839,0.0266574556634247,6.4848539037026e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD300C,CMRF35-like molecule 6,42711,0.0238979313269398,0.00365605245729677,0.0167320685106381,0.0310637941432415,6.52177200679272e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,40223,-0.0140088344849207,0.002143984481583,-0.0182110440688234,-0.00980662490101801,6.68494681875726e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,40182,0.0476983025804672,0.0073009736936085,0.0333883941409946,0.0620082110199399,6.72510572373354e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,40209,0.0369728622547474,0.0056647845400512,0.025869884556247,0.0480758399532477,7.01456570037702e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,40229,0.0375565435790458,0.00575980407650659,0.0262673275890929,0.0488457595689987,7.31560078675492e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD226,CD226 antigen,40199,0.0280340293923825,0.0043183247445228,0.0195701128931178,0.0364979458916472,8.84224918232707e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RWDD1,RWD domain-containing protein 1,42711,0.0413032665075236,0.00637398384175808,0.0288102581776778,0.0537962748373694,9.49169067142464e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA2,Carbonic anhydrase 2,42573,0.045690955729892,0.00705756943208685,0.0318581196430018,0.0595237918167823,9.87496385639972e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,40199,0.0221274102898048,0.00341892402063992,0.0154263192093506,0.0288285013702591,1.00799905048939e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOA4,Apolipoprotein A-IV,40539,0.0237954903112939,0.00368305247054628,0.0165767074690232,0.0310142731535647,1.08409492912725e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD46,Membrane cofactor protein,42580,0.0190160736937516,0.00294471195244817,0.0132444382669532,0.02478770912055,1.09975597806357e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],42365,0.0315037610125283,0.00487855264188911,0.0219417978344257,0.041065724190631,1.10107827891281e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUDC,Nuclear migration protein nudC,42754,0.0405449428287906,0.00628176605393403,0.0282326813630799,0.0528572042945013,1.12354555574122e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CENPF,Centromere protein F,40302,0.0359012063574901,0.00556300973608778,0.0249977072747581,0.0468047054402222,1.13803208345335e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,42721,0.026025220055354,0.00403549074030924,0.0181156582043479,0.0339347819063602,1.16352553669505e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",42602,-0.0374206086932554,0.00580486450480344,-0.0487981431226701,-0.0260430742638407,1.18442171255234e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,40511,0.0263592511467545,0.00408981146179471,0.0183432206816369,0.0343752816118722,1.20217984134311e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD274,Programmed cell death 1 ligand 1,42495,0.0229075038605037,0.00355519987308174,0.0159393121092635,0.0298756956117439,1.20867169843251e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GRSF1,G-rich sequence factor 1,40014,0.0529774344200707,0.00823196370511052,0.0368427855580541,0.0691120832820873,1.28207661169063e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GTPBP2,GTP-binding protein 2,40182,0.0528026368699124,0.00820561244231409,0.0367196364829768,0.0688856372568481,1.28661604262419e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RTBDN,Retbindin,42587,0.0195497263480625,0.00303906984192902,0.0135931494578816,0.0255063032382434,1.29533139367594e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C2,Complement C2,42663,0.0149752139174664,0.00233069538039375,0.0104070509718946,0.0195433768630381,1.36114689866403e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL12,Stromal cell-derived factor 1,42370,-0.0262836822194959,0.004091863760331,-0.0343037351897447,-0.0182636292492472,1.37841402754974e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,40482,0.0263417235666154,0.00410125716875092,0.0183032595158636,0.0343801876173672,1.3912970077762e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BOLA1,BolA-like protein 1,40136,0.0354783660198241,0.00552465116129419,0.0246500497436875,0.0463066822959607,1.40228731779983e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,42357,0.0491864981327073,0.0076681003233587,0.0341570214989242,0.0642159747664904,1.46184572564318e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,40482,0.0607426247166034,0.00947051914108462,0.0421804072000776,0.0793048422331293,1.47546989629783e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,40511,0.0589371913852787,0.00919494206265171,0.0409151049424814,0.0769592778280761,1.51563620390897e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINA6,Corticosteroid-binding globulin,40539,-0.0102680604247122,0.00160272697612748,-0.0134094052979221,-0.00712671555150235,1.54671958978023e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,42587,0.0138443959932979,0.00216164906444262,0.00960756382699041,0.0180812281596055,1.5584785866062e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SH3BP1,SH3 domain-binding protein 1,40449,0.0311772028201346,0.00486913576629642,0.0216336967181936,0.0407207089220755,1.58392629733611e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCRLB,Fc receptor-like B,42346,0.0423030530689156,0.00661704738605372,0.0293336401922503,0.0552724659455809,1.68112319129256e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCN2,Ficolin-2,42597,0.0266692145673169,0.00417390411289725,0.0184883625060383,0.0348500666285955,1.71917608140863e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL19,C-C motif chemokine 19,42711,0.0850791789665489,0.0133264451807566,0.0589593464122659,0.111199011520832,1.77883212244063e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,42311,0.0413468499400198,0.00648051245039381,0.0286450455372479,0.0540486543427917,1.82820944299243e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,40199,0.0325089756896706,0.00509504355777519,0.0225226903164312,0.0424952610629099,1.835895324125e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,42721,-0.0379505312498438,0.00595119264914679,-0.0496148688421715,-0.026286193657516,1.86506292578325e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,40482,0.0377203770931335,0.00591768276680658,0.0261217188701926,0.0493190353160744,1.91116530832393e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,42370,0.0279257846070978,0.00438236322555553,0.019336352685009,0.0365152165291867,1.92397806628957e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMP9,Matrix metalloproteinase-9,42594,0.0388912656227406,0.0061134335985536,0.0269089357695756,0.0508735954759057,2.06142571203746e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LIPF,Gastric triacylglycerol lipase,40223,0.0403909001067651,0.00635511970998679,0.027934865475191,0.0528469347383392,2.15741440963895e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,42794,0.0461833254146535,0.00727799835972256,0.0319184486295973,0.0604482021997098,2.28572005428879e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ICA1,Islet cell autoantigen 1,42370,0.0505754886006347,0.00797169315922115,0.0349509700085612,0.0662000071927081,2.30621013445763e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,42346,0.0582841371825343,0.00919888039166316,0.0402543316148745,0.0763139427501941,2.4348885342203e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,42346,0.0193164731976713,0.00304996227682984,0.0133385471350848,0.0252943992602578,2.47705029331403e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,42611,0.0193207567987043,0.00305409064342062,0.0133347391375999,0.0253067744598087,2.5926774679149e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,40302,0.0422733229725983,0.00669338030634453,0.029154297572163,0.0553923483730335,2.79233097265208e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,40483,0.0337746007373281,0.00535157187368854,0.0232855198648986,0.0442636816097577,2.87340394280481e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COMT,Catechol O-methyltransferase,42214,0.0533289477494321,0.00846411666721101,0.0367392790816985,0.0699186164171657,3.06061624779034e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEPTIN8,Septin-8,40470,0.0208265274416066,0.00330667668566297,0.0143454411377072,0.027307613745506,3.12076224176435e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MIF,Macrophage migration inhibitory factor,42586,0.043231840186245,0.00686569230766885,0.0297750832632141,0.056688597109276,3.13357333418002e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,42636,0.042700017402698,0.0067850269029888,0.02940136467284,0.0559986701325561,3.20493362950578e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,42676,0.0832264095979828,0.0132264260503435,0.0573026145393095,0.109150204656656,3.22194410951826e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,40449,0.0576848721364154,0.00917714307849395,0.0396976717025673,0.0756720725702636,3.38429541033186e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C3,Complement C3,39989,0.0302339311744754,0.00481117344121887,0.0208040312296864,0.0396638311192644,3.42456945108153e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPRR3,Small proline-rich protein 3,40483,0.0448802066445302,0.00714401027205034,0.0308779465113115,0.0588824667777488,3.46066820691483e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,40482,0.0723455583162553,0.0115210725407032,0.0497642561364771,0.0949268604960336,3.52342369786027e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",42636,0.0466732155046699,0.00743747318468801,0.0320957680626814,0.0612506629466584,3.59411498745867e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD86,T-lymphocyte activation antigen CD86,40449,-0.0194397224931493,0.00309809687184559,-0.0255119923619666,-0.0133674526243319,3.63108335733395e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,40283,0.0267903478779116,0.00427880415298264,0.0184038917380656,0.0351768040177576,3.9621297827313e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CST7,Cystatin-F,42642,0.0597904259871788,0.00955245091440634,0.0410676221949424,0.0785132297794152,3.98782377938336e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,40449,0.048830613375348,0.00780383159559284,0.033535103447986,0.06412612330271,4.0603255957924e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,42636,0.0371064197428253,0.00593319848779758,0.025477350706742,0.0487354887789085,4.12099374361172e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OPTC,Opticin,42587,-0.0295170198748819,0.00472027595761594,-0.0387687607518091,-0.0202652789979546,4.14236683061726e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REEP4,Receptor expression-enhancing protein 4,40482,0.0393294186603488,0.00630254035297957,0.0269764395685088,0.0516823977521887,4.52532576069658e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PI3,Elafin,42446,0.0361074491754803,0.00578914329704649,0.0247607283132692,0.0474541700376914,4.59314593578827e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPP1,Osteopontin,42771,-0.0299501450375642,0.00481241600384279,-0.0393824804050961,-0.0205178096700324,5.00431614960098e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPBP,Platelet basic protein,40471,0.0533021796481771,0.00856401619753274,0.0365167079010129,0.0700876513953413,5.01939353320304e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DLG4,Disks large homolog 4,40483,0.0442615437770414,0.0071139662695737,0.0303181698886769,0.0582049176654058,5.08949393509154e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANPEP,Aminopeptidase N,42666,-0.0175733762780399,0.00282765805072842,-0.0231155860574676,-0.0120311664986122,5.28990676838849e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GRN,Progranulin,42552,0.0155003693487926,0.00249772399865283,0.0106048303114331,0.0203959083861522,5.60287243076669e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RGCC,Regulator of cell cycle RGCC,40482,0.0474811582763566,0.00766453411527438,0.0324586714104188,0.0625036451422944,6.03457897342791e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42495,-0.075276451843701,0.0121600272437621,-0.0991101052414747,-0.0514427984459274,6.17430370198469e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,40482,0.0734535190657006,0.0118670677929638,0.0501940661914915,0.0967129719399097,6.23728309114116e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASP2,Caspase-2,42594,0.0420959501762838,0.00681407310475142,0.028740366890971,0.0554515334615966,6.68840828851704e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TWF2,Twinfilin-2,40527,0.0520512928492972,0.00842471854656277,0.0355388444980341,0.0685637412005602,6.69756523488251e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPARC,SPARC,42679,0.0438334713551535,0.00710428662685852,0.0299090695665108,0.0577578731437962,7.02425582629815e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD244,Natural killer cell receptor 2B4,42754,0.0171618099194931,0.0027824133245279,0.0117082798034184,0.0226153400355677,7.11430172503332e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DSC2,Desmocollin-2,42488,0.0222364768344225,0.00360645451520839,0.0151678259846141,0.029305127684231,7.21832406348264e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DENR,Density-regulated protein,40199,0.0358242894122639,0.00581072224431777,0.0244352738134011,0.0472133050111267,7.2859486102883e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,42705,-0.0126825270376009,0.00205858587262942,-0.0167173553479545,-0.00864769872724718,7.44351431847603e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,42311,0.0417878322471012,0.00678681507808313,0.0284856746940582,0.0550899898001441,7.61994247686152e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,40482,0.0672728797580551,0.0109374580568124,0.0458354619667028,0.0887102975494074,7.97588624218974e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42594,0.0265071075210139,0.0043167042468233,0.0180463671972403,0.0349678478447876,8.45392111421663e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AZU1,Azurocidin,42216,0.0476237972791287,0.00775977022274349,0.0324146476425515,0.062832946915706,8.6388994669374e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LGALS1,Galectin-1,42636,0.0218839145359353,0.00356789707095743,0.0148908362768588,0.0288769927950119,8.83431196178453e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLAMF6,SLAM family member 6,42346,0.0242168334566008,0.00394835251431805,0.0164780625285375,0.0319556043846642,8.84850858312605e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,40449,0.0319173006657406,0.00521045363695142,0.0217048115373158,0.0421297897941654,9.33432726172732e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ASAH1,Acid ceramidase,40418,0.028499115752932,0.00465384624399488,0.019377577114702,0.037620654391162,9.4439687305573e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,40223,0.0570228228057716,0.00931348308834915,0.0387683959526073,0.0752772496589359,9.51871038047847e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,42679,0.0146572175707642,0.00239547752795558,0.00996208161597131,0.0193523535255572,9.69512886498899e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD59,CD59 glycoprotein,42130,0.0156000811460926,0.00255024836004043,0.0106015943604134,0.0205985679317719,9.80525905346063e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BGN,Biglycan,42328,-0.0747688504136818,0.0122292455382422,-0.0987381716686365,-0.0507995291587271,9.99572983251856e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,42713,0.0179912051019507,0.00294472415614697,0.0122195457559026,0.0237628644479987,1.02597329332908e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DPEP2,Dipeptidase 2,42587,-0.0183706655197544,0.00300716078786995,-0.0242647006639794,-0.0124766303755293,1.03051797751052e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MPO,Myeloperoxidase,42611,0.0288859431234574,0.00472924533891089,0.0196166222591921,0.0381552639877228,1.03714709708584e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,40199,0.0219101945944298,0.00358769335801641,0.0148783156127176,0.0289420735761419,1.04920691849983e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPART,Spartin,40283,0.047552685229686,0.00780270635451857,0.0322593807748296,0.0628459896845424,1.13510022533439e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTGES2,Prostaglandin E synthase 2,40102,0.0337967589123848,0.00554700853171439,0.0229246221902246,0.044668895634545,1.14704238986323e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DOK1,Docking protein 1,40483,0.0840186233078155,0.013792118054998,0.0569860719200195,0.111051174695611,1.15295322708401e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,40482,0.0414509232571971,0.00681012741438252,0.0281030735250073,0.0547987729893868,1.19034355913381e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,40449,0.0549311413564442,0.00903002553043453,0.0372322913167926,0.0726299913960959,1.21660840555418e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,40451,0.0319553161694656,0.00525927248880832,0.0216471420914013,0.0422634902475299,1.27204909227593e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL19,Interleukin-19,42261,0.0447930875057499,0.00738043562046313,0.0303274336896421,0.0592587413218576,1.3213505064365e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTN,Pleiotrophin,42357,0.0306309540715722,0.00504827143345126,0.0207363420620077,0.0405255660811366,1.3338896782249e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,40135,0.0263997619504004,0.00435056885545031,0.0178726469937178,0.034926876907083,1.33703372725847e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,42681,0.0168286725613019,0.00277693413424392,0.0113858816581838,0.02227146346442,1.39607840039924e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,42660,0.0326497395908482,0.00538840778077593,0.0220884603405274,0.0432110188411691,1.40400975975164e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CETN3,Centrin-3,40449,0.0465987411580951,0.00769818571423215,0.0315102971582001,0.0616871851579901,1.46510747209151e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CACYBP,Calcyclin-binding protein,40267,0.0628442991410748,0.0103889292042693,0.0424819979007069,0.0832066003814426,1.50306584474868e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMPD3,AMP deaminase 3,40483,0.0436229371101423,0.00721630258647524,0.0294789840406509,0.0577668901796338,1.54079260853464e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STK24,Serine/threonine-protein kinase 24,42311,0.0377419919817892,0.0062515267490346,0.0254889995536814,0.049994984409897,1.61001863684271e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VEGFC,Vascular endothelial growth factor C,42679,0.0339910966867571,0.00563517763212,0.0229461485278019,0.0450360448457123,1.66234161060943e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,42636,0.0416970508927901,0.00691929356241557,0.0281352355104556,0.0552588662751246,1.7224888286766e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",40199,0.0224098928541235,0.00372043045946176,0.0151178491535784,0.0297019365546685,1.76176417794373e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UBXN1,UBX domain-containing protein 1,40283,0.0419672449994554,0.00696739440055676,0.0283111519743642,0.0556233380245467,1.7623273550657e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL17C,Interleukin-17C,42370,0.0457979049694573,0.00760551669977734,0.0308910922378937,0.0607047177010209,1.77220817390534e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPAG1,Sperm-associated antigen 1,40482,0.0351704966540801,0.0058437138776609,0.0237168174538648,0.0466241758542955,1.81487261454425e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,42737,0.0190979781136527,0.00317490562722419,0.0128751630842933,0.0253207931430121,1.84192520671605e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,42495,0.0480487617433144,0.00799108941959439,0.0323862264809094,0.0637112970057194,1.8713260921832e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINI2,Serpin I2,40449,0.0342969297056247,0.00571117245137955,0.0231030317009208,0.0454908277103287,1.96954365395346e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERI1,3'-5' exoribonuclease 1,40302,0.0210747556869848,0.00350978848839488,0.0141955702497308,0.0279539411242387,1.97844603589144e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,40223,0.0319225044085768,0.00531973954886993,0.0214958148927917,0.0423491939243619,2.02561827216047e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD7,T-cell antigen CD7,40166,0.0273253960377659,0.00456243186130138,0.0183830295896152,0.0362677624859166,2.17463269639714e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42587,0.0533395605572871,0.00890845457737062,0.0358789895856407,0.0708001315289335,2.18515850872148e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42545,0.0172759496312368,0.00288654288814611,0.0116183255704704,0.0229335736920032,2.21940552945021e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",40223,0.0528068912173875,0.00882852309807671,0.0355029859451572,0.0701107964896179,2.2809711954237e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GET3,ATPase GET3,40511,0.0329037283041479,0.0055029391523687,0.0221179675655052,0.0436894890427905,2.30861329231039e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42495,0.056472599966216,0.00945298496857834,0.0379447494278024,0.0750004505046295,2.3734708315709e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TBCB,Tubulin-folding cofactor B,42495,0.0601866541113564,0.0100774166961945,0.0404349173868152,0.0799383908358977,2.39711306425257e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FOLR1,Folate receptor alpha,42600,0.0184211357251808,0.00308745320791334,0.0123697274376707,0.0244725440126909,2.4858435990028e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42579,0.0148428365836661,0.00248872899239753,0.00996492775856696,0.0197207454087653,2.52307367912345e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCRL6,Fc receptor-like protein 6,42594,0.0423586079944683,0.00712084547463358,0.0284017508641865,0.0563154651247501,2.77295179087372e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,40449,0.0297836980195295,0.00501130821094368,0.0199615339260799,0.0396058621129791,2.87622531100961e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",40302,0.0296127482014884,0.00500054239954876,0.0198116850983728,0.039413811304604,3.27651426725804e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CIAPIN1,Anamorsin,42679,0.0371973870179961,0.00629055936021996,0.024867890671965,0.0495268833640272,3.43625329680837e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,42346,0.035625563884439,0.00603130428087023,0.0238042074939334,0.0474469202749447,3.57487226127533e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,40199,0.0528757890389034,0.00895701147975171,0.0353200465385901,0.0704315315392168,3.66853464118145e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42594,0.0366520990950585,0.00621058633448304,0.0244793498794718,0.0488248483106453,3.68798139382758e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42658,0.0307708177368019,0.00521429561743076,0.0205507983266376,0.0409908371469662,3.6944964185531e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HMOX1,Heme oxygenase 1,42500,-0.029030982795277,0.00492082084310303,-0.038675791647759,-0.0193861739427951,3.7318971895926e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,40116,0.0221253623304148,0.00375141954366826,0.014772580024825,0.0294781446360046,3.79151575933882e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PF4,Platelet factor 4,40463,0.0588736243383568,0.00998894397785971,0.0392952941417518,0.0784519545349619,3.88037755786405e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCN3,CCN family member 3,42779,0.0212630046183188,0.00361339529291876,0.014180749844198,0.0283452593924396,4.08679109435019e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,40283,0.0504939730624891,0.00859374864488258,0.0336502257185192,0.0673377204064589,4.33264604968013e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,40182,0.0385831441637507,0.00656711040767092,0.0257116077647157,0.0514546805627857,4.34564423933591e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,42311,0.0229010688296623,0.00389982569939668,0.0152574104588448,0.0305447272004798,4.40112239762627e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MINK1,Misshapen-like kinase 1,40483,0.0550876697011962,0.00941318275746514,0.0366378314965645,0.0735375079058279,4.98648717370022e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,40199,0.032323195385822,0.00552768251246558,0.0214889376613895,0.0431574531102546,5.13165263282392e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,42587,0.0684422056540482,0.0117088011806069,0.0454929553400587,0.0913914559680376,5.1722937814419e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,42569,0.0525468863627162,0.00899409467117532,0.0349184608072126,0.0701753119182198,5.26586768451109e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FABP3,"Fatty acid-binding protein, heart",40511,0.0312574517533578,0.00535438534220382,0.0207628564826383,0.0417520470240772,5.43701772035768e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEMA7A,Semaphorin-7A,42760,0.0169097547059074,0.00289847570023183,0.011228742333453,0.0225907670783618,5.53428449550294e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TBCA,Tubulin-specific chaperone A,40283,0.0503692772084969,0.00863446738476128,0.0334457211343648,0.0672928332826291,5.57894043352805e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GNAS,Neuroendocrine secretory protein 55,40482,0.0510900271646285,0.00875871523184767,0.033922945310207,0.0682571090190499,5.59167535249216e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EGF,Pro-epidermal growth factor,42597,0.0608150232847578,0.0104309350313564,0.0403703906232993,0.0812596559462164,5.66167876694215e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ALPP,"Alkaline phosphatase, placental type",42587,0.0598515499925472,0.0102665003332177,0.0397292093394406,0.0799738906456539,5.6775436192875e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,42721,-0.0352372779995901,0.00604446256886275,-0.0470844246345611,-0.0233901313646191,5.68005363792685e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,42346,0.049935658140845,0.00857224890454211,0.0331340502879425,0.0667372659937475,5.83544809039193e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FIS1,Mitochondrial fission 1 protein,42624,0.0445524968943628,0.00765276041851249,0.0295530864740783,0.0595519073146473,5.95634617169249e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMP8,Neutrophil collagenase,42681,0.0432001467549054,0.00742958683810131,0.0286381565522269,0.057762136957584,6.21517014558414e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,42746,0.0309314825059517,0.00533720188950546,0.020470566802521,0.0413923982093824,6.96541413190897e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNX5,Sorting nexin-5,40223,0.0171637811593889,0.00296415686181595,0.0113540337102297,0.0229735286085482,7.2117316771818e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPD52L2,Tumor protein D54,40283,0.0632044829070564,0.0109170888273512,0.041806988805448,0.0846019770086647,7.25116530045482e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCRG1,Scrapie-responsive protein 1,40511,0.0168546496223443,0.00291185808211112,0.0111474077814065,0.0225618914632821,7.29992185069362e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THTPA,Thiamine-triphosphatase,40436,0.0516807938483038,0.00894418851568477,0.0341501843575617,0.069211403339046,7.7535292794692e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL5,C-X-C motif chemokine 5,42605,0.0664104770211435,0.0114979550688258,0.043874485086245,0.0889464689560421,7.82633829251269e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,40116,0.0405543170755549,0.00703215374663865,0.0267712957321431,0.0543373384189666,8.28922673640104e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCRIB,Protein scribble homolog,40223,0.0532847053074525,0.00925298380339597,0.0351488570527964,0.0714205535621086,8.70535920653122e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,42311,0.0305826005300165,0.00531217665925756,0.0201707342778717,0.0409944667821613,8.75004641685367e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CAT,Catalase,40361,0.0319097071313093,0.00554423395748231,0.021043008574644,0.0427764056879747,8.86718889779537e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,40255,-0.0284422216817079,0.0049487660280672,-0.0381418030967196,-0.0187426402666962,9.30563821273817e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,42357,0.0316473115382629,0.00551485718509362,0.0208381914554794,0.0424564316210464,9.75918623590548e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PGA4,Pepsin A-4,40532,0.0473711408172624,0.00826136467628442,0.0311788660517449,0.0635634155827799,1.00560553646945e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGAL,Integrin alpha-L,40199,0.0260914449540414,0.00455257540487945,0.0171683971604776,0.0350144927476051,1.02378866097547e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GGH,Gamma-glutamyl hydrolase,42437,0.0198812148931097,0.00348028589972092,0.0130598545296567,0.0267025752565627,1.13707829154192e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAP3,Cytosol aminopeptidase,42370,0.0280638901319608,0.00492110123148635,0.0184185317182476,0.0377092485456741,1.20410553178612e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,40199,0.0523361290461194,0.00917822693026947,0.0343468042627912,0.0703254538294475,1.21313389345906e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,42754,0.0200864757871532,0.00352362638155944,0.0131801680792967,0.0269927834950097,1.21936401065181e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,42587,-0.0384203569429176,0.00674461180143756,-0.0516397960737352,-0.0252009178121,1.24899720300663e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAP2,Microtubule-associated protein 2,40483,0.0268899066289721,0.00472552323382838,0.0176278810906685,0.0361519321672757,1.29931149984282e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GAS2,Growth arrest-specific protein 2,40302,0.0305839167177261,0.0053763693535361,0.0200462327847954,0.0411216006506569,1.31336174209692e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB10,Ras-related protein Rab-10,40511,0.0308864784138454,0.00544306275666055,0.0202180754107908,0.0415548814169001,1.42538217586778e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BAP18,Chromatin complexes subunit BAP18,40483,0.0391023303677682,0.00689147343427985,0.0255950424365797,0.0526096182989567,1.42921485546789e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDCD6,Programmed cell death protein 6,42636,-0.0406716677837693,0.00717906817587958,-0.0547426414084933,-0.0266006941590453,1.49766966261971e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,42346,0.0334220225281363,0.0058998409765455,0.0218583342141071,0.0449857108421655,1.50192338740773e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL15,Interleukin-15,42594,0.0190843291423583,0.00337232699380524,0.0124745682345,0.0256940900502166,1.55288590485898e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LYZL2,Lysozyme-like protein 2,40080,0.020813431837812,0.00367972200709309,0.0136011767039096,0.0280256869717145,1.58617290740785e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPME1,Protein phosphatase methylesterase 1,42587,0.0342686125971066,0.00606605800601121,0.0223791389053246,0.0461580862888886,1.64440899237949e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINA7,Thyroxine-binding globulin,40539,0.0106524743215705,0.00188573989033527,0.00695642413651339,0.0143485245066276,1.65304099713465e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",42679,0.034689389173388,0.00615021062569702,0.0226349763470218,0.0467438019997542,1.73107422779431e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYOC,Myocilin,42611,-0.0256487848132232,0.0045509827585705,-0.0345687110200214,-0.016728858606425,1.7767556659402e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,42346,0.0560479048718776,0.00995861413661215,0.0365290211641178,0.0755667885796374,1.85947322020282e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,40182,0.0246127281740826,0.004374968467241,0.0160377899782902,0.033187666369875,1.8915936674021e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC51B,Organic solute transporter subunit beta,40116,0.0442997901386837,0.00787974930492957,0.0288554815010218,0.0597440987763457,1.93415208058393e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,40223,0.0300300855324645,0.00534375638258036,0.019556323022607,0.040503848042322,1.95978180440792e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMED8,Protein TMED8,40449,0.0582771980515902,0.0103746095304772,0.0379429633718548,0.0786114327313255,1.98578661711589e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42638,0.0199362175059027,0.00355163732908715,0.0129750083408919,0.0268974266709135,2.02492787353281e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GBP1,Guanylate-binding protein 1,40466,0.0374385945962556,0.00667751964699738,0.0243506560881408,0.0505265331043705,2.11117947691698e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,42721,0.0234421405770158,0.0041853511662302,0.0152388522912046,0.031645428862827,2.17276153941424e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,40449,0.0333342488770127,0.00595095080663264,0.0216703852960127,0.0449981124580127,2.17493378738394e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,42190,0.0688719449548585,0.0122980750353952,0.044767717885484,0.092976172024233,2.18420320759851e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HEPACAM2,HEPACAM family member 2,40483,-0.0240418803859021,0.00429867215190842,-0.0324672778036426,-0.0156164829681616,2.28552125065734e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MGLL,Monoglyceride lipase,42654,0.0487124897737572,0.00871339810142314,0.0316342294949679,0.0657907500525466,2.30783413130307e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,40511,0.0345793062093189,0.00619139327663091,0.0224441753871223,0.0467144370315155,2.39009740713688e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYL4,Myosin light chain 4,40223,0.0297539628158805,0.00532943219328031,0.0193082757170511,0.0401996499147099,2.42062672905781e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNPEP,Aspartyl aminopeptidase,40483,0.0324804599582077,0.00582419457055969,0.0210650385999107,0.0438958813165047,2.50595143624643e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,40511,0.0185859128496753,0.00333379063870174,0.0120516831978199,0.0251201425015307,2.53188457655733e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,42754,0.0344329527455992,0.00618901850061119,0.0223024764844013,0.0465634290067971,2.69337936488975e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,40283,0.0466431630674169,0.0083902223142011,0.0301983273315827,0.063087998803251,2.77237346746248e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BLVRB,Flavin reductase,42611,0.0371388316762331,0.00668957983753904,0.0240272551946566,0.0502504081578096,2.88203821567907e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42495,0.0171322768772344,0.00308807101346283,0.0110796576908472,0.0231848960636215,2.94660843958705e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42721,0.0192851071450111,0.00348315091105183,0.0124581313593495,0.0261120829306726,3.13994058592286e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,40223,0.0179968699299207,0.00325109431966938,0.0116247250633688,0.0243690147964727,3.17196519396589e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAX,Protein max,42311,0.0588882533118282,0.0106541927082718,0.0380060356036154,0.079770471020041,3.31522325306613e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,40185,0.0156472971628894,0.00283673971355229,0.0100872873243269,0.0212073070014519,3.54764953162813e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DXO,Decapping and exoribonuclease protein,40483,0.0256103739007147,0.00464369950489129,0.0165087228711278,0.0347120249303016,3.56297322570833e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZBP1,Z-DNA-binding protein 1,40199,0.022530552771824,0.00408571018390376,0.0145225608113727,0.0305385447322754,3.57719104161218e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SUSD1,Sushi domain-containing protein 1,42357,0.0276609014192774,0.00502149237254321,0.0178187763690927,0.037503026469462,3.68692950213698e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GAL,Galanin peptides,42676,-0.0359728593299452,0.00655011603538182,-0.0488110867592936,-0.0231346319005968,4.04736129371173e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHRDL2,Chordin-like protein 2,42636,0.0263630166491131,0.00480950909240951,0.0169363788279904,0.0357896544702357,4.29492698571257e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCTN6,Dynactin subunit 6,42311,0.0400267613851826,0.00730535852201088,0.0257082586820412,0.0543452640883239,4.35390172866909e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CALB1,Calbindin,42587,0.0254559997830927,0.00464861759113215,0.0163447093044737,0.0345672902617117,4.42797720592247e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,40500,0.0265327260943559,0.00484898971781325,0.0170287062474419,0.0360367459412699,4.54970780916688e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,40189,0.0196077754755571,0.00358511704450927,0.0125809460683189,0.0266346048827952,4.61925813764047e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TBC1D23,TBC1 domain family member 23,42587,0.049616664273762,0.0090775349072555,0.0318246958555412,0.0674086326919828,4.68873296922816e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,40449,0.0482511756342424,0.00883881799585825,0.0309270923623602,0.0655752589061246,4.88962372791887e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,40199,0.0194017885630682,0.00355583307040475,0.0124323557450748,0.0263712213810615,4.96614010332699e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASP7,Caspase-7,40483,0.0463287083836664,0.00849179303335723,0.0296847940382862,0.0629726227290466,4.98086485879489e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,42346,0.0281277994840921,0.00516293439148042,0.0180084480767905,0.0382471508913937,5.18483934064586e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42594,0.083467416335649,0.0153328640552344,0.0534150027873895,0.113519829883908,5.31055304315103e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",40482,0.026618687856096,0.00489237362996879,0.0170296355413572,0.0362077401708349,5.41332034469213e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,40223,0.0405587528078476,0.00745583182556713,0.025945322429736,0.0551721831859592,5.44585662608809e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF2,Fibroblast growth factor 2,42594,0.037647331398777,0.00693962083255555,0.0240456745669681,0.0512489882305859,5.89663648787213e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPRY2,Protein sprouty homolog 2,42370,0.0505212114134227,0.00932814601450615,0.0322380452249906,0.0688043776018547,6.2017783299055e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYO9B,Unconventional myosin-IXb,42370,0.0362726836133905,0.00669972368019511,0.0231412252002081,0.0494041420265729,6.26924882736049e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB44,Ras-related protein Rab-44,40451,0.0232002565850946,0.00428490155440854,0.0148018495384539,0.0315986636317354,6.27509331165285e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NRGN,Neurogranin,40532,0.0500828246290414,0.00926595307350328,0.031921556604975,0.0682440926531079,6.61074639746819e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,42794,-0.0174046059535469,0.00322887607401954,-0.0237332030586252,-0.0110760088484686,7.1514505516122e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,40451,0.0449950093388273,0.00835137856407848,0.0286263073532334,0.0613637113244211,7.2789236141007e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINB6,Serpin B6,42679,0.0315684070111532,0.00587034984147271,0.0200625213218667,0.0430742927004397,7.6743087564486e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL2A1,Collagen alpha-1(II) chain,40223,0.0443315662593258,0.00824486900434744,0.0281716230108049,0.0604915095078468,7.73399302012076e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TTF2,Transcription termination factor 2,40182,0.026781248072012,0.00498574592651499,0.0170091860560426,0.0365533100879814,7.96500818121454e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,40223,0.0227937606650535,0.00424774439371804,0.0144681816533662,0.0311193396767409,8.20931156057724e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,42679,-0.0137536530896731,0.00256470199103519,-0.0187804689921021,-0.00872683718724415,8.33529417900488e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SOD3,Extracellular superoxide dismutase,40532,-0.0319828844165823,0.00598210360493679,-0.0437078074822584,-0.0202579613509062,9.14486282990705e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,40223,0.0287158490371653,0.00537316563987545,0.0181844443830094,0.0392472536913211,9.25724224256596e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AIF1,Allograft inflammatory factor 1,42346,0.0282626435160798,0.00529333217422724,0.0178877124545944,0.0386375745775651,9.48623254699881e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFNG,Interferon gamma,42370,0.0613533257131334,0.0114979588029986,0.038817326459256,0.0838893249670107,9.65828993372962e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42495,0.0197750589277783,0.00370826499421052,0.0125068595391257,0.027043258316431,9.83473870089085e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,40223,0.0302842417126636,0.00568305519904038,0.0191454535225445,0.0414230299027827,1.00775277501964e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL13,C-C motif chemokine 13,42734,0.0373444535362764,0.00700973493606462,0.0236053730615897,0.051083534010963,1.0116099681813e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42636,-0.0179310882638729,0.00337101216936724,-0.0245382721158327,-0.0113239044119131,1.05895389271337e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,40199,0.0432407588033012,0.00812995235641103,0.0273060521847356,0.0591754654218668,1.06561444614603e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMP3,Stromelysin-1,42611,-0.0273161985885591,0.00513843500425463,-0.0373875311968982,-0.01724486598022,1.07740947620625e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",40511,0.0393757732474237,0.00741038433331811,0.0248514199541202,0.0539001265407272,1.09524852322495e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPQ,Carboxypeptidase Q,40516,0.0193387419503785,0.00364075169121108,0.0122028686356048,0.0264746152651522,1.10638874994848e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,42311,0.0340116458277967,0.00640410718170572,0.0214595957516535,0.04656369590394,1.10859856998727e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",40511,0.0164323384764187,0.00309406324869431,0.0103679745089779,0.0224967024438596,1.11137015616661e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSV,Cathepsin L2,42677,-0.0226157393826604,0.00425953956658843,-0.0309644369331738,-0.0142670418321471,1.11711925411074e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDCP1,CUB domain-containing protein 1,42495,0.0292994879774756,0.0055192989425099,0.0184816620501562,0.040117313904795,1.12275782549922e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACHE,Acetylcholinesterase,40283,0.0180656737016922,0.00340310580242416,0.0113955863289408,0.0247357610744436,1.12613398677818e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PKD2,Polycystin-2,40116,0.0315481421825411,0.00594533441602466,0.0198952867271328,0.0432009976379495,1.14019192941824e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",40483,0.0523721923502541,0.009870432742241,0.0330261441754618,0.0717182405250465,1.14198579565819e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANXA10,Annexin A10,42311,0.0466631498591221,0.00881005179239801,0.029395448346022,0.0639308513722222,1.19898114129256e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,40199,0.0491245113861088,0.00927490436132043,0.0309456988379207,0.0673033239342968,1.20321315917424e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42681,0.0161925667352007,0.00305878877074656,0.0101973407445375,0.022187792725864,1.21689960302286e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,40449,0.0248457787933966,0.00469611377082919,0.0156413958025714,0.0340501617842218,1.24129518207649e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,40449,0.062955639668502,0.0119165460441471,0.0395992094219738,0.0863120699150302,1.29426583542859e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,42679,0.013254430091932,0.00250941487486626,0.00833597693719412,0.0181728832466699,1.29852461663448e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42587,0.0212940114007623,0.00403309185249476,0.0133891513698726,0.0291988714316521,1.31330008547225e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TBC1D17,TBC1 domain family member 17,42311,0.0244040969448356,0.00462664731359225,0.0153358682101948,0.0334723256794764,1.35100695612359e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,40283,0.0322538356625348,0.00611682970419174,0.020264849442319,0.0442428218827507,1.36761230647593e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,42495,-0.0195168726386721,0.0037039489888183,-0.026776612656756,-0.0122571326205883,1.39154483413316e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNX9,Sorting nexin-9,42636,0.0358005144569142,0.00680682060281718,0.0224591460753925,0.0491418828384359,1.46658911173555e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42636,0.0443146788899082,0.00842585647264696,0.0278000002035201,0.0608293575762962,1.46768953885544e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CAPG,Macrophage-capping protein,42461,0.0313358438719282,0.0059600210931784,0.0196542025292985,0.0430174852145579,1.48154277502777e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,40482,0.0454364887393745,0.00864564758756041,0.0284910194677561,0.0623819580109929,1.50382247538867e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,40182,0.0367490440171221,0.00700272884739055,0.0230236954762366,0.0504743925580075,1.56779292765441e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LACTB2,Endoribonuclease LACTB2,42636,0.0346444301764871,0.00660970496665763,0.0216894084418382,0.0475994519111361,1.61732493284087e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,40511,0.0480617733401218,0.00917932126877361,0.0300703036533255,0.066053243026918,1.67149285199734e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,42439,-0.0318627593620437,0.00608854217362652,-0.0437963020223517,-0.0199292167017357,1.69114331740936e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HDGF,Hepatoma-derived growth factor,42700,0.0494297388319062,0.00944840593290557,0.0309108632034113,0.0679486144604012,1.70615227955441e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLSTN2,Calsyntenin-2,42754,-0.0211140914522773,0.00403615004537494,-0.0290249455412122,-0.0132032373633424,1.70879206628764e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPXM1,Probable carboxypeptidase X1,42679,0.0369529595890717,0.00706751747718451,0.0231006253337901,0.0508052938443533,1.73385921313943e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APRT,Adenine phosphoribosyltransferase,42480,0.0250714364701016,0.00480264440377614,0.0156582534387004,0.0344846195015028,1.81287871853526e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HMBS,Porphobilinogen deaminase,42721,0.022885466799508,0.0043927021651344,0.0142757705558445,0.0314951630431714,1.91735519783648e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,42357,0.0185839161726482,0.00356954075100471,0.011587616300679,0.0255802160446174,1.95598690551067e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,40283,0.0627837615042559,0.0120589898171098,0.0391481414627206,0.0864193815457912,1.96000073096926e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPA33,Cell surface A33 antigen,42587,0.0736640291660092,0.0141565966925518,0.0459170996486076,0.101410958683411,1.98444899681417e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SWAP70,Switch-associated protein 70,40449,0.0188885364328175,0.00363438597849535,0.0117651399149666,0.0260119329506684,2.05884444745928e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINA11,Serpin A11,42794,-0.021632605700414,0.00416458791218796,-0.0297951980083024,-0.0134700133925256,2.08329051400785e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42679,0.0378088776134291,0.00728700102593547,0.0235263556025955,0.0520913996242626,2.15026575307277e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GFRAL,GDNF family receptor alpha-like,40109,-0.0332820711529196,0.00642227924278079,-0.0458697384687699,-0.0206944038370693,2.23100789690229e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CFB,Complement factor B,40344,0.0170871450951946,0.00330283085322121,0.010613596622881,0.0235606935675081,2.33758231859711e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,42711,0.0242304822548955,0.00468776149539034,0.0150424697239304,0.0334184947858606,2.38857437068895e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OBP2B,Odorant-binding protein 2b,42462,-0.0322684570882759,0.00624421386650435,-0.0445071162666244,-0.0200297979099274,2.40384322920293e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LGMN,Legumain,42676,0.0187440167977391,0.00363259695387031,0.0116241267681533,0.0258639068273249,2.50524124152114e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,40283,-0.0147289399795447,0.00285459849387886,-0.0203239530275473,-0.00913392693154218,2.51588662476025e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,40483,0.020345446589543,0.00394909083367236,0.0126052285555452,0.0280856646235408,2.6216750279929e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSPN,Persephin,42594,0.0486496575079242,0.00945693679998966,0.0301140613799445,0.0671852536359039,2.72259913255153e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPTX1,Neuronal pentraxin-1,42611,-0.0209940430206279,0.00408131742103722,-0.0289934251658609,-0.012994660875395,2.72831489046752e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,42357,0.0573397730548705,0.011150702723165,0.0354843957174672,0.0791951503922738,2.75354521336649e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,40449,-0.0267512449160234,0.0052156492932974,-0.0369739175308863,-0.0165285723011605,2.96076842637307e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,42475,0.01390192820883,0.00271355114894092,0.0085833679569058,0.0192204884607542,3.0468675706383e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BAG6,Large proline-rich protein BAG6,42357,0.0185570332414234,0.00362735759891652,0.011447412347547,0.0256666541352998,3.16718022310535e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42679,-0.0233345088116895,0.00456833690593413,-0.0322884491473204,-0.0143805684760586,3.30242928796229e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,40116,0.0359479414069431,0.00704182337949948,0.0221459675831241,0.0497499152307621,3.36506575639234e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42587,0.0355889588891653,0.0069775165707396,0.0219130264105157,0.0492648913678149,3.43351454987163e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NEXN,Nexilin,40532,0.0358929084165557,0.00703741272975525,0.0220995794662354,0.049686237366876,3.44596288930307e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",42676,0.0566385330154567,0.0111324747652482,0.0348188824755703,0.0784581835553431,3.67331804340103e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,40511,0.0147382406018135,0.00289726919180803,0.00905959298586972,0.0204168882177572,3.69712995593521e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,42346,0.0292555858244459,0.00575501510958132,0.0179757562096665,0.0405354154392252,3.75644562811698e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,40483,0.0197910351963304,0.00389951700740019,0.012147981861826,0.0274340885308347,3.93141180093031e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,S100G,Protein S100-G,40482,-0.0249420673536222,0.00493028310477596,-0.0346054222389831,-0.0152787124682613,4.28194261404508e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",42370,0.0366078110518333,0.00727030862839647,0.0223580061401762,0.0508576159634904,4.83535468334987e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TCTN3,Tectonic-3,40511,0.0153783353197187,0.00305487142539637,0.0093907873259418,0.0213658833134956,4.87645625415201e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PEPD,Xaa-Pro dipeptidase,40532,-0.0135866120596058,0.00270677212400513,-0.0188918854226559,-0.00828133869655578,5.25958576290165e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFNL1,Interferon lambda-1,42311,0.0233662995066058,0.00467658909223772,0.0142001848858198,0.0325324141273917,5.91504249665112e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,42679,0.0422065063824136,0.00846913074513578,0.0256070101219475,0.0588060026428798,6.31959609177874e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BAX,Apoptosis regulator BAX,42292,0.0451190942708617,0.00905515717341901,0.0273709862109604,0.062867202330763,6.35047872746592e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,40482,0.0243390413599823,0.00488575454867502,0.0147629624445792,0.0339151202753853,6.39833315029752e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,40116,0.0189852775631691,0.00382089712597584,0.0114963191962565,0.0264742359300818,6.83892342409898e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MICALL2,MICAL-like protein 2,40182,0.0347882936552198,0.00700670191922483,0.0210551578935391,0.0485214294169005,6.97320397105986e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BST2,Bone marrow stromal antigen 2,42711,0.0258154708659932,0.0052051855255133,0.0156133072359871,0.0360176344959992,7.150820052793e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,40511,0.0490141588631454,0.00989479542425489,0.0296203598316058,0.068407957894685,7.39325693008682e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,40283,0.01647897457132,0.00333048423661987,0.009951225467545,0.0230067236750949,7.61116893653738e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,40332,0.0287744067387925,0.00581683289749061,0.0173734142597109,0.0401753992178741,7.65658361299404e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NID2,Nidogen-2,42611,0.0371043809742893,0.0075181534529266,0.0223688002065532,0.0518399617420254,8.09863197394108e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNR,Tenascin-R,42495,-0.021277215272696,0.00431138283405075,-0.0297275256274355,-0.0128269049179565,8.10691747545329e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL17,C-C motif chemokine 17,42604,0.0459413950054277,0.00931945296857841,0.027675267187014,0.0642075228238414,8.3373443475071e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IST1,IST1 homolog,40375,0.049462318553444,0.0100395257247361,0.0297848481329613,0.0691397889739267,8.48025224929332e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLGN,Calmegin,40182,0.0233654180318352,0.00474523875311436,0.0140647500757311,0.0326660859879394,8.60388870142436e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLG,Plasminogen,40285,0.0107158907188184,0.00218745134682242,0.00642848607904651,0.0150032953585904,9.77848531817851e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SYAP1,Synapse-associated protein 1,40283,0.0286118610525112,0.00584064888925454,0.0171641892295723,0.0400595328754501,9.78123557583278e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,40182,0.0242021323773286,0.00494089420850046,0.0145179797286677,0.0338862850259895,9.80320681239094e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,42587,0.0278397411432638,0.00570533720405289,0.0166572802233202,0.0390222020632075,1.07526886683515e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPHB4,Ephrin type-B receptor 4,42794,0.0131213271748735,0.00268921999560462,0.00785045598348843,0.0183921983662586,1.07706687737882e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BSG,Basigin,42746,0.010782183685369,0.0022113059484559,0.00644802402639546,0.0151163433443426,1.09522585209043e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COMMD9,COMM domain-containing protein 9,40451,0.0197692863667712,0.00405770539780963,0.0118161837870643,0.027722388946478,1.11958920120335e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42667,0.0548179367163173,0.0112543248534237,0.0327594600036068,0.0768764134290278,1.12391416616524e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NRCAM,Neuronal cell adhesion molecule,42636,0.0144294353631451,0.00296289700483909,0.00862215723366053,0.0202367134926297,1.12843921194829e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,42664,0.0586864337578553,0.0120531052315319,0.0350623475040529,0.0823105200116578,1.13443722268216e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,40511,0.0347784191803795,0.00714850619157951,0.0207673470448837,0.0487894913158753,1.15922548619862e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMOTL2,Angiomotin-like protein 2,40404,0.0239573662328045,0.00492646786201789,0.0143014892232494,0.0336132432423595,1.1719600167545e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,40302,0.0339889054362415,0.00699353837577331,0.0202815702197258,0.0476962406527572,1.18964648220568e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BIN2,Bridging integrator 2,42611,0.0444549700487926,0.00916357756730568,0.0264943580168735,0.0624155820807118,1.24052769782396e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIGLEC1,Sialoadhesin,42676,0.0213662401065652,0.00440533956272903,0.0127317745636163,0.0300007056495141,1.24791343302047e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA1,Carbonic anhydrase 1,42362,0.0296967480108775,0.00613232899985486,0.017677383171162,0.0417161128505931,1.29572727821789e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ICAM1,Intercellular adhesion molecule 1,42595,0.0143826356667514,0.00297165434860766,0.00855819314348038,0.0202070781900224,1.3132441053412e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DKK3,Dickkopf-related protein 3,42794,-0.0148721648795828,0.00307469971475383,-0.0208985763205003,-0.00884575343866526,1.33291925479465e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIFBP,KIF-binding protein,42587,0.0400759361876436,0.00828559559159111,0.023836168828125,0.0563157035471621,1.33400390753087e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,40116,0.0338390434093685,0.00699618182501259,0.0201265270323439,0.0475515597863932,1.3375632505201e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GZMH,Granzyme H,42357,0.0383258415985559,0.00793067275970059,0.0227817229895427,0.053869960207569,1.36275511119124e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD84,SLAM family member 5,42594,0.0153614746431689,0.00318270777435882,0.00912336740542559,0.0215995818809122,1.40455734800699e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,40511,-0.0182301277049053,0.00377762888576452,-0.0256342803210038,-0.0108259750888069,1.41254910815448e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DMD,Dystrophin,40223,0.0253350816805238,0.00525680151016903,0.0150317507205925,0.0356384126404551,1.45847866046593e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMEM106A,Transmembrane protein 106A,40451,0.0343617124874418,0.00713771351139397,0.0203717940051097,0.048351630969774,1.49783325952818e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,40116,0.0192177606866951,0.00399575535590771,0.011386080189116,0.0270494411842742,1.53296091760914e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AKAP12,A-kinase anchor protein 12,40283,-0.0108484084641812,0.00225596236289512,-0.0152700946954556,-0.00642672223290678,1.53857218933392e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,42676,-0.0101558851230441,0.00211345019164191,-0.0142982474986622,-0.00601352274742593,1.56139319394384e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42721,0.0299267020260489,0.00622805299090717,0.0177197181638708,0.0421336858882269,1.56299370891635e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATXN10,Ataxin-10,42311,0.0354141931116468,0.00737094993327927,0.0209671312424194,0.0498612549808741,1.56806722549135e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,40302,0.0361191041941841,0.007522548782995,0.021374908579514,0.0508632998088543,1.59580412863038e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD101,Immunoglobulin superfamily member 2,40449,0.0213399094141194,0.00444724745253847,0.012623304407144,0.0300565144210948,1.61949764690592e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSDE1,Cold shock domain-containing protein E1,40116,0.0570840260173859,0.011901915599717,0.0337562714419407,0.0804117805928312,1.63837068270331e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRLF1,Cytokine receptor-like factor 1,42676,0.0122764437695964,0.00256183694222679,0.00725524336283185,0.0172976441763609,1.66847985472202e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,40483,0.0238391471516759,0.00498203404450486,0.0140743604244464,0.0336039338789055,1.73134035492463e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PROS1,Vitamin K-dependent protein S,40539,0.0127298384965445,0.00266517391061043,0.00750609763174804,0.0179535793613409,1.80728577827319e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STX16,Syntaxin-16,42346,0.0280776688932525,0.00588422001260065,0.0165445976685552,0.0396107401179498,1.84651439802169e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,40302,0.0338687838185288,0.00712396147128437,0.0199058193348115,0.0478317483022462,2.01729703996267e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GMFG,Glia maturation factor gamma,40511,0.0344591984835593,0.007271716603896,0.0202066339399231,0.0487117630271954,2.17606543599557e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42611,0.0260117198928369,0.00550031448290897,0.0152311035063353,0.0367923362793385,2.27775826919325e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42658,-0.0313783569024707,0.00663627027971147,-0.0443854466507052,-0.0183712671542363,2.28689131615097e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UNC79,Protein unc-79 homolog,40080,0.0268353651539772,0.00567773357119903,0.0157070073544271,0.0379637229535273,2.31373877964831e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,40449,-0.0340209817415078,0.00719900693558043,-0.0481310353352455,-0.0199109281477702,2.32000837734652e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HPCAL1,Hippocalcin-like protein 1,42754,0.0347281534843427,0.00735093740692371,0.0203203161667723,0.0491359908019132,2.33207291683207e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,40449,0.0252117599554454,0.00536181036861274,0.0147026116329645,0.0357209082779264,2.60560234546856e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RSPO3,R-spondin-3,42721,0.0141388070055425,0.0030270549222368,0.00820577935795835,0.0200718346531266,3.02897899572473e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,40136,0.0470731216485261,0.0100816692109983,0.0273130499949693,0.0668331933020828,3.06002039351494e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPTXR,Neuronal pentraxin receptor,42636,-0.0161577528104493,0.00346460484860552,-0.0229483783137162,-0.00936712730718253,3.13619641889999e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,40451,0.0511141489032631,0.0109597997210943,0.0296329414499183,0.072595356356608,3.1401844475232e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",40483,-0.0286024426606969,0.00613474389057622,-0.0406265406862263,-0.0165783446351675,3.16172195281154e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BPIFA2,BPI fold-containing family A member 2,39838,-0.0537755220860224,0.0115351347026789,-0.0763843861032729,-0.0311666580687718,3.17127938793242e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINB9,Serpin B9,42495,0.0155332613379298,0.00333340522843463,0.00899978709019796,0.0220667355856617,3.19466553125712e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTF1,Cardiotrophin-1,42357,0.0398671631100666,0.00855805744824705,0.0230933705115024,0.0566409557086308,3.21740709314113e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,40182,0.0297407915940165,0.00638466863222093,0.0172268410748635,0.0422547421131695,3.22796690805948e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIF22,Kinesin-like protein KIF22,40116,0.0593549758403918,0.0127527074150832,0.0343596693068288,0.0843502823739548,3.28903187964366e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,42794,0.0108964540235845,0.0023509796721553,0.00628853386616013,0.0155043741810089,3.60503959857312e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42594,0.0408589879250241,0.00882161870485555,0.0235686152635072,0.0581493605865409,3.66107902745835e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBM17,Splicing factor 45,40482,0.0359844055939945,0.00777130951297908,0.0207526389485555,0.0512161722394335,3.69003342661508e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,40449,0.0192979214507081,0.00417223192541219,0.0111203468769002,0.027475496024516,3.78184304101458e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK11,Kallikrein-11,42543,0.0154023831440012,0.0033340863581055,0.0088675738821144,0.021937192405888,3.87941779480877e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,40302,0.0494524224671103,0.0107101063351787,0.0284606140501601,0.0704442308840605,3.93013128618482e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FN1,Fibronectin,40539,0.0125423776042637,0.00271704057953906,0.00721697806836718,0.0178677771401603,3.95137605309301e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42754,-0.0132158885857,0.00286424915629284,-0.018829816932034,-0.00760196023936606,3.98448006022071e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASP3,Caspase-3,42794,0.0406240516488024,0.00880539996542759,0.0233654677165643,0.0578826355810405,3.99484947158028e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLMP,CXADR-like membrane protein,42721,0.0103133998005879,0.00223619137729445,0.0059304647010908,0.014696334900085,4.02395268966981e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TXN,Thioredoxin,40384,0.0209805951012782,0.0045505007458857,0.0120616136393423,0.0298995765632142,4.05931696360649e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UROS,Uroporphyrinogen-III synthase,40182,0.0319476066446012,0.0069331147791826,0.0183587016774033,0.0455365116117991,4.11190224728349e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RCOR1,REST corepressor 1,42357,0.0208465521115309,0.00452582726030715,0.0119759306813289,0.0297171735417329,4.14076559835941e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,40482,0.0170099760044257,0.00369419798821253,0.00976934794752917,0.0242506040613223,4.17952314380482e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADA2,Adenosine deaminase 2,42572,0.0208452842176134,0.004527862707311,0.0119706733112838,0.0297198951239429,4.18710045449318e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,40482,0.0377121015510131,0.00819938312508567,0.0216413106258452,0.053782892476181,4.28353885068045e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRADD,Death domain-containing protein CRADD,42476,0.0348261760030073,0.00757549408953044,0.0199782075875276,0.0496741444184869,4.32124120460119e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,42458,0.0161632748484447,0.00353045507903138,0.00924358289354315,0.0230829668033462,4.73163640360531e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,40329,0.0260666468825749,0.00569466477480543,0.0149051039239562,0.0372281898411935,4.75932103988905e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,42346,-0.017873269847118,0.00390519079227254,-0.0255274437999722,-0.0102190958942638,4.76469406998704e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NXPH3,Neurexophilin-3,40199,-0.0143495972351727,0.00314289959369408,-0.0205096804388131,-0.00818951403153227,5.03184257432121e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BLNK,B-cell linker protein,40199,0.0190142732076307,0.00416522250585564,0.0108504370961537,0.0271781093191078,5.04890567228951e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRUNE2,Protein prune homolog 2,40302,0.0140167136345934,0.00307346030348917,0.00799273143975468,0.0200406958294322,5.15621798954154e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLAMF8,SLAM family member 8,42346,0.025713570861801,0.00563905350422386,0.0146610259935222,0.0367661157300798,5.16377130549053e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,40283,0.0399218550815502,0.00878214368684783,0.0227088534553284,0.0571348567077719,5.53066994542922e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,40482,0.0305250822610079,0.0067547556096224,0.017285761266148,0.0437644032558678,6.27489634659626e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRSS53,Serine protease 53,40483,-0.0172015331899891,0.00380866820554762,-0.0246665228728624,-0.00973654350711575,6.35326242676956e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCN4B,Sodium channel subunit beta-4,40223,0.0202829306263027,0.00449578284762425,0.0114711962449592,0.0290946650076462,6.50221856230421e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACE,Angiotensin-converting enzyme,40532,0.0123972936123468,0.00275001927791081,0.00700725582764163,0.017787331397052,6.60742612332339e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRG2,Bone marrow proteoglycan,40527,-0.0242241115243655,0.00539070578714407,-0.0347898948671679,-0.0136583281815632,7.06960621502424e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LEFTY2,Left-right determination factor 2,42689,0.0227492426155727,0.00507331586176972,0.012805543526504,0.0326929417046413,7.38271043131e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GUCA2A,Guanylin,42563,0.0166118779722097,0.00371008856935148,0.00934010437628079,0.0238836515681386,7.61516204450411e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,40223,0.010846289472757,0.00242575145551363,0.00609181661995034,0.0156007623255638,7.85180149463154e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F3,Tissue factor,42636,-0.0124073935871268,0.00277836355332627,-0.0178529861516463,-0.00696180102260728,8.04503499495024e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DPT,Dermatopontin,42794,0.0114986403807011,0.00257575054804677,0.00645016930652938,0.0165471114548727,8.10187366510172e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",40511,0.040590063284201,0.009093760912904,0.0227662918949091,0.0584138346734928,8.1408593646693e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANXA3,Annexin A3,42681,0.0314514467322437,0.00705102325477081,0.0176314411528929,0.0452714523115945,8.24104445364104e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEMA4C,Semaphorin-4C,42587,-0.0126391845705463,0.00283592824860496,-0.0181976039378121,-0.00708076520328063,8.38648105007418e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,42636,-0.0181081839852578,0.00406494000174011,-0.0260754663886684,-0.0101409015818472,8.46795739977354e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOA2,Apolipoprotein A-II,40532,-0.0224080133975026,0.00503184749373852,-0.0322704344852301,-0.0125455923097751,8.53940708536602e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",42636,-0.0358154998712443,0.00806122826962813,-0.0516155072797154,-0.0200154924627732,8.94498978348479e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42594,-0.0271520602012163,0.00611794541894898,-0.0391432332223563,-0.0151608871800763,9.14805888921092e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSPAN1,Tetraspanin-1,42357,0.0307788542203566,0.0069377809118983,0.0171808036330359,0.0443769048076773,9.22131223161964e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LPO,Lactoperoxidase,42134,0.027398846120013,0.00617756158177483,0.0152908254197343,0.0395068668202916,9.27368547102866e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,40449,0.00974628503210384,0.00219840908531194,0.00543740322489244,0.0140551668393152,9.36651719049751e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCL2L1,Bcl-2-like protein 1,40483,0.0446003676889054,0.0100732407209941,0.0248568158757569,0.0643439195020538,9.61789197114642e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,40302,0.0172493601249247,0.00389712756669558,0.00961099009420138,0.0248877301556481,9.68346010922809e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD70,CD70 antigen,42594,-0.0194786448306819,0.00440242560227151,-0.0281073990111341,-0.0108498906502298,9.74171114338812e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSPB1,Heat shock protein beta-1,42448,0.030399134273305,0.00687651322329202,0.0169211683556527,0.0438771001909574,9.91551488838096e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPCAM,Epithelial cell adhesion molecule,42616,0.0445438744931813,0.0100770481837615,0.0247928600530087,0.0642948889333538,9.93240038236954e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,40302,0.0304713194439993,0.00690230929341515,0.0169427932289056,0.043999845659093,1.02126260780829e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSC,Dipeptidyl peptidase 1,42616,0.0198090277433083,0.00448825988215278,0.0110120383742888,0.0286060171123278,1.0249658606856e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,42594,-0.0218113180801554,0.00494198231784748,-0.0314976034231364,-0.0121250327371743,1.02519238320448e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CST5,Cystatin-D,42357,0.0255462343633073,0.00579857474287438,0.0141810278672735,0.0369114408593411,1.06322273165906e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42587,0.0244774158624706,0.00555612330907477,0.0135874141766841,0.0353674175482572,1.06367259925728e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,40302,0.0342240614584591,0.00777201530621138,0.0189909114582848,0.0494572114586334,1.07514984349041e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,40532,0.0182862491023098,0.00416273533439179,0.0101272878469019,0.0264452103577177,1.12892679026597e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDK1,Cyclin-dependent kinase 1,40080,0.0165719555189257,0.00377275882362831,0.00917734822461426,0.0239665628132372,1.13098370584144e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,40451,0.0420208050063275,0.00958245827734927,0.0232391867827229,0.060802423229932,1.16942365579784e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,42636,-0.0113552281984663,0.0026081547614824,-0.0164672115309718,-0.00624324486596078,1.34823993743145e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,S100A12,Protein S100-A12,42434,0.0333456615883714,0.00766482293876149,0.0183226086283989,0.0483687145483439,1.36856588655735e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNX2,Sorting nexin-2,40451,0.0364593677312413,0.00838269909498541,0.0200292775050699,0.0528894579574127,1.37737683697611e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,42370,0.0191364610773038,0.00440482026025878,0.0105030133671966,0.027769908787411,1.40678630295074e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",42357,0.0408251408167368,0.00940621113847016,0.0223889669853353,0.0592613146481383,1.43394398823292e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PADI4,Protein-arginine deiminase type-4,42292,0.0318450942610677,0.00733789565012356,0.0174628187868255,0.0462273697353099,1.436731941251e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,42346,0.0332722158286749,0.00767109650929174,0.0182368666704631,0.0483075649868867,1.45286521990031e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STX6,Syntaxin-6,42346,0.0291833191038103,0.00672922864968776,0.0159940309504223,0.0423726072571983,1.45648577298693e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DLL1,Delta-like protein 1,42679,0.013898152265833,0.00320684266460898,0.00761274064319943,0.0201835638884666,1.47548325548146e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,40451,0.0243874620121861,0.00563115714034307,0.0133503940171137,0.0354245300072586,1.4984926069556e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EDF1,Endothelial differentiation-related factor 1,40482,0.0295744888257032,0.00683325248654167,0.0161813139520815,0.0429676636993249,1.51748121873276e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,40166,0.0247693367812904,0.00572789344719899,0.0135426656247804,0.0359960079378004,1.5434323552256e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BDNF,Brain-derived neurotrophic factor,40527,0.0368688563212317,0.00853725746241072,0.0201358316949067,0.0536018809475567,1.58369991372514e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,42587,0.0140265872422852,0.00324912285175199,0.00765830645285127,0.0203948680317191,1.59273134443986e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCAM,Basal cell adhesion molecule,42611,-0.0108316545224582,0.00251086413004554,-0.0157529482173475,-0.00591036082756895,1.61535827531432e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,40482,0.0181098791284021,0.00420058083255495,0.00987674069659443,0.0263430175602098,1.63689808871586e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD48,CD48 antigen,42654,0.0136074645307421,0.00316376663723505,0.00740648192176145,0.0198084471397228,1.71202102928677e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PODXL,Podocalyxin,42587,-0.00669481482647308,0.0015568194719345,-0.0097461809914647,-0.00364344866148147,1.71762623998733e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LTA,Lymphotoxin-alpha,42594,0.0178166445610897,0.00414790254535457,0.00968675557219474,0.0259465335499846,1.75655940406108e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCN5,CCN family member 5,42611,0.0168674988584974,0.00393205662587484,0.00916066787178267,0.0245743298452121,1.80135078907503e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDIA4,Protein disulfide-isomerase A4,40527,0.0261011379752246,0.00608901193519892,0.0141666745822347,0.0380356013682145,1.82931538690529e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VEGFB,Vascular endothelial growth factor B,40199,0.0129608767989667,0.00302380716635789,0.00703421475290527,0.0188875388450282,1.83238817588443e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,40080,0.01831644569377,0.00427847007510603,0.00993064434656218,0.0267022470409778,1.87587179678953e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EDN1,Endothelin-1,40223,0.0132818568800309,0.00310910313809244,0.00718801472936967,0.019375699030692,1.95417658935878e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAGED1,Melanoma-associated antigen D1,42346,0.0209818232352489,0.00491579638530154,0.0113468623200579,0.0306167841504399,1.98397276047549e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD300A,CMRF35-like molecule 8,40283,0.013595106239538,0.00318841173482804,0.00734581923927507,0.019844393239801,2.02542429267855e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,40482,0.014173490272901,0.00332436139200216,0.00765774194457674,0.0206892386012252,2.02865520037628e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCTD,Deoxycytidylate deaminase,40283,0.0407834195993252,0.00958675955478379,0.021993370871949,0.0595734683267014,2.11576528938833e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCRL2,Fc receptor-like protein 2,42681,0.0227728091478548,0.00535820983502072,0.0122707178712142,0.0332749004244954,2.15132566236103e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMS,Spermine synthase,40136,0.0276727232372234,0.00651096795757358,0.0149112260403792,0.0404342204340676,2.15378854119072e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,40116,0.0238207073291637,0.00560909797760593,0.0128268752930561,0.0348145393652713,2.18642683240689e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,42346,0.0318011268884045,0.00750852359168358,0.0170844206487047,0.0465178331281043,2.29761685381627e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,42565,0.0186498738656432,0.00440730640677963,0.0100115533083551,0.0272881944229313,2.33601799768455e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,40451,0.0254105944917807,0.00601346168247068,0.0136242095941382,0.0371969793894232,2.40163498131699e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,42311,0.0314393869870903,0.00744214835059963,0.0168527762199151,0.0460259977542656,2.41084808181432e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,42357,0.0268634187942837,0.00636286822705714,0.0143921970692518,0.0393346405193157,2.43873936237404e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,40199,0.0372085954145585,0.00882232617307408,0.0199168361153333,0.0545003547137837,2.4894857384926e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCARF2,Scavenger receptor class F member 2,42711,-0.0129988608344951,0.00308520830973618,-0.019045869121578,-0.00695185254741218,2.53316401735318e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KEL,Kell blood group glycoprotein,42311,0.0155643088005697,0.00370326963121261,0.00830590032339296,0.0228227172777464,2.6531398981951e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",40482,0.0203238086431871,0.00483551680672473,0.0108461957020066,0.0298014215843676,2.65397021317916e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYOM3,Myomesin-3,40283,-0.0398251035031511,0.00947623770289052,-0.0583985294008165,-0.0212516776054857,2.65901258184902e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42653,-0.0210643109805826,0.00501829160894532,-0.0309001625341154,-0.0112284594270498,2.71603506460876e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEP170,Centrosomal protein of 170 kDa,40223,0.0329473266785254,0.00786312103910584,0.0175356094418779,0.0483590439151728,2.80993656330187e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,42676,0.0121031973895497,0.00289081427763818,0.00643720140537887,0.0177691933737206,2.84739102178997e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,40283,0.0161130739042796,0.00385759370544569,0.0085521902416061,0.0236739575669532,2.9767249363446e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ELOB,Elongin-B,40116,0.017105166336446,0.00409813518548015,0.00907282137290493,0.0251375112999871,3.01763057328761e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APCS,Serum amyloid P-component,40419,0.0145340057296352,0.00348351769757177,0.00770631104239452,0.0213617004168758,3.03916113464648e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRYBB1,Beta-crystallin B1,40511,0.027045161887958,0.00649672411820373,0.0143115826162787,0.0397787411596373,3.16568708936718e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,42370,0.0256919635928062,0.00617234893864434,0.0135941596730633,0.0377897675125491,3.16881257753302e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AGT,Angiotensinogen,40532,0.0101824132495837,0.00244691854139276,0.00538645290845385,0.0149783735907135,3.187473688685e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,40457,0.0160304919738802,0.0038685804797464,0.00844807423357728,0.0236129097141832,3.44146266806041e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",42292,0.0198218059249783,0.00478502851122657,0.0104431500429743,0.0292004618069824,3.45751782828006e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCDH9,Protocadherin-9,40449,0.0145606581756519,0.00351511588904603,0.00767103103312167,0.0214502853181821,3.46355125118241e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,40527,0.0098341548236212,0.00237456212576687,0.00518001305711813,0.0144882965901243,3.47603682485649e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,42346,0.0354815823057272,0.00857153694418038,0.0186813698951336,0.0522817947163207,3.50285899662546e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TREML2,Trem-like transcript 2 protein,42611,0.014645644550756,0.00353944500495077,0.00770833234105247,0.0215829567604595,3.52735223231096e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GBP4,Guanylate-binding protein 4,42311,0.0208580683419009,0.00504215745034021,0.0109754397392341,0.0307406969445677,3.54479240973314e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,40116,0.019314237039592,0.00467004095099638,0.0101609567756391,0.0284675173035449,3.56406964286465e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL6,Interleukin-6,42587,0.0323918781759663,0.00783907481285371,0.017027291542773,0.0477564648091595,3.61642079577734e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,42346,0.0159769406187752,0.00386753820938868,0.0083965657283734,0.023557315509177,3.63365430734403e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,42346,0.0278885031203221,0.00675704502820193,0.0146446948650463,0.0411323113755979,3.69274175245566e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNX18,Sorting nexin-18,40449,0.0184624896094114,0.00447609259132605,0.00968934813041229,0.0272356310884104,3.73904861558689e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA4,Carbonic anhydrase 4,42794,-0.0101156233535923,0.00245649897896685,-0.0149303613523673,-0.00530088535481727,3.84595717448815e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PROCR,Endothelial protein C receptor,40116,-0.0147072787397905,0.00357521838592183,-0.0217147067761973,-0.00769985070338375,3.92268990109926e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TST,Thiosulfate sulfurtransferase,42277,0.0312281186729049,0.00759407813770299,0.0163437255230071,0.0461125118228028,3.94357602240796e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LMOD1,Leiomodin-1,40482,-0.015008274763984,0.00365395226150337,-0.0221700211965306,-0.00784652833143743,4.02945602536937e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PKN3,Serine/threonine-protein kinase N3,40302,0.0312512839750008,0.0076280725836397,0.016300261711067,0.0462023062389347,4.21731912499084e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TK1,"Thymidine kinase, cytosolic",40302,0.019012904450176,0.00464128171359702,0.00991599229152589,0.0281098166088262,4.22461681371393e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGA,Fibrinogen alpha chain,40284,-0.0129345169903511,0.00316457568403083,-0.0191370853310515,-0.00673194864965068,4.39530087560205e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,40483,-0.0130575406002509,0.00320217213671595,-0.0193337979882141,-0.00678128321228763,4.57928179654107e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,40283,0.0516523480143207,0.0126827339302476,0.0267941895110355,0.076510506517606,4.68042223648662e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,40182,0.0252715816656045,0.00620574510972901,0.0131083212505356,0.0374348420806733,4.68800919806633e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,42311,0.0301583537091201,0.00741386851331796,0.0156271714230169,0.0446895359952234,4.77306128989713e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HMCN2,Hemicentin-2,40269,0.0243439314641686,0.00598857962469317,0.01260631539977,0.0360815475285672,4.83521664008044e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,42370,0.0271911906157759,0.00669261073592061,0.0140736735733715,0.0403087076581803,4.87544886604198e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPON2,Spondin-2,42562,0.0148407933157416,0.00365439149139795,0.00767818599260162,0.0220034006388816,4.91238039004386e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PMM2,Phosphomannomutase 2,40116,0.024906281027843,0.00613342108241446,0.0128847757063106,0.0369277863493753,4.92571009260912e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMTN,Smoothelin,40460,0.0380828621065865,0.00938386946755439,0.0196904779501799,0.0564752462629931,4.97580847051775e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,40482,-0.0185362805285407,0.00457269990287719,-0.0274987723381799,-0.00957378871890135,5.07555812537139e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB37,Ras-related protein Rab-37,42370,0.0333466047756053,0.00823197308392537,0.0172119375311116,0.049481272020099,5.1321269406429e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",42495,0.0242018702405352,0.00597897866855687,0.0124830720501638,0.0359206684309067,5.1988009676915e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PARD3,Partitioning defective 3 homolog,40302,0.0306526944306062,0.00758062176041286,0.015794675780197,0.0455107130810154,5.30013794977503e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSNK1D,Casein kinase I isoform delta,40199,0.0259323372787728,0.00642001706922359,0.0133491038230946,0.0385155707344511,5.39763329627108e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINI1,Neuroserpin,40267,-0.0124800631386537,0.0030945156812077,-0.0185453138738208,-0.0064148124034866,5.54477414187012e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SATB1,DNA-binding protein SATB1,40482,0.0120740916373839,0.00299394395573757,0.00620596148413821,0.0179422217906295,5.54697873187767e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TG,Thyroglobulin,40451,-0.0474881719612997,0.0117789541366287,-0.070574922069092,-0.0244014218535075,5.57606562053279e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LPA,Apolipoprotein(a),40324,-0.0748739476991576,0.0185906109046715,-0.111311545072314,-0.0384363503260014,5.67439573351291e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42689,0.0177490920891236,0.00440905587647118,0.00910734257124012,0.0263908416070072,5.71409137630271e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42587,0.0186950623275173,0.0046457597399479,0.00958937323721945,0.0278007514178152,5.75048693510763e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BMP6,Bone morphogenetic protein 6,42342,0.0166187220201887,0.00414025128835952,0.00850382949500402,0.0247336145453734,6.00446508405809e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42794,-0.0112243244382783,0.00280567749558832,-0.0167234523296314,-0.00572519654692515,6.35232146299907e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,40302,0.0142093630086431,0.00356097798110774,0.00722984616567192,0.0211888798516143,6.64141715207663e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,40451,0.0176063212554009,0.00443140848032173,0.00892076063397028,0.0262918818768315,7.13928057794089e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",40116,0.0251830229314403,0.00633859745725697,0.0127593719152166,0.037606673947664,7.14396928816443e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANXA5,Annexin A5,42261,0.0124572401405042,0.00313766724168636,0.00630741234679897,0.0186070679342095,7.21897191240968e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,40283,0.0285862987439888,0.00720419334698957,0.0144660797838892,0.0427065177040883,7.29322872860885e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRYM,Ketimine reductase mu-crystallin,40136,0.0305696729653,0.00774369307340784,0.0153920345414207,0.0457473113891794,7.94039998113554e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,40223,0.0244878174855354,0.00620506394203604,0.0123258921591448,0.0366497428119261,7.98189207503321e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42711,0.0230542878824494,0.00585034835984785,0.0115876050971477,0.0345209706677512,8.16634124887154e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANXA1,Annexin A1,40235,0.0167313974492737,0.0042521366549489,0.00839720960557386,0.0250655852929736,8.37688184883431e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,40483,0.0152587191500734,0.00387937743047559,0.00765513938634124,0.0228622989138056,8.42921838310397e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SAFB2,Scaffold attachment factor B2,40482,0.0110268682575852,0.00280812289953089,0.00552294737450462,0.0165307891406657,8.66042357648776e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42594,0.0324029898346891,0.00825245834367381,0.0162281714810884,0.0485778081882897,8.66349532739282e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CERT,Ceramide transfer protein,42311,0.02438320710279,0.00622156356335582,0.0121889425186126,0.0365774716869674,8.93151018125947e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",40223,0.0194321330413776,0.00496242651681051,0.00970577706842896,0.0291584890143262,9.06276798118e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,40451,0.0137318916914255,0.0035087759526197,0.00685469082429094,0.0206090925585602,9.14714089745492e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ICAM3,Intercellular adhesion molecule 3,42794,-0.010726412710293,0.00274206351448481,-0.0161008571986832,-0.00535196822190276,9.20550905065262e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,40428,0.0164899793158509,0.00422630304234391,0.00820642535285687,0.024773533278845,9.60566360097363e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,42495,0.0233398914950449,0.00598334804349088,0.0116125293298028,0.0350672536602871,9.63438961839494e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,40451,0.0114969578575048,0.0029481457320792,0.00571859222262953,0.01727532349238,9.68614110563131e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42721,-0.0105640744825787,0.00271150876509818,-0.0158786316621711,-0.00524951730298624,9.82598663896859e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",40483,0.0417746924822108,0.0107283111711884,0.0207472025866816,0.06280218237774,9.92241319579265e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,42618,0.0207551487530663,0.0053305354188635,0.0103072993320938,0.0312029981740387,9.92320888613074e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LACRT,Extracellular glycoprotein lacritin,40419,0.0205112815414619,0.0052700704912598,0.0101819433785926,0.0308406197043311,9.99830623443178e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,40116,0.0181404482827249,0.00467460993029477,0.00897821281934717,0.0273026837461027,0.000104797058110376
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,40199,0.0159510644513644,0.00411436251569277,0.00788691392060661,0.0240152149821223,0.00010640089186649
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PXDNL,Peroxidasin-like protein,40451,-0.0220691828476718,0.00570102611050341,-0.0332431940242585,-0.0108951716710851,0.00010896207787341
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DBN1,Drebrin,40199,0.0197210255099884,0.00509779477842113,0.00972934774428302,0.0297127032756939,0.000110119930011777
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,40483,0.0279002367555298,0.00721711060782535,0.0137546999641921,0.0420457735468675,0.000111325329536963
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,XRCC4,DNA repair protein XRCC4,42311,0.0144844118255314,0.00375950475392036,0.00711578250784745,0.0218530411432153,0.000117357247562691
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK1,Kallikrein-1,42505,-0.0508516942087402,0.0131995623076988,-0.0767228363318298,-0.0249805520856506,0.000117452529996547
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MESD,LRP chaperone MESD,42611,0.046990580001499,0.0122058059658344,0.0230672003084636,0.0709139596945343,0.000118736406553308
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42587,0.0362849172353061,0.00945759939493762,0.0177480224212283,0.0548218120493838,0.000125327761164923
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,42370,0.014134145964815,0.00368543745878087,0.00691068854560448,0.0213576033840255,0.000126080510511961
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",42476,0.0283248868615206,0.00738585173556557,0.0138486174598121,0.0428011562632292,0.000126134345274715
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PMVK,Phosphomevalonate kinase,42303,0.0420958916559326,0.0109940088412168,0.0205476343271478,0.0636441489847175,0.000129271813564504
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCDH7,Protocadherin-7,40449,0.0141626657457784,0.00370229119686468,0.0069061749999236,0.0214191564916331,0.000131276643548949
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PREB,Prolactin regulatory element-binding protein,42370,0.0114796944428134,0.00300299755691513,0.00559381923125972,0.017365569654367,0.000132581438080807
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANXA11,Annexin A11,42570,0.0257839320823308,0.00675338754255282,0.0125472924989273,0.0390205716657344,0.000135185528252427
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,40451,0.0214594116260565,0.00562666498399193,0.0104311482574323,0.0324876749946807,0.000137533828883581
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EHD3,EH domain-containing protein 3,40223,0.0453110342287418,0.0119444320511713,0.0218999474084459,0.0687221210490376,0.000149340613473114
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FRMD4B,FERM domain-containing protein 4B,40116,0.0271453649713976,0.00715864885439792,0.0131144132167777,0.0411763167260175,0.000150263392607572
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRDX1,Peroxiredoxin-1,42261,-0.0344386983427381,0.00908978412747129,-0.0522546752325818,-0.0166227214528943,0.000152101323987811
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PI16,Peptidase inhibitor 16,40532,-0.00973004759033376,0.00257278871970597,-0.0147727134809575,-0.00468738169971005,0.000156430931978722
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HMOX2,Heme oxygenase 2,42311,0.0175889153582869,0.00465556179550271,0.00846401423910161,0.0267138164774722,0.000158764147838218
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,JUN,Transcription factor AP-1,42370,0.0184313471736396,0.00488012231289756,0.00886630744036034,0.0279963869069188,0.000159541329462512
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,42346,0.022013276346884,0.00585384512340208,0.0105397399050159,0.0334868127887521,0.00017032146644948
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,42594,0.0186446306449172,0.0049608058743593,0.00892145113117296,0.0283678101586614,0.00017173769053236
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,42311,0.0422891237210404,0.0112713585407673,0.0201972609811365,0.0643809864609443,0.000176248365845156
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C7orf50,Uncharacterized protein C7orf50,40483,0.00868446645292774,0.00231993604363628,0.00413739180740064,0.0132315410984548,0.000182442426292349
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LY96,Lymphocyte antigen 96,42495,0.0135956558658059,0.00363359260307712,0.00647381436377472,0.020717497367837,0.00018357979126513
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",40527,0.0156716433160538,0.00418979907995261,0.00745963711934664,0.0238836495127609,0.000184612503835401
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,40449,0.0113391159558273,0.00303507224398543,0.00539037435761588,0.0172878575540388,0.000187873480978316
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CR2,Complement receptor type 2,42689,0.0182480714522889,0.00488700752443391,0.00866953670439839,0.0278266062001793,0.000189239708505673
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TBC1D5,TBC1 domain family member 5,42594,0.0295957426059071,0.007945934443453,0.0140217110967392,0.045169774115075,0.000196396788629438
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STK4,Serine/threonine-protein kinase 4,42636,0.0324140074797966,0.00871239559958884,0.0153377121046025,0.0494903028549907,0.000199680182125575
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASP1,Caspase-1,42311,0.0261728141926922,0.00705890753607228,0.0123373554219905,0.0400082729633939,0.000209952877586941
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL14,C-X-C motif chemokine 14,42370,0.02130814375658,0.00575237549902048,0.0100334877784999,0.0325827997346601,0.000212897162215624
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,40483,0.0177380036883762,0.00478848158033436,0.00835257979092087,0.0271234275858316,0.000212981184373471
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNPY4,Protein canopy homolog 4,42587,0.0277840677812216,0.00751171339785193,0.0130611095214318,0.0425070260410114,0.000217516705893131
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GP6,Platelet glycoprotein VI,42590,0.0326311512610278,0.0088325933178584,0.0153192683580253,0.0499430341640302,0.000221281924715975
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,42521,0.0217216551939649,0.00589585177947656,0.0101657857061908,0.0332775246817389,0.000230306101096583
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,40223,0.0171534025244658,0.00465900570175263,0.00802175134903068,0.026285053699901,0.000232722945867784
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",42346,0.0186567808918601,0.00506847933455505,0.00872256139613221,0.028591000387588,0.00023330253550922
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNN,Tenascin-N,40527,0.0165573563143613,0.00449939282118404,0.00773854638484055,0.025376166243882,0.000234398865768767
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,42618,0.111317740419792,0.0302576210228397,0.0520128032150257,0.170622677624557,0.000235067109479655
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,40080,0.0300386427250276,0.00816756856614898,0.0140302083353756,0.0460470771146796,0.000236392040890696
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBP7,Retinoid-binding protein 7,40449,0.0225097144294912,0.00612997063279211,0.0104949719892187,0.0345244568697637,0.00024170285946217
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIL1,Nucleotide exchange factor SIL1,40223,0.0115961632277727,0.0031644015608408,0.00539393616852476,0.0177983902870207,0.000248918835221368
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LGALS7_LGALS7B,Galectin-7,42524,0.0161493489613675,0.0044105223399737,0.00750472517501904,0.024793972747716,0.000251663252592887
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LIF,Leukemia inhibitory factor,42311,0.0191945611382178,0.00525312666552248,0.00889843287379377,0.0294906894026419,0.000259263040453442
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,40223,0.0378682864647687,0.0103729219306598,0.0175373594806756,0.0581992134488619,0.000262749537215298
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,40519,0.00941599995286197,0.00258911939565684,0.00434132593737456,0.0144906739683494,0.000277316805870516
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,40482,-0.016846339446947,0.00463470825790905,-0.0259303676324487,-0.00776231126144524,0.000279408880941264
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRDX2,Peroxiredoxin-2,40333,0.0232263564827379,0.0063962619619997,0.0106896830372185,0.0357630299282573,0.00028332934283808
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",40451,0.0139691675971161,0.00384931796546788,0.00642450438479902,0.0215138308094331,0.000285783665530501
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DGKZ,Diacylglycerol kinase zeta,42370,0.0128761598239548,0.00354911459928191,0.00591989520936226,0.0198324244385473,0.000286713595188407
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,42794,0.0241747566918229,0.00666771496981797,0.0111060353509796,0.0372434780326661,0.000289295823096547
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DAPK2,Death-associated protein kinase 2,40199,0.0200368603073127,0.00552818017006407,0.00920162717398713,0.0308720934406383,0.000290832651971509
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NT5E,5'-nucleotidase,42679,0.0207107999455819,0.00575738465627497,0.00942632601928294,0.0319952738718808,0.00032273941097708
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSMG4,Proteasome assembly chaperone 4,40199,0.0209312722917374,0.00582385693872736,0.0095165126918318,0.032346031891643,0.000326991550288262
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,42357,0.0203748428324888,0.00567091683520852,0.00925984583548015,0.0314898398294976,0.000328254237203519
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UNC5D,Netrin receptor UNC5D,40199,-0.00954647197157058,0.00267681417738365,-0.0147930277592425,-0.00429991618389863,0.000363516321766874
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,42636,0.0136692605027113,0.00383356064596844,0.00615548163661314,0.0211830393688094,0.000364170409433933
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,40302,0.033062779791804,0.00927386647243287,0.0148860015058356,0.0512395580777724,0.000365167342401729
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,42311,0.0152330156646617,0.0042778069960228,0.006848513952457,0.0236175173768664,0.000370837302114329
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C2orf69,UPF0565 protein C2orf69,40182,0.0221490193914809,0.00622537560060608,0.00994728321429301,0.0343507555686689,0.000375462910128964
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,40482,0.0359575184966118,0.0101078302167141,0.0161461712718521,0.0557688657213714,0.000376089946980458
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDZD2,PDZ domain-containing protein 2,40116,0.0219054252819307,0.00616883470247203,0.00981450926508554,0.0339963412987759,0.000385410911828484
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LXN,Latexin,42461,-0.0244260141458689,0.00689025194415749,-0.0379309079564176,-0.0109211203353202,0.000393949130545513
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ROBO1,Roundabout homolog 1,42638,0.00883452507002555,0.00250033464446786,0.00393386916686853,0.0137351809731826,0.000411725736356374
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,42292,0.0154850074114729,0.00438848224454301,0.0068835822121686,0.0240864326107772,0.00041926450484256
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TYMP,Thymidine phosphorylase,42563,0.0233255346340764,0.00661805013787096,0.0103541563638493,0.0362969129043035,0.000425648403605032
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AHNAK2,Protein AHNAK2,40223,0.0108832924592648,0.003089282670019,0.00482829842602759,0.0169382864925021,0.000428548747482715
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,40302,0.0133526293557103,0.0038025387606185,0.00589965338489805,0.0208056053265226,0.000447347426786127
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,42370,0.0153817412441129,0.00439646749765506,0.00676466494870894,0.0239988175395168,0.000469146855593507
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL1R1,Interleukin-1 receptor type 1,42590,0.00838425036265177,0.00240077295621497,0.00367873536847042,0.0130897653568331,0.000480400526337172
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,40449,0.0337418195426912,0.00966156912540209,0.0148051440569031,0.0526784950284793,0.000480583425187027
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPING1,Plasma protease C1 inhibitor,40516,-0.0065272372973821,0.00186967426305471,-0.0101917988529693,-0.00286267574179487,0.000482851913886311
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,40483,-0.0251805342947142,0.00721897301797698,-0.0393297214099491,-0.0110313471794793,0.000488310154210266
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,42370,0.0116291087194397,0.00333643122322717,0.00508970352191446,0.018168513916965,0.000492828735334167
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MB,Myoglobin,42794,0.0188170935365202,0.00541138868494065,0.00821077171403652,0.0294234153590039,0.00050804818811632
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPMT,Thiopurine S-methyltransferase,42346,0.0256499244086443,0.00740606930903407,0.0111340285629375,0.0401658202543511,0.000535161350305286
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACRBP,Acrosin-binding protein,40451,0.0138494947241272,0.00399925065424114,0.00601096344181461,0.0216880260064399,0.000536129823066842
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,40483,0.0191063988052909,0.00552180135812373,0.00828366814336837,0.0299291294672134,0.000541819766635342
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,40527,0.0223318884626047,0.00647522390098957,0.00964044961666513,0.0350233273085443,0.000565087436613043
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEZ6L,Seizure 6-like protein,42679,-0.0098534363841746,0.0028615331383878,-0.0154620413354147,-0.00424483143293451,0.000576169543195463
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLTA,Clathrin light chain A,42357,0.0167513138759976,0.00486590227149004,0.00721414542387711,0.0262884823281181,0.000577960633534077
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL16,C-X-C motif chemokine 16,42778,0.00835120190592911,0.00243125398251888,0.00358594410019211,0.0131164597116661,0.000594464932132622
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDCD1,Programmed cell death protein 1,42689,0.0157566484009512,0.0045911801267883,0.00675793535244613,0.0247553614494563,0.00060108004623748
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPP3R1,Calcineurin subunit B type 1,42495,0.0139373004566042,0.00406601379170203,0.0059679134248682,0.0219066874883402,0.000610436730799693
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,42721,0.0293371518669393,0.00855922459297053,0.0125610716647171,0.0461132320691616,0.000610872150428233
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL17A,Interleukin-17A,42347,0.0150716851584788,0.00439996385333532,0.00644775600594159,0.023695614311016,0.000615744899337518
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MANSC1,MANSC domain-containing protein 1,42679,-0.00979770226199886,0.00286240686753061,-0.0154080197223589,-0.00418738480163887,0.000621433672712276
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GZMB,Granzyme B,42594,0.0230857524463791,0.00674949530772898,0.00985674164323028,0.0363147632495279,0.000627231370309769
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",42357,0.030591447234286,0.00894677472851002,0.0130557687664063,0.0481271257021656,0.000629795411456526
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPM1F,Protein phosphatase 1F,40511,0.0181037270509083,0.00530428256380455,0.00770733322585142,0.0285001208759652,0.000644676394636096
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,42676,0.0300512290652253,0.00880677494792397,0.0127899501672943,0.0473125079631563,0.000646098954523216
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,40451,0.014282211816406,0.00419217159472093,0.00606555549075294,0.022498868142059,0.000659406799745397
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MSTN,Growth/differentiation factor 8,42357,0.0185514506604833,0.00544554435228251,0.00787818373000963,0.0292247175909571,0.000659449239825169
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,40451,0.0168994926395524,0.00497481781370974,0.00714884972468126,0.0266501355544235,0.000683629141557864
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD40LG,CD40 ligand,42754,0.0267460868677606,0.00787484703865216,0.0113113866720023,0.0421807870635188,0.000684758859627098
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STX5,Syntaxin-5,40199,0.0142430615474416,0.00419908375917383,0.00601285737946091,0.0224732657154223,0.000696426671242563
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TGFBR1,TGF-beta receptor type-1,40199,0.0074885622312216,0.00221136349452817,0.00315428978194638,0.0118228346804968,0.000710637760226156
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL1,Growth-regulated alpha protein,42607,0.0329237231792454,0.00973019857380493,0.0138525339745877,0.051994912383903,0.000717301556834469
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINC1,Antithrombin-III,40516,0.00508269605536134,0.0015022102057086,0.00213836405217247,0.0080270280585502,0.000718164420351531
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,40199,0.0134126173109026,0.00396784284874129,0.00563564532736965,0.0211895892944355,0.000726505612981018
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA3,Carbonic anhydrase 3,42770,0.0205174379451961,0.00607441721450139,0.00861158020477335,0.0324232956856188,0.000733054066703731
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NID1,Nidogen-1,42652,0.0131849665957253,0.0039049692434817,0.00553122687850117,0.0208387063129494,0.000736332235442902
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEZ6,Seizure protein 6 homolog,40182,-0.0108315007783348,0.00320887807681067,-0.0171209018088837,-0.00454209974778588,0.000739424612284915
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,42587,0.0144296000407949,0.00428272498864579,0.00603545906304918,0.0228237410185407,0.000755838117448494
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIF1C,Kinesin-like protein KIF1C,40116,0.012378774413535,0.00367540034962827,0.00517498972826359,0.0195825590988064,0.000759752540635087
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASP9,Caspase-9,40199,0.0214971386721917,0.00638721715364287,0.00897819305105165,0.0340160842933317,0.000766246569302574
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,42346,0.0176248943446578,0.00524955343872137,0.00733576960476394,0.0279140190845517,0.00078899915017027
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA9,Carbonic anhydrase 9,42721,0.0165484296777224,0.00493752346214078,0.00687088369192646,0.0262259756635183,0.000805763340434914
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,40223,0.0114816171597061,0.00342710037870844,0.00476450041743755,0.0181987339019746,0.000810117461781157
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TCN2,Transcobalamin-2,42771,0.0104944490714741,0.00314533816524221,0.00432958626759935,0.0166593118753488,0.000850653604327653
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STX3,Syntaxin-3,40483,0.0131696957259134,0.00396252323197658,0.00540315019123933,0.0209362412605875,0.000891581271610015
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42674,0.02423641606346,0.00729928449624294,0.00992981845082388,0.0385430136760962,0.000901328668967194
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42619,0.019748784092478,0.00596467247819784,0.00805802603521025,0.0314395421497458,0.000932221930434797
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACTN2,Alpha-actinin-2,40116,-0.0201392028505357,0.00608798302163337,-0.0320716495729371,-0.0082067561281343,0.000942599583656386
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UBQLN3,Ubiquilin-3,40116,0.0183666920323475,0.00555336270086055,0.00748210113866077,0.0292512829260341,0.000945008097681533
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD22,B-cell receptor CD22,42754,0.0146244103631719,0.00443297562787884,0.00593577813252937,0.0233130425938144,0.000972780764956976
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD2,T-cell surface antigen CD2,40116,0.0129663874157892,0.00394341057330737,0.0052373026921068,0.0206954721394717,0.00101179432347311
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,40527,-0.013259223222474,0.00404349473985883,-0.0211844729125973,-0.00533397353235064,0.00104434475087754
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGB5,Integrin beta-5,42679,-0.0124265801376278,0.00379117178551568,-0.0198572768372385,-0.00499588343801701,0.00104896197765758
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDHR1,Cadherin-related family member 1,42311,0.0142949820316054,0.00437295005209489,0.00572399992949941,0.0228659641337114,0.00108222996288925
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TEK,Angiopoietin-1 receptor,42679,0.00730383372938962,0.00223617847625716,0.00292092391592558,0.0116867435428537,0.00109268654359194
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,42636,-0.00582731634076934,0.00178466026613349,-0.00932525046239098,-0.00232938221914769,0.00109651054606033
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42594,0.0327034817216162,0.0100322036861082,0.0130403624968442,0.0523666009463883,0.00111749152949156
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,40116,0.0204910741736696,0.00629170518755798,0.00815933200605591,0.0328228163412832,0.00113003821829314
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,40449,0.0166463076877769,0.0051124474815271,0.00662591062398383,0.02666670475157,0.00113314024283265
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,40199,0.00689537937700744,0.00211849733594252,0.00274312459856011,0.0110476341554548,0.00113797223637474
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLU,Clusterin,40539,-0.0104875716476895,0.00322355733815157,-0.0168057440304666,-0.00416939926491244,0.00114360208631664
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,40482,0.0415940478779675,0.0127992510764577,0.0165075157681104,0.0666805799878247,0.00115854853363705
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42594,0.0394528412447175,0.0121412097917879,0.0156560700528133,0.0632496124366217,0.00115893800142328
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MPI,Mannose-6-phosphate isomerase,42587,0.0277798196406483,0.00857736125247234,0.0109681915858025,0.0445914476954941,0.00120352684321572
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,42292,0.0219054496877233,0.0067650527087667,0.00864594637854054,0.035164952996906,0.0012065744406151
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INSL4,Early placenta insulin-like peptide,40451,0.0161130735346633,0.00498167595310911,0.00634898866656941,0.0258771584027571,0.00122221065117717
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCGB1A1,Uteroglobin,42646,0.0183642134499193,0.00568660044982698,0.00721847656825846,0.0295099503315802,0.00124355221520393
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,S100A16,Protein S100-A16,42292,0.0199999379858836,0.00620676543656296,0.00783467773022022,0.032165198241547,0.00127485646970472
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42618,0.0245293839484448,0.00761322046743178,0.00960747183227855,0.0394512960646111,0.00127626875984819
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,40080,0.0215206440777446,0.00668067391182619,0.00842652321056524,0.0346147649449239,0.00127972956713337
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCT,Secretin,40182,0.0164431794199942,0.00510552830010646,0.00643634395178555,0.0264500148882029,0.00128267193856413
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SELENOP,Selenoprotein P,40539,-0.00756694767356678,0.00235309055197658,-0.0121790051554409,-0.00295489019169268,0.00130469363827313
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,40116,-0.0128386144116779,0.00399323833422056,-0.0206653615467502,-0.00501186727660561,0.0013078367235762
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,42656,0.030368907589096,0.00945818519807053,0.0118308646008777,0.0489069505773142,0.00132649199896394
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,40439,-0.00898623487114524,0.00279933790524199,-0.0144729371654195,-0.00349953257687094,0.0013304828292231
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,40223,0.0162281245883405,0.00505768513785725,0.0063150617181403,0.0261411874585407,0.00133760979780112
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRIM26,Tripartite motif-containing protein 26,40080,0.0184427518706121,0.00575672148713903,0.00715957775581964,0.0297259259854046,0.00136069241134254
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,42679,-0.00897851533961221,0.002807179573992,-0.0144805873046365,-0.00347644337458789,0.00138506290746944
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLNS1A,Methylosome subunit pICln,40182,0.0109077191544307,0.00341116331003403,0.00422183906676398,0.0175935992420974,0.00138943179617247
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,40199,0.0098437460309233,0.00308139391626746,0.00380421395503908,0.0158832781068075,0.00140431412254272
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NECTIN4,Nectin-4,42679,0.0112155648644993,0.00352002536855564,0.00431631514213026,0.0181148145868684,0.00144474855339078
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42676,0.0381405854618975,0.0119849243899293,0.014650133657636,0.0616310372661589,0.001464013867657
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42711,-0.00921929430335662,0.00290084462440535,-0.0149049497671911,-0.00353363883952214,0.00148556260484806
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42594,0.0385128352094787,0.012119138298831,0.01475932414377,0.0622663462751875,0.00148707095331148
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MST1,Hepatocyte growth factor-like protein,40370,0.0212444783897309,0.00669604395156047,0.00812023224467235,0.0343687245347894,0.00151442013103721
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPHB6,Ephrin type-B receptor 6,42476,0.0108182621727953,0.00341573050631767,0.00412343038041263,0.0175130939651779,0.00154268854668476
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL34,Interleukin-34,42292,0.0118338764172742,0.00373653095075884,0.00451027575378688,0.0191574770807615,0.00154333521797822
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NAA10,N-alpha-acetyltransferase 10,40116,0.0166072497438997,0.00525144552714664,0.00631441651069226,0.0269000829771071,0.00156894697386276
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VIM,Vimentin,42357,0.0373864868118987,0.0118495496102521,0.0141613695758046,0.0606116040479928,0.00160805599381714
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COPB2,Coatomer subunit beta',40116,0.0139445539226916,0.00443191420865679,0.00525800207372427,0.0226311057716589,0.0016574048870715
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,40449,0.0362395541849776,0.0115323493612557,0.0136361494369164,0.0588429589330388,0.00167988831709958
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,42311,0.016201795618478,0.00515888278479294,0.0060903853602838,0.0263132058766721,0.00168998087955661
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,42594,0.0105615187539092,0.00336333297183768,0.00396938612910732,0.017153651378711,0.00169202815051065
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GSTP1,Glutathione S-transferase P,42237,-0.0224915728812121,0.00717668487524802,-0.0365578752366982,-0.00842527052572595,0.00172836041419382
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42594,0.0259250749690604,0.00827320659920337,0.0097095900346218,0.042140559903499,0.00173037456566045
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DRAXIN,Draxin,42495,0.0139564177481795,0.00446262142768625,0.00520967974991441,0.0227031557464445,0.00176738125665708
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL22,Interleukin-22,40451,0.0223077976172948,0.00716142221905198,0.00827141006795289,0.0363441851666366,0.0018440982139036
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AK1,Adenylate kinase isoenzyme 1,42636,0.0199526858673622,0.00641556003734419,0.00737818819416755,0.0325271835405568,0.00187449475719297
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,40482,0.00934474472556532,0.00301328203845294,0.00343871193019756,0.0152507775209331,0.0019322293176302
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,40302,0.0139369116346461,0.00450261087674928,0.00511179431621754,0.0227620289530747,0.00197105839647438
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TLR1,Toll-like receptor 1,40199,0.00846909236551621,0.00273942987056912,0.00309980981920075,0.0138383749118317,0.00199610131539845
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,42346,0.0146809318708411,0.00474922466786492,0.00537245152182589,0.0239894122198564,0.00199747779560328
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1QL2,Complement C1q-like protein 2,40199,-0.0139102413374497,0.0045094430876676,-0.0227487497892782,-0.0050717328856212,0.00204268420235261
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SUGT1,Protein SGT1 homolog,42346,0.025087591067088,0.00813610098560459,0.00914083313530301,0.041034348998873,0.00205011279247781
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",40449,0.027575401052377,0.00894361952964817,0.0100459067742666,0.0451048953304874,0.00205249576803838
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,40428,0.0217241092228403,0.00704587526773244,0.00791419369808469,0.0355340247475959,0.00205257817615277
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,40182,-0.0199891284245204,0.00648549244045036,-0.0327006936078031,-0.00727756324123772,0.00206034037854277
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42613,0.0101916452640329,0.00331490371964252,0.00369443397353357,0.0166888565545323,0.00211284769412533
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FABP6,Gastrotropin,42334,0.0184502905431696,0.0060029248958065,0.00668455774738886,0.0302160233389503,0.00211961484600742
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AOC3,Membrane primary amine oxidase,42689,-0.00943591874901548,0.0030821477458869,-0.0154769283309538,-0.00339490916707715,0.00220682300833963
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHGA,Chromogranin-A,40527,0.0305897833672218,0.00999612601634879,0.0109973763751782,0.0501821903592654,0.00221733084996366
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,40511,0.00886245491718107,0.00290192617538155,0.00317467961343323,0.0145502302209289,0.00226344002414554
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LY6D,Lymphocyte antigen 6D,42548,0.0127165999304018,0.00416720318123829,0.00454888169517478,0.0208843181656289,0.00228078948694285
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42649,-0.00666847452395459,0.00218568342015621,-0.0109524140274608,-0.00238453502044841,0.00228540591712853
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCRL3,Fc receptor-like protein 3,42370,0.0174471729123057,0.005751362300492,0.00617450280334138,0.02871984302127,0.002421474835511
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEMA4D,Semaphorin-4D,42711,0.00920722939971353,0.00303735683589447,0.00325401000136037,0.0151604487980667,0.00243940302784518
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,42636,-0.00877683630806208,0.0028958717160611,-0.0144527448715418,-0.00310092774458233,0.00244362855722474
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHGB,Secretogranin-1,42664,0.0132476534672746,0.00437563675236816,0.00467140543263303,0.0218239015019162,0.00246974859731048
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,40482,0.0117595555339398,0.00388423571845329,0.00414645352577133,0.0193726575421082,0.00247135462359153
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,42357,0.0179935445941275,0.00594625611524627,0.00633888260824485,0.0296482065800102,0.00248267005419269
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MKI67,Proliferation marker protein Ki-67,40199,0.0119877882419374,0.00396218003242835,0.00422191537837783,0.019753661105497,0.00248751487543674
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENSA,Alpha-endosulfine,40451,0.0163830610317182,0.00542672021128857,0.00574668941759258,0.0270194326458438,0.00254210571059223
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,POMC,Pro-opiomelanocortin,40223,0.0215300362926842,0.00714138375244603,0.00753292413788995,0.0355271484474784,0.00257710741388133
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CBX2,Chromobox protein homolog 2,40116,-0.0123872038051519,0.00410923741730768,-0.0204413091430749,-0.00433309846722885,0.00258013291656762
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLIC5,Chloride intracellular channel protein 5,40182,-0.00974537670573137,0.00323534546684777,-0.016086653820753,-0.00340409959070974,0.00259986523263738
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NOS1,"Nitric oxide synthase, brain",42311,0.0166406250864919,0.00554368858717022,0.00577499545563829,0.0275062547173455,0.00268960386492101
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNU13,NHP2-like protein 1,40116,0.0194608761598899,0.00648313336413388,0.00675393476618752,0.0321678175535923,0.00269021565364399
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GP5,Platelet glycoprotein V,40283,0.0110655675806647,0.00369332536405357,0.00382664986711968,0.0183044852942097,0.00274062538145128
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTX3,Pentraxin-related protein PTX3,42594,-0.0148670929725108,0.00497240716067091,-0.0246130110074258,-0.00512117493759578,0.00279558499876439
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PADI2,Protein-arginine deiminase type-2,42370,0.0169574319601975,0.00567745199891757,0.00582962604231902,0.0280852378780759,0.00282429789999105
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,40136,-0.0196723560541966,0.00658783348807118,-0.0325845096908161,-0.00676020241757711,0.00283125872500599
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,40223,0.0121858417667538,0.00408933586636978,0.00417074346866901,0.0202009400648385,0.00288964142550689
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,42517,0.0126617731121277,0.00424985060952255,0.00433206591746352,0.0209914803067919,0.00289385738311225
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,42113,-0.0114505461695762,0.00384483532124861,-0.0189864233992235,-0.00391466893992891,0.00290520182370992
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HBQ1,Hemoglobin subunit theta-1,42721,-0.0182774725089339,0.00613899847869064,-0.0303099095271675,-0.00624503549070024,0.0029134036309647
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42794,0.00885833127664092,0.00297725549199826,0.00302291051232433,0.0146937520409575,0.00293183537454864
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBM25,RNA-binding protein 25,40080,-0.0144670760324687,0.00486214460629933,-0.0239968794608154,-0.00493727260412199,0.0029320007231265
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STC2,Stanniocalcin-2,42591,0.00753551303303822,0.00253510970783761,0.0025666980056765,0.0125043280603999,0.00295948652782026
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,40065,0.0266919392414059,0.00898290350033189,0.00908544838075541,0.0442984301020564,0.00297079138837772
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STXBP1,Syntaxin-binding protein 1,40482,0.0232336671283197,0.00782120816090395,0.00790409913294794,0.0385632351236914,0.00297846154501261
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINF2,Alpha-2-antiplasmin,40317,0.00408788591984063,0.00137714271151136,0.00138868620527836,0.0067870856344029,0.00300009789864053
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RGMB,RGM domain family member B,42711,0.00860314223427502,0.0029013184157968,0.00291655813931329,0.0142897263292367,0.00302962662461293
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENG,Endoglin,42794,-0.00525629685510571,0.00177285894950665,-0.00873110039613875,-0.00178149331407267,0.00303336000723255
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCDHB15,Protocadherin beta-15,40451,0.0121756012553115,0.00412157543447641,0.0040973134037377,0.0202538891068852,0.00314217519266115
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,42583,0.00991243144167571,0.00335727401521704,0.00333217437185031,0.0164926885115011,0.00315734927041098
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNTN2,Contactin-2,42721,-0.0134123185408642,0.00454299401680204,-0.0223165868137962,-0.00450805026793225,0.00315949742736187
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PODXL2,Podocalyxin-like protein 2,42679,-0.0084998447575986,0.00288425864113093,-0.0141529916942152,-0.00284669782098198,0.00321446080162135
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPTX2,Neuronal pentraxin-2,40527,-0.00986607631205721,0.00335446198807965,-0.0164408218086933,-0.0032913308154211,0.00327625831818801
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,42370,0.0198405799199263,0.00674858896478111,0.00661334554895537,0.0330678142908973,0.0032882502210995
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CFP,Properdin,40539,0.00668837995526753,0.00227579358349486,0.00222782453161761,0.0111489353789174,0.00330019459125736
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCGB2A2,Mammaglobin-A,40116,-0.00955747058675611,0.0032544708781653,-0.0159362335079601,-0.00317870766555212,0.00332395464990063
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,40199,0.011101533465443,0.00378489894100433,0.00368313154107453,0.0185199353898115,0.00336274545893424
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42676,-0.0126506197471575,0.00431474461025632,-0.0211075191832599,-0.00419372031105515,0.00337406010690338
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FBLN2,Fibulin-2,40527,-0.00977578019349831,0.00333528045586812,-0.0163129298869998,-0.0032386304999968,0.00338523677382242
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,40539,-0.00764991583705202,0.00261398330121866,-0.0127733231074406,-0.00252650856666346,0.00343440043635361
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FSHB,Follitropin subunit beta,40223,-0.0162009376017565,0.00553643608859036,-0.0270523523353936,-0.00534952286811936,0.00343786720397413
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSBP1,Heat shock factor-binding protein 1,40223,0.0282340818403681,0.00965904795593704,0.00930234784673147,0.0471658158340047,0.00347301930954029
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TJP3,Tight junction protein ZO-3,40136,-0.0125633297964546,0.00430719052520855,-0.0210054232258633,-0.00412123636704582,0.00354330484948244
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,40302,0.0217901504918061,0.00747153632265183,0.00714593929940853,0.0364343616842037,0.00354780113202823
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RRP15,RRP15-like protein,40136,-0.027321378765077,0.00940142558576187,-0.0457481729131703,-0.00889458461698375,0.00366711341824247
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,40302,0.025644090524194,0.00883402340215332,0.00832940465597353,0.0429587763924145,0.00370478336681916
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ROBO2,Roundabout homolog 2,42711,-0.00692286047372039,0.0023849496171537,-0.0115973617233416,-0.00224835922409913,0.00370525496674841
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",40511,0.0155451426270523,0.00535988999224393,0.00503975824225424,0.0260505270118504,0.00373555781041459
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PER3,Period circadian protein homolog 3,40199,0.0364642511547935,0.0125793390548742,0.01180874660724,0.061119755702347,0.00375403938972807
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GRK5,G protein-coupled receptor kinase 5,42357,0.0150146613168508,0.00518675331899697,0.00484862481161673,0.0251806978220848,0.00380012554740228
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",40451,0.0156319660661207,0.00541988547641185,0.00500899053235346,0.0262549415998879,0.003931691932972
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DGCR6,Protein DGCR6,40136,0.013046021049535,0.00453394279409631,0.00415949317310626,0.0219325489259638,0.00401727444426907
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL18,C-C motif chemokine 18,42477,0.0204116108007057,0.00710310506225875,0.00648952487867858,0.0343336967227329,0.00406442921325899
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,42587,0.0133173190981544,0.00464266658465037,0.00421769259223967,0.0224169456040691,0.00413115444897791
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,40223,-0.0116075674653456,0.00405098663909377,-0.0195475012779694,-0.00366763365272178,0.00417312212990527
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NTF3,Neurotrophin-3,42594,0.0104448162528769,0.00364987219667566,0.00329106674739266,0.0175985657583612,0.00422036409607038
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,40527,-0.0149892522409898,0.00524424251329355,-0.0252679675670452,-0.00471053691493443,0.00426787827863263
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CABP2,Calcium-binding protein 2,40182,0.0188433863046303,0.00659938502063473,0.00590859166418625,0.0317781809450744,0.00430734029095758
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,42572,-0.00992724390689149,0.00348406339253731,-0.0167560081562646,-0.00309847965751836,0.00438784011837894
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",40223,0.0265646464507899,0.00933115686573315,0.00827557899395296,0.0448537139076269,0.00442320768618567
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,40116,0.011650103701069,0.004093086210109,0.00362765472925532,0.0196725526728826,0.00443145273200205
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",40116,-0.0139621431471541,0.00490657620006506,-0.0235790324992816,-0.00434525379502661,0.00444106400822993
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTRC,Chymotrypsin-C,42626,-0.0191887700901304,0.00675552899553466,-0.0324296069213783,-0.00594793325888247,0.00451170909905183
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MIA,Melanoma-derived growth regulatory protein,42679,0.0108549820887485,0.00383968636965329,0.00332919680422801,0.0183807673732689,0.00470482835626105
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,40136,-0.00838263455379364,0.00297093637372057,-0.0142056698462859,-0.00255959926130133,0.00478788535531555
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,40080,-0.0137606379076339,0.00488286512734907,-0.0233310535572381,-0.00419022225802976,0.00483886004067373
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL10,Interleukin-10,42370,0.0243517751452256,0.00865868471509133,0.00738075310364658,0.0413227971868046,0.00492444334600673
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,42357,0.00960548039548694,0.00342660533766772,0.00288933393365822,0.0163216268573157,0.00506713682025706
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DPP7,Dipeptidyl peptidase 2,42551,0.0172056148224322,0.00613907609733912,0.00517302567164753,0.0292382039732169,0.00507593671666448
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,40116,-0.00594944095910141,0.00212705168551332,-0.0101184622627075,-0.0017804196554953,0.00516639362009614
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1RL,Complement C1r subcomponent-like protein,40519,0.00565750290691395,0.00202431501666231,0.00168984547425581,0.00962516033957208,0.00520233695824006
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACRV1,Acrosomal protein SP-10,40199,0.0228821706106858,0.00820330736098884,0.00680368818314769,0.0389606530382239,0.00528992559658383
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NEDD9,Enhancer of filamentation 1,40199,0.00947130994792082,0.00340622369595225,0.00279511150385441,0.0161475083919872,0.00543525073123912
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PZP,Pregnancy zone protein,40539,0.0144823444352447,0.00520883706175572,0.00427302379420351,0.0246916650762859,0.00543912928311938
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,40116,0.0285363067673806,0.0102771596804514,0.00839307379369581,0.0486795397410653,0.00550120459085212
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,40449,0.0274844945214586,0.00989927017540669,0.00808192497766153,0.0468870640652558,0.00550526291150714
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENPEP,Glutamyl aminopeptidase,40116,-0.0135404026033518,0.00488370167972443,-0.0231124578956117,-0.0039683473110919,0.0055709879388705
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RELB,Transcription factor RelB,40199,0.0140670802931591,0.00508493459080614,0.00410060849517906,0.0240335520911391,0.00567695161167502
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CREG1,Protein CREG1,42445,0.0107802706314499,0.00391548530652459,0.00310591943066169,0.0184546218322381,0.00590889918207272
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,42346,0.0152150930640142,0.00553779749489323,0.00436100997402348,0.0260691761540049,0.00601334777767998
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,42495,-0.0145252779760396,0.00529425098958907,-0.0249020099156342,-0.00414854603644501,0.00608519705576696
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EFHD1,EF-hand domain-containing protein D1,40482,-0.0101043839767232,0.00369118108807816,-0.0173390989093564,-0.00286966904409006,0.00620165276804302
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,40283,0.010219299161212,0.00373845866158078,0.0028919201845137,0.0175466781379104,0.00627531788611614
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CST1,Cystatin-SN,39042,0.03066127916226,0.011266354798976,0.00857922375626701,0.0527433345682531,0.00651024667163423
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42586,-0.0167859995486784,0.00618098394392355,-0.0289007280787685,-0.00467127101858822,0.00662109012181508
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,42370,0.0160549144185941,0.00591254346127106,0.00446632923450283,0.0276434996026854,0.00662822381672568
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,40429,0.0238481117614796,0.00881089742603006,0.00657875280646067,0.0411174707164985,0.00680663181928383
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCND2,G1/S-specific cyclin-D2,40302,-0.0101933588060549,0.00377642409351814,-0.0175951500293504,-0.0027915675827593,0.00696096290866586
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42611,-0.00649088318829401,0.0024189957103233,-0.0112321147805277,-0.00174965159606034,0.0072989687725333
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,S100A11,Protein S100-A11,42531,0.0124026421237859,0.00464338609694598,0.00330160537377178,0.0215036788738,0.00757097626325927
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,40283,0.0170198268528202,0.00637565727319443,0.0045235385973591,0.0295161151082813,0.00760745899782351
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VGF,Neurosecretory protein VGF,40482,0.00860287205672445,0.00322398561970347,0.00228386024210564,0.0149218838713432,0.00763231568494505
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,40283,-0.0118281456860823,0.00443311406988535,-0.0205170492630576,-0.00313924210910705,0.00763845721681836
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THBS4,Thrombospondin-4,42652,-0.0124424986116311,0.00466700196734175,-0.021589822467621,-0.00329517475564132,0.00768381107572916
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APPL2,DCC-interacting protein 13-beta,40283,0.0301605751575463,0.0113170826717866,0.00797909312084461,0.0523420571942479,0.00770886722501873
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,40136,-0.00928117586702466,0.00348294001849983,-0.0161077383032843,-0.00245461343076499,0.00771578461603626
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,40532,0.0195845848357935,0.00736420876068654,0.00515073566484792,0.0340184340067392,0.00783834238865156
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENO2,Gamma-enolase,42711,0.0174176283749337,0.0065499705700815,0.00457968605757396,0.0302555706922934,0.00784206644803919
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL8,C-C motif chemokine 8,42706,0.016343732480933,0.0061472237186097,0.00429517399245803,0.0283922909694081,0.00785310816432947
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,40116,0.0109891986135924,0.00413409580046673,0.00288637084467763,0.0190920263825072,0.0078676796943452
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,40482,0.0106164415100273,0.00399494132397329,0.00278635651503968,0.018446526505015,0.0078840180698493
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,40182,0.0149521976485946,0.00562898773331905,0.0039193816912893,0.0259850136059,0.00791208406508536
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DLGAP5,Disks large-associated protein 5,40482,-0.0137911961725417,0.00519756735329857,-0.0239784281850069,-0.00360396416007649,0.00797982948930183
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RPA2,Replication protein A 32 kDa subunit,40199,0.00859445887563732,0.00324159091789337,0.00224094067656632,0.0149479770747083,0.00802953248334495
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HCG22,Protein PBMUCL2,40116,-0.0154385423356135,0.00583615348759938,-0.0268774031713083,-0.00399968149991872,0.0081728525227927
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,42459,0.00801695870298076,0.00303213395323333,0.00207397615464344,0.0139599412513181,0.00820293410796769
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",40116,0.0105979945060869,0.0040110557653422,0.00273632520601615,0.0184596638061576,0.00824878680605185
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPC1,Glypican-1,42721,0.00803996629571417,0.00304498153552,0.00207180248609496,0.0140081301053334,0.00829035501352558
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBP2,Retinol-binding protein 2,42587,-0.0207611352268521,0.00787379248794502,-0.0361937685032243,-0.00532850195047988,0.00838038265207104
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LIFR,Leukemia inhibitory factor receptor,42594,0.00644467966335594,0.00245611182416592,0.00163070048799074,0.0112586588387211,0.00870187059571911
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INHBB,Inhibin beta B chain,40283,-0.0146440041292755,0.0055865770634858,-0.0255936951737077,-0.00369431308484335,0.00877188655435047
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRELP,Prolargin,42618,0.00650684186760174,0.00248451162136701,0.00163719908972241,0.0113764846454811,0.00882968628083494
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPSAB1,Tryptase alpha/beta-1,42741,0.0139564394028512,0.00533600596591846,0.00349786770965107,0.0244150110960514,0.00891900173340687
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CORO1A,Coronin-1A,42353,0.0236859938154117,0.00905707942151267,0.00593411814924691,0.0414378694815766,0.00892792589493628
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,40199,0.00948524753922466,0.00362732882634012,0.00237568303959802,0.0165948120388513,0.00893647963219302
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDIA5,Protein disulfide-isomerase A5,40080,0.0164066429463634,0.00627559503684357,0.00410647667414998,0.0287068092185768,0.0089518822820913
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,42346,-0.00818742656793447,0.00313216483889482,-0.0143264696521683,-0.00204838348370062,0.00895953815617617
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCRN1,Secernin-1,42594,0.0146087883639624,0.00560905297602174,0.00361504453095974,0.025602532196965,0.00921095182550317
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THBD,Thrombomodulin,42636,0.00800729972337365,0.00307910686407778,0.0019722502697812,0.0140423491769661,0.00931826438223283
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK8,Kallikrein-8,42154,0.00987568307175185,0.00380158020170442,0.00242458587641118,0.0173267802670925,0.00939336939353986
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,40483,0.0124845104088357,0.00480828385482729,0.00306027405337419,0.0219087467642972,0.00943123075671612
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,42315,-0.00767001137921513,0.00296568723847684,-0.0134827583666297,-0.00185726439180052,0.00971329508179965
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERC2,ERC protein 2,40182,0.0200424078199386,0.00776043952983806,0.00483194634145603,0.0352528692984212,0.00981761790090571
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLXDC1,Plexin domain-containing protein 1,42346,0.00830000399301013,0.0032161209527246,0.0019964069256699,0.0146036010603503,0.00986932885319579
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,40483,0.0074387791235887,0.00288994561412802,0.00177448571989778,0.0131030725272796,0.0100650656450431
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,40451,0.0120212789369399,0.00467290317841528,0.00286238870724598,0.0211801691666339,0.0101079223148778
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PMS1,PMS1 protein homolog 1,40182,0.0136742618512142,0.00531663999200178,0.00325364746689072,0.0240948762355377,0.0101250563340004
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGA6,Integrin alpha-6,42594,0.0132385088944985,0.00516490848168631,0.00311528827039337,0.0233617295186037,0.0103831131027677
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",40283,0.023035084410787,0.00900759771513121,0.00538019288912982,0.0406899759324442,0.0105621590858246
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,42490,0.0262766941057704,0.0102778231338098,0.00613216076350321,0.0464212274480376,0.0105798604763121
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPM3,Tropomyosin alpha-3 chain,40116,-0.0114577954733059,0.00448717628147482,-0.0202526609849965,-0.00266292996161525,0.0106795206538648
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRYGD,Gamma-crystallin D,40483,0.0253237410316486,0.00992817755821492,0.00586451301754732,0.0447829690457498,0.0107639537695037
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GNLY,Granulysin,42611,0.013883949465127,0.00545512829707914,0.00319189800285191,0.0245760009274021,0.0109351537282427
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CGA,Glycoprotein hormones alpha chain,42611,-0.0163195132571923,0.00642190071717455,-0.0289064386628544,-0.00373258785153018,0.011057549171596
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINA12,Serpin A12,42249,0.0267367659236489,0.0105335926423327,0.00609092434467687,0.0473826075026209,0.0111527363335747
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,42311,0.0125239296246082,0.00494425275640607,0.00283319422205231,0.0222146650271641,0.0113197516407807
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,42794,-0.00892489892447431,0.00352507692830839,-0.0158340497039588,-0.00201574814498985,0.0113580295453247
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRSS27,Serine protease 27,42603,0.0104079542584625,0.00411100843735167,0.00235037772125328,0.0184655307956718,0.0113615297040405
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,42559,-0.00558302247778873,0.00220631973828415,-0.00990740916482566,-0.0012586357907518,0.0114024137290215
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FADD,FAS-associated death domain protein,42636,0.0194168657126119,0.00767831353014825,0.00436737119352128,0.0344663602317024,0.0114568929988389
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCDH12,Protocadherin-12,40482,0.00666673492991512,0.00263819376974174,0.0014958751412213,0.0118375947186089,0.0115174539295728
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,42689,-0.009262851569136,0.00367175223723187,-0.0164594859541105,-0.00206621718416154,0.0116560663193401
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FMR1,Synaptic functional regulator FMR1,42346,0.0091157164983344,0.00361356749972599,0.00203312419887145,0.0161983087977973,0.0116595772704439
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PKLR,Pyruvate kinase PKLR,42636,0.0167850840063667,0.00665450486248626,0.0037422544758936,0.0298279135368397,0.0116683478972661
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,40116,0.0172659019381382,0.0068455784188732,0.00384856823714668,0.0306832356391296,0.0116765096367559
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,40223,0.0166819744060182,0.0066196545354412,0.00370745151655341,0.0296564972954829,0.0117472429358532
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42495,-0.0176809830752507,0.00701784104854189,-0.0314359515303928,-0.00392601462010857,0.0117660068578616
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INSL3,Insulin-like 3,40483,-0.0200300247593393,0.00798637211245116,-0.0356833140997435,-0.00437673541893499,0.0121547065047572
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOE,Apolipoprotein E,40539,-0.0186222093200262,0.00742793059522099,-0.0331809532866594,-0.00406346535339309,0.0121881408448617
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CFHR2,Complement factor H-related protein 2,40451,0.0147836331822724,0.0059096686775041,0.0032006825743644,0.0263665837901804,0.0123773990370941
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",40080,0.0148663422464164,0.00594744479354574,0.00320935045106679,0.0265233340417661,0.0124473190512135
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RILPL2,RILP-like protein 2,40511,0.0245858267814368,0.00985936617587592,0.00526146907671995,0.0439101844861536,0.0126578140127439
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,40451,0.0132912114838535,0.00533363981997274,0.00283727743670698,0.0237451455310001,0.0127183465142232
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,42607,-0.00564971138486003,0.00227178559461621,-0.0101024111503078,-0.00119701161941227,0.0128981018241655
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC39A14,Zinc transporter ZIP14,42311,0.00875763487289015,0.0035278886272408,0.00184297316349818,0.0156722965822821,0.0130624402823909
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,42297,0.0142821261149027,0.00575904728099778,0.00299439344414706,0.0255698587856584,0.0131526988758496
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,40483,0.00508017506359474,0.00205146520518005,0.00105930326144183,0.00910104686574764,0.0132873550547951
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42674,0.00877866005944995,0.00355163785118034,0.00181744987113648,0.0157398702477634,0.0134586768543301
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",40482,0.0183090452944158,0.00740989171415984,0.00378565753466255,0.0328324330541691,0.013492292258212
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ECE1,Endothelin-converting enzyme 1,42311,-0.00897569776379443,0.0036333782116963,-0.0160971190587192,-0.00185427646886968,0.0135109015720777
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",40116,0.00986952072116828,0.00399725628629692,0.00203489840002632,0.0177041430423102,0.013561513952746
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,42613,0.0119290866259589,0.00484393776361973,0.00243496860926421,0.0214232046426536,0.0138026182454669
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NRTN,Neurturin,42370,0.012350305557675,0.00501588665386215,0.00251916771610516,0.0221814433992448,0.0138200152679274
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLKB1,Plasma kallikrein,40293,0.00618144234899658,0.00251064153428894,0.00126058494179024,0.0111022997562029,0.0138278265447418
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGB6,Integrin beta-6,42370,-0.00782458134632408,0.00318126510831296,-0.0140598609586175,-0.00158930173403069,0.0139226557301369
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFIC,Nuclear factor 1 C-type,40482,0.0119369999848154,0.00485502611658036,0.00242114879631786,0.0214528511733129,0.0139594325520709
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRND,Prion-like protein doppel,40483,0.0131402219095336,0.00534751787760499,0.00265908686942782,0.0236213569496394,0.0140152068593945
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SFRP1,Secreted frizzled-related protein 1,42457,0.0110105516575968,0.00449501575251777,0.00220032078266199,0.0198207825325317,0.0143182183495641
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,40136,-0.0081345280705086,0.00332368561809462,-0.0146489518819741,-0.00162010425904315,0.014403032532687
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",40182,0.00967896088111836,0.00395542266013704,0.00192633246724977,0.017431589294987,0.0144202149842821
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LUZP2,Leucine zipper protein 2,40451,0.0114749098437693,0.00470043291399368,0.00226206133234167,0.0206877583551969,0.0146520054321023
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MSMB,Beta-microseminoprotein,42559,0.0179650334017968,0.00738309638641036,0.00349416448443249,0.0324359023191611,0.0149763471076979
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMP13,Collagenase 3,42311,-0.0082634885930157,0.00340862627919057,-0.0149443961002292,-0.00158258108580219,0.0153518999751308
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,XG,Glycoprotein Xg,42734,0.00850650790544042,0.0035150646902697,0.0016169811125118,0.015396034698369,0.0155329611336695
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C9orf40,Uncharacterized protein C9orf40,40449,0.020060395964455,0.00830393298915798,0.00378468730570532,0.0363361046232046,0.0157177766487026
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLC,Galectin-10,42611,-0.0162195453491564,0.00672050298236363,-0.0293917311945891,-0.00304735950372368,0.0158159454937047
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD99,CD99 antigen,42611,-0.00494895091575164,0.0020592986785136,-0.0089851763256383,-0.000912725505864973,0.0162648255492631
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,40451,0.0122794494311869,0.00511365651249349,0.00225668266669971,0.0223022161956742,0.0163528232232832
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,42635,-0.00920950656103822,0.00383691785825666,-0.0167298655632213,-0.00168914755885516,0.0163980393136056
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TXNL1,Thioredoxin-like protein 1,40124,0.0241402022077976,0.0100941037334298,0.00435575889027519,0.04392464552532,0.016795793819491
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDIA2,Protein disulfide-isomerase A2,40080,-0.0103237589847962,0.0043172190902121,-0.0187855084016119,-0.00186200956798052,0.0168057784914975
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TEX101,Testis-expressed protein 101,40182,0.0129298299120049,0.00541349596437542,0.00231937782182909,0.0235402820021807,0.016936683415142
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCRL1,Fc receptor-like protein 1,42636,0.0114094147028057,0.0047922809371055,0.00201654406607887,0.0208022853395324,0.0172894031584237
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL3,C-X-C motif chemokine 3,42620,0.0225400328507133,0.00947796395653914,0.00396322349589665,0.0411168422055301,0.0174135919761416
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CGN,Cingulin,40182,0.0100265924043352,0.00421613684706271,0.00176296418409227,0.0182902206245781,0.0174168933304445
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPR15L,Protein GPR15L,40449,0.0147677603070991,0.00621186806731327,0.00259249889516506,0.0269430217190331,0.0174543279680371
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK6,Kallikrein-6,42656,0.00767709764056061,0.00323392714357033,0.00133860043916275,0.0140155948419585,0.0176141125860999
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,42346,0.0194800232747313,0.0082099309030326,0.00338855870478744,0.0355714878446752,0.0176710307033561
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK13,Kallikrein-13,42381,0.0111451724408002,0.00470214080509744,0.0019289764628092,0.0203613684187912,0.0177911477147462
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,40136,-0.0149373925324604,0.00630801686755386,-0.0273011055928659,-0.0025736794720548,0.0179017534806418
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,42698,0.015754746929271,0.00666617077058221,0.00268905221892987,0.0288204416396122,0.0181227905959475
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGB7,Integrin beta-7,42721,-0.0110945875891298,0.00469511581896764,-0.0202970145943063,-0.00189216058395318,0.0181414343740731
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH6,Cadherin-6,42636,-0.00932591083686803,0.00394879337217369,-0.0170655458463285,-0.0015862758274076,0.0182049681344795
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRH,Corticoliberin,42322,0.0206596769369729,0.00875413332098298,0.00350157562784629,0.0378177782460996,0.0182899192170371
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BTC,Probetacellulin,42346,0.0179550185416682,0.00760946823860117,0.00304046079400986,0.0328695762893264,0.0183110093623698
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,42311,-0.0135174641227415,0.00574775043309161,-0.024783054971601,-0.00225187327388194,0.0186983550346334
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ELAVL4,ELAV-like protein 4,40136,0.0204057337016208,0.00869547299414442,0.00336260663309776,0.0374488607701439,0.0189578410017198
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFNW1,Interferon omega-1,40116,-0.0088547822711825,0.00377435439865063,-0.0162525168925377,-0.00145704764982727,0.0189919093046065
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,42425,-0.0411032062631659,0.0175262422514402,-0.0754546410759888,-0.00675177145034302,0.0190296393098135
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SDC1,Syndecan-1,42636,0.00971131797445755,0.00414779114605331,0.00158164732819307,0.017840988620722,0.0192300753606912
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK3,Prostate-specific antigen,40527,-0.023471025390821,0.0100307359602926,-0.0431312678729945,-0.0038107829086474,0.019305619886554
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MDM1,Nuclear protein MDM1,40182,0.00748572721759929,0.0031996303473275,0.00121445173683738,0.0137570026983612,0.0193242825009529
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAP,Prolyl endopeptidase FAP,42794,-0.00650492444905653,0.00278324327128671,-0.0119600812607785,-0.00104976763733458,0.0194445588345688
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,40116,0.0106948141883359,0.00457814426115328,0.00172165143647547,0.0196679769401963,0.0195061724598496
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",40527,0.015021400784275,0.00644403021754352,0.00239110155788972,0.0276517000106603,0.0197678074197683
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPHA4,Ephrin type-A receptor 4,40283,0.00693871840884363,0.00298669368925211,0.00108479877790949,0.0127926380397778,0.0201858359695018
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDI2,Protein DDI1 homolog 2,40283,0.0186176191312945,0.00802194926568796,0.0028945985705461,0.0343406396920429,0.0203138044672741
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL31,Interleukin-31,40199,-0.0133792803468186,0.00576804584972191,-0.0246846502122736,-0.00207391048136365,0.0203833517964616
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,42587,-0.00970164391323968,0.00418802342521363,-0.0179101698266584,-0.00149311799982097,0.0205448572912285
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,YAP1,Transcriptional coactivator YAP1,40483,0.0067980516574376,0.00293667996022194,0.0010421589354026,0.0125539443794726,0.020637534244769
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPL,Periplakin,40199,0.00786523217698849,0.00340657159544569,0.00118835184991493,0.014542112504062,0.0209708407198615
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42587,0.00588726841414082,0.00255431374419489,0.000880813475518827,0.0108937233527628,0.0211911056769034
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRTAP,Cartilage-associated protein,40182,0.0112813995104702,0.00489943611298221,0.00167850472902512,0.0208842942919154,0.0213204385050444
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",42311,0.0065965769403029,0.00286767337314618,0.000975937128936398,0.0122172167516694,0.0214455068186399
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STXBP3,Syntaxin-binding protein 3,42346,0.0100815592335564,0.00440842440805336,0.00144104739377181,0.018722071073341,0.0222183547599823
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42611,0.0275753846514077,0.0120956849532257,0.00386784214308528,0.0512829271597301,0.0226369321937399
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLSTN1,Calsyntenin-1,42311,-0.0123573790272187,0.00543199920107795,-0.0230040974613314,-0.00171066059310588,0.0229266255144077
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,40483,0.0550782171434251,0.0244797777405318,0.00709785277198271,0.103058581514867,0.024471450780835
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOL1,Apolipoprotein L1,40532,-0.0133989610894216,0.0059557122857806,-0.0250721571695515,-0.00172576500929158,0.0244828808219346
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,40532,0.00627374007303536,0.00279214071736651,0.000801144266996988,0.0117463358790737,0.0246637652100921
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GJA8,Gap junction alpha-8 protein,40080,0.0150002109937295,0.006685237289568,0.00189714590617626,0.0281032760812828,0.0248664897939899
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,40182,0.0117437955986847,0.00524008125622161,0.00147323633649032,0.022014354860879,0.0250364033110863
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LY75,Lymphocyte antigen 75,42594,0.00881661298057694,0.00396011428973646,0.00105478897269349,0.0165784369884604,0.0260070959951599
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,40116,0.010018185525541,0.00450984162995827,0.00117889593082284,0.0188574751202593,0.0263439531541156
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRDX6,Peroxiredoxin-6,42721,-0.013712060242032,0.00617417747790454,-0.0258134480987249,-0.00161067238533914,0.0263761042678764
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,40199,0.0140925998872428,0.0063568526257005,0.00163316874086984,0.0265520310336158,0.0266492836821496
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SAA4,Serum amyloid A-4 protein,40539,0.00733397190599133,0.00331144816031381,0.000843533511776275,0.0138244103002064,0.0267982244114188
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,42587,0.0119168065425457,0.00538197856659509,0.00136812855201929,0.022465484533072,0.0268314220861157
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC4A1,Band 3 anion transport protein,40527,0.010583126721736,0.00479037345659352,0.00119399474681269,0.0199722586966593,0.0271772670463433
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SF3B4,Splicing factor 3B subunit 4,42587,0.0163335286409766,0.0074035215677097,0.0018226263682656,0.0308444309136876,0.0273880521128165
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NDRG1,Protein NDRG1,42311,0.0146593025143175,0.0066552457670508,0.00161502081089794,0.0277035842177371,0.0276354265291589
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42636,0.0110275731414487,0.00500818920155614,0.0012115223063987,0.0208436239764988,0.0276887125498012
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRNN,Cornulin,42209,-0.0155054346793214,0.00704547105779727,-0.0293145579526041,-0.0016963114060388,0.0277700762523355
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AHCY,Adenosylhomocysteinase,42636,0.0150237073631198,0.00683271953067783,0.00163157708299127,0.0284158376432484,0.0279099165095939
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,42311,0.0335202592306384,0.0152555643305234,0.00361935314281252,0.0634211653184644,0.0280201567872247
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,42346,0.00979077610845779,0.00445771577203676,0.00105365319526573,0.0185278990216498,0.028083136287071
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",42603,0.0242358701086514,0.0110633899082123,0.00255162588855522,0.0459201143287475,0.0284952331152874
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,42292,-0.0125764576207607,0.00575093465528334,-0.023848289545116,-0.00130462569640532,0.0287707700175912
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,42587,0.00483643757996607,0.0022150992975076,0.000494842956851162,0.00917803220308097,0.0290240016379758
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42638,0.00574990981545554,0.00263996682796821,0.000575574832637847,0.0109242447982732,0.0294216063806222
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,42794,0.0069785832459512,0.00320591582924329,0.000694988220634339,0.0132621782712681,0.0295138996476624
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,40449,0.00960825836626922,0.00443267594359938,0.000920213516814445,0.018296303215724,0.0302102009365012
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,42566,0.00667906079597232,0.00308519938836012,0.000632069994786478,0.0127260515971582,0.0304151454380392
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYOM2,Myomesin-2,40116,-0.0111687292621486,0.00516041006505651,-0.0212831329896594,-0.00105432553463786,0.0304621329491467
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA13,Carbonic anhydrase 13,42483,0.0226134238505219,0.0104664907289885,0.00209910202170434,0.0431277456793394,0.0307475822038391
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ABHD14B,Protein ABHD14B,42460,0.0124733512909532,0.00578266898306762,0.00113932008414068,0.0238073824977657,0.0310217591029637
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GBA,Lysosomal acid glucosylceramidase,40182,0.0122175666952227,0.00566862567662891,0.00110706036903007,0.0233280730214154,0.0311603233846279
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,QSOX1,Sulfhydryl oxidase 1,40342,0.00954684883730524,0.00443273583302787,0.000858686604570629,0.0182350110700399,0.0312839150218722
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NLGN2,Neuroligin-2,40136,-0.0105888024743077,0.00492103363739731,-0.0202340284036064,-0.000943576545008935,0.031439370244519
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCG3,Secretogranin-3,42638,-0.00750337416436418,0.00348740315906253,-0.0143386843561267,-0.000668063972601627,0.031449397161544
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,40417,0.00951510451275818,0.0044325880395945,0.000827231955152967,0.0182029770703634,0.0318445117278649
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CILP,Cartilage intermediate layer protein 1,40527,0.0120663404340633,0.00563482937937455,0.0010220748504892,0.0231106060176374,0.0322642460597947
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTNNA1,Catenin alpha-1,40136,-0.00770609521745213,0.00360118282330603,-0.0147644135511319,-0.000647776883772315,0.0323866042681797
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",40136,0.00709372910915178,0.00331956738335882,0.000587377037768498,0.0136000811805351,0.0326246685943092
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GFRA3,GDNF family receptor alpha-3,42474,-0.0062564001346808,0.00292994546078999,-0.0119990932378292,-0.000513707031532406,0.0327523161386117
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNASE3,Eosinophil cationic protein,42578,0.0239272905011574,0.0112063475024896,0.00196284939627772,0.0458917316060371,0.0327664442332128
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42594,0.0195741040348667,0.00917978124889614,0.0015817327870303,0.0375664752827032,0.0329998158331881
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDIA3,Protein disulfide-isomerase A3,40283,0.00538678084680526,0.00253109248097846,0.000425839584087474,0.0103477221095231,0.0333388960538846
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RCC1,Regulator of chromosome condensation,40451,0.0114123393098152,0.00536937029896025,0.000888373523853158,0.0219363050957773,0.0335706206320029
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCL2,Apoptosis regulator Bcl-2,40449,0.0123730917362868,0.00584531192866109,0.000916280356111059,0.0238299031164625,0.0343025513187822
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGB2,Integrin beta-2,42569,-0.00615805860752541,0.00291528025054621,-0.011872007898596,-0.000444109316454835,0.0346759139224104
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EGFLAM,Pikachurin,40449,0.00666936516833434,0.00316650197609907,0.000463021295180157,0.0128757090414885,0.0352069080275765
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",40482,-0.0096167931717796,0.0045809174444172,-0.0185953913628373,-0.000638194980721892,0.035811204401266
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,40199,0.00522572682698083,0.0024900708643155,0.000345187932922451,0.0101062657210392,0.0358726360519298
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ABO,Histo-blood group ABO system transferase,40532,-0.0312434568285725,0.0148941316743895,-0.060435954910376,-0.00205095874676896,0.0359535171027739
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",40482,0.0196290881825338,0.00936208179216129,0.00127940786989769,0.0379787684951699,0.0360460164744573
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,40199,0.0178515704643355,0.00852113238660317,0.00115015098659331,0.0345529899420777,0.0361958998092307
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EDNRB,Endothelin receptor type B,40199,0.0095339515735745,0.0045635199524542,0.000589452466764265,0.0184784506803847,0.0367156782586896
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RPS10,40S ribosomal protein S10,40116,-0.00870794618138131,0.00416911025383735,-0.0168794022789025,-0.000536490083860114,0.0367594399795092
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42618,0.00622975077211515,0.00299301214861304,0.000363446960833591,0.0120960545833967,0.0374133006912399
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,42292,0.0102636848674291,0.00493822058859413,0.000584772513784597,0.0199425972210736,0.0376903296210539
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,42611,0.00705574054870328,0.00340035380339664,0.000391047094045865,0.0137204340033607,0.03800537293536
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,40482,0.00689021672250277,0.00332338845204262,0.000376375356499245,0.0134040580885063,0.0381716051356713
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLA2G1B,Phospholipase A2,42782,-0.0096437187920023,0.00465204269834258,-0.0187617224807538,-0.000525715103250848,0.0381903976525642
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,42439,-0.00613577266170514,0.00296311875944155,-0.0119434854302106,-0.000328059893199699,0.0384048209217593
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPON1,Spondin-1,42638,0.00716244190025828,0.00345946902495011,0.000381882611356062,0.0139430011891605,0.0384351040432862
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,42558,0.00739779428105622,0.00357725097719898,0.000386382365746223,0.0144092061963662,0.0386581870821673
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARFIP1,Arfaptin-1,40482,0.0144033652438697,0.00696963155587062,0.000742887394363295,0.0280638430933761,0.0387956325235094
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,40511,0.00576342988500699,0.00279375580185214,0.000287668513376802,0.0112391912566372,0.0391383919113302
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPB2,Carboxypeptidase B2,40516,0.00465780530594448,0.00226550151420126,0.00021742233811001,0.00909818827377896,0.039808191440987
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINA1,Alpha-1-antitrypsin,40327,-0.00171692601053528,0.00083533112574189,-0.00335417501698939,-7.96770040811775e-05,0.0398652294201535
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,42794,-0.00476287035738308,0.00232013833036517,-0.00931034148489882,-0.000215399229867343,0.040107288694301
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEMA3G,Semaphorin-3G,40283,0.00938630863696295,0.00458522484554276,0.000399267939699133,0.0183733493342268,0.0406740358225472
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,40136,-0.0123997694030527,0.00606290675206478,-0.0242830666370996,-0.000516472169005695,0.0408604348993181
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PALM,Paralemmin-1,40384,0.00657482337674311,0.00322053489568552,0.000262574981199487,0.0128870717722867,0.041221432595226
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",40223,-0.00921339500333777,0.00451359644209982,-0.0180600440298534,-0.000366745976822114,0.0412493774252779
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CBLN1,Cerebellin-1,40136,-0.0197764889535869,0.00971668750877897,-0.0388211964707937,-0.000731781436380152,0.0418435554466605
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RGS10,Regulator of G-protein signaling 10,40482,0.0123086529333769,0.00605216770767211,0.000446404226339554,0.0241709016404142,0.0419991984694168
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",40302,0.0146790987958633,0.00723531960397854,0.000497872372065377,0.0288603252196612,0.0425013090972753
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,40182,-0.00771649428454369,0.00380442535567516,-0.015173167981667,-0.000259820587420382,0.0425542930174657
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,40136,-0.00656488115999077,0.00324085540743259,-0.0129169577585586,-0.000212804561422898,0.0428235436368972
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,40182,-0.00754302086247634,0.00372914528695191,-0.0148521456249021,-0.000233896100050588,0.0431260824408568
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PALLD,Palladin,40199,-0.0080579021047678,0.00398925503932945,-0.0158768419818535,-0.000238962227682073,0.0434177939966188
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VIT,Vitrin,40511,-0.00794546140402371,0.00393798504522472,-0.0156639120926642,-0.00022701071538327,0.0436516560551637
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCDH1,Protocadherin-1,42721,0.00445372086137483,0.0022090301330923,0.000124021800513927,0.00878341992223573,0.0438047436712579
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSHB,Thyrotropin subunit beta,42636,-0.0162730855123293,0.00808653477032539,-0.0321226936621671,-0.000423477362491508,0.0442010451579321
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,42611,-0.0070668241925886,0.00351180007910505,-0.0139499523476345,-0.000183696037542706,0.0442074019324035
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,42357,-0.00631322390249318,0.00314213802970831,-0.0124718144407215,-0.000154633364264893,0.0445349486472045
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GKN1,Gastrokine-1,42017,0.00575599348911749,0.00287118470120066,0.000128471474764193,0.0113835155034708,0.0450112863557468
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GC,Vitamin D-binding protein,40539,0.00528215949139387,0.0026445544058526,9.88328559227789e-05,0.010465486126865,0.0458086035406171
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42495,0.012541989371841,0.00628692595105766,0.000219614507767956,0.024864364235914,0.0460706718800342
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MSLNL,Mesothelin-like protein,40182,-0.00803176257485132,0.00402732659053391,-0.0159253226922978,-0.000138202457404852,0.0461421788533888
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,42311,-0.0124774303161442,0.00626965983408049,-0.024765963590942,-0.000188897041346477,0.0465974764555366
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,H2AP,Huntingtin-interacting protein M,40080,-0.0107359180916879,0.0053961958537061,-0.0213124619649518,-0.000159374218423911,0.0466672118351985
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RLN1,Prorelaxin H1,40482,0.00983664980726906,0.00495363303282984,0.000127529062922583,0.0195457705516155,0.0470858476919078
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42706,0.00595360381186982,0.00300513358299321,6.35419892031286e-05,0.0118436656345365,0.0475953128802529
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",42754,0.0132809629487375,0.00670975184019102,0.000129849341963051,0.0264320765555119,0.047796543677642
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DSG4,Desmoglein-4,42543,-0.0101088041274084,0.00510973466368899,-0.0201238840682388,-9.37241865779925e-05,0.0479106316493882
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,40451,0.00942271065640966,0.0047790456459327,5.57811903815607e-05,0.0187896401224378,0.0486715055523588
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NXPH1,Neurexophilin-1,42311,0.00783410323716063,0.00397594390269838,4.1253187871809e-05,0.0156269532864494,0.0488163274619892
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,42711,0.00467451431628154,0.00237365801281725,2.21446111597226e-05,0.00932688402140335,0.0489356777620564
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,40116,0.0168492245919325,0.00855748479337372,7.65543969199756e-05,0.033621894786945,0.048984546521703
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARG1,Arginase-1,42488,0.0103720935844602,0.00526869194274799,4.54573766741247e-05,0.0206987297922462,0.0490165871432108
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,42587,0.00401703811317675,0.00204092607766168,1.68230009598494e-05,0.00801725322539364,0.049060699351052
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LCN15,Lipocalin-15,40482,0.012578194510662,0.00640397021458433,2.64128900766582e-05,0.0251299761312472,0.0495401614740051
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERVV_1,,40116,-0.00875449749279644,0.00446887555157407,-0.0175134935738816,4.49858828874446e-06,0.050138970763502
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",40482,-0.00818137051333551,0.0041779548677292,-0.0163701620540848,7.42102741372631e-06,0.0502283552610545
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,40116,-0.00784710530740129,0.00401043848388126,-0.0157075647358086,1.33541210059797e-05,0.0504117033802417
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,40287,-0.0100402938460031,0.00513724261105612,-0.020109289363673,2.87016716669416e-05,0.0506774786959145
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RSPO1,R-spondin-1,42495,-0.00674457961476892,0.00345288846851896,-0.0135122410130661,2.30817835282513e-05,0.05080319104668
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KITLG,Kit ligand,42636,-0.00745659213644651,0.0038257733215897,-0.0149551078467623,4.19235738693072e-05,0.051311205032269
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CYTL1,Cytokine-like protein 1,40527,-0.00508004578508569,0.00261167093570468,-0.0101989208190669,3.88292488954925e-05,0.0517837418992937
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FBN2,Fibrillin-2,40182,0.0121117201513787,0.00623006864359786,-9.92143900730887e-05,0.0243226546928305,0.0519119082170193
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,42346,0.0103124987695166,0.00531224341245438,-9.94983188939355e-05,0.0207244958579272,0.0522468689917525
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VCAM1,Vascular cell adhesion protein 1,42663,0.00551301613063276,0.0028510429251629,-7.50280026865224e-05,0.011101060263952,0.0531729169138923
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD55,Complement decay-accelerating factor,42201,-0.00536690479371476,0.00278362119463985,-0.0108228023352089,8.89927477793562e-05,0.0538731546642951
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,40116,0.0118529635437748,0.0061770317128773,-0.000254018613464706,0.0239599457010143,0.055025945894774
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC1A4,Neutral amino acid transporter A,40182,0.010226076382868,0.0053318154058674,-0.000224281812632078,0.0206764345783681,0.0551451202547341
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,42311,-0.00774040300157453,0.00404380292731922,-0.0156662567391202,0.000185450735971151,0.0556240662597198
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TUBB3,Tubulin beta-3 chain,40136,-0.00549875235677856,0.00288019824532171,-0.0111439409176091,0.000146436204052,0.0562678943903448
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PALM3,Paralemmin-3,40116,0.0139252756912692,0.00732627651058548,-0.000434226269478286,0.0282847776520168,0.0573636493643544
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,40483,0.00656559413508598,0.00345990756566868,-0.000215824693624639,0.0133470129637966,0.0577714815102104
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,40511,-0.00765141983614151,0.00403580672681101,-0.0155616010206911,0.00025876134840807,0.0580008863717432
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRR5,Proline-rich protein 5,40199,0.00927300191449763,0.00489229018019042,-0.000315886838675596,0.0188618906676708,0.0580614097113028
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCRL5,Fc receptor-like protein 5,42611,0.0113756034322773,0.00600985988095085,-0.000403721934386356,0.023154928798941,0.0584028602997379
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,40451,-0.0101298211950042,0.00539221043253502,-0.0206985536427728,0.000438911252764441,0.0603245802139385
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL36G,Interleukin-36 gamma,40154,0.0131261752198483,0.00704229372654553,-0.000676720484180958,0.0269290709238775,0.0623615906969101
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,42592,-0.00927636967965408,0.00499609342284098,-0.0190687127884224,0.000515973429114242,0.0633722756700682
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",40483,0.0103036696508459,0.00555432141350122,-0.000582800319616508,0.0211901396213083,0.0636119067714123
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSF3,Granulocyte colony-stimulating factor,42370,0.00922076958764251,0.00497847910459979,-0.000537049457373075,0.0189785886326581,0.0640301127327216
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,40470,0.00774570124871323,0.0041831357071113,-0.000453244737224918,0.0159446472346514,0.0641022906688595
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL7,Interleukin-7,42594,0.0118469829397309,0.00643738115679535,-0.000770284127588032,0.0244642500070497,0.0657401418949824
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,40302,-0.0131498814774965,0.00714847987402996,-0.0271609020305953,0.000861139075602171,0.0658631519423825
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD14,Monocyte differentiation antigen CD14,42416,-0.00780391868897325,0.00425891298690157,-0.0161513881433003,0.000543550765353834,0.0669182925454621
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD109,CD109 antigen,42611,-0.00627794001866951,0.00342900329112141,-0.0129987864692675,0.000442906431928461,0.067147307038056
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42587,0.00704479882465635,0.00385739553584567,-0.000515696425601171,0.0146052940749139,0.0678258775815509
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,40182,0.01436825179539,0.00788343964694866,-0.00108328991262941,0.0298197935034094,0.0683931844696593
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,42754,-0.00678530151090322,0.00372320055618597,-0.0140827746010277,0.000512171579221276,0.0684105933735745
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,40302,0.0100810114392657,0.00553181210095336,-0.000761340278602925,0.0209233631571342,0.0684256538270006
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,40182,0.0200081424093729,0.0109899999826194,-0.00153225755656124,0.041548542375307,0.0686983525370189
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,40136,-0.00560865643600452,0.00309027717679252,-0.0116655997025179,0.000448286830508821,0.0695610558941319
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AFP,Alpha-fetoprotein,42459,-0.0123548453424109,0.00681358708479793,-0.0257094760286148,0.000999785343793065,0.069813405162063
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TAGLN3,Transgelin-3,40080,0.011369813591244,0.0062802317090027,-0.000939440558401273,0.0236790677408893,0.0702593129780305
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RGMA,Repulsive guidance molecule A,42711,-0.00590157308868288,0.00326473620125029,-0.0123004560431335,0.000497309865767686,0.0706797435781472
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,40136,-0.0144893532863252,0.00803298301333229,-0.0302339999924565,0.00125529341980605,0.0713007303870988
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA12,Carbonic anhydrase 12,42587,0.00608835647678979,0.00337715051642389,-0.000530858535401028,0.0127075714889806,0.0714407265804306
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEMA6C,Semaphorin-6C,40199,0.00483547486815477,0.00268643498889037,-0.00042993771007036,0.0101008874463799,0.0718943696829785
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL20,Interleukin-20,42370,-0.00899626563718541,0.00501366223666635,-0.0188230436210515,0.000830512346680641,0.0727802126803072
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,42594,-0.00655391028151923,0.00365612537145263,-0.0137199160095664,0.00061209544652792,0.0730620833226207
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,40451,0.00768046169247974,0.00429262831421851,-0.000733089803388538,0.016094013188348,0.0736060699559307
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDSN,Corneodesmosin,42710,-0.00811353909079793,0.0045384611617978,-0.0170089229679216,0.000781844786325751,0.0738421204267418
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42582,0.00492988638495971,0.00275800705118518,-0.000475807435363235,0.0103355802052827,0.0738823233248222
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,40511,0.00540609975221887,0.0030245264419097,-0.000521972073924144,0.0113341715783619,0.0738963451153313
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42587,-0.010163532471505,0.00568933491175305,-0.0213146288985409,0.000987563955531017,0.0740541542522991
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH4,Cadherin-4,40136,-0.00903500442351784,0.00509367470778119,-0.019018606850769,0.000948598003733292,0.0761291045298046
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MELTF,Melanotransferrin,40511,-0.00546975423758485,0.00308589814408732,-0.011518114599996,0.000578606124826295,0.0763385039054374
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAMA4,Laminin subunit alpha-4,42676,0.0059798916001009,0.00337595117054286,-0.000636972694163107,0.0125967558943649,0.0765300029789502
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,40116,-0.0107917852899489,0.00613419464669753,-0.022814806797476,0.00123123621757829,0.0785574224757811
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL11,Interleukin-11,42370,-0.0112371632403566,0.00638962665460805,-0.0237608314833884,0.00128650500267514,0.0786589538881541
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42754,0.00638920753534528,0.00363580408035676,-0.00073696846215397,0.0135153835328445,0.0788888289152174
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CST6,Cystatin-M,42332,0.00906864301002394,0.00516601669780573,-0.00105674971767529,0.0191940357377232,0.0792070254508674
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,42781,0.01060609128846,0.00605413025892792,-0.00126000401903869,0.0224721865959588,0.0798175265932238
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,42636,-0.00515637710600247,0.00295061121087883,-0.010939575079325,0.000626820867320031,0.0805626702530948
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,40449,0.0100231838268331,0.00573901609734216,-0.00122528772395752,0.0212716553776238,0.0807516218165872
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42722,0.00505825747987958,0.00289678134603862,-0.000619433958356108,0.0107359489181153,0.0808050258389612
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNNI3,"Troponin I, cardiac muscle",42357,0.0150616572431083,0.00862956578583297,-0.00185229169712432,0.0319756061833409,0.0809463976617465
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,42357,-0.00563442022368182,0.00323708285994509,-0.0119791026291742,0.000710262181810553,0.0817795886137389
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,40116,-0.00951333140903089,0.00546612223768219,-0.020226930994888,0.0012002681768262,0.0818140070502558
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,40080,0.00649128686928677,0.0037660527026563,-0.000890176427919574,0.0138727501664931,0.0848027914392415
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEPTIN9,Septin-9,42587,0.00498346413942691,0.00289868452516898,-0.000697957529904281,0.0106648858087581,0.0855981973181508
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,40302,0.00786079207227833,0.00457659073721519,-0.00110932577266344,0.0168309099172201,0.0858958837084147
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SAT1,Diamine acetyltransferase 1,40116,-0.00903285352463755,0.0052620231573979,-0.0193464189131374,0.00128071186386234,0.0860783925061957
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NLGN1,Neuroligin-1,40182,-0.0122569467044404,0.00714991347849814,-0.0262707771222968,0.00175688371341593,0.0865056941155952
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F13B,Coagulation factor XIII B chain,40479,0.00452740971694805,0.00264426106528385,-0.000655341971008292,0.0097101614049044,0.0868938455320502
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARG2,"Arginase-2, mitochondrial",40451,0.00748263101547787,0.00437239220599796,-0.00108725770827814,0.0160525197392339,0.0870467014425484
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASP8,Caspase-8,42674,0.0106437722514703,0.00622855152536828,-0.00156418873825157,0.0228517332411921,0.0874984264354837
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,40080,0.00506216833043593,0.00296346777683247,-0.000746228512155718,0.0108705651730276,0.0876294581013339
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,40283,-0.00467489291297652,0.00273721451324711,-0.0100398333589409,0.000690047532987826,0.0876826006434375
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,40080,0.00470299047299143,0.0027558285441656,-0.000698433473573143,0.010104414419556,0.0879321354289816
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LBP,Lipopolysaccharide-binding protein,42689,-0.0102154828958883,0.00598910469729071,-0.0219541281025781,0.00152316231080152,0.088091097935925
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",42611,0.00651506726245766,0.00384494550068061,-0.00102102591887633,0.0140511604437917,0.0902030443881998
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,42587,-0.00584371355747576,0.00345911445135641,-0.0126235778821343,0.000936150767182805,0.0911724102203212
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SH3GL3,Endophilin-A3,40250,0.0147439229627434,0.00873590510723692,-0.00237845104744092,0.0318662969729278,0.091489652716335
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",40182,-0.0135837222777447,0.00806470714380679,-0.029390548279606,0.00222310372411665,0.0921440581336709
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,S100A13,Protein S100-A13,40199,0.00612118056608801,0.00364019223308633,-0.00101359621076119,0.0132559573429372,0.0926836903753203
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCUN1D2,DCN1-like protein 2,40080,-0.0137895745037661,0.00821096577152996,-0.0298830674159648,0.00230391840843266,0.0931009459006872
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,40116,-0.0123233431081971,0.00733922132454537,-0.026708216904306,0.00206153068791182,0.0931596577884212
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,40199,0.0109105227804718,0.00653297043390764,-0.00189409926998714,0.0237151448309308,0.0949338067076524
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EP300,Histone acetyltransferase p300,40199,0.00524758206186404,0.00316868975798653,-0.000963049863789546,0.0114582139875176,0.0977355136837388
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,42794,-0.002688880540386,0.00162623318357211,-0.00587629758018733,0.000498536499415331,0.0982642344274899
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DUSP29,Dual specificity phosphatase 29,40182,-0.0113911380886951,0.00689062918494148,-0.0248967712911804,0.0021144951137902,0.0983320239210427
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MRC1,Macrophage mannose receptor 1,40532,0.00493849552400254,0.00299393292241799,-0.000929613003936722,0.0108066040519418,0.09907272844783
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,40199,-0.0152789962939228,0.0092710898478162,-0.0334503323956426,0.00289233980779691,0.0993759008457717
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BPIFB2,BPI fold-containing family B member 2,40473,0.0115479908222394,0.00702529321647003,-0.00222158388204184,0.0253175655265207,0.100250868108689
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB2B,Ras-related protein Rab-2B,40451,0.0101340501280912,0.00617557824444781,-0.00197008323102654,0.0222381834872089,0.100827831701558
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,40199,0.00749208858199929,0.00456602854762463,-0.00145732737134499,0.0164415045353436,0.100860742204372
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,42689,0.0114278770475289,0.00696969194268541,-0.00223271916013451,0.0250884732551923,0.10110062247594
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CR1,Complement receptor type 1,40509,-0.00606405385128086,0.00370390720879926,-0.0133237119805274,0.00119560427796568,0.101615538398697
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRP2BP,LRP2-binding protein,40182,0.0144465135389772,0.00882974863439566,-0.00285979378443824,0.0317528208623927,0.10184346591289
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL33,Interleukin-33,42370,0.00646284573436074,0.00395170427657932,-0.00128249464773473,0.0142081861164562,0.101976992433706
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REST,RE1-silencing transcription factor,40080,-0.00574346466664007,0.0035146991098171,-0.0126322749218816,0.00114534558860145,0.102261105425935
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,40116,-0.00686086011413404,0.00420297059439683,-0.0150986824791518,0.00137696225088374,0.102627536901092
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RP2,Protein XRP2,42587,0.00696656119134593,0.0042708692969806,-0.00140434263073604,0.0153374650134279,0.102875628721615
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAMA1,Laminin subunit alpha-1,40116,-0.00899813941760869,0.00552138499033276,-0.0198200539986609,0.00182377516344352,0.103196117550309
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,40116,-0.00807528808919485,0.00495645197661768,-0.0177899339633655,0.0016393577849758,0.103289427060251
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TOP1,DNA topoisomerase 1,40449,0.0186685599527601,0.0114713441412769,-0.00381527456414257,0.0411523944696627,0.103678414932981
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANXA4,Annexin A4,42584,0.011817748273306,0.00726578730870211,-0.0024231948517501,0.0260586913983622,0.10386846726926
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UPK3A,Uroplakin-3a,40136,-0.0085084081620788,0.0052339813517717,-0.0187670116115513,0.00175019528739373,0.104061618624271
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OTOA,Otoancorin,40136,-0.00908400912638707,0.00559527932427518,-0.0200507566019664,0.00188273834919229,0.104508576888785
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MSLN,Mesothelin,42553,0.00984416708008081,0.00608278191575918,-0.00207808547480719,0.0217664196349688,0.105607364867825
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,40482,0.00816159547854246,0.0050569256893355,-0.00174997887255511,0.01807316982964,0.106567498955677
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,40182,0.0125368996265849,0.00777917635044993,-0.00271028602029696,0.0277840852734668,0.107078318874172
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBP1,Retinol-binding protein 1,40182,0.0112672039708884,0.00699240270214989,-0.00243790532532544,0.0249723132671021,0.107132308621857
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,42370,0.00608509245886931,0.00378008331834234,-0.00132387084508169,0.0134940557628203,0.107470430070226
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF19,Fibroblast growth factor 19,42676,0.0126896754460116,0.00790008763633286,-0.00279449632120083,0.028173847213224,0.108237971510221
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,40223,-0.00648087998624311,0.00404910815288345,-0.0144171319658947,0.00145537199340844,0.10950089007953
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNPO1,Transportin-1,40302,-0.00579270422329109,0.00362672659974831,-0.0129010883587978,0.00131567991221561,0.110243648392318
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL5,Interleukin-5,42370,-0.0226986816383463,0.0142144145750291,-0.0505589342054033,0.00516157092871072,0.110316952643308
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,40116,-0.0082785097806963,0.0052126463872063,-0.0184952966996206,0.00193827713822805,0.112279400280643
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PFDN2,Prefoldin subunit 2,42311,0.00897764970506797,0.00565754458550265,-0.00211113768251722,0.0200664370926532,0.112571723201047
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENO1,Alpha-enolase,42588,0.0126830113566417,0.00801828804643746,-0.00303283321437569,0.0283988559276592,0.113727865595678
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL17RA,Interleukin-17 receptor A,42611,0.00707468073434766,0.00448413366426108,-0.00171422124760405,0.0158635827162994,0.114654889536391
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL1B,Interleukin-1 beta,42293,0.00913817367979426,0.0057926569256764,-0.00221543389453148,0.02049178125412,0.114694454393868
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MN1,Transcriptional activator MN1,40182,-0.00955546672898725,0.00606679883054696,-0.0214463924368593,0.0023354589788848,0.115275396393662
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,40199,0.00864743201159433,0.00549187209188112,-0.00211663728849267,0.0194115013116813,0.115380483089762
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DEFB116,Beta-defensin 116,40136,-0.0124015299972087,0.00788491758617474,-0.0278559684661112,0.00305290847169383,0.115790181881192
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,40116,-0.0119935569767078,0.00762807926905068,-0.0269445923440471,0.00295747839063155,0.115912148723115
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLB,Beta-klotho,42311,-0.0119249240343647,0.00761749646389764,-0.0268552171036041,0.00300536903487468,0.117498042830709
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB39B,Ras-related protein Rab-39B,40116,0.0147875446095284,0.00945262378973769,-0.00373959801835749,0.0333146872374142,0.117756109360915
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",40116,-0.00693211976836244,0.00443500329838581,-0.0156247262331986,0.00176048669647374,0.118070450475777
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,40449,-0.00741298423937206,0.00476142930677563,-0.0167453856806523,0.00191941720190818,0.119526587646617
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MUC16,Mucin-16,42587,0.0304679196335222,0.0195821764002851,-0.00791314611103659,0.068848985378081,0.11975536366801
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,40136,-0.0116761236200615,0.0075104069927817,-0.0263965213259136,0.00304427408579061,0.120056168300992
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNTF,Ciliary neurotrophic factor,40136,-0.00546896372485797,0.00351933973738079,-0.0123668696101243,0.00142894216040837,0.120219453269503
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",40199,0.0102060132313268,0.00659182855105405,-0.00271397072873913,0.0231259971913927,0.121583034600874
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOB,Apolipoprotein B-100,40532,-0.00352646875651768,0.00228725049100993,-0.00800947971889714,0.000956542205861778,0.123151603020243
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42636,-0.0181341974790841,0.0117622936997602,-0.041188293130614,0.00491989817244579,0.123164485682957
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPN1,Epsin-1,40302,0.00701059540583126,0.00455567189583042,-0.00191852150999637,0.0159397123216589,0.123864059365912
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,40511,0.0117161356973861,0.00761552424681142,-0.00321029182636429,0.0266425632211365,0.123965542123304
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39940,0.0167018434035224,0.0108838484319933,-0.00463049952318448,0.0380341863302292,0.124923078892599
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DKKL1,Dickkopf-like protein 1,42587,-0.0137299074255591,0.00897015187198245,-0.0313114050946447,0.00385159024352648,0.125886579747001
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,40302,-0.00453199863068842,0.00296459629584228,-0.0103426073705393,0.00127861010916246,0.126365610311901
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GFRA2,GDNF family receptor alpha-2,42587,-0.00331339818822248,0.00217283499444608,-0.0075721547773368,0.000945358400891836,0.127302819998569
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NTF4,Neurotrophin-4,42346,0.00605400723571731,0.0039814287645884,-0.00174959314287596,0.0138576076143106,0.128393957517535
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,40182,-0.00589241551514897,0.00387738756950511,-0.013492095151379,0.00170726412108105,0.128618430573432
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF7,Fibroblast growth factor 7,40080,-0.0123353308105193,0.00812359481890051,-0.0282575766555644,0.00358691503452566,0.128928228231979
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC13A1,Solute carrier family 13 member 1,40451,0.00970376182923298,0.00640331856659594,-0.00284674256129507,0.022254266219761,0.129692382224491
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CBLN4,Cerebellin-4,42721,0.00501854005719358,0.00331285871672602,-0.00147466302758941,0.0115117431419766,0.129829475885706
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GSR,"Glutathione reductase, mitochondrial",40490,0.0034700249489914,0.00230302869253868,-0.00104391128838441,0.00798396118636721,0.131909787266667
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",40080,0.00854092560674955,0.00568928770740623,-0.00261007829976667,0.0196919295132658,0.133325257886739
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,40182,0.0061008261851558,0.00408594681559579,-0.00190762957341195,0.0141092819437236,0.135433383466128
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ICAM2,Intercellular adhesion molecule 2,42794,0.00492986768277351,0.00330689927661687,-0.00155165489939555,0.0114113902649426,0.136041790841742
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSCA,Prostate stem cell antigen,40449,0.0404985413079393,0.0272132002250591,-0.0128393311331766,0.0938364137490551,0.136727561433119
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SAG,S-arrestin,40136,-0.00797775366927684,0.00536559044972866,-0.018494310950745,0.00253880361219134,0.137086913217023
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LEG1,Protein LEG1 homolog,39926,-0.0106209248900544,0.00714854503108827,-0.0246320731509874,0.00339022337087858,0.137375591660583
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,42173,-0.0130656998425851,0.00879459549689083,-0.0303031070164911,0.00417170733132093,0.137395738195872
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,40199,0.00888129184310031,0.00598463575201127,-0.00284859423084178,0.0206111779170424,0.137833464264384
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF16,Fibroblast growth factor 16,40199,0.00715395652847198,0.00484578145939949,-0.00234377513195102,0.016651688188895,0.139884822955886
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCN3B,Sodium channel subunit beta-3,40136,-0.00725740854660332,0.00493039020653132,-0.0169209733514047,0.00240615625819806,0.14105652987051
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RYR1,Ryanodine receptor 1,40116,-0.00519699130334078,0.00353216246297927,-0.0121200297307802,0.00172604712409859,0.141229578579294
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CYB5A,Cytochrome b5,40080,0.0110170857188797,0.00748907001378396,-0.00366149150813688,0.0256956629458963,0.14129605488898
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,40136,-0.00917032724333031,0.00624639865164674,-0.0214132686005579,0.0030726141138973,0.142106267562819
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VWF,von Willebrand factor,42794,0.0107472786219778,0.00732633201109422,-0.00361233211976683,0.0251068893637225,0.142415903910042
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42676,0.00854195215278313,0.00586359687054509,-0.00295069771348524,0.0200346020190515,0.145201277950501
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,40199,0.00461714289205097,0.00317862644601309,-0.00161296494213469,0.0108472507262366,0.146374708383379
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF5,Fibroblast growth factor 5,42370,0.00489357858685541,0.00336901461472746,-0.00170969005801041,0.0114968472317212,0.146379443311708
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PFDN4,Prefoldin subunit 4,40080,-0.00780489934718162,0.00538033257726552,-0.018350351198622,0.0027405525042588,0.146910305233709
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1QA,Complement C1q subcomponent subunit A,42701,0.00324928763457677,0.00224428913984088,-0.00114951907951136,0.0076480943486649,0.147695477488834
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EFNB2,Ephrin-B2,40182,0.0080596668353027,0.00558289686074559,-0.00288281101175865,0.0190021446823641,0.148870106417715
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF20,Fibroblast growth factor 20,40199,-0.0066655447930492,0.00461969460911016,-0.0157201462269051,0.00238905664080671,0.149090067736654
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,42370,0.00660825747782388,0.0045843976840143,-0.00237716198284416,0.0155936769384919,0.149476589771547
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PGM2,Phosphoglucomutase-2,40182,-0.0088128350490201,0.00611798340418484,-0.0208040825212224,0.00317841242318218,0.149760029628339
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,42582,0.00498527510237423,0.0034745399827978,-0.00182482326390946,0.0117953734686579,0.151367035321566
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,40116,-0.00476921438769928,0.00332573463679253,-0.0112876542758126,0.00174922550041408,0.151591373657087
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPESP1,Sperm equatorial segment protein 1,40511,0.00465605961032336,0.00324779441142974,-0.00170961743607893,0.0110217366567256,0.151712176167333
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,40302,0.00838782081583532,0.00586391225685602,-0.00310544720760248,0.0198810888392731,0.152626427444047
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC12A2,Solute carrier family 12 member 2,40116,-0.0039857793087747,0.00278940717843136,-0.00945301737850016,0.00148145876095075,0.153062050217224
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RALB,Ras-related protein Ral-B,40199,0.00438005227260392,0.0030682310389507,-0.00163368056373946,0.0103937851089473,0.153449886840569
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,40302,0.00949947956266295,0.00666886694600156,-0.00357149965150011,0.022570458776826,0.154343818991125
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,40136,-0.00608811499994576,0.00429258892246572,-0.0145015892879786,0.00232535928808706,0.15613601797506
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IMPA1,Inositol monophosphatase 1,42495,0.00869727730097716,0.00614192207757337,-0.00334088997106664,0.020735444573021,0.156783874770115
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,40199,-0.00629833994620725,0.00445440042895846,-0.0150289647869658,0.00243228489455133,0.157402204228669
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",42311,0.00763756784147993,0.00540894924221707,-0.00296397267326552,0.0182391083562254,0.157966524390292
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCP2,Non-specific lipid-transfer protein,42346,0.0106510991951102,0.00754335455671177,-0.00413387573604486,0.0254360741262653,0.157978204078991
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCC,Netrin receptor DCC,40182,0.00334282799159759,0.00237074143287044,-0.00130382521682848,0.00798948120002366,0.158557703632174
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,40080,0.00653040921956781,0.00463368918897402,-0.00255162159082126,0.0156124400299569,0.158765409413666
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CADPS,Calcium-dependent secretion activator 1,40182,-0.0061710035393736,0.00438270117791325,-0.0147610978480836,0.00241909076933637,0.159148532076319
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOH,Beta-2-glycoprotein 1,42611,0.00521705691842116,0.0037126409762998,-0.00205971939512644,0.0124938332319688,0.159980657837177
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GAD1,Glutamate decarboxylase 1,40080,-0.00376525886848533,0.00268161953496315,-0.0090212331570131,0.00149071542004243,0.160317948032727
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,42311,0.0122749151125668,0.00874335818783315,-0.0048620669355862,0.0294118971607198,0.160368402495544
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,40116,0.00578296692348769,0.00412308710974892,-0.00229828381162019,0.0138642176585956,0.160770006270487
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,40116,-0.00369953649140868,0.00264883554954474,-0.00889125416851638,0.00149218118569902,0.162542646092294
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,42689,-0.00394286404198784,0.00282578937534206,-0.00948141121765829,0.00159568313368261,0.162944071844418
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,42794,-0.00583479722421009,0.00419594457435016,-0.0140588485899364,0.00238925414151622,0.164375533338179
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GM2A,Ganglioside GM2 activator,40269,0.00581249977593348,0.00418046827962929,-0.00238121805213993,0.0140062176040069,0.164437078908444
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ALCAM,CD166 antigen,42794,0.00278391008234997,0.0020039267086282,-0.00114378626656131,0.00671160643126125,0.164786328178983
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TEX33,Testis-expressed protein 33,40302,-0.00540625335380075,0.00390497323792942,-0.0130600009001424,0.00224749419254091,0.166247486953865
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",42346,0.0109063460731407,0.00787990366806709,-0.00453826511627075,0.0263509572625522,0.166360203914069
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,YY1,Transcriptional repressor protein YY1,40199,0.00398579801932677,0.00288576762947305,-0.00167030653444041,0.00964190257309394,0.1672480993243
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLSTN3,Calsyntenin-3,40483,0.00431594256193223,0.00313091918607155,-0.00182065904276801,0.0104525441666325,0.168079194744546
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASQ2,Calsequestrin-2,40116,-0.00692982946008628,0.0050289748671673,-0.0167866201997342,0.00292696127956162,0.16823752890414
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KCNIP4,Kv channel-interacting protein 4,42311,-0.00694359253920734,0.00504216161980266,-0.0168262293140206,0.00293904423560588,0.168502884564198
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42711,0.00648889155588147,0.00474389801557404,-0.00280914855464365,0.0157869316664066,0.171385029181267
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,40182,-0.00712103489867901,0.00521257045707338,-0.0173376729945428,0.00309560319718483,0.171926963015612
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,42346,-0.00725981743921122,0.00532122615200191,-0.017689420697135,0.00316978581871253,0.172492454320901
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPRING1,SREBP regulating gene protein,40080,0.00827055866161554,0.00606234556230652,-0.00361163864050524,0.0201527559637363,0.172516905753692
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FXN,"Frataxin, mitochondrial",42721,0.010132566099106,0.00743655977588627,-0.00444309106163112,0.0247082232598431,0.173052081790725
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",40268,0.00885788967346656,0.00650151029876978,-0.0038850705121222,0.0216008498590553,0.173088134247812
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTTG1,Securin,40302,0.00569945208140868,0.00419238765347425,-0.00251762771940085,0.0139165318822182,0.174023271402328
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,40451,0.0074640695551803,0.00549417661793987,-0.00330451661598185,0.0182326557263425,0.174318995118309
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,40136,-0.00461217297519007,0.00340620021494574,-0.0112883253964837,0.00206397944610358,0.175747680789576
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPPB,Natriuretic peptides B,42357,0.0195587838039656,0.0144773241893511,-0.00881677160716263,0.0479343392150938,0.17672044997287
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TLR4,Toll-like receptor 4,40199,-0.00405229696148113,0.00299958938834695,-0.00993149216264114,0.00182689823967888,0.176739044883348
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STAM,Signal transducing adapter molecule 1,40451,0.00516144276929962,0.00382262110192623,-0.00233089459047579,0.012653780129075,0.176967259868885
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,40080,0.0197482641785226,0.0146828937934389,-0.00903020765661777,0.0485267360136629,0.178658267642973
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,40302,0.00714773580083013,0.00535670885904516,-0.00335141356289838,0.0176468851645586,0.182115837642953
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,42346,-0.0043343837485859,0.00325016853948763,-0.0107047140859816,0.00203594658880985,0.182362215994486
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EXOSC10,Exosome component 10,40116,-0.00822513593835832,0.00618525846921541,-0.0203482425380205,0.00389797066130388,0.183613053175119
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAMDC2,MAM domain-containing protein 2,40511,-0.00494828441393667,0.00373325934828976,-0.0122654727365846,0.00236890390871126,0.185045519217717
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,42587,-0.0034847794788262,0.0026674565105142,-0.00871299423943403,0.00174343528178163,0.191437178575902
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BRDT,Bromodomain testis-specific protein,40116,0.00492593511489348,0.00380417324555876,-0.00253024444640168,0.0123821146761887,0.195390155937789
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TP53BP1,TP53-binding protein 1,40199,0.0114785791395744,0.00888630470856872,-0.00593857808922026,0.0288957363683691,0.196482751912927
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DENND2B,DENN domain-containing protein 2B,40116,-0.00659623233801508,0.00511541323545996,-0.0166224422795166,0.00342997760348644,0.197257940296847
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SDHB,Succinate dehydrogenase,40449,0.00873621629371659,0.00677687751821594,-0.00454646364198665,0.0220188962294198,0.19738245719059
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLXDC2,Plexin domain-containing protein 2,40483,-0.00359523023548834,0.00278890332009468,-0.00906148074287392,0.00187102027189724,0.197382886289774
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSP90B1,Endoplasmin,42247,-0.00878033567348914,0.0068183167200283,-0.0221442364447446,0.00458356509776633,0.197853364644744
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NRXN3,Neurexin-3,40182,0.00467133682420641,0.00363743139824295,-0.00245802871634977,0.0118007023647626,0.199084884451507
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NCLN,Nicalin,42370,0.00678807869290103,0.00528665662265188,-0.00357376828749665,0.0171499256732987,0.19916376597416
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SKIV2L,Helicase SKI2W,40116,0.00519249463172639,0.00407735855460457,-0.00279912813529857,0.0131841173987513,0.202869643054096
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLASP1,CLIP-associating protein 1,40080,0.0094359508935269,0.00744095330291177,-0.00514831758018016,0.024020219367234,0.204785617988659
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,40182,0.00639246669380934,0.00504106051490926,-0.00348801191541282,0.0162729453030315,0.204796344490564
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,40136,0.00785369753886447,0.00620066987469656,-0.00429961541554078,0.0200070104932697,0.205329405264816
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",40199,0.00560530808822366,0.00443309646661798,-0.00308356098634759,0.0142941771627949,0.206105104066772
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMP15,Matrix metalloproteinase-15,40511,0.0063016072004909,0.00499483935756226,-0.00348827794033113,0.0160914923413129,0.207110263551278
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEP164,Centrosomal protein of 164 kDa,42370,0.00848901074510304,0.00672976154022011,-0.00470132187372838,0.0216793433639344,0.207182308995323
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HGFAC,Hepatocyte growth factor activator,40428,-0.0035845788142727,0.00284316144331953,-0.00915717524317899,0.00198801761463359,0.207417128021673
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,40451,-0.0057628240636619,0.00459490902618759,-0.0147688457549896,0.00324319762766577,0.209804127435565
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRC1,Protein regulator of cytokinesis 1,40451,0.00570579567955278,0.00455689580765521,-0.00322572010345143,0.014637311462557,0.210550931933872
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TFRC,Transferrin receptor protein 1,42673,0.00482617575621867,0.00386315442666516,-0.00274560692004505,0.0123979584324824,0.211583030583129
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,40449,0.00348698718667385,0.00279336196995651,-0.00198800227444091,0.0089619766477886,0.211942798773399
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,42357,-0.00422578299147602,0.00340339073436033,-0.0108964288308223,0.00244486284787023,0.214391874443958
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,40539,0.00237679029432104,0.00191581468230208,-0.00137820648299103,0.00613178707163311,0.214773303638061
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,42357,0.00351374117144218,0.00283643643783447,-0.00204567424671339,0.00907315658959775,0.215446402587724
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NEFL,Neurofilament light polypeptide,42262,0.00585267244822403,0.00472896702028493,-0.00341610291153443,0.0151214478079825,0.21587858117619
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,40527,0.00319477978185,0.0025825070745423,-0.00186693408425291,0.00825649364795291,0.216081301719247
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HLA_DRA,,42549,0.00463242842585385,0.00375814021415832,-0.00273352639389646,0.0119983832456042,0.217732353717976
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA8,Carbonic anhydrase-related protein,40199,0.00360731048443296,0.00293171316248681,-0.00213884731404118,0.00935346828290711,0.218556978576805
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TREML1,Trem-like transcript 1 protein,40532,0.00660139875159807,0.00536732833639818,-0.00391856478774237,0.0171213622909385,0.218751586847056
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STX1B,Syntaxin-1B,40182,0.00510424975233332,0.00415138141169322,-0.00303245781458539,0.013240957319252,0.218899324275217
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,40223,0.00355199866926175,0.00288984636920177,-0.00211210021437372,0.00921609755289721,0.219049057929372
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL24,C-C motif chemokine 24,42654,-0.0103630717582978,0.00843747931045297,-0.0269005312067857,0.00617438769018999,0.219386272454615
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANK2,Ankyrin-2,40116,-0.00921150751735281,0.00754027076955459,-0.0239904382256798,0.00556742319097419,0.221869603313816
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NINJ1,Ninjurin-1,42346,-0.00671702933737376,0.00550578529632119,-0.0175083685181633,0.00407430984341578,0.222488728033919
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH23,Cadherin-23,40483,-0.0032506209438584,0.00266845754386233,-0.00848079772982857,0.00197955584211177,0.223186826502959
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,42346,0.00588160190539865,0.00484252736114962,-0.0036097517224546,0.0153729555332519,0.224550883027019
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMP10,Stromelysin-2,42608,-0.00724484510886886,0.00599019255720817,-0.0189856225209969,0.00449593230325915,0.226510893660782
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NECTIN1,Nectin-1,40199,0.00404091235188972,0.00334751135002259,-0.00252020989415456,0.010602034597934,0.227404464870457
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SULT1A1,Sulfotransferase 1A1,42711,0.0156148953366814,0.0129862002817751,-0.0098380572155978,0.0410678478889606,0.229221060347633
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,40451,0.0041016907910695,0.00342480397803081,-0.0026109250058709,0.0108143065880099,0.231081440909331
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MEP1B,Meprin A subunit beta,42636,-0.0143595459063457,0.0120381380323855,-0.0379542964498213,0.00923520463712995,0.232953963440066
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CFD,Complement factor D,40539,0.00255690771470972,0.00214433152382115,-0.00164598207197973,0.00675979750139917,0.233128135815609
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,40136,-0.00496061153360335,0.00416031034066896,-0.0131148198013145,0.00319359673410782,0.233143723534278
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,40451,0.00799746452147726,0.00674464274519418,-0.00522203525910333,0.0212169643020578,0.235745813586826
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TCP11,T-complex protein 11 homolog,40302,-0.00715527487766791,0.00605915332674846,-0.0190312153980949,0.00472066564275907,0.237666377350577
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL1A,Interleukin-1 alpha,42370,0.00699483459208824,0.00594471673447379,-0.00465681020748038,0.0186464793916569,0.239357587146664
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSPAN7,Tetraspanin-7,40136,-0.0113229762229736,0.0096519819020322,-0.0302408607509567,0.0075949083050095,0.24077142855496
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,S100A3,Protein S100-A3,40451,0.00522339526987041,0.00445388017739843,-0.00350620987783052,0.0139530004175713,0.240911227362447
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,40080,0.0040999923147103,0.00350106089890834,-0.00276208704715006,0.0109620716765706,0.241595708278851
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,40136,-0.00613931015692827,0.00526000504667366,-0.0164489200484087,0.0041702997345521,0.243167920434666
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,40136,-0.00684554660188836,0.00589265736120589,-0.0183951550298519,0.00470406182607519,0.245379475881547
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,42346,0.00487100236966875,0.00419523611419029,-0.00335166041414423,0.0130936651534817,0.245630670551624
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,40080,0.0102974266522598,0.00887020545495909,-0.00708817603946002,0.0276830293439796,0.245707789170882
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PROK1,Prokineticin-1,42594,0.00652036513754151,0.00562223883038575,-0.00449922297001456,0.0175399532450976,0.246173178729443
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HEBP1,Heme-binding protein 1,42357,-0.00623873221822776,0.00539700301174452,-0.016816858121247,0.0043393936847915,0.247717542958248
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAG,Myelin-associated glycoprotein,40182,-0.00579230378649664,0.00502003367130574,-0.0156315697822559,0.00404696220926261,0.24859183677176
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,42346,0.00559084558585526,0.00486388398214575,-0.00394236701915042,0.0151240581908609,0.250386787243088
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,40080,0.00695101064909778,0.00605271505963214,-0.00491231086778121,0.0188143321659768,0.250823753343948
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,42346,0.00462422810060454,0.00403444365509256,-0.00328328146337688,0.012531737664586,0.251738512764763
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPA4,Carboxypeptidase A4,40060,0.00519418945055857,0.00453447528898934,-0.00369338211586053,0.0140817610169777,0.252032070169642
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DAND5,DAN domain family member 5,40199,0.00645464332235807,0.00567424556554572,-0.00466687798611153,0.0175761646308277,0.25534017472944
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,40080,-0.00356224721105123,0.00313805616565201,-0.00971283729572917,0.00258834287362671,0.256326420601645
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,40182,0.00781142351300267,0.00690608851283243,-0.00572450997214888,0.0213473569981542,0.25804093257234
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EBI3_IL27,Interleukin-27,42689,0.00355000213459401,0.00314136180409429,-0.0026070670014308,0.00970707127061882,0.258460993617131
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPHS2,Podocin,40199,-0.01209603575691,0.0107531400389773,-0.0331721902333055,0.00898011871948546,0.260662703353883
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BMP4,Bone morphogenetic protein 4,42475,-0.00531933850926327,0.00474264642558856,-0.0146149255034168,0.0039762484848903,0.262054060632515
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL2,Interleukin-2,42370,0.00366915708873594,0.00327155974266336,-0.00274310000688425,0.0100814141843561,0.262082157966279
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,42679,-0.0110637869527041,0.00992977696080292,-0.0305261497958779,0.00839857589046959,0.265211980859173
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGLON5,IgLON family member 5,40080,-0.0108039078782393,0.00971055613750603,-0.0298365979077511,0.00822878215127253,0.265907345485357
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,40284,-0.00606050462328508,0.00547809803512373,-0.0167975767721276,0.00467656752555743,0.268613994000917
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",40199,0.00321651904351596,0.00290843413667922,-0.0024840118643753,0.00891704995140722,0.268781815781308
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYOM1,Myomesin-1,40136,0.00544958716502138,0.00492872285398249,-0.00421070962878429,0.0151098839588271,0.268889633476605
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FSTL1,Follistatin-related protein 1,40223,0.0025587529749185,0.00231610205698949,-0.00198080705678089,0.0070983130066179,0.269284691056974
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,42689,0.00518201190164417,0.00470151581209891,-0.00403295909006969,0.014396982893358,0.270394279825488
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,40302,-0.0079389575922738,0.00721654664397973,-0.0220833890144741,0.00620547382992647,0.271310303381352
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,40482,0.0129206737631901,0.0117927009522624,-0.0101930201032442,0.0360343676296244,0.273255311350526
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,42370,0.00409021795402759,0.00373440854992949,-0.00322922280383421,0.0114096587118894,0.273414598222794
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,40080,-0.0065859415951228,0.00601572735513575,-0.0183767672111889,0.00520488402094327,0.27363407617599
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42654,0.00984013959863173,0.00900733449888322,-0.00781423601917937,0.0274945152164428,0.274651151914962
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD5L,CD5 antigen-like,40479,-0.0053234253242668,0.00488115647977777,-0.0148904920246312,0.00424364137609762,0.27546896234634
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEP290,Centrosomal protein of 290 kDa,40302,0.00607918054498897,0.00558142012041443,-0.00486040289102333,0.0170187639810013,0.276097404751095
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,40182,-0.00413511593871939,0.00379702359599037,-0.0115772821868605,0.00330705030942173,0.276159508214706
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEP112,Centrosomal protein of 112 kDa,40116,0.00500200390814649,0.00459434948549474,-0.00400292108342321,0.0140069288997162,0.276297202400206
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,40302,0.00604393689124547,0.00555751981849248,-0.00484880195299978,0.0169366757354907,0.276828838026126
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LTO1,Protein LTO1 homolog,42370,0.00462906623769841,0.00429266396092541,-0.00378455512571541,0.0130426876011122,0.280889844466766
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMEM25,Transmembrane protein 25,40482,0.00502854834908232,0.00466630880972846,-0.00411741691798546,0.0141745136161501,0.281222512374543
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,40302,-0.00816252310103929,0.00757977014666931,-0.0230188725885111,0.00669382638643256,0.281556073717987
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCNE1,G1/S-specific cyclin-E1,40199,0.00975974276581262,0.00907215633849243,-0.00802168365763255,0.0275411691892578,0.282044389758942
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,40302,-0.00892211205844693,0.00830361787692227,-0.0251972030972146,0.00735297898032072,0.282628746168535
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDCL2,Phosducin-like protein 2,40080,0.00579772269642626,0.0054360483710977,-0.00485693211092524,0.0164523775037778,0.286206611411287
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KHDC3L,KH domain-containing protein 3,40080,-0.00753455644825371,0.00707230240569928,-0.0213962691634243,0.00632715626691687,0.286736144452893
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,42311,0.00916447783699095,0.00861320955221129,-0.00771741288534317,0.0260463685593251,0.287347082928886
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,40136,0.0131043052911245,0.0123598533983848,-0.0111210073697097,0.0373296179519588,0.289062718558059
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SHC1,SHC-transforming protein 1,40080,-0.0128337948038262,0.0121049146911209,-0.0365594275984231,0.0108918379907708,0.289070971571922
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,40451,0.00982229645928102,0.00927160180595801,-0.00835004308039668,0.0279946359989587,0.289442270160186
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SDK2,Protein sidekick-2,40283,0.00437733141113857,0.00413995118795463,-0.00373697291725251,0.0124916357395296,0.29037998132994
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPM1B,Protein phosphatase 1B,40199,0.00658942533533587,0.00624498127769059,-0.00565073796893768,0.0188295886396094,0.291377449866807
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,40116,-0.00729579407600359,0.00692232495017722,-0.0208635509783509,0.00627196282634376,0.291928482788674
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,40136,-0.00688230063399626,0.00653166433607807,-0.0196843627327093,0.00591976146471675,0.292051554108343
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGL1,Fibrinogen-like protein 1,40532,-0.00705500845649939,0.00673044188030395,-0.0202466745418951,0.00613665762889634,0.294557913529423
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHRDL1,Chordin-like protein 1,42654,-0.00345206327592215,0.00329879362076528,-0.00991769877262209,0.0030135722207778,0.295366417142317
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,42357,-0.00640656069256189,0.00612817424173642,-0.0184177822063653,0.00560466082124148,0.295844718827644
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FZD10,Frizzled-10,40182,0.00645653742259817,0.00620913764322892,-0.00571337235813051,0.0186264472033268,0.298435046101783
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,42357,0.00515629259035961,0.00496852166233788,-0.00458200986782263,0.0148945950485419,0.299385913080148
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TBR1,T-box brain protein 1,40182,-0.00514989425336071,0.00496498502319493,-0.0148812648988228,0.00458147639210135,0.299645607937373
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NGF,Beta-nerve growth factor,42495,-0.00126381217194689,0.00122209984632783,-0.00365912787074944,0.00113150352685566,0.301093407442203
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ALMS1,Alstrom syndrome protein 1,40302,-0.00471684228602429,0.00456474476688191,-0.0136637420291128,0.00423005745706426,0.301476643967638
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL28,C-C motif chemokine 28,42538,0.00614087032804266,0.0059737229597282,-0.0055676266730246,0.0178493673291099,0.303977663906404
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRTN3,Myeloblastin,42276,0.00509885506363302,0.00496516591582738,-0.00463287013138864,0.0148305802586547,0.30447457352672
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",40116,0.00733865294652429,0.00715948740950231,-0.00669394237610023,0.0213712482691488,0.305374134707583
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",40116,-0.00544639388200086,0.00532267243037703,-0.0158788318455398,0.00498604408153813,0.306215045269468
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",40116,0.00591003338992233,0.00578044062406231,-0.00541963023323979,0.0172396970130845,0.306605189148496
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NENF,Neudesin,40451,0.0115120918468078,0.0112639213744195,-0.0105651940470544,0.0335893777406701,0.306787560182972
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,40116,-0.00504240084944067,0.00493845645249288,-0.0147217754963267,0.00463697379744537,0.307254335484537
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,42603,-0.00314052821169704,0.00307638279678134,-0.00917023849338847,0.0028891820699944,0.307343492002516
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPHA10,Ephrin type-A receptor 10,42311,-0.00698777819489644,0.00684717714222762,-0.0204082453936626,0.00643268900386968,0.307494016996173
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EVPL,Envoplakin,40302,-0.00367253783166668,0.00360267911371179,-0.0107337888945418,0.00338871323120843,0.308039688017824
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,40223,-0.00244825287344708,0.00241321233853236,-0.00717814905697051,0.00228164331007634,0.310356809509227
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMIGO1,Amphoterin-induced protein 1,40182,-0.00524334059965371,0.00517411294901129,-0.0153846019797158,0.00489792078040843,0.310901184901559
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZNF75D,Zinc finger protein 75D,40302,0.00636012060260461,0.00627974227267606,-0.00594817425184046,0.0186684154570497,0.311177941080381
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,40539,-0.00204722316753492,0.00202210479708213,-0.00601054856981589,0.00191610223474604,0.31135796586456
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,42594,-0.00490455289625908,0.00488027711475922,-0.0144698960411871,0.00466079024866899,0.314927389759219
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,40199,0.0104289674119525,0.0103997653303342,-0.00995457263550258,0.0308125074594076,0.315975577991766
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NOS2,"Nitric oxide synthase, inducible",40116,0.00408748364986987,0.00407956557525577,-0.00390846487763145,0.0120834321773712,0.316394328891727
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,40136,-0.0054960506372382,0.00548775679124706,-0.0162520539480824,0.00525995267360603,0.316601809111876
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,40182,-0.00471957054223562,0.00471596577459232,-0.0139628634604366,0.00452372237596532,0.316962774046436
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GAD2,Glutamate decarboxylase 2,40199,-0.00472345684268944,0.00472048501139108,-0.013975607465016,0.00452869377963708,0.317027933988442
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,40136,-0.00797780230338623,0.00797948667998535,-0.0236175961961575,0.00766199158938505,0.317434781807751
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFNL2,Interferon lambda-2,40136,0.00633056471311679,0.00633972857069319,-0.00609530328544186,0.0187564327116754,0.318032615441825
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAEP,Glycodelin,42495,0.00914130085756749,0.00917198254226612,-0.00883578492527411,0.0271183866404091,0.318950204324167
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MUC2,Mucin-2,40527,0.00945903483611827,0.00949740996875025,-0.00915588870263223,0.0280739583748688,0.319291131045048
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NRN1,Neuritin,40482,0.00369384861125327,0.00372229264138319,-0.00360184496585778,0.0109895421883643,0.321043963948479
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MATN2,Matrilin-2,42638,-0.00293526267914547,0.00301742642530963,-0.00884941847275236,0.00297889311446141,0.330684999795096
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",40182,0.00835632348320658,0.00860220113780042,-0.00850399074688225,0.0252166377132954,0.331362103539815
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,40199,-0.00291236789836089,0.00300050226425475,-0.00879335233630019,0.00296861653957841,0.331755489362813
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,40302,0.00699279670218057,0.00724513729441568,-0.00720767239487416,0.0211932657992353,0.33448016101394
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,40199,0.00394930221028098,0.0041078490655206,-0.00410208195813939,0.0120006863787014,0.336370234828039
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,42618,-0.0025177552481218,0.00262573303431336,-0.00766419199537599,0.00262868149913239,0.337637937263577
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCN,Decorin,42357,-0.00235806356445546,0.00245974059167448,-0.00717915512413744,0.00246302799522653,0.337745891221876
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HDAC9,Histone deacetylase 9,40136,-0.00644251046215633,0.00672037967629607,-0.0196144546276966,0.00672943370338397,0.337754890010058
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMEM132A,Transmembrane protein 132A,40223,-0.00611996258530959,0.00641068204136722,-0.0186848993863893,0.00644497421577016,0.339775253291418
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42495,-0.0028176902997108,0.00295413293399165,-0.00860779085033443,0.00297241025091283,0.340195657471756
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD33,Myeloid cell surface antigen CD33,42679,-0.007793856958176,0.00817439207385802,-0.0238156654229377,0.00822795150658572,0.340380271496424
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK4,Kallikrein-4,42721,-0.00615024348140405,0.00647928037690026,-0.0188496330201286,0.00654914605732046,0.342527183464508
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",40449,0.00983817121868068,0.010399039659011,-0.0105439465129809,0.0302202889503422,0.34413555947526
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,40182,0.00995511120157107,0.0105276389969881,-0.0106790612325255,0.0305892836356677,0.344364918612513
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TCN1,Transcobalamin-1,40337,-0.00329138841384998,0.00350585685145465,-0.0101628678427011,0.00358009101500114,0.347840604971338
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD300LF,CMRF35-like molecule 1,42721,0.00582268485736556,0.00620674961379325,-0.0063425443856692,0.0179879141004003,0.348198756540898
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,40116,-0.00311597534251413,0.00333570143151527,-0.00965395014828406,0.00342199946325579,0.350258020651573
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,40136,-0.00719681007759252,0.00774314985649703,-0.0223733837963267,0.00797976364114165,0.352680480588617
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,40136,0.00665373233337329,0.00718564931715138,-0.00743014032824343,0.02073760499499,0.354479343385549
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAGEA3,Melanoma-associated antigen 3,40302,0.00822595628253582,0.00888659553979009,-0.00919177097545275,0.0256436835405244,0.354643381005415
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,42475,-0.00323372359311331,0.00349363935130463,-0.0100812567216704,0.00361380953544376,0.3546690732579
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAM171A2,Protein FAM171A2,40482,-0.0150935062921846,0.0163640653167911,-0.0471670743130952,0.0169800617287259,0.356362228973495
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,40080,-0.00290545389103128,0.00315060085991087,-0.00908063157645659,0.00326972379439402,0.356449703197123
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,40116,-0.00341959523463529,0.0037130341665169,-0.0106971422010084,0.00385795173173784,0.357086127806667
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EVI2B,Protein EVI2B,40080,-0.00384828503638204,0.00419528510648835,-0.0120710438450992,0.00437447377233513,0.359012021135075
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCUN1D1,DCN1-like protein 1,40136,0.00703334657227649,0.00767417660470444,-0.00800803957294422,0.0220747327174972,0.359427384737291
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",40116,-0.00462947199187645,0.00507404682047689,-0.0145746037600112,0.00531565977625826,0.361587487783168
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,40482,0.00319504058214921,0.00350481945180789,-0.00367440554339426,0.0100644867076927,0.361991702294745
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BRD3,Bromodomain-containing protein 3,40116,0.00464064485835469,0.00509293691526575,-0.00534151149556618,0.0146228012122756,0.362214174471106
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,40527,0.0025983153766157,0.00285992559841957,-0.00300713879628665,0.00820376954951805,0.363619958822808
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MLLT1,Protein ENL,40080,-0.0061787981640592,0.00680228253271067,-0.0195112719281721,0.00715367560005372,0.363717725663925
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GBP2,Guanylate-binding protein 2,42370,0.00560001108141103,0.00618891012103873,-0.00653025275582488,0.0177302749186469,0.365563478394254
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TET2,Methylcytosine dioxygenase TET2,40286,0.00945648994068761,0.0104804881379796,-0.0110852668097524,0.0299982466911276,0.366919880130517
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,40080,0.00715428098780366,0.00796302585146996,-0.00845324968107746,0.0227618116566848,0.368972225872545
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HMMR,Hyaluronan mediated motility receptor,40059,0.00457371038172243,0.00509154131698685,-0.00540571059957179,0.0145531313630166,0.369047755816769
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPRR1B,Cornifin-B,40302,0.00759923590888161,0.00850162415368645,-0.00906394743234384,0.0242624192501071,0.371417794981209
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DSG3,Desmoglein-3,42651,-0.00319566321902786,0.00358231282515545,-0.0102169963563325,0.00382566991827682,0.372372947484438
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK12,Kallikrein-12,42346,0.0126792365055115,0.0142440812685295,-0.0152391627808063,0.0405976357918292,0.37340662188988
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WNT9A,Protein Wnt-9a,42370,0.00269252402190118,0.00302676003287632,-0.00323992564253641,0.00862497368633877,0.373711446881043
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CAPS,Calcyphosin,40483,-0.00937206034590574,0.0105788934292523,-0.0301066914672402,0.0113625707754287,0.375679147899409
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,40199,0.00263612999650995,0.00297781603204131,-0.00320038942629102,0.00847264941931092,0.376037828629442
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRX,Cone-rod homeobox protein,42357,-0.00960658230536441,0.010877697815788,-0.0309268700243089,0.0117137054135801,0.377174167792259
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINB5,Serpin B5,42357,0.00438410198314755,0.0049812033441787,-0.00537905657144269,0.0141472605377378,0.378805448091132
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL17D,Interleukin-17D,42370,0.00308864943853738,0.00351036826371161,-0.00379167235833737,0.00996897123541214,0.378948607324097
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,40451,0.00869927134874869,0.00988916733804642,-0.0106834966338223,0.0280820393313197,0.379053184095488
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",40136,0.0040164284962742,0.00456739539928559,-0.00493566648632556,0.012968523478874,0.379220240763398
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIF20B,Kinesin-like protein KIF20B,40136,0.00702325399231025,0.00801231014606316,-0.00868087389397353,0.022727381878594,0.380746041777989
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1R,Complement C1r subcomponent,40539,-0.00173999870766377,0.00198579997743864,-0.00563216666344351,0.00215216924811598,0.380928709901976
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SYT1,Synaptotagmin-1,40483,-0.00378803344739425,0.00432944633312038,-0.0122737482603102,0.00469768136552171,0.381621689181141
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39845,-0.00462262365724436,0.00528527077905466,-0.0149817543841915,0.00573650706970278,0.381798349950158
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",40223,0.00229084742537666,0.00262239027889063,-0.00284903752124898,0.00743073237200229,0.382370253579563
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACTA2,"Actin, aortic smooth muscle",42357,0.00389551236902472,0.0044979145569854,-0.00492040016266666,0.0127114249007161,0.386467133171242
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPLX2,Complexin-2,40080,-0.00281688436563023,0.00325372784021517,-0.00919419093245197,0.00356042220119151,0.386651496593278
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,40116,-0.00430419776774048,0.00498085982840148,-0.0140666830314074,0.00545828749592642,0.387525823470625
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",40199,0.00416594277620922,0.00483125982252062,-0.00530332647593118,0.0136352120283496,0.388547228103685
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,40223,0.00224159980310285,0.00262247099564202,-0.00289844334835552,0.00738164295456122,0.392699110398287
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GSAP,Gamma-secretase-activating protein,42346,-0.00745642502637413,0.0087330437484873,-0.0245731907734092,0.00966034072066099,0.393221702094039
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,40182,-0.00316369602498652,0.00371223154285267,-0.0104396698489778,0.00411227779900471,0.39410189361775
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSH,Pro-cathepsin H,42332,0.00648006866182553,0.00761291510804434,-0.00844124494994138,0.0214013822735924,0.394677035955295
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,40302,-0.00347874268436717,0.00408743882986274,-0.0114901227908981,0.00453263742216379,0.394742547742912
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,40116,-0.00868001703067232,0.010235838678031,-0.0287422608396131,0.0113822267782685,0.396455148330099
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,40182,0.00470454051203593,0.00557781284643936,-0.00622797266698521,0.0156370536910571,0.399001766955802
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPTN,Neuroplastin,42346,-0.00676149372207978,0.00802425813002961,-0.0224890396569378,0.00896605221277826,0.399449817434985
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,40283,-0.00322222326866171,0.00386526595623643,-0.0107981445428851,0.0043536980055617,0.404504319347033
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD82,CD82 antigen,40302,-0.00347512085407219,0.00419289714809575,-0.0116931992643399,0.00474295755619548,0.407228958431206
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRR4,Proline-rich protein 4,40198,-0.00590277383272147,0.0071331761965197,-0.0198837991779001,0.00807825151245714,0.40796606497792
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCN2B,Sodium channel subunit beta-2,40182,-0.00245652621642794,0.00298123158897911,-0.00829974013082699,0.00338668769797111,0.409959084360847
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,40449,-0.0125191105658523,0.0151943533502855,-0.0423000431324119,0.0172618220007073,0.409995782104125
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,40116,0.00318926537682424,0.00388061239187657,-0.00441673491125384,0.0107952656649023,0.411182547382264
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,40116,-0.00325218491928858,0.0039794678994154,-0.0110519420021428,0.0045475721635656,0.413808457165737
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,40080,-0.00484821010138292,0.00593348107054558,-0.0164778329996523,0.00678141279688642,0.413892754760263
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL9,Interleukin-9,40302,-0.00468451521734775,0.00575729513019186,-0.0159688136725238,0.0065997832378283,0.415853765780336
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PMCH,Pro-MCH,40116,0.00699212415790811,0.00867852536219199,-0.0100177855519882,0.0240020338678044,0.420444270192611
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,40182,-0.00259193411136361,0.00324427780235575,-0.00895071860398088,0.00376685038125367,0.424351265026518
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",42311,0.00245597963664457,0.00307491831550532,-0.00357086026174586,0.008482819535035,0.424470854653808
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,40283,-0.00434632041352566,0.0054427076328693,-0.0150140273739495,0.00632138654689816,0.424563564487638
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,40527,-0.00300731614631068,0.00377680642815524,-0.0104098567454949,0.00439522445287359,0.425898184057856
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,40451,0.00297494101333309,0.00374717599189152,-0.00436952393077429,0.0103194059574405,0.427261374106507
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH22,Cadherin-22,40302,-0.00227258872786951,0.0028766525071897,-0.00791082764196132,0.00336565018622231,0.429537882673
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MANSC4,MANSC domain-containing protein 4,40116,-0.00578332330499306,0.00733213498833561,-0.0201543078821309,0.00858766127214474,0.430267139371454
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,40080,-0.00203586795057578,0.0025838463379949,-0.00710020677304579,0.00302847087189423,0.430759809975385
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LTB,Lymphotoxin-beta,40451,0.00287985441936588,0.00366331350834826,-0.00430024005699672,0.0100599488957285,0.431805675595997
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,40136,0.00356621299712656,0.0045478148927574,-0.00534750419267794,0.0124799301869311,0.432963404674001
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGAX,Integrin alpha-X,40302,-0.00435602897570323,0.00557102129080763,-0.0152752307056862,0.00656317275427972,0.434285007359945
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,42357,0.00619450637812749,0.00795613233609458,-0.00939951300061788,0.0217885257568729,0.436239614441089
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDC123,Cell division cycle protein 123 homolog,40080,0.00502637332667401,0.00646950417392875,-0.00765385485422635,0.0177066015075744,0.437214996009586
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPR101,Probable G-protein coupled receptor 101,40136,-0.0048034896754687,0.0061851707454274,-0.0169264243365064,0.007319444985569,0.43740337593269
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSPAN15,Tetraspanin-15,40116,-0.00413200033658829,0.00533713871235709,-0.0145927922128082,0.00632879153963161,0.438830665962288
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MTR,Methionine synthase,40116,0.0052241379194995,0.00679625632300429,-0.00809652447358891,0.0185448003125879,0.44210065426048
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C5,Complement C5,40539,0.00118078825068713,0.00153874650463025,-0.00183515489838817,0.00419673139976242,0.442877396006587
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",40483,0.00204612257430556,0.0026698682791897,-0.00318681925290625,0.00727906440151737,0.44346872225982
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSLP,Thymic stromal lymphopoietin,42357,0.00478689918351173,0.00624620054399417,-0.00745565388271684,0.0170294522497403,0.4434700666038
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,40182,0.00283803701674478,0.00370455877554984,-0.0044228981833329,0.0100989722168225,0.443637348824177
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA7,Carbonic anhydrase 7,40302,-0.00275765081373427,0.00360421045890105,-0.00982190331318033,0.00430660168571178,0.444216791278005
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,40116,0.0026339237719204,0.00344684761237866,-0.00412189754834178,0.00938974509218257,0.444791744385862
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,40116,-0.00860433279817161,0.0112894724912299,-0.0307316988809823,0.013523033284639,0.445983699466767
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,40080,0.00498922250242357,0.00655914613079534,-0.00786670391393529,0.0178451489187824,0.446881892985776
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF12,Fibroblast growth factor 12,40199,-0.00363614182156448,0.00479358046398263,-0.0130315595309704,0.00575927588784149,0.448141611984916
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",40080,-0.00376958823712211,0.00501663785339466,-0.0136021984297756,0.00606302195553142,0.452417826262938
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC44A4,Choline transporter-like protein 4,40182,-0.0054735110102877,0.00729751620993537,-0.019776642781761,0.00882962076118563,0.453239909912917
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,40511,-0.00212962163549685,0.0028475879840052,-0.00771089408414705,0.00345165081315335,0.454554959553984
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RGS8,Regulator of G-protein signaling 8,42370,-0.00489403052810233,0.00657526673729279,-0.0177815533331962,0.00799349227699153,0.45670280218596
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ESPL1,Separin,40080,-0.00438282159453075,0.00589410614181794,-0.0159352696324939,0.00716962644343241,0.457138220110342
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LMOD2,Leiomodin-2,40136,-0.00474065570425117,0.00638806347069853,-0.0172612601068203,0.00777994869831794,0.458035679635193
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCS,Copper chaperone for superoxide dismutase,42495,0.00355909375349603,0.00482890630729335,-0.00590556260879894,0.013023750115791,0.46111144695719
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,40451,0.00302355090668912,0.00410741052400611,-0.00502697372036285,0.0110740755337411,0.46167243716505
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,40451,0.00334284571627644,0.00454214401660021,-0.00555975655625996,0.0122454479888129,0.461769115388204
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSMA1,Proteasome subunit alpha type-1,42346,0.00346652719479538,0.00471660879640084,-0.00577802604615027,0.012711080435741,0.462375875875436
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LHB,Lutropin subunit beta,42346,-0.00630804072400845,0.00859402748501263,-0.0231523345946332,0.0105362531466163,0.462960081649902
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",40182,-0.00374654799488616,0.00510534707421078,-0.0137530282603393,0.00625993227056698,0.463057128877205
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ROBO4,Roundabout homolog 4,40223,-0.00135171587905765,0.00186200219264279,-0.00500124017663753,0.00229780841852222,0.467886346066447
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,42311,0.00485571873341458,0.00671055413770094,-0.00829696737647926,0.0180084048433084,0.469327744393851
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,40182,0.00620787277146216,0.00860027317794402,-0.0106486626573081,0.0230644082002324,0.470418824793611
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HIP1,Huntingtin-interacting protein 1,40116,0.00244757476355645,0.00342192533189607,-0.00425939888695985,0.00915454841407274,0.474462163568283
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPC5,Glypican-5,42495,0.0040693048758618,0.00572105045419821,-0.0071439540143667,0.0152825637660903,0.476919305457956
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",40511,0.00520297850327825,0.00732976589830266,-0.00916336265739497,0.0195693196639515,0.477816507387415
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,40136,-0.00657588701321594,0.00930298418710568,-0.0248097360199431,0.0116579619935112,0.479669898039111
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CAPN3,Calpain-3,40451,-0.00276340597069954,0.0039130224406759,-0.0104329299544243,0.00490611801302523,0.480073694391123
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1S,Complement C1s subcomponent,40539,0.00149649532231809,0.00212420680876954,-0.00266695002287021,0.00565994066750639,0.481138365291674
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,40116,-0.00441435697086109,0.00627705591966459,-0.0167173865734037,0.00788867263168149,0.481913227745242
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",42459,-0.00297297725657197,0.0042314324192368,-0.0112665847982761,0.00532063028513216,0.482321392765257
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,40136,0.00800342515354123,0.0114703709332342,-0.0144785018755978,0.0304853521826802,0.485349805882639
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPT1,Translationally-controlled tumor protein,42370,-0.0046089458303308,0.0066648223531572,-0.0176719976425189,0.00845410598185733,0.489242717876059
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BGLAP,Osteocalcin,40527,-0.00635392126089608,0.00923453172533061,-0.0244536034425441,0.0117457609207519,0.491428442442137
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",40116,-0.00287346813687002,0.00417768929952257,-0.0110617391639343,0.00531480289019422,0.491585286475883
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42737,0.00242658507783636,0.00353965575152038,-0.00451114019514359,0.00936431035081631,0.493013274236684
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MERTK,Tyrosine-protein kinase Mer,42754,0.00178259396529634,0.00260180081436326,-0.00331693563085566,0.00688212356144833,0.493268224859106
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPB41L5,Band 4.1-like protein 5,40182,0.00428992036012753,0.00627070972541832,-0.00800067070169238,0.0165805114219474,0.493913577094228
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,40281,-0.00380710414309651,0.00557580463730618,-0.0147356812322166,0.00712147294602361,0.494753759516829
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRYBB2,Beta-crystallin B2,40483,0.00569365483301116,0.00834415171089354,-0.0106608825203402,0.0220481921863625,0.495029928265789
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,42346,-0.00398579892817022,0.00588199974644958,-0.0155145184312114,0.00754292057487094,0.498020456439929
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,42311,0.00533540050447381,0.00789806002823957,-0.0101447971508758,0.0208155981598234,0.499349075441362
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD276,CD276 antigen,42618,-0.00252367595386372,0.00374592465669755,-0.00986568828099093,0.00481833637326348,0.500505765572044
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CALCB,Calcitonin gene-related peptide 2,40483,-0.00281988007969809,0.0041901269986138,-0.0110325289969811,0.00539276883758496,0.50097251320816
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,42172,0.00456226838523681,0.00680519118059218,-0.00877590632872387,0.0179004430991975,0.502608375354293
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASP4,Caspase-4,40302,-0.01182134513669,0.0176808201301221,-0.0464757525917294,0.0228330623183494,0.50376641374553
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRTG,Protogenin,42721,-0.00169103631422869,0.00253597778072049,-0.00666155276444084,0.00327948013598346,0.504899595135894
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SUMF1,Formylglycine-generating enzyme,40199,0.00437874388467412,0.00656894303373551,-0.00849638446144748,0.0172538722307957,0.505052686656814
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAPPA,Pappalysin-1,42370,-0.00317534407107425,0.00476444988371186,-0.0125136658431495,0.006162977701001,0.505124929076613
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SHD,SH2 domain-containing adapter protein D,40083,-0.00590056976567527,0.00899509947373514,-0.0235309647341961,0.0117298252028456,0.511853398219199
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYH4,Myosin-4,40116,-0.0030388049234042,0.00464416395733772,-0.0121413662797861,0.00606375643297773,0.512914508257528
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATXN2,Ataxin-2,40136,0.00738099835202608,0.0113001644574743,-0.0147673239846236,0.0295293206886758,0.513656422999441
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,40080,-0.00563556088258989,0.00866662723587672,-0.0226221502649083,0.0113510284997285,0.515538023258483
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AFAP1,Actin filament-associated protein 1,40283,-0.00550057101554992,0.00850393135813316,-0.0221682764774909,0.0111671344463911,0.517757409702981
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NOP56,Nucleolar protein 56,40116,0.00741192174633309,0.0114603151846272,-0.0150502960155362,0.0298741395082024,0.517809443287415
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,40116,-0.00457691986534858,0.00712356052827285,-0.0185390985007634,0.0093852587700662,0.520559139185132
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CENPJ,Centromere protein J,40302,0.00464193759595506,0.00725100617806609,-0.00957003451305448,0.0188539097049646,0.522069822368556
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,40482,0.00493861391175549,0.00772140918236673,-0.0101953480856833,0.0200725759091943,0.522445611932183
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL13,Interleukin-13,42370,-0.00306838532040461,0.00484196971519888,-0.0125586459621944,0.0064218753213852,0.526283700480223
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DUOX2,Dual oxidase 2,42357,-0.00460671709754592,0.00731798789274199,-0.0189499733673202,0.00973653917222837,0.52902878426741
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,40199,-0.00268385914845517,0.00426849063356826,-0.011050100790249,0.00568238249333862,0.529518783737555
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAP1A,Ras-related protein Rap-1A,40199,0.00454971340573948,0.00726859694760887,-0.00969673661157391,0.0187961634230529,0.531366571162255
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,40080,-0.0027219947791924,0.00435034841889076,-0.0112486776802183,0.0058046881218335,0.531527598927
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BTLA,B- and T-lymphocyte attenuator,40080,0.00563946387544251,0.00902410499587098,-0.0120477819164646,0.0233267096673496,0.532027922359959
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL36A,Interleukin-36 alpha,40199,-0.00366899300411379,0.00589357132117668,-0.0152203927936201,0.00788240678539251,0.533598732445949
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,42346,-0.00227711405880094,0.0036824823326324,-0.00949477943076044,0.00494055131315856,0.536346211001645
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZNF830,Zinc finger protein 830,40451,0.00486229890456921,0.00793631371100103,-0.0106928759689928,0.0204174737781312,0.540110473529995
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,40080,-0.00412108681168283,0.00676249844044333,-0.0173755837549518,0.00913341013158611,0.542270070482148
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,39633,0.0034056224235017,0.00559048289183762,-0.00755172404450005,0.0143629688915034,0.542416963324887
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,40145,0.002386160930937,0.00392057833738447,-0.00529817261033655,0.0100704944722106,0.542785832654766
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMY2A,Pancreatic alpha-amylase,42114,-0.00302902864502126,0.00498987068691374,-0.0128091751913722,0.00675111790132968,0.543838020712525
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,40223,-0.00229970958487082,0.00379236624810276,-0.00973274743115223,0.00513332826141059,0.54425837727461
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMY2B,Alpha-amylase 2B,41779,-0.00309170338870608,0.0051066018686718,-0.0131006430513028,0.00691723627389064,0.544902494450742
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",40116,0.00370082745397514,0.00614115617667925,-0.00833583865231619,0.0157374935602665,0.546769265100358
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPBGL,Trophoblast glycoprotein-like,40182,-0.00258882174724707,0.00429860453973908,-0.0110140866451357,0.00583644315064152,0.547022152395047
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",42311,-0.00251175802985996,0.00418317336654381,-0.0107107778282858,0.00568726176856591,0.548221273772621
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",42370,0.00691028374381268,0.0116199992791807,-0.0158649148433815,0.0296854823310069,0.552061703147958
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GBP6,Guanylate-binding protein 6,40116,0.0028043797244236,0.00472511212161743,-0.00645684003394655,0.0120655994827938,0.552855237165891
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,42676,-0.00175397049831451,0.00295662938463199,-0.00754896409219322,0.00404102309556419,0.553035096221483
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,40182,0.00182349662015884,0.00307779852960084,-0.0042089884978588,0.00785598173817648,0.553549547334398
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ISM2,Isthmin-2,40527,-0.00261284871953507,0.00442790053475787,-0.0112915337676605,0.00606583632859034,0.555143759277534
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,40182,-0.00221548935634591,0.00377207505643879,-0.00960875646696594,0.00517777775427412,0.556987664983178
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPGN,Epigen,40451,0.00272870286703325,0.00465762572307783,-0.00640024355019929,0.0118576492842658,0.557983327088896
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMIGO2,Amphoterin-induced protein 2,42587,-0.0014017411835802,0.00239317164675258,-0.00609235761121526,0.00328887524405485,0.558069998156792
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FOS,Proto-oncogene c-Fos,40065,0.00213240590124426,0.0036623495837487,-0.00504579928290319,0.0093106110853917,0.560409848620693
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RUVBL1,RuvB-like 1,42346,0.00625548039340961,0.0107827463443623,-0.0148787024415406,0.0273896632283598,0.561831529924829
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BRD1,Bromodomain-containing protein 1,40302,-0.00181595898513594,0.00313058865027074,-0.00795191273966659,0.00431999476939472,0.561879518050173
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,42636,-0.00186983132080128,0.003231077853554,-0.00820274391376713,0.00446308127216456,0.562799940342679
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,42644,0.00289910749660104,0.00502696258862774,-0.00695373917710933,0.0127519541703114,0.564143965231827
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL26,C-C motif chemokine 26,42594,-0.00545864801277896,0.0094810068047692,-0.0240414213501266,0.0131241253245687,0.564796812489778
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,40449,0.00208624917593698,0.00362936541472488,-0.00502730703692379,0.00919980538879775,0.565421295559227
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,40527,-0.001756517332794,0.00307062045917775,-0.00777493343278239,0.00426189876719439,0.567306309094864
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PKD1,Polycystin-1,40511,-0.00156628279396168,0.002743136691036,-0.00694283070839223,0.00381026512046888,0.568022905285127
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHIT1,Chitotriosidase-1,42699,0.00898242494605658,0.0157412777592234,-0.0218704794620213,0.0398353293541344,0.568260849982281
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MORN4,MORN repeat-containing protein 4,40080,0.00449557529322667,0.00787871083515666,-0.0109466979436804,0.0199378485301337,0.56828406811013
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FH,"Fumarate hydratase, mitochondrial",40136,0.00500054365923446,0.00876594835709544,-0.0121807151206726,0.0221818024391415,0.568383587555803
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CORO6,Coronin-6,40136,-0.00216031656566689,0.00381054951162992,-0.00962899360846154,0.00530836047712776,0.570773061583965
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDAN1,Codanin-1,40483,0.0013093888804523,0.00231144611327476,-0.00322104550156624,0.00583982326247084,0.571078525789329
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,40116,0.002828162186209,0.00502712325182078,-0.00702499938735972,0.0126813237597777,0.573732028701936
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRL,Prolactin,42711,0.00426422449318164,0.00762796565083447,-0.0106865881824539,0.0192150371688172,0.576153830636463
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,42357,-0.00176821496079742,0.00317671201287928,-0.0079945705060408,0.00445814058444596,0.577797942699855
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,40199,-0.00232896904022223,0.00420602288933213,-0.0105727739033132,0.00591483582286874,0.579780100446861
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",40482,0.00407869037684708,0.00737766000444664,-0.0103815232318683,0.0185389039855625,0.580381619224125
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,40080,-0.00314664967304727,0.00569289576071582,-0.0143047253640503,0.00801142601795574,0.580457804052419
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HLA_A,,40482,-0.00186268813313918,0.00339453635350489,-0.00851597938600876,0.0047906031197304,0.583200758700638
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",40223,0.00387431393303978,0.0070707116794662,-0.00998428095871397,0.0177329088247935,0.583745339412664
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYL6B,Myosin light chain 6B,40182,0.00509036366156165,0.00930790924708612,-0.0131531384627271,0.0233338657858504,0.584468277905143
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NME1,Nucleoside diphosphate kinase A,40199,0.0012262260460246,0.00225334199999644,-0.00319032427396841,0.00564277636601762,0.586327906322473
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,40223,0.014989079772297,0.0277191767533789,-0.0393405066643255,0.0693186662089196,0.588692448470957
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,40429,-0.00218488441696197,0.00404057611209525,-0.0101044135966687,0.00573464476274472,0.588700374498913
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,40302,-0.00363781155992983,0.00673568306985367,-0.016839750376843,0.00956412725698335,0.589152295989992
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLSPN,Claspin,42292,-0.00192150786424553,0.00358140770853929,-0.00894106697298255,0.00509805124449149,0.59160620714213
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,42594,-0.00315064740157792,0.00587415133099538,-0.0146639840103289,0.00836268920717302,0.591720133588131
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,40483,-0.00206329875243768,0.00385664268107322,-0.00962231840734119,0.00549572090246583,0.592661305907192
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ICAM5,Intercellular adhesion molecule 5,42636,-0.00250040971535367,0.00467950849962239,-0.0116722463746136,0.00667142694390622,0.593120903228305
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENOPH1,Enolase-phosphatase E1,40451,-0.0030061962020787,0.00562764417811437,-0.0140363787911829,0.00802398638702546,0.593224943333815
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,40449,0.00140112033918051,0.00262329010505032,-0.00374052826671811,0.00654276894507914,0.593277335637618
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,40483,0.00216267572160731,0.00407979343165164,-0.0058337194044299,0.0101590708476445,0.596056895243424
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42711,0.00382401088030306,0.00727190388684043,-0.0104289207379042,0.0180769424985103,0.598993392649489
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL3,Interleukin-3,40080,0.00332061766224296,0.00633193309074841,-0.00908997119562394,0.0157312065201098,0.599994347129349
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,40482,0.00127098688387397,0.00242874498250947,-0.00348935328184458,0.00603132704959253,0.600768716052954
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,42587,-0.00209198109698019,0.00400183396371951,-0.00993557566587043,0.00575161347191004,0.601152991289753
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,42448,0.00115932631296071,0.0022258947213866,-0.00320342734095701,0.00552207996687844,0.602489657474099
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF9,Fibroblast growth factor 9,40065,-0.00219630111408197,0.00422330284371285,-0.0104739746877592,0.00608137245959522,0.603043858964761
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,40080,-0.00512088804750184,0.00986533028264966,-0.0244569354014952,0.0142151593064915,0.603716043732034
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD99L2,CD99 antigen-like protein 2,42611,0.00128019320591669,0.0024677447902082,-0.00355658658289138,0.00611697299472477,0.603929345693505
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPM1A,Protein phosphatase 1A,42346,0.00168126528287042,0.00324613005572726,-0.004681149626355,0.00804368019209584,0.604516435721535
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL21R,Interleukin-21 receptor,40199,-0.00296690893377235,0.00572859194437328,-0.014194949144744,0.00826113127719927,0.604529785046775
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",40116,0.0020707654112987,0.00403737805233442,-0.00584249557127676,0.00998402639387416,0.608032649975315
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SUSD4,Sushi domain-containing protein 4,40451,-0.00219922802876009,0.00429593758975244,-0.0106192657046749,0.0062208096471547,0.608708626521408
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFNGR1,Interferon gamma receptor 1,42676,-0.00113776224737134,0.00223573273442439,-0.00551979840684316,0.00324427391210047,0.610831319182811
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,40199,-0.00254429388113428,0.00501170188448299,-0.0123672295747209,0.00727864181245238,0.611694518813183
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MARCO,Macrophage receptor MARCO,42636,0.00134533641163878,0.00267421799037662,-0.00389613084949939,0.00658680367277695,0.614918682289263
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,40136,0.00193390327206309,0.00388500987489934,-0.0056807160827396,0.00954852262686579,0.618644934198303
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GHRL,Appetite-regulating hormone,42636,0.00422876904830488,0.00865320648667364,-0.0127315156655755,0.0211890537621852,0.625066410108942
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,42346,0.00281505649189788,0.00577692792489025,-0.00850772224088702,0.0141378352246828,0.626058835028918
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PVALB,Parvalbumin alpha,42654,0.005442420023824,0.0111779459755861,-0.0164663540883247,0.0273511941359727,0.626344853968234
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,40451,0.00314878080565251,0.00652177332294369,-0.00963389490731712,0.0159314565186221,0.629239665358605
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LCP1,Plastin-2,40527,0.00235434986401185,0.00489823124169875,-0.00724618336971771,0.0119548830977414,0.630772371630159
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,40302,0.00187551449722227,0.00390208408586892,-0.00577257031108081,0.00952359930552535,0.630778786346658
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DHODH,Dihydroorotate dehydrogenase,40116,0.00237968031790727,0.00498100033995788,-0.00738308034841018,0.0121424409842247,0.632836654847584
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCARB1,Scavenger receptor class B member 1,42311,0.00283216129315192,0.00594473625775624,-0.00881952177205032,0.0144838443583542,0.633786713542623
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL25,Interleukin-25,40036,0.00169409457452963,0.00358268432108034,-0.00532796669478783,0.0087161558438471,0.636325278096781
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,40116,-0.00252468605377259,0.00536810440887548,-0.0130461706951685,0.00799679858762335,0.638141232450289
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNLZ,DNL-type zinc finger protein,40136,-0.00438071060226711,0.0093229134348201,-0.0226536209345145,0.0138921997299803,0.638445517040246
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDC25A,M-phase inducer phosphatase 1,40080,0.00187665312966719,0.00399464314024626,-0.00595284742521547,0.00970615368454986,0.638512729574729
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TTN,Titin,40116,-0.0031327100596641,0.00672176032349137,-0.0163073602937072,0.010041940174379,0.641185421203596
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,JCHAIN,Immunoglobulin J chain,42370,-0.00296249362537234,0.00638616229604112,-0.0154793717256129,0.00955438447486824,0.642732336587983
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,42346,0.00597296481210239,0.0129444284705454,-0.0193981149901666,0.0313440446143713,0.644496811058235
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,40302,0.00222977515351351,0.00484612354523491,-0.00726862699514692,0.0117281773021739,0.645442533048052
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK7,Kallikrein-7,40009,0.00184264205572901,0.00401220621055613,-0.00602128211696102,0.00970656622841903,0.646057373299433
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,42689,0.00147289320752045,0.00323039826664254,-0.00485868739509892,0.00780447381013983,0.648434802209411
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BTNL10,Butyrophilin-like protein 10,40080,-0.00199014386758141,0.00437010782066093,-0.0105555551960768,0.00657526746091401,0.648831110187185
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,40223,-0.00183202017862096,0.00409183647330513,-0.00985201966629902,0.0061879793090571,0.654359995287731
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,42698,0.00187859161840989,0.00420915741066694,-0.00637135690649731,0.0101285401433171,0.655380048265762
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GH2,Growth hormone variant,42346,-0.00757177176394311,0.0170206658700869,-0.0409322768693134,0.0257887333414272,0.656430020339825
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL17F,Interleukin-17F,42370,0.00342787796272429,0.00770705917521464,-0.0116779580206964,0.018533713946145,0.656492414506377
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,40080,-0.00230368235235717,0.00518016459603807,-0.0124568049605918,0.00784944025587744,0.656536598632192
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPSD1,Tryptase delta,40482,0.00174517348047881,0.00392956922048689,-0.00595678219167549,0.0094471291526331,0.656969271667963
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UNG,Uracil-DNA glycosylase,40451,0.00152382274222534,0.00349187052499797,-0.00532024348677068,0.00836788897122136,0.662561047966194
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD177,CD177 antigen,42595,-0.00583280943769612,0.0134388648178873,-0.0321729844807552,0.0205073656053629,0.664276942544647
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,40080,-0.00139374502793114,0.00323221456243572,-0.00772888557030515,0.00494139551444286,0.666328318728218
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,40527,0.00621826967138625,0.0145099714249458,-0.0222212743215075,0.03465781366428,0.668257809528809
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TAP1,Antigen peptide transporter 1,40302,-0.00270011217580072,0.00630658735518887,-0.0150610233919709,0.00966079904036947,0.668556358149471
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,40182,-0.00308474749146906,0.00733794041997821,-0.0174671107146263,0.0112976157316882,0.6742136981102
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",40199,-0.00182377182015931,0.00434667415917383,-0.01034325317214,0.00669570953182139,0.674801453689308
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,42721,0.00142516363752769,0.00346029609617417,-0.00535701671097368,0.00820734398602906,0.680447277054355
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SSB,Lupus La protein,42311,0.0024517874741951,0.00595455649874824,-0.00921914326335146,0.0141227182117417,0.680529543937033
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,40182,-0.00176621192322758,0.00430054111636304,-0.0101952725112991,0.00666284866484397,0.681303999190839
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL24,Interleukin-24,42370,-0.00210702860806654,0.0051540039971768,-0.0122088764425331,0.00799481922639998,0.682682863634015
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NMI,N-myc-interactor,40421,-0.00298194296817215,0.00735917037973808,-0.0174059169124588,0.0114420309761145,0.685337513468219
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42662,0.00201623844342089,0.00502810892936175,-0.00783885505812814,0.0118713319449699,0.688431352057017
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYL3,Myosin light chain 3,40223,-0.00298809929483973,0.007504500946841,-0.0176969211506481,0.0117207225609686,0.690509427387677
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,40182,-0.00165220323146734,0.00419432798308652,-0.00987308607831692,0.00656867961538223,0.693652403217805
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,40182,0.00171928840256786,0.00438111203095209,-0.00686769117809823,0.0103062679832339,0.694746683560195
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,40532,0.00108144827493941,0.00276098846451471,-0.00433008911550942,0.00649298566538824,0.695295523306424
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMBN,Ameloblastin,42370,-0.00113941564022539,0.00292144763652921,-0.00686545300782265,0.00458662172737187,0.696529926886601
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,40136,-0.00214723145083212,0.00553205341275087,-0.0129900561398238,0.00869559323815959,0.697917275755659
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PYDC1,Pyrin domain-containing protein 1,40223,0.00168392601168373,0.00437830877110807,-0.00689755917968808,0.0102654112030556,0.700536393328641
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,42311,0.00157019964483653,0.00413083031153872,-0.00652622776577936,0.00966662705545242,0.703864574379419
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HRAS,GTPase Hras,40286,0.00386298426694914,0.0102058561552549,-0.0161404937973504,0.0238664623312487,0.705061509984998
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLHL41,Kelch-like protein 41,40482,-0.0018553885609797,0.00490323456063604,-0.0114657282998263,0.00775495117786694,0.705139886854072
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",40199,-0.00135306645923215,0.0036129640151658,-0.00843447592895711,0.00572834301049281,0.708037218025218
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SOX2,Transcription factor SOX-2,40461,-0.000915476673322205,0.00244880130854921,-0.00571512723807866,0.00388417389143425,0.708525290271715
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,40527,0.00111782619244384,0.00300351577408216,-0.0047690647247572,0.00700471710964488,0.709771324394433
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL4,Interleukin-4,42370,-0.00355186874267484,0.00955166413305433,-0.0222731304434613,0.0151693929581116,0.710004087860355
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,40302,0.00252945207010095,0.0068614304310256,-0.0109189515747092,0.0159778557149111,0.712397196479487
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IKZF2,Zinc finger protein Helios,42346,-0.00328131487775565,0.00897523822573673,-0.0208727818001996,0.0143101520446883,0.714672133599671
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CYTH3,Cytohesin-3,40080,0.00278648768680563,0.00765378115610578,-0.0122149233791617,0.017787898752773,0.715815191326408
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TERF1,Telomeric repeat-binding factor 1,40199,-0.00109739555313341,0.00302721869451159,-0.00703074419437612,0.0048359530881093,0.716978282542571
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SOX9,Transcription factor SOX-9,40182,0.00101526947774541,0.00283371971053355,-0.00453882115490034,0.00656936011039117,0.720139509811172
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,40116,-0.00209396268804931,0.00586906522647078,-0.013597330531932,0.00940940515583343,0.721263708855543
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BSND,Barttin,40080,0.00124774294345575,0.0034983226845676,-0.00560896951829674,0.00810445540520825,0.721346594717942
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCARE,Photoreceptor cilium actin regulator,40136,-0.00306772338402107,0.00860822854863299,-0.0199398513393417,0.0138044045712996,0.72156958338504
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KDM3A,Lysine-specific demethylase 3A,40199,0.00319483072108954,0.00897137097587931,-0.0143890563916339,0.020778717833813,0.721762026381691
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,40302,0.00159780570261834,0.00449274897209063,-0.0072079822826793,0.010403593687916,0.722116193850992
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZPR1,Zinc finger protein ZPR1,40136,-0.00354364764629551,0.00998461467748351,-0.0231134924141632,0.0160261971215722,0.722663252721963
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEP152,Centrosomal protein of 152 kDa,40080,0.00151350985997625,0.00427051763751265,-0.00685670470954855,0.00988372442950105,0.723039259877424
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,40302,0.00190235166756997,0.0053805990481195,-0.00864362246674425,0.0124483258018842,0.723677167056355
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MUCL3,Mucin-like protein 3,40080,0.00153545693650907,0.00436219651740867,-0.00701444823761192,0.0100853621106301,0.724851305861014
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ICOSLG,ICOS ligand,42587,0.000694725328928795,0.00197445209226429,-0.00317520077190922,0.00456465142976681,0.724950839506427
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",40199,0.00102047186880747,0.00291097349710992,-0.00468503618552797,0.00672597992314292,0.725924921641879
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,40302,0.00226463970121976,0.00648723275202431,-0.0104503364927479,0.0149796158951874,0.727027016008428
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42570,-0.00651486442745343,0.0186912445476359,-0.0431497037408198,0.0301199748859129,0.727431405164672
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,40532,-0.00134086634539771,0.00386792441457273,-0.00892199819796026,0.00624026550716485,0.728850931010489
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK10,Kallikrein-10,42636,0.00141564727645254,0.0041387178272175,-0.00669623966489376,0.00952753421779885,0.732318822255919
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPR158,Probable G-protein coupled receptor 158,40482,-0.00125430941920503,0.003685127449259,-0.00847715921975266,0.0059685403813426,0.733583712621816
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYH7B,Myosin-7B,40080,0.00154700892207279,0.00459631268304458,-0.00746176393669459,0.0105557817808402,0.736442975575748
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,40136,-0.00244066527505008,0.00729171577105133,-0.0167324281863107,0.0118510976362105,0.737844573310465
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,METAP1,Methionine aminopeptidase 1,42311,0.000997134636246277,0.00298492005381072,-0.00485330866922273,0.00684757794171529,0.738341584576542
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEPTIN7,Septin-7,40302,0.00179948897407174,0.00556924660217238,-0.00911623436618613,0.0127152123143296,0.746616699634215
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,40080,-0.00208076714944284,0.00648913002438576,-0.0147994619972389,0.0106379276983533,0.748478572647518
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C7,Complement component C7,40251,0.0010774297197914,0.00336656503712747,-0.00552103775297843,0.00767589719256124,0.748945351191202
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK15,Kallikrein-15,40429,-0.00174660678040633,0.00546322054532059,-0.0124545190492347,0.00896130548842203,0.749199598882558
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BLMH,Bleomycin hydrolase,42794,0.00101179118114028,0.00318626895274156,-0.00523329596623317,0.00725687832851373,0.750833211235581
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEPTIN3,Neuronal-specific septin-3,40482,0.00242349898963603,0.00766468624273348,-0.0125992860461216,0.0174462840253936,0.75186396097453
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPHS1,Nephrin,40199,-0.00108405602410602,0.00343920627870387,-0.0078249003303656,0.00565678828215356,0.752611763155996
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,40449,-0.00178988249658573,0.0056924594800634,-0.01294710307751,0.00936733808433853,0.753199973657454
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TEF,Thyrotroph embryonic factor,40116,0.00139525898781271,0.00444890081968711,-0.00732458661877402,0.0101151045943994,0.753816559409858
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42794,-0.00220459247922668,0.00716644660357601,-0.0162508278222357,0.0118416428637823,0.758370882443473
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,40065,-0.00162135267259078,0.00533399627521901,-0.01207598537202,0.00883328002683848,0.761159731851206
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,42760,0.00141771278032913,0.00466939825836688,-0.00773430780606996,0.0105697333667282,0.761423687399051
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",40482,-0.00114639012001621,0.00379798672494065,-0.00859044410089988,0.00629766386086746,0.762778431533531
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",40136,0.00175390050864232,0.00583285639948408,-0.00967849803434648,0.0131862990516311,0.76365413447863
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,40482,0.000823542399503402,0.0027808361397897,-0.00462689643448442,0.00627398123349122,0.767121589642093
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,42565,0.000786643133587115,0.00266564800242054,-0.00443802695115714,0.00601131321833137,0.767919088951707
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,40449,0.00132253360146301,0.00449163401795784,-0.00748106907373435,0.0101261362766604,0.76842426388891
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,40532,0.000847256193896899,0.00292314144794963,-0.00488210104408438,0.00657661343187818,0.771940575171166
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,40302,0.00188159809861503,0.00651453899691283,-0.0108868983353341,0.0146500945325642,0.77271641665181
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TP73,Tumor protein p73,40182,-0.00101550943253388,0.00353785482939281,-0.00794970489814379,0.00591868603307603,0.774086329890702
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42611,-0.00103975085319688,0.00362442866154581,-0.00814363102982667,0.0060641293234329,0.77421396723458
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,40080,-0.00166726275720033,0.00590948176455302,-0.0132498470157242,0.00991532150132359,0.777846512382607
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMOD4,Tropomodulin-4,40080,-0.00117261889983462,0.00422739053894463,-0.0094583043561661,0.00711306655649686,0.78148900703934
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHP1,Calcineurin B homologous protein 1,40136,-0.00209654699618642,0.00759046282215672,-0.0169738541276136,0.0127807601352408,0.782393484911053
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FOSB,Protein fosB,42311,0.00108009293989942,0.00391946104651651,-0.00660205071127294,0.00876223659107177,0.782881311605967
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,40110,-0.000965528867200234,0.00351838032765246,-0.00786155430939905,0.00593049657499858,0.783763805579689
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,40136,-0.00157380770306234,0.00575457075228813,-0.0128527663775471,0.00970515097142239,0.784483055946237
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,42370,-0.00109236102273258,0.00400336126381223,-0.00893894909980455,0.00675422705433939,0.784964368851112
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TXK,Tyrosine-protein kinase TXK,40302,0.00206670457211262,0.00768028357648697,-0.0129866512378018,0.0171200603820271,0.787863713595855
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,42346,0.00123710419803479,0.00459975434464178,-0.0077784143174631,0.0102526227135327,0.78797233358173
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,40182,-0.00216006657270337,0.00804069937127136,-0.0179198373403952,0.0135997041949885,0.788210517976359
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STEAP4,Metalloreductase STEAP4,40136,-0.00200247892940916,0.00745776266109738,-0.01661969374516,0.0126147358863417,0.788312348466957
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FZD8,Frizzled-8,40136,0.00125788282123313,0.00468579672783089,-0.00792627876531542,0.0104420444077817,0.788361189334461
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,42346,-0.00144577942611739,0.0053986290672719,-0.0120270923979703,0.00913553354573552,0.78885368293335
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,40511,0.000904658054333593,0.00340219805234665,-0.00576365012826583,0.00757296623693302,0.790317991951852
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENAH,Protein enabled homolog,42370,-0.0012454182153017,0.00480655514704374,-0.0106662663035074,0.00817542987290403,0.795555747622164
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF3,Fibroblast growth factor 3,40199,-0.000771632799850505,0.0029787547241464,-0.00660999205917744,0.00506672645947643,0.795605033059115
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB6B,Ras-related protein Rab-6B,42311,-0.00129885211412378,0.00503783925053004,-0.0111730170451627,0.00857531281691509,0.796550424712086
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,40302,0.00106491230257939,0.00414769258278606,-0.00706456515968129,0.00919438976484007,0.797377971503909
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",40080,0.00242278394654083,0.0094678640056521,-0.0161342295045373,0.020979797397619,0.798036351976021
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACTN4,Alpha-actinin-4,42370,-0.000835814654793631,0.00333866152330927,-0.00737959124047981,0.00570796193089255,0.802325056246707
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NEB,Nebulin,40116,-0.000980890653080488,0.00393279748806266,-0.00868917372968331,0.00672739242352233,0.803046053308175
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",40223,0.00216336623205376,0.00867501085665881,-0.0148396550469975,0.019166387511105,0.80307220935356
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HK2,Hexokinase-2,42357,-0.000701709462850497,0.00282419482929207,-0.00623713132826294,0.00483371240256195,0.803779647771274
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,40116,-0.00122908737564088,0.00498009084911645,-0.0109900654399091,0.00853189068862735,0.80506750064069
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F11,Coagulation factor XI,40383,-0.000753973656956084,0.00307698870220851,-0.00678487151328476,0.00527692419937259,0.806432886153641
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FRZB,Secreted frizzled-related protein 3,42454,-0.00062063997025618,0.00253418613607765,-0.00558764479696837,0.00434636485645601,0.806532217095793
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PFDN6,Prefoldin subunit 6,40182,0.00162237236942766,0.00662946566871938,-0.0113713803412623,0.0146161250801177,0.806676697469889
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SDC4,Syndecan-4,42636,-0.0011716607068122,0.00480108367248929,-0.0105817847048912,0.00823846329126681,0.807202880070227
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",40136,-0.00136563717687916,0.00562134975282586,-0.0123834826924178,0.00965220833865952,0.808058296625727
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNM1,Dynamin-1,40449,0.00273148470363651,0.0116174538529501,-0.0200387248481457,0.0255016942554187,0.814120611398092
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAM171B,Protein FAM171B,40451,-0.000625954007642748,0.00270339611999594,-0.0059246104028348,0.0046727023875493,0.816896743984453
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,40136,-0.00118744968637001,0.00515118463003023,-0.0112837715612293,0.00890887218848924,0.817692244071453
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGFL4,Insulin growth factor-like family member 4,40199,0.00173205446260167,0.00753616129943814,-0.0130388216842971,0.0165029306095004,0.818226234757387
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNPY2,Protein canopy homolog 2,42357,0.00141788325104811,0.00631186302155818,-0.0109533682712059,0.0137891347733022,0.822264514871283
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FRMD7,FERM domain-containing protein 7,40182,-0.000762730037176028,0.00342511820322591,-0.0074759617154988,0.00595050164114675,0.823783090766918
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,42346,0.00278690937196036,0.0125265649553277,-0.0217651579404819,0.0273389766844026,0.823943745188941
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,42570,0.00195755393644375,0.00879974259516339,-0.0152899415500765,0.019205049422964,0.823962460194166
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HDAC8,Histone deacetylase 8,40199,0.00133923406640138,0.00605094992015694,-0.0105206277771062,0.013199095909909,0.824842517006184
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,40080,-0.00105806978616973,0.00488748315637362,-0.010637536772662,0.00852139720032256,0.828613295082082
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INSR,Insulin receptor,40199,0.000364440359277969,0.00177712198016687,-0.00311871872184911,0.00384759944040504,0.837518609647232
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MTPN,Myotrophin,42357,0.000695922235969025,0.00339595582241613,-0.00596015117596659,0.00735199564790465,0.837632513210794
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRKCQ,Protein kinase C theta type,42370,-0.000900495899448499,0.00446699640750979,-0.00965580885816769,0.00785481705927069,0.840241409291251
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",40116,-0.00180919408778202,0.00901101435975001,-0.019470782232892,0.015852394057328,0.840877584014915
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",42311,0.000999981482679494,0.00519238795881822,-0.00917709891660422,0.0111770618819632,0.847286153009746
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,40136,-0.00145167156492736,0.00761629068388916,-0.0163796013053501,0.0134762581754954,0.848841851272938
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DBH,Dopamine beta-hydroxylase,40515,0.00211727554896164,0.0112395612332997,-0.0199122644683058,0.0241468155662291,0.850584454302212
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF6,Fibroblast growth factor 6,40199,-0.000793514290765458,0.00424590471186975,-0.00911548752603017,0.00752845894449925,0.85175084955398
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLI2,Zinc finger protein GLI2,40199,-0.000608714070354698,0.0032855438657733,-0.00704838004727036,0.00583095190656097,0.853020357182746
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,40223,-0.00103167119488307,0.00569419615764886,-0.0121922956638748,0.0101289532741087,0.856230071786908
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DLL4,Delta-like protein 4,40223,0.00156914844472432,0.0087709381283695,-0.0156218902868799,0.0187601871763285,0.858017036847034
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNAP25,Synaptosomal-associated protein 25,40136,0.000852658066565329,0.0048415367267793,-0.00863675391792211,0.0103420700510528,0.860208344555871
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42711,-0.000852550227985639,0.00485363060407933,-0.0103656662119811,0.00866056575600985,0.86056992907805
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSC1,Hamartin,40199,0.00131262015283154,0.00751393984963901,-0.0134147019524609,0.016039942258124,0.861325393497225
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,40177,0.000667055847913163,0.00389165842192684,-0.00696059465906345,0.00829470635488978,0.863907241573582
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,40302,-0.000741027053089551,0.00444528154325717,-0.0094537788778736,0.0079717247716945,0.867609384041634
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SHH,Sonic hedgehog protein,40199,-0.00071582296253354,0.00432463107363867,-0.00919209986686532,0.00776045394179824,0.868535924790277
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PITHD1,PITH domain-containing protein 1,40065,-0.00135616587311261,0.00827479758546026,-0.0175747691406147,0.0148624373943895,0.869819901795619
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,40182,0.00085621433524198,0.00530101384575768,-0.00953377280244307,0.011246201472927,0.871687635446573
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,40116,0.000973963856745494,0.00606314359456185,-0.0109097975885957,0.0128577253020867,0.872382456555638
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41948,-0.000477513728448374,0.00300164151322604,-0.00636073109437141,0.00540570363747466,0.873605057909308
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MILR1,Allergin-1,42370,-0.000818095063568537,0.00525018639382397,-0.0111084603954635,0.00947227026832643,0.876175638066534
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPSG1,Tryptase gamma,40199,-0.000416695832848814,0.00272195209658054,-0.00575172194214667,0.00491833027644905,0.878332372179212
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,40116,-0.000731852204350775,0.00487312632487116,-0.0102831798010982,0.0088194753923967,0.880624391383671
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUP50,Nuclear pore complex protein Nup50,40116,-0.000533702521429022,0.00355533076504985,-0.00750215082092672,0.00643474577806867,0.880677979436999
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BRK1,Protein BRICK1,42311,0.000687987730887503,0.00459098332522937,-0.00831033958656206,0.00968631504833706,0.880880301345107
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,40136,-0.0007600334257541,0.00511418091366966,-0.0107838280165466,0.00926376116503844,0.881861805827491
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SHPK,Sedoheptulokinase,40302,0.000624387473502539,0.00420408711311815,-0.00761562326820904,0.00886439821521411,0.881935764526444
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BEX3,Protein BEX3,40080,-0.000715138418308626,0.00489890710611091,-0.010316996346286,0.00888671950966876,0.883940531042172
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCNA,Proliferating cell nuclear antigen,40080,-0.000924120103679037,0.0064089464159365,-0.0134856550789146,0.0116374148715565,0.885351366715991
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLPS,Colipase,42590,0.00104289455070005,0.00742635073593869,-0.0135127528917398,0.0155985419931399,0.888321078442811
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,42594,-0.000593228371224333,0.00425831349649974,-0.00893952282436383,0.00775306608191516,0.889206777295582
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,40136,-0.00061310629741747,0.0044283543296385,-0.00929268078350893,0.00806646818867399,0.889887216622529
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,42311,0.000932731726180392,0.006835347872191,-0.012464550103314,0.0143300135556748,0.891462033176529
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,42443,0.000425960506506238,0.00312243755895495,-0.00569401710904546,0.00654593812205794,0.891491950460507
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",40223,0.000462152196393374,0.00342692601200064,-0.00625462278712789,0.00717892717991464,0.892725729536825
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCIN,Adseverin,40136,0.00100294890200992,0.00746776617656925,-0.0136338728040658,0.0156397706080856,0.89316486868076
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DEFB118,Beta-defensin 118,40136,0.000783524995882329,0.00583902498365685,-0.0106609639720851,0.0122280139638497,0.893256665471664
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FOLR3,Folate receptor gamma,42629,-0.00252445474976501,0.0189240907531586,-0.0396156726259558,0.0345667631264258,0.893879835549519
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,40302,0.00108074110645725,0.00817853867555964,-0.0149491946976396,0.0171106769105541,0.894873146084644
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,40199,0.000809510997620679,0.0062971803918206,-0.0115329625703477,0.0131519845655891,0.897715018300403
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,42475,-0.000528863983514311,0.00412702179888781,-0.00861782670933441,0.00756009874230579,0.898034865864173
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FABP9,Fatty acid-binding protein 9,42594,0.000728466260998514,0.00577789680057428,-0.0105962114681271,0.0120531439901241,0.899671992877582
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,40116,-0.000604978978728033,0.00491890757826835,-0.010246037832134,0.00903607987467793,0.902116871458565
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RASA1,Ras GTPase-activating protein 1,42311,-0.000406962660743804,0.00331150301902675,-0.00689750857803624,0.00608358325654863,0.902193204576127
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,40136,-0.000715902077227846,0.00598818085622847,-0.0124527365554356,0.01102093240098,0.90483983276425
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,40080,0.000693180972872451,0.00588254521283383,-0.0108366076442819,0.0122229695900268,0.906199054361616
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,40136,0.000603732293353129,0.00528276250873747,-0.00975048222377231,0.0109579468104786,0.909015203097448
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP1B4,Protein ATP1B4,40080,0.000493527094968485,0.00433242861954066,-0.00799803299933121,0.00898508718926818,0.909307551926347
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,40080,0.000297274261876544,0.00267912864832405,-0.0049538178888386,0.00554836641259169,0.911650660178033
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEP350,Centrosome-associated protein 350,40080,0.000427793841000672,0.00389550921339764,-0.0072074042172587,0.00806299189926004,0.912556389113886
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NXPE4,NXPE family member 4,40116,0.000378394332122347,0.00345257333915866,-0.00638864941262863,0.00714543807687332,0.912730394306643
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OSTN,Osteocrin,40182,-0.000460219637238248,0.00428101571037728,-0.00885101042957772,0.00793057115510122,0.914392351909788
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLINT1,Clathrin interactor 1,40080,-0.000494653566451396,0.00473338830821138,-0.0097720946505457,0.00878278751764291,0.916772064590333
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,42370,-0.000314164831169887,0.00303436678131776,-0.00626152372255269,0.00563319406021291,0.917539512648209
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,40080,-0.000351980661094628,0.0035444336328049,-0.00729907058139222,0.00659510925920297,0.920897784994497
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,40199,-0.000497375537323078,0.00501307260303538,-0.0103229978392724,0.00932824676462627,0.920968811936517
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HBZ,Hemoglobin subunit zeta,40511,-0.00107739943971774,0.0108760938518205,-0.022394543389286,0.0202397445098505,0.921091394147394
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F2,Prothrombin,40539,0.000147724770522421,0.00151922040609759,-0.00282994722542885,0.0031253967664737,0.922539727582015
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,42311,-0.000440491440692097,0.00466218548926083,-0.00957837499964333,0.00869739211825914,0.924727922663677
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",40059,0.00024745525899644,0.00271347166376652,-0.00507094920198593,0.00556585971997881,0.927339267302128
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,40182,0.000511111864933272,0.00572554233074994,-0.0107109511033366,0.0117331748332031,0.928869975432641
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYO6,Unconventional myosin-VI,40482,0.00032351616963601,0.00371928097633518,-0.00696627454398093,0.00761330688325295,0.93068615050215
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FOLR2,Folate receptor beta,42711,0.000261276181264399,0.00301655031512177,-0.00565116243637428,0.00617371479890308,0.930979437837849
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GUK1,Guanylate kinase,40116,-0.00032879423611843,0.0039349244756237,-0.00804124620834089,0.00738365773610403,0.933409429590606
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITM2A,Integral membrane protein 2A,42594,-0.000492946800755762,0.00628126401814762,-0.0128042242763251,0.0118183306748136,0.937448271679886
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ESR1,Estrogen receptor,40199,0.000399486961798345,0.00566231556019082,-0.0106986515361757,0.0114976254597724,0.943755697546147
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,40451,-0.000530202867344452,0.00784273822234117,-0.0159019697831331,0.0148415640484442,0.946101828940006
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COPE,Coatomer subunit epsilon,42311,-0.000324092105135701,0.00485019462877119,-0.00983047357752723,0.00918228936725582,0.946725674990162
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],42370,0.00038591823206476,0.00579419212522119,-0.0109706983333688,0.0117425347974983,0.946897716291602
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,40116,0.000247707601883829,0.00387175826718816,-0.00734093860180496,0.00783635380557262,0.94898886347126
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ECM1,Extracellular matrix protein 1,40269,0.000242459957918696,0.00382021657211222,-0.00724516452342126,0.00773008443925865,0.949395308100269
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGA2,Integrin alpha-2,40283,0.000224570605210936,0.00357017534685501,-0.00677297307462488,0.00722211428504675,0.949845801839695
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PGR,Progesterone receptor,40199,0.000553379806505625,0.0100134771659635,-0.0190730354387828,0.0201797950517941,0.955929542794397
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RTKN2,Rhotekin-2,40116,0.000287339382155848,0.00528510134469934,-0.0100714592534549,0.0106461380177665,0.956643119732578
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,42357,0.000186286455047841,0.0035920685709243,-0.00685416794396379,0.00722674085405948,0.958640639056876
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAPT,Microtubule-associated protein tau,42311,0.0002662814290152,0.00544250556777797,-0.0104010294838296,0.01093359234186,0.960978808340139
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THPO,Thrombopoietin,42357,-0.000188666728992196,0.00397917437950821,-0.00798784851282829,0.0076105150548439,0.962184360026251
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBM19,Probable RNA-binding protein 19,40116,-0.000214821200788915,0.00494505698127289,-0.00990713288408378,0.00947749048250595,0.965350308937725
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZNF174,Zinc finger protein 174,40199,-0.000147794505334197,0.00383266570291991,-0.00765981928305723,0.00736423027238883,0.969240454729097
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GAGE2A,G antigen 2A,40080,-0.000251309582387375,0.00683098442419213,-0.013640039053804,0.0131374198890292,0.970653394567602
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",40080,-0.000191472745350467,0.00527760295469035,-0.0105355745365436,0.0101526290458426,0.971059564400623
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,40449,-0.000639904528121774,0.0179109022212857,-0.0357452728818418,0.0344654638255983,0.971500598217133
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,40302,-0.000127480086371994,0.0037710487213734,-0.00751873558026386,0.00726377540751987,0.973033301794584
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BRD2,Bromodomain-containing protein 2,40136,-0.000122859141109968,0.00366220305512675,-0.00730077712915839,0.00705505884693846,0.973238298128788
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,40116,-0.000121220597885438,0.00386468849888393,-0.00769601005569794,0.00745356885992707,0.97497806836363
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OMP,Olfactory marker protein,40136,0.000140645650857467,0.00515365440162566,-0.00996051697632882,0.0102418082780438,0.978228555555402
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARTN,Artemin,42370,0.000108915715545357,0.00455902698993959,-0.00882677718473623,0.00904460861582695,0.980940614512653
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LMNB1,Lamin-B1,40434,0.000137484366876547,0.00610755325633078,-0.0118333200155318,0.0121082887492849,0.982041098131196
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NEO1,Neogenin,40482,-4.87639293656586e-05,0.00227339831499254,-0.00450462462675103,0.00440709676801972,0.982887230600575
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",40223,0.000165108440548421,0.00780208451667168,-0.0151269772121281,0.0154571940932249,0.983116735482978
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TLR2,Toll-like receptor 2,40302,4.98656379600625e-05,0.00239694009231527,-0.00464813694297787,0.00474786821889799,0.983402481632205
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,40182,0.00015156494264401,0.00729368629560747,-0.0141440601967466,0.0144471900820346,0.983421295088056
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,42357,7.4084939242969e-05,0.00363491776117922,-0.0070503538726683,0.00719852375115424,0.983739380656933
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,40136,0.000115866851170039,0.0059433120715297,-0.0115330248090282,0.0117647585113683,0.984446315092793
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLAMF7,SLAM family member 7,42594,8.64996687804042e-05,0.0060527771030594,-0.011776943453216,0.0119499427907768,0.988598107584195
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,40116,-0.000132641908687491,0.00979626690019949,-0.0193333250330785,0.0190680412157035,0.989197183398236
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,40116,-4.22318753581348e-05,0.00347600093064706,-0.00685519369942638,0.00677072994871011,0.990306515538427
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,40136,7.01556255415646e-05,0.0064109200549543,-0.0124952476821689,0.012635558933252,0.99126900759765
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EXTL1,Exostosin-like 1,40116,4.99024483340307e-05,0.00484749151336347,-0.00945118091785838,0.00955098581452644,0.991786519215562
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,40199,-5.74963936970703e-05,0.00561225741950415,-0.0110575209359252,0.0109425281485311,0.991826169624749
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,40302,-8.12537210175932e-05,0.00824765610354008,-0.0162466596839562,0.016084152241921,0.992139756940439
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,40302,5.58295084500792e-05,0.00644158597676629,-0.0125696790060119,0.012681338022912,0.993084941701728
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,42346,3.0529142249055e-05,0.00492779832788552,-0.00962795558040656,0.00968901386490467,0.995056998930122
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCLRE1C,Protein artemis,40080,8.60730435102068e-06,0.0032022122348899,-0.00626772867603318,0.00628494328473522,0.997855398467538
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,40136,-1.69063555951478e-05,0.00633118420814492,-0.0124260274035592,0.0123922146923689,0.997869435569087
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42794,-3.8173681716864e-06,0.00279575735966124,-0.00548350179310771,0.00547586705676434,0.998910577063747
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA11,Carbonic anhydrase-related protein 11,42346,4.24150175903861e-06,0.00331348930120695,-0.00649019752860658,0.00649868053212466,0.998978670758317
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,40136,3.36296758425878e-06,0.00551483125858931,-0.0108057062992508,0.0108124322344193,0.999513457744017
